0001493152-21-028718.txt : 20211115 0001493152-21-028718.hdr.sgml : 20211115 20211115170226 ACCESSION NUMBER: 0001493152-21-028718 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 68 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211115 DATE AS OF CHANGE: 20211115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNIQ Corp. CENTRAL INDEX KEY: 0000278165 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 020314487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40768 FILM NUMBER: 211412105 BUSINESS ADDRESS: STREET 1: 1865 WEST 2100 SOUTH CITY: SALT LAKE CITY STATE: UT ZIP: 84119 BUSINESS PHONE: 800-242-7272 MAIL ADDRESS: STREET 1: 1865 WEST 2100 SOUTH CITY: SALT LAKE CITY STATE: UT ZIP: 84119 FORMER COMPANY: FORMER CONFORMED NAME: Quest Solution, Inc. DATE OF NAME CHANGE: 20140813 FORMER COMPANY: FORMER CONFORMED NAME: AMERIGO ENERGY, INC. DATE OF NAME CHANGE: 20081112 FORMER COMPANY: FORMER CONFORMED NAME: STRATEGIC GAMING INVESTMENTS, INC. DATE OF NAME CHANGE: 20060501 10-Q 1 form10-q.htm
0000278165 false --12-31 Q3 P5Y five years 0000278165 2021-01-01 2021-09-30 0000278165 2021-11-15 0000278165 2021-09-30 0000278165 2020-12-31 0000278165 us-gaap:TradeNamesMember 2021-09-30 0000278165 us-gaap:TradeNamesMember 2020-12-31 0000278165 us-gaap:CustomerRelationshipsMember 2021-09-30 0000278165 us-gaap:CustomerRelationshipsMember 2020-12-31 0000278165 us-gaap:OtherIntangibleAssetsMember 2021-09-30 0000278165 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0000278165 us-gaap:SeriesAPreferredStockMember 2021-09-30 0000278165 us-gaap:SeriesAPreferredStockMember 2020-12-31 0000278165 us-gaap:SeriesBPreferredStockMember 2021-09-30 0000278165 us-gaap:SeriesBPreferredStockMember 2020-12-31 0000278165 us-gaap:SeriesCPreferredStockMember 2021-09-30 0000278165 us-gaap:SeriesCPreferredStockMember 2020-12-31 0000278165 2021-07-01 2021-09-30 0000278165 2020-07-01 2020-09-30 0000278165 2020-01-01 2020-09-30 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2019-12-31 0000278165 us-gaap:CommonStockMember 2019-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000278165 us-gaap:TreasuryStockMember 2019-12-31 0000278165 us-gaap:RetainedEarningsMember 2019-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000278165 2019-12-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-01-01 2020-03-31 0000278165 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000278165 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0000278165 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000278165 2020-01-01 2020-03-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-03-31 0000278165 us-gaap:CommonStockMember 2020-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000278165 us-gaap:TreasuryStockMember 2020-03-31 0000278165 us-gaap:RetainedEarningsMember 2020-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000278165 2020-03-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-04-01 2020-06-30 0000278165 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0000278165 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0000278165 us-gaap:TreasuryStockMember 2020-04-01 2020-06-30 0000278165 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0000278165 2020-04-01 2020-06-30 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-06-30 0000278165 us-gaap:CommonStockMember 2020-06-30 0000278165 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000278165 us-gaap:TreasuryStockMember 2020-06-30 0000278165 us-gaap:RetainedEarningsMember 2020-06-30 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000278165 2020-06-30 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0000278165 us-gaap:CommonStockMember 2020-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000278165 us-gaap:TreasuryStockMember 2020-12-31 0000278165 us-gaap:RetainedEarningsMember 2020-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0000278165 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000278165 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0000278165 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0000278165 2021-01-01 2021-03-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-03-31 0000278165 us-gaap:CommonStockMember 2021-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000278165 us-gaap:TreasuryStockMember 2021-03-31 0000278165 us-gaap:RetainedEarningsMember 2021-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000278165 2021-03-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0000278165 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000278165 us-gaap:TreasuryStockMember 2021-04-01 2021-06-30 0000278165 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0000278165 2021-04-01 2021-06-30 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-06-30 0000278165 us-gaap:CommonStockMember 2021-06-30 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000278165 us-gaap:TreasuryStockMember 2021-06-30 0000278165 us-gaap:RetainedEarningsMember 2021-06-30 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0000278165 2021-06-30 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0000278165 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0000278165 us-gaap:TreasuryStockMember 2021-07-01 2021-09-30 0000278165 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-09-30 0000278165 us-gaap:CommonStockMember 2021-09-30 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000278165 us-gaap:TreasuryStockMember 2021-09-30 0000278165 us-gaap:RetainedEarningsMember 2021-09-30 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0000278165 2020-09-30 0000278165 2020-01-01 2020-12-31 0000278165 srt:MinimumMember 2021-01-01 2021-09-30 0000278165 srt:MaximumMember 2021-01-01 2021-09-30 0000278165 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0000278165 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0000278165 us-gaap:ConvertiblePreferredStockMember 2021-01-01 2021-09-30 0000278165 us-gaap:ConvertiblePreferredStockMember 2020-01-01 2020-12-31 0000278165 us-gaap:WarrantMember 2021-01-01 2021-09-30 0000278165 us-gaap:WarrantMember 2020-01-01 2020-12-31 0000278165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OMQS:TwoCustomersMember 2021-01-01 2021-09-30 0000278165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OMQS:TwoCustomersMember 2020-01-01 2020-12-31 0000278165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember OMQS:FourCustomersMember 2021-01-01 2021-09-30 0000278165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember OMQS:OneCustomersMember 2020-01-01 2020-12-31 0000278165 us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember OMQS:OneVendorMember 2021-01-01 2021-09-30 0000278165 us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember OMQS:OneVendorMember 2020-01-01 2020-12-31 0000278165 OMQS:AssetPurchaseAgreementMember OMQS:EyepaxITConsultingLLCMember 2020-02-01 2020-02-28 0000278165 OMQS:EmploymentAgreementMember OMQS:MrCalderaMember 2020-02-01 2020-02-28 0000278165 OMQS:DefinitiveAcquisitionAgreementMember OMQS:DangotComputersLtdMember 2021-05-03 0000278165 OMQS:OmniqTechnologiesMember 2021-05-02 2021-05-03 0000278165 OMQS:DefinitiveAcquisitionAgreementMember OMQS:OmniqTechnologiesMember 2021-07-07 2021-07-08 0000278165 OMQS:SecuritiesPurchaseAgreementMember 2021-07-07 2021-07-08 0000278165 OMQS:DefinitiveAcquisitionAgreementMember 2021-07-06 2021-07-08 0000278165 OMQS:DefinitiveAcquisitionAgreementMember 2021-07-08 0000278165 OMQS:HaimDagotMember 2021-05-02 2021-05-03 0000278165 OMQS:DefinitiveAcquisitionAgreementMember 2021-05-03 0000278165 OMQS:DefinitiveAcquisitionAgreementMember OMQS:HaimDangotMember 2021-07-07 2021-07-08 0000278165 OMQS:AssetPurchaseAgreementMember OMQS:HaimDangotMember 2020-02-01 2020-02-28 0000278165 OMQS:DefinitiveAcquisitionAgreementMember OMQS:HaimDangotMember 2021-05-03 0000278165 OMQS:DangotSharesMember 2021-05-02 2021-05-03 0000278165 OMQS:DangotSharesMember 2021-05-03 0000278165 OMQS:FactoringAndSecurityAgreementMember OMQS:ActionCapitalCorporationMember 2016-07-31 0000278165 OMQS:FactoringAndSecurityAgreementMember OMQS:ActionCapitalCorporationMember 2016-07-01 2016-07-31 0000278165 OMQS:FactoringAndSecurityAgreementMember OMQS:ActionCapitalCorporationMember us-gaap:PrimeRateMember 2016-07-01 2016-07-31 0000278165 OMQS:NotePayableMarinMember 2021-09-30 0000278165 OMQS:NotePayableMarinMember 2020-12-31 0000278165 OMQS:NotePayableThometMember 2021-09-30 0000278165 OMQS:NotePayableThometMember 2020-12-31 0000278165 OMQS:NotePayableShareholderConvertibleNoteMember 2021-09-30 0000278165 OMQS:NotePayableShareholderConvertibleNoteMember 2020-12-31 0000278165 OMQS:MarinNoteMember 2017-12-31 0000278165 OMQS:MarinNoteMember 2018-10-01 2018-10-31 0000278165 OMQS:ThometNoteMember 2017-12-31 0000278165 OMQS:ThometNoteMember 2018-10-01 2018-10-31 0000278165 OMQS:ShareholderConvertibleNoteMember 2018-10-31 0000278165 OMQS:NotePayableSupplierMember 2021-09-30 0000278165 OMQS:NotePayableSupplierMember 2020-12-31 0000278165 OMQS:AllOtherMember 2021-09-30 0000278165 OMQS:AllOtherMember 2020-12-31 0000278165 OMQS:SecuredPromissoryNoteMember 2016-07-18 0000278165 OMQS:SecuredPromissoryNoteMember 2016-07-17 2016-07-18 0000278165 OMQS:SecuredPromissoryNoteMember OMQS:SixthAmendmentAgreementMember 2018-09-07 0000278165 OMQS:SecuredPromissoryNoteMember OMQS:SixthAmendmentAgreementMember 2018-09-06 2018-09-07 0000278165 OMQS:SecuredPromissoryNoteMember OMQS:SixthAmendmentAgreementMember OMQS:FirstThreeMonthlyPaymentsMember 2018-09-06 2018-09-07 0000278165 OMQS:SecuredPromissoryNoteMember OMQS:SixthAmendmentAgreementMember OMQS:LastTwoMonthlyPaymentsMember 2018-09-06 2018-09-07 0000278165 OMQS:FirstMinimumPaymentMember 2019-04-01 2019-04-30 0000278165 OMQS:EighthAmendmentMember srt:MaximumMember 2021-07-19 2021-07-20 0000278165 OMQS:EighthAmendmentMember srt:MinimumMember 2021-07-19 2021-07-20 0000278165 OMQS:EighthAmendmentMember 2021-07-19 2021-07-20 0000278165 srt:DirectorMember 2021-01-01 2021-09-30 0000278165 us-gaap:SeriesCPreferredStockMember 2021-01-01 2021-09-30 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2020-08-01 2020-08-31 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2020-08-31 0000278165 OMQS:EquityIncentivePlanMember OMQS:ConsultantsAndAdvisorsMember us-gaap:CommonStockMember 2021-01-01 2021-09-30 0000278165 OMQS:EmployeeStockPurchasePlanMember us-gaap:CommonStockMember 2021-01-01 2021-09-30 0000278165 us-gaap:CommonStockMember OMQS:OrionFourLLCMember OMQS:ConsultingAgreementMember 2021-02-14 2021-02-15 0000278165 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0000278165 OMQS:SecuritiesPurchaseAgreementMember 2021-07-08 0000278165 us-gaap:WarrantMember 2021-07-07 2021-07-08 0000278165 us-gaap:WarrantMember 2021-11-08 0000278165 us-gaap:WarrantMember 2021-07-08 0000278165 OMQS:PlacementAgencyAgreementMember 2021-07-07 2021-07-08 0000278165 OMQS:PlacementAgencyAgreementMember 2021-11-08 0000278165 OMQS:PlacementAgencyAgreementMember 2021-07-08 0000278165 us-gaap:WarrantMember OMQS:ExercisePriceRangeOneMember 2021-01-01 2021-09-30 0000278165 us-gaap:WarrantMember OMQS:ExercisePriceRangeOneMember 2021-09-30 0000278165 us-gaap:WarrantMember OMQS:ExercisePriceRangeTwoMember 2021-01-01 2021-09-30 0000278165 us-gaap:WarrantMember OMQS:ExercisePriceRangeTwoMember 2021-09-30 0000278165 us-gaap:WarrantMember OMQS:ExercisePriceRangeThreeMember 2021-01-01 2021-09-30 0000278165 us-gaap:WarrantMember OMQS:ExercisePriceRangeThreeMember 2021-09-30 0000278165 us-gaap:WarrantMember OMQS:ExercisePriceRangeFourMember 2021-01-01 2021-09-30 0000278165 us-gaap:WarrantMember OMQS:ExercisePriceRangeFourMember 2021-09-30 0000278165 us-gaap:WarrantMember OMQS:ExercisePriceRangeFiveMember 2021-01-01 2021-09-30 0000278165 us-gaap:WarrantMember OMQS:ExercisePriceRangeFiveMember 2021-09-30 0000278165 us-gaap:WarrantMember srt:MinimumMember 2021-01-01 2021-09-30 0000278165 us-gaap:WarrantMember srt:MaximumMember 2021-01-01 2021-09-30 0000278165 us-gaap:WarrantMember 2021-01-01 2021-09-30 0000278165 us-gaap:WarrantMember 2021-09-30 0000278165 OMQS:OctoberTenTwoThousandTwentyMember 2021-09-30 0000278165 OMQS:OctoberTenTwoThousandTwentyMember 2020-09-30 0000278165 OMQS:DecemberThirtyTwoThousandTwentyMember 2021-09-30 0000278165 OMQS:DecemberThirtyTwoThousandTwentyMember 2020-09-30 0000278165 OMQS:FebruaryTwoThousandTwentyOneMember 2021-09-30 0000278165 OMQS:FebruaryTwoThousandTwentyOneMember 2020-09-30 0000278165 OMQS:AugustTwoTwoThousandTwentyOneMember 2021-09-30 0000278165 OMQS:AugustTwoTwoThousandTwentyOneMember 2020-09-30 0000278165 OMQS:OctoberTenTwoThousandTwentyOneMember 2021-09-30 0000278165 OMQS:OctoberTenTwoThousandTwentyOneMember 2020-09-30 0000278165 OMQS:FebruaryTwentySevenThousandTwentyTwoMember 2021-09-30 0000278165 OMQS:FebruaryTwentySevenThousandTwentyTwoMember 2020-09-30 0000278165 OMQS:MayEighteenTwoThousandTwentyThreeMember 2021-09-30 0000278165 OMQS:MayEighteenTwoThousandTwentyThreeMember 2020-09-30 0000278165 OMQS:OctoberFourteenTwoThousandTwentyThreeMember 2021-09-30 0000278165 OMQS:OctoberFourteenTwoThousandTwentyThreeMember 2020-09-30 0000278165 OMQS:OctoberSixTwoThousandTwentyFourMember 2021-09-30 0000278165 OMQS:OctoberSixTwoThousandTwentyFourMember 2020-09-30 0000278165 OMQS:SeptemberOneTwoThoousandTwentyFiveMember 2021-09-30 0000278165 OMQS:SeptemberOneTwoThoousandTwentyFiveMember 2020-09-30 0000278165 OMQS:JuneFourTwoThousandTwentySixMember 2021-09-30 0000278165 OMQS:JuneFourTwoThousandTwentySixMember 2020-09-30 0000278165 OMQS:JulyEightTwoThousandTwentySixMember 2021-09-30 0000278165 OMQS:JulyEightTwoThousandTwentySixMember 2020-09-30 0000278165 OMQS:DecemberFourTwoThousandTwentySevenMember 2021-09-30 0000278165 OMQS:DecemberFourTwoThousandTwentySevenMember 2020-09-30 0000278165 us-gaap:EmployeeStockOptionMember 2020-09-29 2020-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeOneMember 2021-01-01 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeOneMember 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeTwoMember 2021-01-01 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeTwoMember 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeThreeMember 2021-01-01 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeThreeMember 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeFourMember 2021-01-01 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeFourMember 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeFiveMember 2021-01-01 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeFiveMember 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeSixMember 2021-01-01 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeSixMember 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeSevenMember 2021-01-01 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeSevenMember 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeEightMember 2021-01-01 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeEightMember 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeNineMember 2021-01-01 2021-09-30 0000278165 OMQS:StockOptionsMember OMQS:ExercisePriceRangeNineMember 2021-09-30 0000278165 OMQS:StockOptionsMember srt:MinimumMember 2021-01-01 2021-09-30 0000278165 OMQS:StockOptionsMember srt:MaximumMember 2021-01-01 2021-09-30 0000278165 OMQS:StockOptionsMember 2021-01-01 2021-09-30 0000278165 OMQS:StockOptionsMember 2021-09-30 0000278165 OMQS:AugustTwoTwoThousandTwentyOneMember 2021-01-01 2021-09-30 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoMember 2021-01-01 2021-09-30 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoMember 2021-09-30 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoMember 2020-09-30 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoOneMember 2021-01-01 2021-09-30 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoOneMember 2021-09-30 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoOneMember 2020-09-30 0000278165 OMQS:FebruaryTwentyEightTwoThoudsandTwentyThreeMember 2021-01-01 2021-09-30 0000278165 OMQS:FebruaryTwentyEightTwoThoudsandTwentyThreeMember 2021-09-30 0000278165 OMQS:FebruaryTwentyEightTwoThoudsandTwentyThreeMember 2020-09-30 0000278165 OMQS:MarchZeroFiveTwoThousandTwentyThreeMember 2021-01-01 2021-09-30 0000278165 OMQS:MarchZeroFiveTwoThousandTwentyThreeMember 2021-09-30 0000278165 OMQS:MarchZeroFiveTwoThousandTwentyThreeMember 2020-09-30 0000278165 OMQS:JulyThirtyOneTwoThousandTwentyThreeMember 2021-01-01 2021-09-30 0000278165 OMQS:JulyThirtyOneTwoThousandTwentyThreeMember 2021-09-30 0000278165 OMQS:JulyThirtyOneTwoThousandTwentyThreeMember 2020-09-30 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentyThreeMember 2021-01-01 2021-09-30 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentyThreeMember 2021-09-30 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentyThreeMember 2020-09-30 0000278165 OMQS:NovemberThirtyTwoThousandTwentyThreeMember 2021-01-01 2021-09-30 0000278165 OMQS:NovemberThirtyTwoThousandTwentyThreeMember 2021-09-30 0000278165 OMQS:NovemberThirtyTwoThousandTwentyThreeMember 2020-09-30 0000278165 OMQS:NovemberTwentyThousandTwentyFourMember 2021-01-01 2021-09-30 0000278165 OMQS:NovemberTwentyThousandTwentyFourMember 2021-09-30 0000278165 OMQS:NovemberTwentyThousandTwentyFourMember 2020-09-30 0000278165 OMQS:AprilTwentyTwoThousandTwentyFiveMember 2021-01-01 2021-09-30 0000278165 OMQS:AprilTwentyTwoThousandTwentyFiveMember 2021-09-30 0000278165 OMQS:AprilTwentyTwoThousandTwentyFiveMember 2020-09-30 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyMember 2021-01-01 2021-09-30 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyMember 2021-09-30 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyMember 2020-09-30 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyOneMember 2021-01-01 2021-09-30 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyOneMember 2021-09-30 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyOneMember 2020-09-30 0000278165 us-gaap:EmployeeStockOptionMember 2021-09-30 0000278165 us-gaap:EmployeeStockOptionMember 2020-09-30 0000278165 OMQS:AkronMember 2021-01-01 2021-09-30 0000278165 OMQS:AkronMember 2021-09-30 0000278165 OMQS:VehicleLeaseMember 2021-01-01 2021-09-30 0000278165 OMQS:VehicleLeaseMember 2021-09-30 0000278165 OMQS:SaltLackCityMember 2021-01-01 2021-09-30 0000278165 OMQS:SaltLakeCityUTMember 2021-09-30 0000278165 OMQS:YadHaruzimMember srt:MinimumMember 2021-01-01 2021-09-30 0000278165 OMQS:YadHaruzimMember srt:MaximumMember 2021-01-01 2021-09-30 0000278165 OMQS:YadHaruzimMember 2021-09-30 0000278165 OMQS:GamdanOfficeMember srt:MinimumMember 2021-01-01 2021-09-30 0000278165 OMQS:GamdanOfficeMember srt:MaximumMember 2021-01-01 2021-09-30 0000278165 OMQS:GamdanOfficeMember 2021-09-30 0000278165 OMQS:RivalWareHouseMember srt:MinimumMember 2021-01-01 2021-09-30 0000278165 OMQS:RivalWareHouseMember srt:MaximumMember 2021-01-01 2021-09-30 0000278165 OMQS:RivalWareHouseMember 2021-09-30 0000278165 OMQS:HofmanMember 2021-01-01 2021-09-30 0000278165 OMQS:HofmanMember 2021-09-30 0000278165 OMQS:RentalCarsMember 2021-01-01 2021-09-30 0000278165 OMQS:RentalCarsMember OMQS:SixtyFiveEmployeesMember 2021-01-01 2021-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:D iso4217:ILS

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: September 30, 2021

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from________ to__________

 

Commission File Number: 000-09047

 

OMNIQ Corp.

(Exact name of registrant as specified in its charter)

 

Delaware   20-3454263

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

1865 West 2100 South

Salt Lake City, UT 84119

(Address of principal executive offices) (Zip Code)

 

(801) 244-9577

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Ticker symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   Accelerated filer
         
Non-accelerated filer   Smaller reporting company
(Do not check if a smaller reporting company)        
         
Emerging growth company      

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

APPLICABLE ONLY TO CORPORATE ISSUERS:

 

Indicate the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: 7,459,286 shares of common stock, $0.001 par value, as of November 15, 2021.

 

 

 

 

 

 

TABLE OF CONTENTS

 

PART I - FINANCIAL INFORMATION  
ITEM 1. FINANCIAL STATEMENTS F-1
CONDENSED CONSOLIDATED BALANCE SHEETS AT SEPTEMBER 30, 2021 AND DECEMBER 31, 2020, (UNAUDITED) F-1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020, (UNAUDITED) F-2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) AT SEPTEMBER 30, 2021 AND DECEMBER 31, 2020, (UNAUDITED) F-3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020, (UNAUDITED) F-4
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) F-5
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 4
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 8
ITEM 4. CONTROLS AND PROCEDURES 8
PART II - OTHER INFORMATION  
ITEM 1. LEGAL PROCEEDINGS. 9
ITEM 1A. RISK FACTORS. 9
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS. 9
ITEM 3. DEFAULTS UPON SENIOR SECURITIES. 10
ITEM 4. MINE SAFETY DISCLOSURES. 10
ITEM 5. OTHER INFORMATION. 10
ITEM 6. EXHIBITS. 10
SIGNATURES 11

 

2

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements include statements preceded by, followed by or that include the words “may”, “could”, “would”, “should”, “believe”, “expect”, “anticipate”, “plan”, “estimate”, “target”, “project”, “intend”, “foresee” and similar expressions. These statements include, among others, statements regarding our expected business outlook, anticipated financial and operating results, our business strategy and means to implement the strategy, our objectives, the amount and timing of capital expenditures, the likelihood of our success in expanding our business, financing plans, budgets, working capital needs and sources of liquidity. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.

 

Forward-looking statements are only predictions and are not guarantees of performance. These statements are based on our management’s beliefs and assumptions, which in turn are based on currently available information. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding demand for our products, the expansion of product offerings geographically or through new marketing applications, the timing and cost of planned capital expenditures, competitive conditions and general economic conditions. These assumptions could prove inaccurate. Forward-looking statements also involve known and unknown risks and uncertainties, which could cause actual results to differ materially from those contained in any forward-looking statement. In addition, even if our actual results are consistent with the forward-looking statements contained in this Quarterly Report on Form 10-Q, those results may not be indicative of results or developments in subsequent periods. Many of these factors are beyond our ability to control or predict. Such factors include, but are not limited to, the following:

 

  risks related to the impact of the COVID-19 global pandemic, such as the scope and duration of the outbreak, government actions and restrictive measures implemented in response, material delays and cancellations of projects, supply chain disruptions and other impacts to the business;
     
  our ability to raise capital when needed and on acceptable terms and conditions;
     
  our ability to manage credit and debt structures from vendors, debt holders and secured lenders.
     
  our ability to manage the growth of our business through internal growth and acquisitions;
     
  competitive pressures;
     
  general economic conditions, including the overall effect of the current COVID19 Crisis; and
     
  our ability to attract and retain management, and to integrate and maintain technical information and management information systems.
     
  compliance with laws and regulations, including those relating to environmental matters, corporate governance matters and tax matters, as well as any future changes to such laws and regulations; and
     
  other factors discussed under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 and in Item 1A — “Risk Factors” in this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021.

 

Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the Securities and Exchange Commission (“SEC”), we are under no obligation to publicly update or revise any forward-looking statements after we file this Quarterly Report on Form 10-Q, whether as a result of any new information, future events or otherwise. Investors, potential investors and other readers are urged to consider the above-mentioned factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results or performance.

 

For a more detailed discussion of some of the foregoing risks and uncertainties, see Item 1A — “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 and Item 1A — “Risk Factors” in this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, as well as other reports and registration statements filed by us with the SEC. These factors should not be construed as exhaustive and should be read with other cautionary statements in this Quarterly Report on Form 10-Q and our other public filings. For more information about us and the announcements we make from time to time, visit our Internet website at www.omniq.com.

 

3

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

OMNIQ CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

           
(In thousands, except share and per share data)  As of 
   September 30, 2021   December 31, 2020 
   (UNAUDITED)     
ASSETS          
Current assets          
Cash and cash equivalents  $9,993   $4,594 
Accounts receivable, net   20,629   9,661 
Inventory   6,794   1,507 
Prepaid expenses   1,809   670 
Other current assets   10   10 
Total current assets   39,235   16,442 
           
Property and equipment, net of accumulated depreciation of $767 and $555 respectively   888   289 
Goodwill   16,453   14,695 
Trade name, net of accumulated amortization of $3,714 and $1,156, respectively   2,570   1,028 
Customer relationships, net of accumulated amortization of $9,279 and $4,885, respectively   6,450   4,479 
Other intangibles, net of accumulated amortization of $1,402 and $1,104, respectively   931   1,042 
Restricted Cash   -   533 
Right of use lease asset   3,749   76 
Other assets   2,322   74 
Total assets  $72,598   $38,658 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities          
Accounts payable and accrued liabilities  $38,619   $26,811 
Line of credit   5,839    4,914 
Accrued payroll and sales tax   2,061    1,717 
Notes payable, related parties – current portion   390    433 
Notes payable – current portion   5,641    6,449 
Lease liability – current portion   1,310    31 
Other current liabilities   2,796    1,412 
Total current liabilities   56,656    41,767 
           
Long term liabilities          
Notes payable, related party, less current portion   390    683 
Accrued interest and accrued liabilities, related party   63    56 
Notes payable, less current portion   2,327    1 
Lease liability   2,472    48 
Other long-term liabilities   2,057    1,146 
Total liabilities   63,965    43,701 
           
Stockholders’ equity (deficit)          
Series A Preferred stock; $0.001 par value; 1,000,000 shares designated, 0 shares issued and outstanding   -    - 
Series B Preferred stock; $0.001 par value; 1 share designated, 0 shares issued and outstanding   -    - 
Series C Preferred stock; $0.001 par value; 5,000,000 shares designated, 745,030 shares issued and outstanding, respectively   1    2 
Common stock; $0.001 par value; 15,000,000 shares authorized; 7,448,597 and 4,684,736 shares issued and outstanding, respectively.   20    5 
Additional paid-in capital   70,276    51,842 
Accumulated (deficit)   (67,883)   (56,726)
Cumulative Translation Adjustment   (190)   

(166

)
Total OmniQ stockholders’ equity (deficit)   2,224   (5,043)
Non-controlling interest   6,409    - 
TOTAL EQUITY (DEFICIT)   8,633    

(5,043

)
           
Total liabilities and equity (deficit)  $72,598   $38,658 

 

The accompanying unaudited notes should be read on conjunction with these unaudited condensed consolidated financial statements.

 

F-1

 

 

OMNIQ CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(UNAUDITED)

 

                 
   For the three months   For the nine months 
   ending September 30,   ending September 30, 
(In thousands, except share and per share data)  2021   2020   2021   2020 
Revenues                
Total Revenues  $20,513   $15,833   $53,383   $42,309 
                     
Cost of goods sold                    
Cost of goods sold   15,842    13,024    42,778    33,886 
                     
Gross profit   4,671    2,809    10,605    8,423 
                     
Operating expenses                    
Research & Development   474    428    1,437    1,260 
Selling, general and administrative   6,801    4,808    15,348    11,838 
Depreciation   82    44    167    134 
Amortization   1,528    550    2,575    1,562 
Total operating expenses   8,885    5,830    19,527    14,794 
                     
Loss from operations   (4,214)   (3,021)   (8,922)   (6,371)
                     
Other income (expenses):                    
Interest expense   (587)   (744)   (1,890)   (1,957)
Other (expenses) income   (159)   (16)   2    (318)
Total other expenses   (746)   (760)   (1,888)   (2,275)
                     
Net Loss Before Income Taxes   (4,960)   (3,781)   (10,810)   (8,646)
                     
Provision for Income Taxes                 
Current   (117)   -    (119)   - 
Total Provision for Income Taxes   (117)   -    (119)   - 
                     
Net Loss  (5,076)  (3781)  (10,929)  (8,646)
Net income attributable to noncontrolling interest   

166

    -    

166

    - 
Net Loss attributable to OmniQ Corp  $

(5,242

)  $

(3,781

)  $

(11,095

)  $

(8,646

)
                     
Net Loss  $

(5,076

)  $

(3,781

)  $

(10,929

)  $

(8,646

)
                     
Foreign currency translation adjustment   (58)   (16)   (24)   (30)
                     
Comprehensive loss  $(5,134)  $(3,797)  $(10,953)  $(8,676)
                     
Reconciliation of net loss to net loss attributable to common shareholders                    
Net loss  $(5,076)  $(3781)  $(10,929)  $(8,646)
                     
Less: Preferred stock – Series C dividend   

(12

)   (32)   

(57

)   (158)
                     
Net loss less series C dividend  (5,064)  (3813)  (10,872)  (8,804)
                     
Net income after series C dividend attributable to noncontrolling interest   166    -    166    - 
Net loss after series C dividend attributable to common stockholders’ of OmniQ Corp  $

(5,230

)  $

(3,813

)  $

(11,038

)  $

(8,804

)
Net (loss) per share - basic attributable to common stockholders’ of OmniQ Corp  $(0.73)  $(0.83)  $(1.86)  $(2.03)
                     
Weighted average number of common shares outstanding - basic   7,224,958    4,588,944    5,971,440    4,339,634 

 

The accompanying unaudited notes should be read in conjunction with these unaudited condensed consolidated financial statements.

 

F-2

 

 

OMNIQ CORP.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(UNAUDITED) 

 

                                                                   
    Series C           Additional                 Non     Other    

Total

Stockholders’

 
    Preferred Stock     Common Stock     Paid-in     Shares     Accumulated     Controlling     Comprehensive     Equity  
(In thousands)   Shares     Amount     Shares     Amount      Capital     Repurchased     Deficit     Interest     Income (Loss)     (Deficit)  
Balance, December 31, 2019     4,829     $ 5       3,960     $ 4     $ 46,861     $         -     $ (45,063 )   $ -     $ 1     $ 1,808  
Dividend on Class C Shares     -       -       -       -       -       -       (72 )     -       -       (72  
Accumulated other comprehensive loss     -       -       -       -       -       -       -       -       (17 )     (17  
Stock-based compensation – options and warrants     -       -       -       -       190       -       -       -       -       190  
Subscribed common stock                     -               440       -       -       -       -       440  
Professional fees – restricted shares     -       -       65       -       354       -       -       -       -       354  
Other misc. items     -       -       -       -       -       -       14       -       -       14  
Net (loss)     -       -       -       -       -       -       (2,873 )     -       -       (2,873  
Balance, March 31, 2020     4,829     $ 5       4,025     $ 4     $ 47,845     $ -     $ (47,994 )   $ -     $ (16 )   $ (156 )
Dividend on Class C Shares     -       -       -       -       -       -       (54 )     -       -       (54 )
Accumulated other comprehensive loss     -       -       -       -       -       -       -       -       3       3  
Stock-based compensation – options and warrants     -       -       -       -       105       -       -       -       -       105  
Subscribed common stock                     80               -       -       -       -       -       -  
Professional fees – restricted shares     -       -       67       -       547       -       -       -       -       547  
Exercise of stock options and warrants     -       -       34       -       -       -       -       -       -       -  
Conversion agreements - preferred shares     (2,684 )     (3 )     -       -       3       -       -       -       -       -  
Conversion agreements - debt     -       -       -       -       822       -       -       -       -       822  
Net (loss)     -       -       -       -       -       -       (1,992 )     -       -       (1,992 )
Balance, June 30, 2020     2,145     $ 2       4,206     $ 4     $ 49,322     $ -     $ (50,040 )   $ -     $ (13 )   $ (725 )
Balance, December 31, 2020     2,145     $ 2       4,685     $ 5     $  51,842     $ -     $ (56,726 )   -     $ (166 )   $ (5,043 )
Dividend on Class C Shares     -       -       -       -       -       -       (31 )     -       -       (31 )
ESPP Stock Issuance     -       -       -       -       1       -       -       -       -       1  
Stock-based compensation – options, warrants, issuances     -       -       -       -       786       -       -       -       -       786  
Stock and Warrant issued for services     -       -       25       -       188       -       -       -       -       188  
Exercise of stock options and warrants     -       -       6       -       2       -       -       -       -       2  
Cumulative Translation Adjustment     -       -       -       -       -       -       -       -       105       105  
Other     -       -       -       -       -       -       (4 )     -       -       (4 )
Conversion of Equity     -       -       -       -       -       -       -       -       -       -  
Net (loss) income     -       -       -       -       -       -       (3,343 )     -       -       (3,343 )
Balance, March 31, 2021     2,145      

$

2       4,716      $ 5      

$

52,819      

$

-      

$

(60,104 )    

$

-      

$

(61 )    

$

(7,339 )
Dividend on Class C Shares     -       -       -       -       -       -       (14 )     -       -       (14 )
ESPP Stock Issuance     -       -       1       -       4       -       -       -       -       4  
Stock-based compensation – options, warrants, issuances     -       -       -       -       786       -       -       -       -       786  
Exercise of stock options and warrants     -       -       240       -       304       -       -       -       -       304  
Cumulative Translation Adjustment     -       -       -       -       -       -       -       -       (71 )     (71 )
Conversion of Equity     (1,400 )     (1 )     70       -       1       -       -       -       -       -  
Conversion of debt     -       -       25       -       203       -       -       -       -       203  
Net (loss) income     -       -       -       -       -       -       (2,510 )     -       -       (2,510 )
Balance, June 30, 2021    

745      

$

1      

5,052      $ 5      

$

54,117      

$

-      

$

(62,628 )    

$

-      

$

(132 )    

$

(8,637 )
Dividend on Class C Shares     -       -       -       -       -       -       (12 )     -       -       (12 )
ESPP Stock Issuance     -       -       1       -       9       -       -       -       -       8  
Stock-based compensation – options, warrants, issuances     -       -       -       -       653       -       -       -       -       653  
Stock and warrant issuances, net of issuance costs     -       -       2,143       15       13,280       -       -       -       -       13,295  
Exercise of stock options and warrants     -       -       33       -       132       -       -       -       -       132  
Stock and warrant issuance for Acquisition     -       -       220       -       2,084       -       -                   2,084  
Dangot Acquisition     -       -       -      

-

     

-

     

-

      -       6,508      

-

      6,508  
Post acquisition adjustment     -      

-

     

-

     

-

     

-

     

-

      (1 )    

(324

   

-

      (325 )
Cumulative translation adjustment    

-

     

-

     

-

     

-

     

-

     

-

     

-

      59       (58)     1
Net (loss) income     -       -       -       -       -       -       (5,242 )     166       -       (5,076 )
Balance, September 30, 2021     745      $ 1       7,449      $ 20      

$

70,276      $ -      $ (67,883 )    

$

6,409      

$

(190 )    

$

8,633  

 

The accompanying unaudited notes should be read in conjunction with these condensed unaudited consolidated financial

statements.

 

F-3

 

 

OMNIQ CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(UNAUDITED)

 

           
   For the nine months ended 
   September 30, 
(In thousands)  2021   2020 
Cash flows from continuing operating activities:          
Net loss  $(10,929)  $(8,646)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:          
Stock based compensation   2,620    2,275 
Amortization of ROU lease asset   53   40 
Depreciation and amortization   3,544    1,696 
Changes in operating assets and liabilities:          
Accounts receivable   2,502    (3,193)
Prepaid expenses   (1,139)   (116)
Inventory   (671)   218 
Accounts payable and accrued liabilities   (1,104)   9,673 
Accrued interest and accrued liabilities, related party   7    (26)
Accrued payroll and sales taxes payable   345   (14) 
Other Current assets   428    48 
Lease liability   920   (39)
Other liabilities   

1,632

   (420)
Net cash (used in) provided by operating activities   

(1,792)

   

1,496

           
Cash flows from investing activities:          
           
Payments for acquisition, net of cash acquired   

(4,392

)   - 
Other assets   -   66 
Purchase of property and equipment   (976)   (5)
Net cash provided by (used in) investing activities   (5,368)   61 
           
Cash flows from financing activities:          
Proceeds from private placement   

13,295

    

-

 
Proceeds from ESPP stock issuance   14    - 
Proceeds from / (payments on) line of credit   926   1,870 
Net proceeds from Warrant exercise   279    - 
Net Proceeds from Options Exercise   156    - 
Proceeds from notes/loans payable   

2,172

    898 
Payment on notes/loans payable   

(4,793

)   (874)
Net cash provided by (used in) financing activities   (12,049)  1,894 
           
Net increase (decrease) in cash   4,889    3,451 
Cash and restricted cash, beginning of period   5,127    1,615 
Foreign currency Exchange   (23)   - 
Cash and restricted cash, end of period  $9,993   $5,066 
           
Cash paid for interest  $

1,101

   $77 
Cash paid for taxes  $

110

   $- 
Supplementary for non-cash flow information:          
Right of use lease asset  $1,276   - 
Stock issued for services 

188

   1,971 
Net assets acquired in business combination 

13,052

    -  
Intangible assets acquired in non-cash exchange  -   885 
Conversion of notes payable   -    281

 
Stock options and warrants issued 

171

   304 

 

The accompanying unaudited notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-4

 

 

OMNIQ CORP.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1 – NATURE OF OPERATIONS

 

OMNIQ Corp., a Delaware corporation, formerly Quest Solution, Inc., together with its wholly owned subsidiaries, referred to herein as “we,” “us,” and “our” (“OMNIQ” or the “Company”), was incorporated in 1973. Since its incorporation, the Company has been involved in various lines of business.

 

From 2008 and to 2013, we were in the business of developing oil and gas reserves. In January 2014, we determined it was in the best interest of our stockholders to focus on operating companies with a track record of positive cash flows and larger existing revenue bases. Our strategy developed into leveraging management’s relationships in the business world for investments for the Company.

 

Since 2014, we have made the following acquisitions resulting in us becoming a leading provider of computerized and machine vision image processing solutions:

 

  Quest Solution, Inc. (January 2014)
  Bar Code Specialties, Inc. (November 2014)
  ViascanQdata, Inc (October 2015 – later sold in September 2016)
  HTS Image Processing, Inc. (October 2018)
  EyepaxIT Consulting LLC. (February 2021)

 

We use patented and proprietary artificial intelligence (AI) technology to deliver data collection, real time surveillance and monitoring for supply chain management, homeland security, public safety, traffic & parking management and access control applications. The technology and services we provide helps our clients move people, assets and data safely and securely through airports, warehouses, schools, national borders, and many other applications and environments.

 

We offer end-to-end solutions that include hardware, software, communications, and full lifecycle management services. We are an established manufacturer and distributor of barcode labels, tags, and ribbons, as well as RFID labels and tags. Our highly tenured team of professionals has the knowledge and expertise to simplify the integration process for our customers, and our team delivers proven problem-solving solutions backed by numerous customer references. We offer comprehensive packaged and configurable software, and we are a leading provider of best-in-class mobile and wireless equipment.

 

Our customers include government agencies and leading Fortune 500 companies from diverse sectors, including healthcare, food and beverage, manufacturing, retail, distribution, transportation and logistics, and oil, gas, and chemicals.

 

COVID-19

 

The outbreak of the COVID-19 pandemic continues to affect the United States of America and the world, including in the primary regions we operate. Many State Governors issued temporary Executive Orders in 2020, that, among other stipulations, effectively limited in-person work activities for most industries and businesses having the effect of suspending or severely curtailing operations. Many of these orders are in the process of being lifted. To date, we have not incurred any significant interruptions to our day-to-day operations or supply chain, except some of our employees have or are working remotely. In response to the COVID-19 pandemic, we proactively implemented certain measures to strengthen cash flow, manage costs, strengthen liquidity, and enhance employee safety. These measures included the reduction of payroll costs, a reduction in capital expenditures and other discretionary spending, the elimination of most business travel and restriction of visitors to our corporate office, enhanced cleaning and disinfection procedures at our corporate office and branch locations, promotion of social distancing and the wearing of face coverings (masks) at our corporate office and branch locations, and requirements for employees to work from home where possible.

 

The extent of the ultimate impact of the pandemic on our operational and financial performance will depend on various developments, including the duration and spread of the outbreak, the impact on capital and financial markets, governmental limitations on business operations generally, and its and their impact on potential customers, employees, vendors, and distribution partners, all of which cannot be reasonably predicted at this time.

 

F-5

 

 

NOTE 2 –SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES 

 

We describe our significant accounting policies in Note 2 of the notes to consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020. During the nine-month period ended September 30, 2021, there were no significant changes to those accounting policies.

 

Principles of Consolidation and Basis of Presentation

 

Our unaudited condensed consolidated financial statements include the financial position and results of operations of OMNIQ Corp. and its wholly owned subsidiaries Quest Marketing, Inc., Quest Exchange Ltd., OmniQ Technologies Ltd., HTS Image Ltd., and HTS Image Processing, Inc., collectively referred to herein as “we” or “us” or “our” or the “Company.”

 

All significant intercompany accounts and transactions have been eliminated in these unaudited condensed consolidated financial statements. Business combinations are included in the unaudited condensed consolidated financial statements from their respective dates of acquisition.

 

We have prepared the interim unaudited condensed consolidated financial statements included herein, in accordance with accounting principles generally accepted in the United States of America, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although we believe the disclosures are adequate to make the information presented not misleading.

 

These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. It is suggested that these interim financial statements be read in conjunction with our financial statements for the year ended December 31, 2020 and notes thereto included in our Form 10-K filed with the SEC on March 31, 2021. The Company operates in one segment.

 

Operating results for the nine months ended September 30, 2021, are not necessarily indicative of the results that may be expected for the year ended December 31, 2021.

 

Use of Estimates

 

We prepare our unaudited condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, which requires management to use its judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reported period. These assumptions and estimates could have a material effect on our unaudited condensed consolidated financial statements. Actual results may differ materially from those estimates. We review our estimates on an ongoing basis based on information currently available, and changes in facts and circumstances may cause us to revise these estimates.

 

Goodwill and Intangibles

 

We have made acquisitions in the past that resulted in the recognition of goodwill. Goodwill is the excess of the consideration transferred plus the fair value of any non-controlling interest in the acquiree at the acquisition date over the fair values of the identifiable net assets acquired. We evaluate goodwill for impairment annually or more frequently, if triggering events occur or other impairment indicators arise which might impair recoverability.

 

F-6

 

 

Application of the goodwill impairment test requires judgment. We performed a Step 1 quantitative assessment of goodwill impairment as of December 31, 2020, our annual impairment test date. We compared the carrying value inclusive of goodwill and definite-lived intangible assets, to its fair value. We estimated the fair value of these reporting units by weighting results from the income approach and the market approach, as further described in Note 2 in our Annual Report on Form 10-K for the year ended December 31, 2020. Based on this quantitative test, we determined there was no impairment as of the December 31, 2020.

 

Intangible assets with a limited life are being amortized on the straight-line method over useful lives ranging from 3 to 11 years. No events or indicators have occurred subsequent to December 31, 2020 that would affect the intangible assets. No impairment expense was recognized for the nine months ended September 30, 2021.

 

Foreign Currency Translation

 

Our unaudited condensed consolidated financial statements are presented in U.S. dollars. The functional currency for the Company is U.S. dollars. Transactions in currencies other than the functional currency are recorded using the appropriate exchange rate at the time of the transaction. All of our continuing operations are conducted in U.S. dollars except its subsidiary located in Israel. The records of the Israeli operation were maintained in the local currency and re-measured to the functional currency as follows: monetary assets and liabilities are converted using the balance sheet period-end date exchange rate, while the non-monetary assets and liabilities are converted using the historical exchange rate. Expenses and income items are converted using the weighted average exchange rates for the reporting period. Foreign transaction gains and losses are reported on the unaudited condensed consolidated statement of operations and were included in the amount of loss from comprehensive income.

 

Net Loss Per Common Share

 

Net loss per share is provided in accordance with FASB ASC 260-10, “Earnings per Share”. Basic net loss per common share (“EPS”) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued, unless doing so is anti-dilutive. The weighted-average number of common shares outstanding for computing basic EPS for the nine-months ended September 30, 2021 and 2020 were 5,971,440 and 4,339,634, respectively. Diluted net loss per share of common stock is the same as basic net loss per share of common stock because the effects of potentially dilutive securities are antidilutive.

 

The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported as of:

 

In thousands  September 30, 2021   December 31, 2020 
Options to purchase common stock   1,654    1,553 
Convertible preferred stock   -    - 
Warrants to purchase common stock   1,404    75 
Potential shares excluded from diluted net loss per share   3,058    1,628 

 

Purchase Accounting and Business Combinations

 

We account for our business combinations using the purchase method of accounting which requires that intangible assets be recognized apart from goodwill if they are contractual in nature or separately identifiable. Acquisitions are measured on the fair value of consideration exchanged and, if the consideration given is not cash, measurement is based on the fair value of the consideration given or the fair value of the assets acquired, whichever is more reliably measurable. The excess of cost of an acquired entity over the fair value of identifiable acquired assets and liabilities assumed is allocated to goodwill.

 

F-7

 

 

The valuation and allocation processes rely on significant assumptions made by management. In certain situations, the allocations of excess purchase price are based upon preliminary estimates and assumptions. Accordingly, the allocations are subject to revision when we receive updated information, including appraisals and other analyses, which are completed within one year of the acquisition. Revisions to the fair values, which may be significant, are recorded when pending information is finalized, within one year from the acquisition date.

 

Revenue Recognition.

 

When entering into contracts with our customers, we review follow the five steps outline in Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606):

 

  i. Identify the contract with our customer.
     
  ii. Identify the performance obligations in the contract.
     
  iii. Determine the transaction price.
     
  iv. Allocate the transaction price to the performance obligations. And
     
  v. Evaluate the satisfaction of the performance obligations,

 

We account for contracts, with our customers, when we have approval and commitment from both parties, the rights of the parties are identified, payment terms are established, the contract has commercial substance and collectability of consideration is probable.

 

We evaluate, in accordance with Topic 606, whether we meet the criteria to be a principal or an agent and record the revenue on a gross or net basis. We are considered a principal if we obtain control of any one of the following:

 

  i. A good or another asset from another party that we then transfer to our customer.
     
  ii. A right to a service to be performed by another party, which gives the us the ability to direct that party to provide the service to the customer on our behalf, and
     
  iii. A good or service from another party that we then combine with other goods or services in providing the specified good or service to our customer.

 

We have certain relationships with manufacturers and suppliers to sell us products or provide services. Our contracts may transfer to our customer a right to a future service or product to be provided by our manufacturer or supplier. When a specified good or service is a right to a good or service is provided by a manufacturer or supplier, we evaluate whether we control the right to the goods or services before that right is transferred to the customer rather than whether we control the underlying goods or services.

 

Indicators that we control the specified good or service before it is transferred to the customer (and we are therefore a principal) include, but are not limited to, the following:

 

  i. We are responsible for fulfilling the promise to provide the specified good or service. This typically includes responsibility for the acceptability of the specified good or service. If we are primarily responsible for fulfilling the promise to provide the specified good or service, this may indicate that the other party involved in providing the specified good or service is acting on our behalf. Often, we provide value added services (combining hardware, integrating hardware to software, etc.) to the products and services purchased from our manufacturers and suppliers.
     
  ii. We have inventory risk before the specified good or service has been transferred to a customer. Our purchases of products or services from our manufactures and suppliers is evidenced by our issuing a binding purchase order contract with the negotiated terms including specifications, pricing, delivery among other things. Our obligation for purchased products and services is mutually exclusive of our customers’ performance (failure to take acceptance, make payment, etc.

 

F-8

 

 

  iii. We have sole discretion in establishing our price for the specified good or service. Establishing the price our customer pays for a specified good or service may indicate we have the ability to direct the use of that good or service and obtain substantially all of the remaining benefits. We control and set the pricing for the product or services to be provided to our customers.

 

If the terms of a transaction do not indicate we are acting as a principal in the transaction, we are then considered acting as an agent and the associated revenues would be recognized on a net basis.

 

As principal, when (or as) we satisfy a performance obligation, we recognize revenue in the gross amount of consideration which we expect to be entitled in exchange for the specified good or service transferred. We are an agent if our performance obligation is to arrange for the provision of the specified good or service by another party. As an agent, we do not control the specified good or service provided by another party before that good or service is transferred to our customer. As an agent, when (or as) we satisfy a performance obligation, we recognize revenue in the amount of any fee or commission which we expect to be entitled in exchange for arranging for the specified goods or services to be provided by another party to our customer.

 

Under Topic 606, we recognize revenue (on either a gross or net basis previously discussed) only when we satisfy a performance obligation by transferring a promised good or service to our customer. A good or service is considered to be transferred when the customer obtains control. The standard defines control as an entity’s ability to direct the use of, and obtain substantially all of the remaining benefits from, an asset. We recognize revenue (either gross or net) once control has passed to the customer. The following indicators are evaluated in determining when control has passed to the customer:

 

  i. We have a right to payment for the product or service,
  ii. The customer has legal title to the product,
  iii. We have transferred physical possession of the product to the customer,
  iv. The customer has the risk and rewards of ownership of the product, and
  v. The customer has accepted the product.

 

Revenue Recognition for Hardware. Revenues from sales of hardware products are recognized on a gross basis as we are acting as a principal in these transactions, with the selling price to the customer recorded as sales and the acquisition cost of the product recorded as cost of sales. We recognize revenue from these transactions when control has passed to the customer.

 

Manufacturers and suppliers, from whom we purchase hardware, often provide their warranties only providing assurance the products and services will conform to their specifications. These assurance type warranties are not sold separately and are not considered separate performance obligations. In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.

 

Revenue Recognition for Software. Sales of software licenses are generally considered a single performance obligation. When we are considered to be the principal, we recognize revenues on a gross basis at the point the software is delivered to and accepted by our customer. Generally, software licenses are sold with accompanying third-party delivered software assurance, which is a product that allows customers to upgrade, at no additional cost, to the latest technology if new capabilities are introduced during the period that the software assurance is in effect.

 

F-9

 

 

As explained above, we evaluate whether the software assurance is a separate performance obligation by assessing if the third-party delivered software assurance is critical or essential to the core functionality of the software itself. This involves considering:

 

  i. If the software provides its original intended functionality to the customer without the updates,
  ii. If the customer would ascribe a higher value to the upgrades versus the up-front deliverable,
  iii. If the customer would expect frequent intelligence updates to the software (such as updates that maintain the original functionality), and
  iv. If the customer chooses to not delay or always install upgrades.

 

If we determine the accompanying third-party delivered software assurance is critical or essential to the core functionality of the software license, the software license and the accompanying third-party delivered software assurance are recognized as a single performance obligation.

 

In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.

 

Revenue Recognition for Services. We provide professional services, which include project managers and consultants recommending, designing and implementing IT solutions. Revenue from professional services is recognized either on a time and materials basis or proportionally, as costs are incurred for fixed fee project work. Revenue is recognized on a gross basis each month as work is performed and we transfer those services.

 

Revenues from the sale of professional and support services, provided by us, are recognized over the period the service is provided. As the customer receives the benefit of the service each month, we recognize the respective revenue on a gross basis as we are acting as a principal in the transaction. Additionally, we manage services team provides project support to customers that are billed on a fixed fee basis. We are acting as the principal in the transaction and recognize revenue on a gross basis based on the total number of hours incurred for the period over the total expected hours for the project. Total expected hours to complete the project is updated for each period and best represents the transfer of control of the service to the customer.

 

Contract Asset. The Company recognizes revenue as explained in accordance with ASC 606. The Company has entered into contracts with customers that only allow us to invoice the customer once the total project is completed, creating a contract asset which is presented on a separate line item on the balance sheet as a current asset.

 

Freight Costs. We record both the freight billed to its customers and the related freight costs as cost of sales when the underlying product revenue is recognized. For freight not billed to its customers, we record the freight costs as cost of sales. The Company considers shipping to be a fulfillment activity and not a separate performance obligation.

 

Stock-Based Compensation

 

We periodically issue stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. We account for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by Financial Accounting Standards Board (the “FASB”) where the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period.

 

We record stock-based compensation expense according to the provisions of ASC Topic 718, Compensation – Stock Compensation. ASC Topic 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Under the provisions of ASC Topic 718, the Company determines the appropriate fair value model to be used for valuing share-based payments and the amortization method for compensation cost. The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model.

 

We account for equity instruments issued to parties other than employees for acquiring goods or services under guidance of section 505-50-30 of the FASB Accounting Standards Codification (“FASB ASC Section 505-50-30”). Pursuant to FASB ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.

 

F-10

 

 

Recent Accounting Pronouncements

 

We have evaluated the recent pronouncements and believe their adoption will not have a material effect on our financial statements.

 

Reclassifications and Comparability

 

Certain amounts in the financial statements of prior years have been reclassified to conform to the current year presentation for comparative purposes. This had no effect on total assets or net income.

 

NOTE 3 – GOING CONCERN

 

The accompanying unaudited condensed consolidated financial statements have been prepared assuming that we will continue as a going concern. As of September 30, 2021, we had a working capital deficit of $16.6 million and an accumulated deficit of $67.9 million. These facts and others have in the past raised concerns about the Company’s ability to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, which we have successfully accomplished to date.

 

Management has evaluated and assessed the Company’s ability to continue as a going concern. We believe that the achievements of the following positive factors alleviated the substantial doubt about our ability to continue as a going concern (not all inclusive):

 

The successful capital raise of $15 million.
  The Company’s cash balance at September 30, 2021 of $9.99 million.
  The Company’s acquisition of Dangot Computers, Ltd. has improved the balance sheet, profitability and cash flow.
  The Company’s favorable settlement with a major creditor. Reference note 8 supplier note.
  The Company’s up-listing to the NASDAQ stock exchange enhancing the potential to issue additional stock.
  The Company’s historical ability to continue operations and meet cash flow requirements.

 

Management considers these factors in the aggregate and believes that the Company has alleviated the substantial doubt about its ability to continue as a going concern.

 

NOTE 4 – CONCENTRATIONS

 

For the nine-months ended September 30, 2021 and the year ended December 31, 2020, two customers accounted for 26.1% and 37.2%, respectively, of the Company’s consolidated revenues.

 

Accounts receivable at September 30, 2021 and December 31, 2020 are made up of trade receivables due from customers in the ordinary course of business. Four customers made up 20.2% of the accounts receivable balance at September 30, 2021 and one customer represented 46% of the balance of accounts receivable at December 31, 2020.

 

F-11

 

 

Accounts payable are made up of amounts due to suppliers in the ordinary course of business at September 30, 2021 and December 31, 2020. One vendor made up 71% and 92.4% of our accounts payable on September 30, 2021 and December 31, 2020, respectively.

 

NOTE 5 – BUSINESS ACQUISITION

 

In February 2020, OMNIQ entered in an asset purchase agreement with Eyepax IT Consulting LLC, a California limited liability company, (“Eyepax”) and its principal owners (collectively the “Sellers”), pursuant to which we purchased certain assets from the Sellers at a cash purchase price of $245,000. As additional consideration, the Company issued to the Sellers 80,000 shares of the Company’s common stock and an option to purchase 20,000 shares of the Company’s common stock at an exercise price of $5.00 per share, subject to adjustment, which shall vest quarterly in four (4) equal installments and expire on February 28, 2023. The Company entered into an employment agreement with Mr. Lalith Caldera, a principal owner of Eyepax, agreeing to pay Mr. Caldera an annual salary of $100,000.

 

On May 3, 2021, the Company and Omniq Technologies Ltd., a wholly owned subsidiary of the Company (“Omniq Technologies”) entered into a share purchase agreement (the “Dangot Share Purchase Agreement”) with Mr. Haim Dangot. Pursuant to the Dangot Share Purchase Agreement, Omniq Technologies agreed to purchase 51%, or 5,100 shares, of the capital stock of Dangot Computers Ltd., an Israel company (“Dangot”), from Dangot’s sole shareholder, Haim Dangot, for consideration equivalent to 23,740,500 NIS (New Israeli Shekel), which is equal to US$7.6 million (the “Closing Consideration”), based on the then current exchange rate at the date of acquisition of NIS to dollars.

 

The Closing Consideration was paid on July 8, 2021 in the following manner: (a) the Company issued 220,103 shares of its common stock having a share value of $2,000,000 based on the average of the last 30 trading days prior to signing (May 3 ,2021); and (b) cash in the amount of $5,600,000.

 

Haim Dangot also granted Omniq Technologies an irrevocable option to purchase the remaining 4,900 shares, or 49%, of Dangot’s capital stock (the “Dangot Option”) in the 12-month period following the closing date (the “Dangot Option Period”) at a share purchase price of 465,500 NIS (US$143,142 per each 1% of Dangot’s remaining shares on a fully diluted basis) which is the same valuation per share as the purchase price for the 51%. In the event that Omniq Technologies chooses to exercise the Dangot Option, it must do so in whole or by an exercise pursuant to which Omniq Technologies shall purchase at least 26% of the additional Dangot shares on a fully diluted basis (the “Specific Partial Exercise”). Should Omniq Technologies exercise the Specific Partial Exercise, it shall have the right to complete the purchase of the remaining 23% of the Dangot shares on a fully diluted basis in a single exercise until the lapse of the Dangot Option Period. No other partial exercise shall be allowed.

 

The following table summarizes the consideration given and the purchase price allocation:

Purchase Price Consideration (in thousands)  Total Consideration 
Cash payments  $5,058 
Accrued payable to owner  600 
Fair value of stock issued (220,103 shares)   2,084 
Debt assumed   5,310 
Total consideration  $13,052 
      
Cash  $666 
Accounts Receivable   13,470 
Inventory   4,616 
Other Assets   5,392 
Property and equipment   638 
Goodwill   1,758 
Trade name   1,893 
Customer relationship   3,139 
Other intangible assets   899 
Assets acquired  $32,471 
Current liabilities assumed   (12,911)
Non-controlling interest   (6,508)
Net assets acquired  $13,052 

 

The following proforma unaudited revenue and earnings as if the acquisition had been included in the consolidated results of the company for the full year ending December 31, 2020.

 

   2021   2020 
   September 30, 
   2021   2020 
   (in thousands/unaudited) 
Revenue  $72,940   $66,110 
Net income (loss)  $(9,233)  $(7,892)

 

Individual pro forma results for each acquisition are not disclosed, as individually these acquisitions would not have a material impact on the Company’s financial statements.

 

F-12

 

 

NOTE 6 – CREDIT FACILITIES AND LINE OF CREDIT

 

We maintain operating lines of credit, factoring and revolving credit facilities with banks and finance companies to provide us working capital.

 

In July 2016, we entered into a Factoring and Security Agreement (the “FASA”) with Action Capital Corporation (“Action”) to establish a sale of accounts receivable credit facility, whereby we may obtain short-term financing by selling and assigning acceptable accounts receivable to Action. Pursuant to the FASA, the outstanding principal amount of advances made by Action at any time shall not exceed $6.0 million. Action reserves and withholds up to 5% of the face amount of each account purchased in a reserve account. As of September 30, 2021 and December 31, 2020, the balance outstanding was $5.8 million and $4.9 million, respectively.

 

The annual interest rate with respect to the daily average balance of unpaid advances outstanding under the FASA (computed on a monthly basis) is equal to the “Prime Rate” of Wells Fargo Bank N.A. plus 2.0%, plus a monthly fee equal to 0.75% of the average outstanding balance. We also pay all other costs incurred by Action under the FASA, including all bank fees. The FASA continues in full force and effect unless terminated by either party upon 30 days’ prior written notice. The FASA credit facility is collateralized with a security interest in certain assets of the Company. The FASA includes customary representations and warranties and default provisions for transactions of this type.

 

NOTE 7 – RELATED PARTY NOTES PAYABLE

 

Related party notes payable, consisted of the following as of:

 

   September 30, 2021   December 31, 2020 
In thousands        
Note payable –Marin  $480   $660 
Note payable –Thomet   300    413 
           
Note payable–Shareholder Convertible Note   -    43 
Total notes payable   780    1,116 
Less current portion   (390)   (433)
Long-term portion  $390   $683 

 

Note Payable -Marin

 

In December 2017, we entered into a $660 thousand, 1.89% annual interest rate note payable (the “Marin Note”) with two individuals from whom we previously acquired their company (in 2014). The Marin Note is payable in 60 monthly principal payments of $20 thousand beginning in October 2018. Accrued interest payable as of September 30, 2021, was $63 thousand. Accrued interest is payable at maturity.

 

Note Payable – Thomet

 

In December 2017, we entered into a $750 thousand, zero percent annual interest rate note payable (the “Thomet Note”) with an individual from whom we previously acquired his company (in 2014). The Thomet Note is payable in 60 monthly principal payments of $13 thousand beginning in October 2018.

 

Note Payable – Shareholder Convertible Note

 

In October 2018, we entered into a $700 thousand, 6% annual interest rate convertible note payable (the “Shareholder Convertible Note”) with Walefar and Campbeltown (collectively the “Holders”), in connection with the HTS Image Processing, Inc. Mr. Shai Lustgarten, our Chief executive Officer and Director is the principal shareholder in Walefar. Mr. Carlos J. Nissensohn, a consultant and significant shareholder in OMNIQ, is the principal shareholder in Campbeltown. The Shareholder Convertible Note was retired in 2021.

 

Future maturities of related party notes payable as of September 30, 2021, are as follows:

 

In thousands

      
2021   97 
2022   390 
2023   293 
2024   - 
Thereafter   - 
Total  $780 

 

F-13

 

 

NOTE 8 – OTHER NOTES PAYABLE

 

Other notes payable at September 30, 2021 and December 31, 2020, consists of the following:

 

(In thousands)  September 30, 2021   December 31, 2020 
Note Payable- Supplier  $2,843   $6,443 
           
All Other   5,125    7 
Total   7,968    6,450 
Less current portion   (5,641)   (6,449)
Long Term Notes Payable  $2,327   $1 

 

Note Payable - Supplier

 

On July 18, 2016, the Company and the Supplier entered into a certain secured promissory note, with an effective date of July 1, 2016, in the principal amount of $12.5 million (the “Secured Promissory Note”). The USD Note accrues interest at 18% per annum and is payable in six consecutive monthly installments of principal and accrued interest in a minimum principal amount of $250 thousand each, with any remaining principal and accrued interest due and payable on December 31, 2016.

 

  On September 7, 2018, the Company entered into a Sixth Amendment to the Secured Promissory Note (the “Sixth Amendment”) extending the maturity date to January 31, 2019. The Sixth Amendment also increases the principal amount to $8.7 million, an increase of $6.8 million, by rolling the Company’s then existing and outstanding accounts payable into the note by the previously mentioned amount of increase. The Company will continue to make monthly payments in the amount of $300 thousand for the first three monthly payments, and also in the amount of $500 thousand for the last two monthly payments prior to the note’s maturity.
     
  On April 30, 2019, the Company entered into a Seventh Amendment to the Secured Promissory Note (the “Seventh Amendment”) extending the maturity date to July 31, 2019. The Seventh Amendment also provides that the Company will continue to make monthly installments of principal and accrued interest in a minimum principal amount of $350 thousand each. The Company has made partial payments towards the required monthly installments under the terms of the Seventh Amendment.
     
  On July 20, 2021, the Company entered into the Eighth Amendment to the Secured Promissory Note (the “Eighth Amendment”) extending the maturity date to August 15, 2022 and reducing the interest rate from 18% to 10%. The Eighth Amendment also provides that the Company will continue to make monthly installments of principal and accrued interest at a minimum of $300 thousand each month. As has been the case with each previous amendment, the Company is in continual negotiations with the holder of the Secured Promissory Note to extend the maturity date and establish a new schedule of payments.

 

F-14

 

 

NOTE 9 – OTHER LIABILITIES

 

At September 30, 2021 and December 31, 2020, other liabilities consisted of the following:

 

(In thousands)  September 30, 2021   December 31, 2020 
Other vendor payable  $801   $801 
Dividend payable   1,164    253 
Bonus payable   -    27 
Others   2,888    1,477 
Total other liabilities   4,853    2,558 
Less Current Portion   (2,796)   (1,412)
Total long term other liabilities  $2,057   $1,146 

 

NOTE 10 – STOCKHOLDERS’ EQUITY

 

PREFERRED STOCK

 

Series A

 

As of September 30, 2021, there were 1,000,000 Series A preferred shares designated and no Series A preferred shares outstanding. The board of directors of the Company (the “Board”) had previously set the voting rights for the Series A preferred stock at 1 share of preferred to 250 common shares.

 

Series B

 

As of September 30, 2021, there was 1 preferred share designated and no preferred shares outstanding.

 

Series C

 

As of September 30, 2021, there were 3,000,000 Series C Preferred Shares (“Series C”) authorized with 745,030 issued and outstanding. The Series C shares have preferential rights above common shares and the Series B Preferred Shares and is entitled to receive a quarterly dividend at a rate of $0.06 per share per annum and have a liquidation preference of $1 per share. Series C shares outstanding are convertible into common stock at the rate of 20 preferred shares to one share of common stock. As of September 30, 2021, the accrued dividends on the Series C Preferred Stock was $106 thousand.

 

The Series C Preferred Stock has a liquidation value and conversion price of $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) and automatically converts into Common Stock at $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) in the event that the Company’s common stock has a closing price of $30 per share for 20 consecutive trading days.

 

COMMON STOCK

 

In August 2020, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain existing employees and attract new employees, directors, officers, consultants, and advisors to the Company. Pursuant to the Plan, one million (1,000,000) shares of the Company’s common stock, par value $0.001 (the “Shares”), were set aside and reserved for issuance. As of September 30, 2021, we had issued 361,146 shares or $1.8 million to consultants and advisors for services rendered.

 

In December 2015, our Board of Directors approved the OMNIQ. Employee Stock Purchase Plan (the “ESPP”). For the nine months ending September 30, 2021 employees purchased 1,376 or $14 thousand shares of commons stock.

 

On February 15, 2021 the Company issued 25,000 shares to Orion 4, LLC as part of a consulting agreement. The shares were valued at $188 thousand.

 

For the nine months ending September 30, 2021, 342,667 in stock options and stock warrants were exercised in exchange for 2,784,096 shares of OMNIQ common stock.

 

On July 8, 2021, the Company entered into a form of Securities Purchase Agreement (the “Securities Purchase Agreement”) with accredited investors. Pursuant to the Securities Purchase Agreement, on July 8, 2021 (the Closing Date”), the Company sold an aggregate gross proceeds of $15 million of units (the “Units”) before deducting placement agent fees, consultant and legal fees and other offering expenses (the “Offering”). The per Unit purchase price was $7.00.

 

Each Unit is comprised of one share of the Company’s common stock, $0.001 par value per share. As a result of the Offering, the Company issued 2,142,857 shares of common Stock (the “Shares”) and warrants (the “Warrants”) to purchase 171,429 shares of Common Stock (the “Warrant Shares”) at an exercise price equal to $7.70 per Warrant Share, which Warrants are exercisable for a period of five years from the issuance date.

 

ThinkEquity, a division of Fordham Financial Management, Inc. (the “Placement Agent”), acted as the sole placement agent for the Offering. In connection with the Offering, the Company entered into a Placement Agency Agreement with the Placement Agent, pursuant to which it paid the Placement Agent $1.2 million (eight percent of the gross proceeds) in commissions and reimbursed it for $150 thousand of expenses incurred in connection with the Offering plus other miscellaneous expenses. The Company also issued the Placement Agent a warrant (the “Placement Agent Warrant”) to purchase 171,429 shares of the Company’s common stock (the “Placement Agent Warrant Shares”) at an exercise price of $7.70 per share. The Placement Agent Warrant terminates five years from the Closing Date.

 

The Company paid additional legal and other fees directly related to the Offering. The cash fees paid were netted against the Offering proceeds, as follows:

 

(In thousands)    
Total proceeds from issuance of Common Stock and Warrants  $15,000 
      
Placement Agent fees   (1,455)
Commission, Legal and other fees   (264)
Total  $13,281 

 

The fair value of the Warrants issued to the Placement Agent and Consultant are included in the Warrants Paid in Capital account in stockholder’s equity.

 

F-15

 

 

Warrants

 

The following table summarizes information about warrants granted during the nine-month periods ended September 30, 2021 and 2020:

 

   September 30, 2021   September 30, 2020 
  

Number of

warrants

  

Weighted

Average

Exercise

Price

  

Number of

warrants

  

Weighted

Average

Exercise

Price

 
                 
Balance, beginning of period   1,366,667   $7.19    1,166,667   $6.42 
                     
Warrants granted   171,429         325,000    8.20 
Warrants expired   (15,000)   14.00    (10,000)   5.60 
Warrants cancelled, forfeited   -    -    -    - 
Warrants exercised   (119,167)   3.98    (150,000)   4.00 
                     
Balance, end of period   1,403,929   $7.45    1,331,667   $7.14 
                     
Exercisable warrants   1,320,596   $7.45    1,165,001   $7.08 

 

Outstanding warrants as of September 30, 2021 are as follows:

 

   Weighted Average       Weighted       Weighted 
Range of  residual life       Average       Average 
Exercise  span   Outstanding   Exercise   Exercisable   Exercise 
Prices  (in years)   Warrants   Price   Warrants   Price 
                     
7.00   3.27    847,500    7.00    847,500    7.00 
7.50   4.93    250,000    7.50    166,667    7.50 
7.70   4.77    171,429    7.70    171,429    7.70 
8.00   0.41    10,000    8.00    10,000    8.00 
10.00   1.23    125,000    10.00    125,000    10.00 
                          
7.00 to 10.00   3.42    1,403,929   $7.45    1,320,596   $7.45 

 

Warrants outstanding at September 30, 2021 and 2020 have the following expiry date and exercise prices:

 

   Exercise         
Expiry Date  Prices   2021   2020 
             
October 10, 2020   12.00    -    15,000 
December 30, 2020   4.00    -    - 
February 02, 2021   14.00    -    15,000 
August 02, 2021   2.20    -    75,000 
October 10, 2021   10.00    25,000    25,000 
February 27, 2022   8.00    10,000    10,000 
May 18, 2023   10.00    50,000    50,000 
October 14, 2023   10.00    50,000    - 
October 06, 2024   7.00    793,667    891,667 
September 01, 2025   7.50    83,334    83,334 
June 04, 2026   7.50    83,333    83,333 
July 8, 2026   7.70    171429    - 
December 04, 2027   7.50    83,333    83,333 
                
         1,403,929    1,231,667 

 

F-16

 

 

Stock Options

 

The following table summarizes information about stock options granted during the nine months ended September 30, 2021 and 2020:

 

   September 30, 2021   September 30, 2020 
  

Number of

stock options

  

Weighted

Average

Exercise Price

  

Number of

stock options

  

Weighted

Average

Exercise Price

 
                 
Balance, beginning of period   1,811,550   $4.32    1,133,550   $4.00 
                     
Stock options granted   -         775,000    4.63 
Stock options expired   -         (30,250)   3.98 
Stock options cancelled, forfeited   (28,750)        -      
Stock options exercised   (223,500)        (66,750)   2.51 
                     
Balance, end of period   1,559,300   $4.58    1,811,550   $4.32 
                     
Exercisable stock options   1,070,133   $4.56    959,550   $4.02 

 

On September 30, 2020, the Company granted 775,000 stock options. These options were granted as part of the asset acquisition described in Note 4, and to a member of the board of advisors, and to certain employees as part of the Company’s Equity Incentive Plan.

 

Outstanding stock options as of September 30, 2021 are as follows:

 

Range of

Exercise

Prices

  

Weighted

Average

residual life

span

(in years)

   Outstanding Stock Options  

Weighted

Average

Exercise

Price

  

Exercisable Stock

Options

  

Weighted

Average

Exercise

Price

 
                      
$1.50    0.38    38,017   $1.50    38,017   $1.50 
$1.80    0.38    76,033   $1.80    76,033   $1.80 
$                          
$2.40    1.43    247,000   $2.40    247,000   $2.40 
$4.20    3.55    10,000   $4.20    7,500   $4.20 
$4.40    8.24    404,000   $4.40    170,667   $4.40 
$4.84    9.00    380,000   $4.84    126,667   $4.84 
$5.00    1.77    147,500   $5.00    142,500   $5.00 
$5.40    2.17    131,750   $5.40    131,750   $5.40 
$10.00    3.14    125,000   $10.00    125,000   $10.00 
                            
$ 1.50 to 10.00    5.16    1,564,300   $4.58    1,032,116   $4.73 

 

Stock options outstanding at September 30, 2021, and 2020 have the following expiration date and exercise prices:

 

Expiration Date  Exercise Prices   September 30, 2021   September 30, 2020 
August 2, 2021  $2.20    -    175,000 
February 17, 2022  $1.50    38,017    38,017 
February 17, 2022  $1.80    76,033    76,033 
February 28, 2023  $5.00    20,000    - 
March 5, 2023  $2.40    247,000    340,000 
July 31, 2023  $5.00    127,500    127,500 
October 31, 2023  $4.40    59,000    108,250 
November 30, 2023  $5.40    131,750    143,750 
November 20, 2024  $10.00    125,000    125,000 
April 20, 2025  $4.20    10,000    - 
September 30, 2030  $4.40    350,000    - 
September 30, 2030  $4.84    380,000    - 
                
         1,564,300    1,073,300 

 

F-17

 

 

NOTE 11 – COMMITMENTS AND CONTINGENCIES

 

Profit Sharing Plan

 

We maintain a contributory profit-sharing plan covering substantially all fulltime employees within the requirements of the Employee Retirement Income Security Act of 1974 (“ERISA”). In 2016, the Safe Harbor element was removed from the plan and the employer may make a discretionary matching contribution equal to a uniform percentage or dollar amount of participants’ elective deferrals for each Plan Year. In 2015, we were required to make a safe harbor non-elective contribution equal to 3 percent of a participant’s compensation. The plan also includes a 401(k) savings plan feature that allows substantially all employees to make voluntary contributions and provides for discretionary matching contributions determined annually by the Board of Directors. For the nine months ending September 30, 2021, we elected to forgo the match.

 

Operating Leases

 

As of September 30, 2021, we had 8 operating leases as follows:

 

  Office space in Akron, Ohio, with monthly payments of $3 thousand and an incremental borrowing rate of 14.55%. As of September 30, 2021, we had 20 months remaining on the lease.
     
  A vehicle with monthly payments of less than $1 thousand. As of September 30, 2021, the Company had 5 months remaining on the lease.
     
  Office space in Salt Lake City, UT, with monthly payments of $22 thousand. As of September 30, 2021 the company had 58 months remaining on the lease.

 

  Yad haruzim -Dangot main office in Tel-Aviv . with monthly payments of between 62500 NIS to 65365 NIS . As of September 30, 2021, we had 38 months remaining on the lease.
     
  Gamdan office in Tel-Aviv. with monthly payments of between 21,080 NIS to 22,134 NIS . As of September 30, 2021, we had 27 months remaining on the lease.
     
  Rival warehouse in Tel Aviv. . with monthly payments of between 40,000 NIS to 41,200 NIS. As of September 30, 2021, we had 45 months remaining on the lease.
     
  Hofman warehouse in Tel Aviv. . with monthly payments of between 3,500 NIS. As of September 30, 2021, we had 33 months remaining on the lease.
     
  Rental cars- Variable payments, between NIS 2,000 and NIS 6,000 for about 65 employees with 36 payments.

 

NOTE 12 – LITIGATION 

 

In September 2020 the Company was named as a defendant in a Mississippi state lawsuit (the “Mississippi case”) filed by Riverland Technologies LLC (“Riverland”) in the Circuit Court of Rankin County, Mississippi. The subject matter of the Mississippi case directly relates to the RedLPR case, to which Riverland was also a party. Subject to a settlement between the Company and Riverland, all of Riverland’s claims against the Company in the Mississippi case have been dismissed, and the Company is no longer a party to the Mississippi case.

 

The Company was named a defendant in a case involving a former employee who claims he is owed approximately $60 thousand in unpaid commissions. This case was filed in the Superior Court of the State of California, County of San Diego on October 21, 2020. The Company believes the claim is without merit and intends to defend itself against said claim.

 

The Company is not a party to any other pending material legal proceeding. To the knowledge of management, no federal, state or local governmental agency is presently contemplating any proceeding against the Company. To the knowledge of management, no director, executive officer or affiliate of the Company, any owner of record or beneficially of more than five percent of the Company’s Common Stock is a party adverse to the Company or has a material interest adverse to the Company in any proceeding.

 

NOTE 13 – RELATED PARTY TRANSACTIONS

 

Related party transactions are discussed in Note 7.

 

NOTE 14 – SUBSEQUENT EVENTS

 

The Company assessed potential subsequent events and there were none as of the filing date.

 

F-18

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

PRELIMINARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements include statements preceded by, followed by or that include the words “may”, “could”, “would”, “should”, “believe”, “expect”, “anticipate”, “plan”, “estimate”, “target”, “project”, “intend”, “foresee” and similar expressions. These statements include, among others, statements regarding our expected business outlook, anticipated financial and operating results, our business strategy and means to implement the strategy, our objectives, the amount and timing of capital expenditures, the likelihood of our success in expanding our business, financing plans, budgets, working capital needs and sources of liquidity. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.

 

Forward-looking statements are only predictions and are not guarantees of performance. These statements are based on our management’s beliefs and assumptions, which in turn are based on currently available information. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding demand for our products, the expansion of product offerings geographically or through new marketing applications, the timing and cost of planned capital expenditures, competitive conditions and general economic conditions. These assumptions could prove inaccurate. Forward-looking statements also involve known and unknown risks and uncertainties, which could cause actual results to differ materially from those contained in any forward-looking statement. In addition, even if our actual results are consistent with the forward-looking statements contained in this Quarterly Report on Form 10-Q, those results may not be indicative of results or developments in subsequent periods.

 

Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the Securities and Exchange Commission (“SEC”), we are under no obligation to publicly update or revise any forward-looking statements after we file this Quarterly Report on Form 10-Q, whether as a result of any new information, future events or otherwise. Investors, potential investors and other readers are urged to consider the above-mentioned factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results or performance.

 

For a more detailed discussion of some of the foregoing risks and uncertainties, see Item 1A — “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 and Item 1A — “Risk Factors” in this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, as well as other reports and registration statements filed by us with the SEC. These factors should not be construed as exhaustive and should be read with other cautionary statements in this Quarterly Report on Form 10-Q and our other public filings. For more information about us and the announcements we make from time to time, visit our Internet website at www.omniq.com.

 

Introduction

 

We use patented and proprietary artificial intelligence (AI) technology to deliver data collection, real time surveillance and monitoring for supply chain management, homeland security, public safety, traffic & parking management and access control applications. The technology and services we provide helps our clients move people, assets and data safely and securely through airports, warehouses, schools, national borders, and many other applications and environments.

 

We offer end-to-end solutions that include hardware, software, communications, and full lifecycle management services. We are an established manufacturer and distributor of barcode labels, tags, and ribbons, as well as RFID labels and tags. Our highly tenured team of professionals has the knowledge and expertise to simplify the integration process for our customers, and our team delivers proven problem-solving solutions backed by numerous customer references. We offer comprehensive packaged and configurable software and we are a leading provider of best-in-class mobile and wireless equipment.

 

4

 

 

Our customers include government agencies and leading Fortune 500 companies from diverse sectors, including healthcare, food and beverage, manufacturing, retail, distribution, transportation and logistics, and oil, gas, and chemicals.

 

The following is a discussion of our financial condition, results of operations, financial resources, and working capital. This discussion and analysis should be read in conjunction with our unaudited condensed consolidated financial statements contained in this Form 10-Q.

 

OVERVIEW

 

The Company’s sales from continuing operations for the nine months ended September 30, 2021 were $53.4 million, an increase of approximately $11.1 million, or 26.2%, over the nine months ended September 30, 2020.

 

The loss from continuing operations for the nine months ended September 30, 2021 was $8.9 million, an increase of $2.5 million compared with the loss in the nine months ended September 30, 2020 of $6.4 million. Basic loss per share from continuing operations for the nine months ended September 30, 2021 was ($1.80) versus ($0.04) per share for the same time period in 2020.

 

SUBSEQUENT EVENT

 

GOING CONCERN

 

The accompanying unaudited condensed consolidated financial statements have been prepared assuming that we will continue as a going concern. As of September 30, 2021, we had a working capital deficit of $16.6 million and an accumulated deficit of $67.9 million. These facts and others have in the past raised concerns about the Company’s ability to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, which we have successfully accomplished to date.

 

Management has evaluated and assessed the Company’s ability to continue as a going concern. We believe that the achievements of the following positive factors alleviated the substantial doubt about our ability to continue as a going concern (not all inclusive):

 

  The successful capital raise of $15 million.
  The Company’s cash balance at September 30, 2021 of $9.99 million.
  The Company’s acquisition of Dangot Computers, Ltd. has improved the balance sheet, profitability and cash flow.
  The Company’s favorable settlement with a major creditor. Reference note 8 supplier note.
  The Company’s up-listing to the NASDAQ stock exchange enhancing the potential to issue additional stock.
  The Company’s historical ability to continue operations and meet cash flow requirements.

 

Management considers these factors in the aggregate and believes that the Company has alleviated the substantial doubt as its ability to continue as a going concern.

 

Results of Operations

 

The following tables set forth certain selected unaudited condensed consolidated statement of operations data for the periods indicated in dollars. In addition, we note that the period-to-period comparison may not be indicative of future performance.

 

5

 

 

(In thousands, except per share data)  Three months ended September 30,   Variation 
   2021   2020   $   % 
Revenue  $20,513   $15,833    4,680    29.6%
Cost of Goods sold   15,842    13,024    2,815    21.6%
Gross Profit   4,671    2,809    1,862    66.3%
Operating Expenses   6,801    5,830    971    16.7%
Income (loss) from operations   (2,130)   (3,021)   891    (29.5)%
Net loss from continuing operations   (4,214)   (3,781)   (433)   11.5%
Net Loss per common Share  $(0.68)  $(0.83)   0.15    (17.9)%

 

Revenues

 

For the three months ended September 30, 2021 and 2020, the Company generated net revenues in the amount of $20.5 million and $15.8 million, respectively. The increase between the three-month periods was attributable to the additional sales channel’s provided by the acquisition of Dangot.

 

Cost of Goods Sold

 

For the three months ended September 30, 2021 and 2020, the Company recognized a total of $15.8 million and $13 million, respectively, of cost of goods sold. For the three months ended September 30, 2021 and 2020, cost of goods sold were 77.2% and 82.2% of net revenues, respectively. The 2021 decrease in cost of goods sold as a percentage of net revenue was attributable to discounts being granted during the Covid pandemic which are no longer being offered.

 

Operating expenses

 

Total operating expense for the three months ended September 30, 2021 and 2020 recognized was $6.8 million and $5.8 million, respectively, representing an 16.7% increase. The increases are related to the additional operations from Dangot.

 

Research and Development – Research and development expenses for the three months ended September 30, 2021 and 2020 totaled $474 thousand and $428 thousand, respectively, representing a 10.7% increase. The increases are primarily attributed to expanding our range of solutions offered and development of the AI proprietary products.

 

Selling, general and Administrative – Selling, general and administrative expenses for the three months ended September 30, 2021 and 2020 totaled $6.8 million and $4.8 million, respectively, representing a 41% increase. The increase was due primarily to increased number of employees and operating activities from the acquisition of Dangot.

 

Depreciation – Depreciation expenses for the three months ended September 30, 2021 and 2020 totaled $82 thousand and $44 thousand, respectively, representing an 86.3% increase. The increase is directly increased by the acquisition of additional fixed assets.

 

Intangible amortization – Intangible amortization expenses for the three months ended September 30, 2021 and 2020 totaled $1.5 million and $550 thousand, respectively. The increase is directly increased by the acquisition of additional intangible assets and the amortization of the acquired workforce.

 

Other income and expenses

 

Interest Expense - Interest expense for the three months ended September 30, 2021 totaled $587 thousand, as compared to $744 thousand for the three months ended September 30, 2020. The decrease is primarily attributable to renegotiated terms with lenders and vendors.

 

6

 

 

(In thousands, except per share data) 

Nine months ended September 30,

   Variation 
   2021   2020   $   % 
Revenue  $53,383   $42,309    11,074    26.2%
Cost of Goods sold   42,778    33,886    8,889    26.2%
Gross Profit   10,605    8,423    2,182    25.9%
Operating Expenses   15,348    14,794    554    3.7%
Income (loss) from operations   (4,743)   (6,371)   1,628    (25.6)%
Net loss from continuing operations   (8,921)   (8,646)   (275)   3.2%
Net Loss per common Share  $(1.47)  $(2.03)   0.56    (27.7)%

 

Revenues

 

For the nine months ended September 30, 2021 and 2020, the Company generated net revenues in the amount of $53.4 million and $42.3 million, respectively. The increase between the nine-month periods was attributable to stronger fulfillment and deliveries by the Company and demand by certain customers in connection with the COVID-19 pandemic and the additional sales channel’s provided by the acquisition of Dangot.

 

Cost of Goods Sold

 

For the nine months ended September 30, 2021 and 2020, the Company recognized a total of $42.8 million and $33.9 million, respectively, of cost of goods sold. For the nine months ended September 30, 2021 and 2020, cost of goods sold were 80.13% and 80.09% of net revenues, respectively.

 

Operating expenses

 

Total operating expense for the nine months ended September 30, 2021 and 2020 recognized was $19.5 million and $14.8 million, respectively, representing an 32% increase.

 

Research and Development – Research and development expenses for the nine months ended September 30, 2021 and 2020 totaled $1.4 million and $1.3 million, respectively, representing a 14% increase.

 

Selling, general and Administrative – Selling, general and administrative expenses for the nine months ended September 30, 2021 and 2020 totaled $15 million and $11.8 million, respectively, representing a 29.7% increase. The increase was due primarily number of employees and operating activities from the acquisition of Dangot.

 

Depreciation – Depreciation expenses for the nine months ended September 30, 2021 and 2020 totaled $167 thousand and $134 thousand, respectively, representing an 24.6% decrease. The increase is directly increased by the acquisition of additional fixed assets.

 

Intangible amortization – Intangible amortization expenses for the nine months ended September 30, 2021 and 2020 totaled $2.6 million and $1.6 million, respectively.

 

Other income and expenses

 

Interest Expense - Interest expense for the nine months ended September 30, 2021 totaled $1.9 million, as compared to $2 million for the nine months ended September 30, 2020.

 

7

 

 

Net loss from operations

 

The Company realized a net loss from continuing operations of $8.9 million for the nine months ended September 30, 2021, compared to a net loss of $8.6 million for the nine months ended September 30, 2020, an increase of $300 thousand.

 

The decrease in net loss between the nine-month periods is mainly attributable to the Company’s acquisition of Dangot.

 

Liquidity and capital resources

 

As of September 30, 2021, the Company had cash in the amount of $10 million of which $75 thousand is on deposit and a working capital deficit of $16.9 million, compared to cash in the amount of $5.1 million, of which $.5 million was restricted, and a working capital deficit of $25.3 million as of December 31, 2020. In addition, the Company had a stockholders’ deficit of $10.7 million as of September 30, 2021 and stockholders’ deficit of $5 million as of December 31, 2020.

 

The Company’s accumulated deficit was $67.9 million and $56.7 million on September 30, 2021, and December 31, 2020, respectively.

 

The Company’s operations resulted in net cash used of $1.7 million during the nine months ended September 30, 2021, compared to net cash provided of $1.5 million during the nine months ended September 30, 2020, a decrease of $1.2 million.

 

Net cash used in investing activities was $5.4 million for the nine months ended September 30, 2021, compared to net cash provided of $61 thousand for the nine months ended September 30, 2020, an increase of $5.5 million.

 

The Company’s financing activities provided net cash of $12 million during the nine months ended September 30, 2021, compared to net cash provided of $1.9 million during the nine months ended September 30, 2020.

 

Inflation

 

The Company’s results of operations have not been affected by inflation and management does not expect inflation to have a material impact on its operations in the future.

 

Off- Balance Sheet Arrangements

 

The Company currently does not have any off-balance sheet arrangements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not Applicable

 

ITEM 4. CONTROLS AND PROCEDURES

 

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

 

The Company’s management, with the participation of our principal executive officer and our principal financial officer, evaluated the effectiveness of our disclosure controls and procedures (as that term is defined in Rule 13a-15(e)) as of September 30, 2021, the end of the period covered by this Quarterly Report on Form 10-Q.

 

8

 

 

Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer (Principal Financial and Accounting Officer) concluded that, as of September 30, 2021, our disclosure controls and procedures were ineffective as of the end of the period covered to ensure that information required to be disclosed in our reports filed with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to the Company’s management, including its principal executive officer and its principal financial officer, as appropriate to allow timely decisions regarding required disclosure. This was due to the following material weaknesses which are indicative of many small companies with limited staff: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of accounting principles generally accepted in the United States of America and Securities and Exchange Commission guidelines. Management anticipates that such disclosure controls and procedures will not be effective until the material weaknesses are remediated.

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act are recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to management, including our Principal Executive Officer, and our Principal Financial and Accounting Officer, to allow timely decisions regarding required disclosure.

 

During 2020, we identified material weaknesses in our internal control over financial reporting, which were disclosed in our annual report on Form 10-K filed with the SEC on March 31, 2021.

 

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

 

There were no changes in our internal control over financial reporting that occurred during the nine months ended September 30, 2021, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

In September 2020 the Company was named as a defendant in a Mississippi state lawsuit (the “Mississippi case”) filed by Riverland Technologies LLC (“Riverland”) in the Circuit Court of Rankin County, Mississippi. The subject matter of the Mississippi case directly relates to the RedLPR case, to which Riverland was also a party. Subject to a settlement between the Company and Riverland, all of Riverland’s claims against the Company in the Mississippi case have been dismissed, and the Company is no longer a party to the Mississippi case.

 

The Company was named a defendant in a case involving a former employee who claims he is owed approximately $60 thousand in unpaid commissions. This case was filed in the Superior Court of the State of California, County of San Diego on October 21, 2020. The Company believes the claim is without merit and intends to defend itself against said claim.

 

The Company is not a party to any other pending material legal proceeding. To the knowledge of management, no federal, state or local governmental agency is presently contemplating any proceeding against the Company. To the knowledge of management, no director, executive officer or affiliate of the Company, any owner of record or beneficially of more than five percent of the Company’s Common Stock is a party adverse to the Company or has a material interest adverse to the Company in any proceeding.

 

ITEM 1A. RISK FACTORS

 

Not applicable.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

None.

 

9

 

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

Not applicable.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

None.

 

WHERE YOU CAN FIND ADDITIONAL INFORMATION

 

We have filed with the Securities and Exchange Commission this Form 10-Q, including exhibits. You may read and copy all or any portion of the registration statement or any reports, statements or other information in the files at SEC’s Public Reference Room located at 100 F Street, NE., Washington, DC 20549, on official business days during the hours of 10 a.m. to 3 p.m.

 

You can request copies of these documents upon payment of a duplicating fee by writing to the Commission. You may call the Commission at 1-800-SEC-0330 for further information on the operation of its public reference room. Our filings, including the registration statement, will also be available to you on the website maintained by the Commission at http://www.sec.gov.

 

We intend to furnish our stockholders with annual reports which will be filed electronically with the SEC containing consolidated financial statements audited by our independent auditors, and to make available to our stockholders quarterly reports for the first three quarters of each year containing unaudited interim consolidated financial statements.

 

Our website is located at http://www.omniq.com. The Company’s website and the information to be contained on that site, or connected to that site, is not part of or incorporated by reference into this filing.

 

10

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: November 15, 2021

 

OMNIQ CORP.  
     
By: /s/ Shai Lustgarten  
  Shai Lustgarten  
  President and Chief Executive Officer  

 

11

 

 

EXHIBIT INDEX

 

10.1   Share purchase Agreement dated May 3, 2021, by and between OMNIQ Corp, OMNIQ Technologies Ltd. and Haim dangot. (incorporated by reference to the Current Report on Form 8-k filed with the SEC on May 6, 2021)
     
10.2   Conversion Agreement dated May 3, 2021 by and between OMNIQ Corp. and Jason Griffith (incorporated by reference to the current Report on Form 8-k filed with the SEC on May 6, 2021)
     
31.1   Certification of our Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of our Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1   Certification of our Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)

 

101.INS  

Inline XBRL Instance Document.

     
101.SCH  

Inline XBRL Taxonomy Extension Schema Document.

     
101.CAL  

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

     
101.DEF  

Inline XBRL Taxonomy Extension Definition Linkbase Document.

     
101.LAB  

Inline XBRL Taxonomy Extension Label Linkbase Document.

     
101.PRE  

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

     
104  

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

12

 

EX-31.1 2 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13a-14(a) UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

I, Shai Lustgarten, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2021 of OMNIQ Corp.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 15, 2021 /s/ Shai Lustgarten
  Shai Lustgarten,
  Chief Executive Officer

 

 

 

EX-31.2 3 ex31-2.htm

 

EXHIBIT 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(a) UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

I, Neev Nissenson, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2021 of OMNIQ Corp.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 15, 2021 /s/ Neev Nissenson
  Neev Nissenson
  Chief Financial Officer

 

 

 

EX-32.1 4 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13a-14(b) UNDER

THE SECURITIES EXCHANGE ACT OF 1934 AND SECTION 1350 OF

CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE

 

Each of the undersigned, Shai Lustgarten and Neev Nissenson, certifies pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code, that (1) this quarterly report on Form 10-Q for the quarter ended September 30, 2021 of OMNIQ Corp. (the “Company”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, and (2) the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 15, 2021

 

  /s/ Shai Lustgarten
  Shai Lustgarten,
  Chief Executive Officer
   
  /s/ Neev Nissenson
  Neev Nissenson
  Chief Financial Officer

 

 

 

EX-101.SCH 5 omqs-20210930.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flow (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - NATURE OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - CONCENTRATIONS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - BUSINESS ACQUISITION link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - CREDIT FACILITIES AND LINE OF CREDIT link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - RELATED PARTY NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - OTHER NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - OTHER LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - LITIGATION link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - BUSINESS ACQUISITION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - RELATED PARTY NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - OTHER NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - OTHER LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - STOCKHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - CONCENTRATIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - SCHEDULE OF PROFORMA UNAUDITED REVENUE AND EARNINGS (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - BUSINESS ACQUISITION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - CREDIT FACILITIES AND LINE OF CREDIT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - SCHEDULE OF NOTES PAYABLE, RELATED PARTIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - SCHEDULE OF FUTURE MATURITIES OF NOTES PAYABLE, RELATED PARTIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - RELATED PARTY NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SCHEDULE OF OTHER NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - OTHER NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - SCHEDULE OF OTHER LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - SCHEDULE OF ADDITIONAL LEGAL AND OTHER FEES RELATED TO OFFERING (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - SCHEDULE OF STOCK OPTIONS GRANTED (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - SCHEDULE OF OUTSTANDING STOCK OPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - LITIGATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 omqs-20210930_cal.xml INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 omqs-20210930_def.xml INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 omqs-20210930_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Finite-Lived Intangible Assets by Major Class [Axis] Trade Names [Member] Customer Relationships [Member] Other Intangible Assets [Member] Class of Stock [Axis] Series A Preferred Stock [Member] Series B Preferred Stock [Member] Series C Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Treasury Stock [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Antidilutive Securities [Axis] Share-based Payment Arrangement, Option [Member] Convertible Preferred Stock [Member] Warrant [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Two Customers [Member] Accounts Receivable [Member] Four Customers [Member] One Customers [Member] Accounts Payable [Member] One Vendor [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Asset Purchase Agreement [Member] Business Acquisition [Axis] Eyepax I T Consulting L L C [Member] Employment Agreement [Member] Title of Individual [Axis] Mr Caldera [Member] Definitive Acquisition Agreement [Member] Dangot Computers Ltd [Member] Series [Axis] Omniq Technologies [Member] Securities Purchase Agreement [Member] Haim Dagot [Member] Haim Dangot [Member] Dangot Shares [Member] Factoring and Security Agreement [Member] Document and Entity Information Variable Rate [Axis] Prime Rate [Member] Debt Instrument [Axis] Note Payable Marin [Member] Note Payable Thomet [Member] Note Payable - Shareholder Convertible Note [Member] Marin Note [Member] Thomet Note [Member] Share holder Convertible Note [Member] Note Payable- Supplier [Member] All Other [Member] Long-term Debt, Type [Axis] Secured Promissory Note [Member] Sixth Amendment Agreement [Member] First Three Monthly Payments [Member] Last Two Monthly Payments [Member] Scenario [Axis] First Minimum Payment [Member]. Eighth Amendment [Member] Director [Member] Plan Name [Axis] Equity Incentive Plan [Member] Consultants and Advisors [Member] Employee Stock Purchase Plan [Member] Orion 4, LLC [Member] Consulting Agreement [Member] Placement Agency Agreement [Member] Exercise Price Range [Axis] Exercise Price Range 1 [Member] Exercise Price Range 2 [Member] Exercise Price Range 3 [Member] Exercise Price Range 4 [Member] Exercise Price Range Five [Member] Award Date [Axis] October 10, 2020 [Member] December 30, 2020 [Member] February 02, 2021 [Member] August 2, 2021 [Member] October 10, 2021 [Member] February 27, 2022 [Member] May 18, 2023 [Member] October 14, 2023 [Member] October 6, 2024 [Member] September 1, 2025 [Member] June 4, 2026 [Member] July 8, 2026 [Member] December 4, 2027 [Member] Option Indexed to Issuer's Equity, Type [Axis] Stock Options [Member] Exercise Price Range 6 [Member] Exercise Price Range 7 [Member] Exercise Price Range 8 [Member] Exercise Price Range 9 [Member] February 17, 2022 [Member] February 17, 2022 [Member] February 28, 2023 [Member] March 05, 2023 [Member] July 31, 2023 [Member] October 31, 2023 [Member] November 30, 2023 [Member] November 20, 2024 [Member] April 20, 2025 [Member] September 30, 2030 [Member] September 30, 2030 [Member] Award Type [Axis] Geographical [Axis] Akron [Member] Vehicle Lease [Member] Salt Lack City [Member] Salt Lake City UT [Member] Yad Haruzim [Member] Gamdan Office [Member] Rival Ware House [Member] Hofman [Member] Rental Cars [Member] Sixty Five Employees [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement [Table] Statement [Line Items] ASSETS Current assets Cash and cash equivalents Accounts receivable, net Inventory Prepaid expenses Other current assets Total current assets Property and equipment, net of accumulated depreciation of $767 and $555 respectively Goodwill Trade name, net of accumulated amortization of $3,714 and $1,156, respectively Customer relationships, net of accumulated amortization of $9,279 and $4,885, respectively Other intangibles, net of accumulated amortization of $1,402 and $1,104, respectively Restricted Cash Right of use lease asset Other assets Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities Accounts payable and accrued liabilities Line of credit Accrued payroll and sales tax Notes payable, related parties – current portion Notes payable – current portion Lease liability – current portion Other current liabilities Total current liabilities Long term liabilities Notes payable, related party, less current portion Accrued interest and accrued liabilities, related party Notes payable, less current portion Lease liability Other long-term liabilities Total liabilities Stockholders’ equity (deficit) Preferred Stock Value Common stock; $0.001 par value; 15,000,000 shares authorized; 7,448,597 and 4,684,736 shares issued and outstanding, respectively. Additional paid-in capital Accumulated (deficit) Cumulative Translation Adjustment Total OmniQ stockholders’ equity (deficit) Non-controlling interest TOTAL EQUITY (DEFICIT) Total liabilities and equity (deficit) Property and equipment, accumulated depreciation Finite-Lived Intangible Assets, Accumulated Amortization Preferred stock, par value Preferred stock, shares designated Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares, issued Common stock, shares, outstanding Income Statement [Abstract] Revenues Total Revenues Cost of goods sold Cost of goods sold Gross profit Operating expenses Research & Development Selling, general and administrative Depreciation Amortization Total operating expenses Loss from operations Other income (expenses): Interest expense Other (expenses) income Total other expenses Net Loss Before Income Taxes Provision for Income Taxes Current Total Provision for Income Taxes Net Loss Net income attributable to noncontrolling interest Net Loss attributable to OmniQ Corp Net loss Foreign currency translation adjustment Comprehensive loss Reconciliation of net loss to net loss attributable to common shareholders Less: Preferred stock – Series C dividend Net loss less series C dividend Net income after series C dividend attributable to noncontrolling interest Net loss after series C dividend attributable to common stockholders’ of OmniQ Corp Net (loss) per share - basic attributable to common stockholders’ of OmniQ Corp Weighted average number of common shares outstanding - basic Beginning balance, value Shares, Outstanding, Beginning Balance Dividend on Class C Shares Accumulated other comprehensive loss Stock-based compensation – options and warrants Subscribed common stock Subscribed common stock, shares Professional fees – restricted shares Stock Issued During Period, Shares, Restricted Stock Award, Gross Exercise of stock options and warrants exercise of stock options and warrants, shares Conversion agreements - preferred shares Converion agreements - preferred shares, shares Conversion agreements - debt ESPP Stock Issuance ESPP Stock Issuance, shares Stock-based compensation – options, warrants, issuances Stock and warrant issuances, net of issuance costs Stock and warrant issuances, net of issuance costs, shares Stock and Warrant issued for services Stock and Warrant issued for service, shares Stock and warrant issuance for Acquisition Stock and warrant issuance for Acquisition, shares Cumulative translation adjustment Other misc. items Noncontrolling interests - distributions and other Conversion of Equity Conversion of Equity, shares Conversion of debt Conversion of debt, Shares Post acquisition adjustment Dangot Acquisition Net (loss) income Ending balance, value Shares, Outstanding, Ending Balance Statement of Cash Flows [Abstract] Cash flows from continuing operating activities: Adjustments to reconcile net loss to net cash (used in) provided by operating activities: Stock based compensation Amortization of ROU lease asset Depreciation and amortization Changes in operating assets and liabilities: Accounts receivable Prepaid expenses Inventory Accounts payable and accrued liabilities Accrued interest and accrued liabilities, related party Accrued payroll and sales taxes payable Other Current assets Lease liability Other liabilities Net cash (used in) provided by operating activities Cash flows from investing activities: Payments for acquisition, net of cash acquired Other assets Purchase of property and equipment Net cash provided by (used in) investing activities Cash flows from financing activities: Proceeds from private placement Proceeds from ESPP stock issuance Proceeds from / (payments on) line of credit Net proceeds from Warrant exercise Net Proceeds from Options Exercise Proceeds from notes/loans payable Payment on notes/loans payable Net cash provided by (used in) financing activities Net increase (decrease) in cash Cash and restricted cash, beginning of period Foreign currency Exchange Cash and restricted cash, end of period Cash paid for interest Cash paid for taxes Supplementary for non-cash flow information: Right of use lease asset Stock issued for services Net assets acquired in business combination Intangible assets acquired in non-cash exchange Conversion of notes payable Stock options and warrants issued Organization, Consolidation and Presentation of Financial Statements [Abstract] NATURE OF OPERATIONS Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES GOING CONCERN Risks and Uncertainties [Abstract] CONCENTRATIONS Business Combination and Asset Acquisition [Abstract] BUSINESS ACQUISITION Debt Disclosure [Abstract] CREDIT FACILITIES AND LINE OF CREDIT Related Party Notes Payable RELATED PARTY NOTES PAYABLE OTHER NOTES PAYABLE Other Liabilities Disclosure [Abstract] OTHER LIABILITIES Equity [Abstract] STOCKHOLDERS’ EQUITY Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES LITIGATION Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Subsequent Events [Abstract] SUBSEQUENT EVENTS Principles of Consolidation and Basis of Presentation Use of Estimates Goodwill and Intangibles Foreign Currency Translation Net Loss Per Common Share Purchase Accounting and Business Combinations Revenue Recognition. Stock-Based Compensation Recent Accounting Pronouncements Reclassifications and Comparability SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED SCHEDULE OF PROFORMA UNAUDITED REVENUE AND EARNINGS SCHEDULE OF NOTES PAYABLE, RELATED PARTIES SCHEDULE OF FUTURE MATURITIES OF NOTES PAYABLE, RELATED PARTIES SCHEDULE OF OTHER NOTES PAYABLE SCHEDULE OF OTHER LIABILITIES SCHEDULE OF ADDITIONAL LEGAL AND OTHER FEES RELATED TO OFFERING SCHEDULE OF WARRANTS ACTIVITY SCHEDULE OF OUTSTANDING WARRANTS SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES SCHEDULE OF STOCK OPTIONS GRANTED SCHEDULE OF OUTSTANDING STOCK OPTIONS SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Potential shares excluded from diluted net loss per share Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Impairment of goodwill Finite-Lived Intangible Asset, Useful Life Weighted average number of diluted shares outstanding Working capital deficit Accumulated deficit Raise capital Cash Concentration Risk [Table] Concentration Risk [Line Items] Concentration Risk, Percentage Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Cash payments Accrued payable to owner Fair value of stock issued (220,103 shares) Debt assumed Total consideration Cash Accounts Receivable Inventory Other Assets Property and equipment Goodwill Trade name Customer relationship Other intangible assets Assets acquired Current liabilities assumed Non-controlling interest Net assets acquired Business acquisition stock issued, shares Revenue Net income (loss) Cash purchase price Number of shares will be issued Number of options granted to purchase common stock Weighted average exercise price, stock options granted Stock options, expiration date Annual salary Acquisition percentage Stock issued Stock issued during period, new issues Stock issued during period, restricted shares Number of trading days Remaining acquired percentage Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Line of credit, maximum borrowing capacity Percentage of reserve account Line of credit Line of credit facility, unused capacity, commitment fee percentage Schedule of Short-term Debt [Table] Short-term Debt [Line Items] Total notes payable Less: current portion Long Term Notes Payable Schedule Of Future Maturities Of Notes Payable Related Parties 2021 2022 2023 2024 Thereafter Total Note payable, related parties Debt instruments interest rate Monthly principal payments Accrued interest payable Total notes payable Less current portion Total notes payable Debt instrument face amount Debt instruments periodic payment Debt instrument, increase, accrued interest Interest rate Other vendor payable Dividend payable Bonus payable Others Total other liabilities Less Current Portion Total long term other liabilities Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Total Placement Agent fees Commission, Legal and other fees Number of warrants, Outstanding, Beginning of period Weighted Average Exercise Price balance, Outstanding, Beginning of period Number of warrants, Warrants granted Weighted Average Exercise Price, Warrants granted Number of warrants, Warrants expired Weighted Average Exercise Price, Warrants expired Number of warrants, Warrants cancelled, forfeited Weighted Average Exercise Price, Warrants cancelled, forfeited Number of warrants, Warrants exercised Weighted Average Exercise Price, Warrants exercised Number of warrants, Outstanding, End of period Weighted Average Exercise Price, Outstanding, End of period Number of warrants, Exercisable warrants Weighted Average Exercise Price, Exercisable warrants Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit Weighted Average residual life span (in years) Outstanding Warrants Weighted Average Exercise Price Exercisable Warrants Weighted Average Exercise Price Range of Exercise Prices Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Warrant expiry date Warrant Exercise Prices Warrant Outstanding Number of stock options, Outstanding, Beginning of period Weighted Average Exercise Price, Outstanding, Beginning of period Number of stock options, Stock options granted Weighted Average Exercise Price, Stock options granted Number of stock options, Stock options expired Weighted Average Exercise Price, Stock options expired Number of stock options, Stock options cancelled, forfeited Number of stock options, Stock options exercised Weighted Average Exercise Price, Stock options exercised Number of stock options, Outstanding, End of period Weighted Average Exercise Price, Outstanding, End of period Number of stock options, Exercisable stock options Weighted Average Exercise Price, Exercisable stock options Range of Exercise Prices, Upper Range Limit Outstanding Stock Options Exercisable Stock Options Stock option expiration date Stock option exercise prices Stock option outstanding Schedule of Stock by Class [Table] Class of Stock [Line Items] Preferred stock shares authorized Preferred stock voting rights Dividends payable, amount per share Preferred stock, liquidation preference per share Dividends Preferred stock conversion, description Number of stock issued Number of shares for services Number of shares for services, value Stock Issued During Period, Shares, Employee Stock Purchase Plans Stock Issued During Period, Value, Employee Stock Purchase Plan Stock options and warrants exercised Proceeds from offering Number of warrants issued for purchase of common stock Warrants exercise price Warrants exercisable period Proceeds from placement Offering cost Stock options granted Product Liability Contingency [Table] Product Liability Contingency [Line Items] Rental expense monthly expenses Operating Lease, Weighted Average Discount Rate, Percent Operating Lease, Weighted Average Remaining Lease Term Accrued Liabilities for Commissions, Expense and Taxes Stock-based compensation options and warrants. Exercise of stock options and warrants. The gross value of stock issued during the period upon the conversion agreement. Conversion agreements - debt. Conversion of Equity. Working capital deficit. Factoring and Security Agreement [Member] Action Capital Corporation [Member] Percentage of reserve account. Increase in accounts payable and accrued liabilities related party. Increase decrease in operating lease liabilities. Intangible assets acquired in noncash exchange. Stock options and warrants issued. Payments for proceeds from other current assets. Stock issued during period shares exercise of stock options and warrants. Stock issued during period shares conversion agreements preferred shares. Stock issued during period shares conversion of equity. Two Customers [Member]. One Vendor [Member]. Asset Purchase Agreement [Member]. Eyepax IT Consulting, LLC [Member]. Note Payable- Supplier [Member]. Mr.Caldera [Member]. Adjustments to additional paid in capital stock issued issuance costs shares. Definitive Acquisition Agreement [Member]. Dangot computers ltd member. Securities Purchase Agreement [Member]. OtherMisc.Items. Notes Payable Related Parties [TextBlock] Note Payable Marin [Member] Note Payable Thomet [Member] Cumulative translation adjustment. Note Payable - Shareholder Convertible Note [Member] Stock issued during period value other misc items. Marin Note [Member] Thomet Note [Member] Share holder Convertible Note [Member] Schedule of Future Maturities Of Notes Payable Related Parties [Table Text Block] Notes Payable, Related Parties [Member] Note Payable- Supplier [Member] All Other [Member] Secured Promissory Note [Member] Sixth Amendment Agreement [Member] First Three Monthly Payments [Member] Last Two Monthly Payments [Member] First Minimum Payment [Member] Eighth Amendment [Member] Bonus payable. Equity Incentive Plan [Member] Consultants and Advisors [Member] Employee Stock Purchase Plan [Member] Orion 4, LLC [Member] Consulting Agreement [Member] Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. The number of shares into which fully or partially vestednon-option equity outstanding as of the balance sheet date can be currently converted under the non-option equity plan. Share based compensation arrangement by share based payment award non option equity instruments expired in period weighted average exercise price. Weighted average price at which grantees could have acquired the underlying shares with respect to stock non options that were terminated. Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares. The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of non-option equity outstanding and currently exercisable under the non-option equity plan. Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity. Schedule of Outstanding Warrants [Table Text Block] Exercise Price Range 1 [Member] Exercise Price Range 2 [Member] Exercise Price Range 3 [Member] Exercise Price Range 4 [Member] Share based compensation shares authorized under stock option plans exercise price range. Exercise Price Range Five [Member] Schedule of warrants outstanding expiry date and exercise prices [Table Text Block] October 10, 2020 [Member] December 30, 2020 [Member] February 02, 2021 [Member] August 2, 2021 [Member] October 10, 2021 [Member] February 27, 2022 [Member] May 18, 2023 [Member] October 14, 2023 [Member] October 6, 2024 [Member] September 1, 2025 [Member] June 4, 2026 [Member] July 8, 2026 [Member] December 4, 2027 [Member] Stock issued during period shares employee stock purchase plan. Stock Options [Member] Exercise Price Range 6 [Member] Exercise Price Range 7 [Member] Exercise Price Range 8 [Member] Exercise Price Range 9 [Member] Omniq Technologies [Member] Haim Dagot [Member] Remaining acquired percentage Number of trading days. Haim Dangot [Member] Exercise Price Range 10 [Member] February 17, 2022 [Member] February 17, 2022 [Member] February 28, 2023 [Member] March 05, 2023 [Member] July 31, 2023 [Member] October 31, 2023 [Member] November 30, 2023 [Member] November 20, 2024 [Member] April 20, 2025 [Member] September 30, 2030 [Member] September 30, 2030 [Member] Akron [Member] Vehicle Lease [Member] Salt Lack City [Member] Rental expense monthly payments. Raise capital. Four Customers [Member] One Customers [Member] Proceeds from capital raise. Subscribed common stock shares. Stock issued during period warrant issuances net of issuance costs. Stock issued during period shares warrant issuances net of issuance costs, Stock issued during period value noncontrolling interests distributions and other. Series C Preferred Stock [Member] Conversion of debt shares. Stock issued during period value acquisition. Amortization of ROU lease assets. Salt Lake City UT [Member] Yad Haruzim [Member] Gamdan Office [Member] Rival Ware House [Member] Hofman [Member] Rental Cars [Member] Sixty Five Employees [Member] Conversion of notes payable. Net income (loss) before dividend. Net income (loss) after dividend non-controlling interest. Proceeds from other current assets. Right of use lease asset on non cash information. Net assets obtained net of cash including noncontrolling interest. Dangot Shares [Member] Fair value of stock issued. Business combination recognized identifiable assets acquired and liabilities assumed goodwill. Business combination recognized identifiable assets acquired and liabilities assumed trade name. Business combination recognized identifiable assets acquired and liabilities assumed customer relationship. Stock issued during period shares for acquisition. Stock issued during period value for dangot acquisition. Adjustments for post acquisition to additional paid in capital other. Placement agent fees. Schedule of additional legal and other fees related to offering [Table Text Block] Accrued Payable to Owner. February 17, 2022 [Member] [Default Label] September 30, 2030 [Member] [Default Label] Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Cost of Goods and Services Sold Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net Income Tax Expense (Benefit) Net Income (Loss) Attributable to Parent Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent Comprehensive Income (Loss), Net of Tax, Attributable to Parent Preferred Stock Dividends, Income Statement Impact NetIncomeLossBeforeDividend Shares, Outstanding Dividends, Preferred Stock Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense Increase (Decrease) in Inventories Increase (Decrease) in Accounts Payable and Accrued Liabilities IncreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty Increase (Decrease) in Other Operating Assets IncreaseDecreaseInOperatingLeaseLiabilities Net Cash Provided by (Used in) Operating Activities ProceedsFromOtherCurrentAssets Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Debt Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations RightOfUseLeaseAssetOnNonCashInformation Business Combination, Consideration Transferred Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Long-term Line of Credit Other Notes Payable Other Notes Payable, Current Other Notes Payable, Noncurrent Other Liabilities Proceeds from Issuance of Warrants Legal Fees Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price EX-101.PRE 9 omqs-20210930_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 10 form10-q_htm.xml IDEA: XBRL DOCUMENT 0000278165 2021-01-01 2021-09-30 0000278165 2021-11-15 0000278165 2021-09-30 0000278165 2020-12-31 0000278165 us-gaap:TradeNamesMember 2021-09-30 0000278165 us-gaap:TradeNamesMember 2020-12-31 0000278165 us-gaap:CustomerRelationshipsMember 2021-09-30 0000278165 us-gaap:CustomerRelationshipsMember 2020-12-31 0000278165 us-gaap:OtherIntangibleAssetsMember 2021-09-30 0000278165 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0000278165 us-gaap:SeriesAPreferredStockMember 2021-09-30 0000278165 us-gaap:SeriesAPreferredStockMember 2020-12-31 0000278165 us-gaap:SeriesBPreferredStockMember 2021-09-30 0000278165 us-gaap:SeriesBPreferredStockMember 2020-12-31 0000278165 us-gaap:SeriesCPreferredStockMember 2021-09-30 0000278165 us-gaap:SeriesCPreferredStockMember 2020-12-31 0000278165 2021-07-01 2021-09-30 0000278165 2020-07-01 2020-09-30 0000278165 2020-01-01 2020-09-30 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2019-12-31 0000278165 us-gaap:CommonStockMember 2019-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000278165 us-gaap:TreasuryStockMember 2019-12-31 0000278165 us-gaap:RetainedEarningsMember 2019-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000278165 2019-12-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-01-01 2020-03-31 0000278165 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000278165 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0000278165 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000278165 2020-01-01 2020-03-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-03-31 0000278165 us-gaap:CommonStockMember 2020-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000278165 us-gaap:TreasuryStockMember 2020-03-31 0000278165 us-gaap:RetainedEarningsMember 2020-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000278165 2020-03-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-04-01 2020-06-30 0000278165 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0000278165 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0000278165 us-gaap:TreasuryStockMember 2020-04-01 2020-06-30 0000278165 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0000278165 2020-04-01 2020-06-30 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-06-30 0000278165 us-gaap:CommonStockMember 2020-06-30 0000278165 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000278165 us-gaap:TreasuryStockMember 2020-06-30 0000278165 us-gaap:RetainedEarningsMember 2020-06-30 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000278165 2020-06-30 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0000278165 us-gaap:CommonStockMember 2020-12-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000278165 us-gaap:TreasuryStockMember 2020-12-31 0000278165 us-gaap:RetainedEarningsMember 2020-12-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0000278165 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000278165 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0000278165 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0000278165 2021-01-01 2021-03-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-03-31 0000278165 us-gaap:CommonStockMember 2021-03-31 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000278165 us-gaap:TreasuryStockMember 2021-03-31 0000278165 us-gaap:RetainedEarningsMember 2021-03-31 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000278165 2021-03-31 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0000278165 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000278165 us-gaap:TreasuryStockMember 2021-04-01 2021-06-30 0000278165 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0000278165 2021-04-01 2021-06-30 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-06-30 0000278165 us-gaap:CommonStockMember 2021-06-30 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000278165 us-gaap:TreasuryStockMember 2021-06-30 0000278165 us-gaap:RetainedEarningsMember 2021-06-30 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0000278165 2021-06-30 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0000278165 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0000278165 us-gaap:TreasuryStockMember 2021-07-01 2021-09-30 0000278165 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0000278165 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-09-30 0000278165 us-gaap:CommonStockMember 2021-09-30 0000278165 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000278165 us-gaap:TreasuryStockMember 2021-09-30 0000278165 us-gaap:RetainedEarningsMember 2021-09-30 0000278165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0000278165 2020-09-30 0000278165 2020-01-01 2020-12-31 0000278165 srt:MinimumMember 2021-01-01 2021-09-30 0000278165 srt:MaximumMember 2021-01-01 2021-09-30 0000278165 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0000278165 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0000278165 us-gaap:ConvertiblePreferredStockMember 2021-01-01 2021-09-30 0000278165 us-gaap:ConvertiblePreferredStockMember 2020-01-01 2020-12-31 0000278165 us-gaap:WarrantMember 2021-01-01 2021-09-30 0000278165 us-gaap:WarrantMember 2020-01-01 2020-12-31 0000278165 OMQS:TwoCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0000278165 OMQS:TwoCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000278165 OMQS:FourCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0000278165 OMQS:OneCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000278165 OMQS:OneVendorMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0000278165 OMQS:OneVendorMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000278165 OMQS:EyepaxITConsultingLLCMember OMQS:AssetPurchaseAgreementMember 2020-02-01 2020-02-28 0000278165 OMQS:MrCalderaMember OMQS:EmploymentAgreementMember 2020-02-01 2020-02-28 0000278165 OMQS:DangotComputersLtdMember OMQS:DefinitiveAcquisitionAgreementMember 2021-05-03 0000278165 OMQS:OmniqTechnologiesMember 2021-05-02 2021-05-03 0000278165 OMQS:DefinitiveAcquisitionAgreementMember OMQS:OmniqTechnologiesMember 2021-07-07 2021-07-08 0000278165 OMQS:SecuritiesPurchaseAgreementMember 2021-07-07 2021-07-08 0000278165 OMQS:DefinitiveAcquisitionAgreementMember 2021-07-06 2021-07-08 0000278165 OMQS:DefinitiveAcquisitionAgreementMember 2021-07-08 0000278165 OMQS:HaimDagotMember 2021-05-02 2021-05-03 0000278165 OMQS:DefinitiveAcquisitionAgreementMember 2021-05-03 0000278165 OMQS:DefinitiveAcquisitionAgreementMember OMQS:HaimDangotMember 2021-07-07 2021-07-08 0000278165 OMQS:HaimDangotMember OMQS:AssetPurchaseAgreementMember 2020-02-01 2020-02-28 0000278165 OMQS:HaimDangotMember OMQS:DefinitiveAcquisitionAgreementMember 2021-05-03 0000278165 OMQS:DangotSharesMember 2021-05-02 2021-05-03 0000278165 OMQS:DangotSharesMember 2021-05-03 0000278165 OMQS:FactoringAndSecurityAgreementMember OMQS:ActionCapitalCorporationMember 2016-07-31 0000278165 OMQS:FactoringAndSecurityAgreementMember OMQS:ActionCapitalCorporationMember 2016-07-01 2016-07-31 0000278165 OMQS:FactoringAndSecurityAgreementMember us-gaap:PrimeRateMember OMQS:ActionCapitalCorporationMember 2016-07-01 2016-07-31 0000278165 OMQS:NotePayableMarinMember 2021-09-30 0000278165 OMQS:NotePayableMarinMember 2020-12-31 0000278165 OMQS:NotePayableThometMember 2021-09-30 0000278165 OMQS:NotePayableThometMember 2020-12-31 0000278165 OMQS:NotePayableShareholderConvertibleNoteMember 2021-09-30 0000278165 OMQS:NotePayableShareholderConvertibleNoteMember 2020-12-31 0000278165 OMQS:MarinNoteMember 2017-12-31 0000278165 OMQS:MarinNoteMember 2018-10-01 2018-10-31 0000278165 OMQS:ThometNoteMember 2017-12-31 0000278165 OMQS:ThometNoteMember 2018-10-01 2018-10-31 0000278165 OMQS:ShareholderConvertibleNoteMember 2018-10-31 0000278165 OMQS:NotePayableSupplierMember 2021-09-30 0000278165 OMQS:NotePayableSupplierMember 2020-12-31 0000278165 OMQS:AllOtherMember 2021-09-30 0000278165 OMQS:AllOtherMember 2020-12-31 0000278165 OMQS:SecuredPromissoryNoteMember 2016-07-18 0000278165 OMQS:SecuredPromissoryNoteMember 2016-07-17 2016-07-18 0000278165 OMQS:SecuredPromissoryNoteMember OMQS:SixthAmendmentAgreementMember 2018-09-07 0000278165 OMQS:SecuredPromissoryNoteMember OMQS:SixthAmendmentAgreementMember 2018-09-06 2018-09-07 0000278165 OMQS:FirstThreeMonthlyPaymentsMember OMQS:SecuredPromissoryNoteMember OMQS:SixthAmendmentAgreementMember 2018-09-06 2018-09-07 0000278165 OMQS:LastTwoMonthlyPaymentsMember OMQS:SecuredPromissoryNoteMember OMQS:SixthAmendmentAgreementMember 2018-09-06 2018-09-07 0000278165 OMQS:FirstMinimumPaymentMember 2019-04-01 2019-04-30 0000278165 srt:MaximumMember OMQS:EighthAmendmentMember 2021-07-19 2021-07-20 0000278165 srt:MinimumMember OMQS:EighthAmendmentMember 2021-07-19 2021-07-20 0000278165 OMQS:EighthAmendmentMember 2021-07-19 2021-07-20 0000278165 srt:DirectorMember 2021-01-01 2021-09-30 0000278165 us-gaap:SeriesCPreferredStockMember 2021-01-01 2021-09-30 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2020-08-01 2020-08-31 0000278165 OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2020-08-31 0000278165 OMQS:ConsultantsAndAdvisorsMember OMQS:EquityIncentivePlanMember us-gaap:CommonStockMember 2021-01-01 2021-09-30 0000278165 OMQS:EmployeeStockPurchasePlanMember us-gaap:CommonStockMember 2021-01-01 2021-09-30 0000278165 us-gaap:CommonStockMember OMQS:ConsultingAgreementMember OMQS:OrionFourLLCMember 2021-02-14 2021-02-15 0000278165 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0000278165 OMQS:SecuritiesPurchaseAgreementMember 2021-07-08 0000278165 us-gaap:WarrantMember 2021-07-07 2021-07-08 0000278165 us-gaap:WarrantMember 2021-11-08 0000278165 us-gaap:WarrantMember 2021-07-08 0000278165 OMQS:PlacementAgencyAgreementMember 2021-07-07 2021-07-08 0000278165 OMQS:PlacementAgencyAgreementMember 2021-11-08 0000278165 OMQS:PlacementAgencyAgreementMember 2021-07-08 0000278165 OMQS:ExercisePriceRangeOneMember us-gaap:WarrantMember 2021-01-01 2021-09-30 0000278165 OMQS:ExercisePriceRangeOneMember us-gaap:WarrantMember 2021-09-30 0000278165 OMQS:ExercisePriceRangeTwoMember us-gaap:WarrantMember 2021-01-01 2021-09-30 0000278165 OMQS:ExercisePriceRangeTwoMember us-gaap:WarrantMember 2021-09-30 0000278165 OMQS:ExercisePriceRangeThreeMember us-gaap:WarrantMember 2021-01-01 2021-09-30 0000278165 OMQS:ExercisePriceRangeThreeMember us-gaap:WarrantMember 2021-09-30 0000278165 OMQS:ExercisePriceRangeFourMember us-gaap:WarrantMember 2021-01-01 2021-09-30 0000278165 OMQS:ExercisePriceRangeFourMember us-gaap:WarrantMember 2021-09-30 0000278165 OMQS:ExercisePriceRangeFiveMember us-gaap:WarrantMember 2021-01-01 2021-09-30 0000278165 OMQS:ExercisePriceRangeFiveMember us-gaap:WarrantMember 2021-09-30 0000278165 srt:MinimumMember us-gaap:WarrantMember 2021-01-01 2021-09-30 0000278165 srt:MaximumMember us-gaap:WarrantMember 2021-01-01 2021-09-30 0000278165 us-gaap:WarrantMember 2021-01-01 2021-09-30 0000278165 us-gaap:WarrantMember 2021-09-30 0000278165 OMQS:OctoberTenTwoThousandTwentyMember 2021-09-30 0000278165 OMQS:OctoberTenTwoThousandTwentyMember 2020-09-30 0000278165 OMQS:DecemberThirtyTwoThousandTwentyMember 2021-09-30 0000278165 OMQS:DecemberThirtyTwoThousandTwentyMember 2020-09-30 0000278165 OMQS:FebruaryTwoThousandTwentyOneMember 2021-09-30 0000278165 OMQS:FebruaryTwoThousandTwentyOneMember 2020-09-30 0000278165 OMQS:AugustTwoTwoThousandTwentyOneMember 2021-09-30 0000278165 OMQS:AugustTwoTwoThousandTwentyOneMember 2020-09-30 0000278165 OMQS:OctoberTenTwoThousandTwentyOneMember 2021-09-30 0000278165 OMQS:OctoberTenTwoThousandTwentyOneMember 2020-09-30 0000278165 OMQS:FebruaryTwentySevenThousandTwentyTwoMember 2021-09-30 0000278165 OMQS:FebruaryTwentySevenThousandTwentyTwoMember 2020-09-30 0000278165 OMQS:MayEighteenTwoThousandTwentyThreeMember 2021-09-30 0000278165 OMQS:MayEighteenTwoThousandTwentyThreeMember 2020-09-30 0000278165 OMQS:OctoberFourteenTwoThousandTwentyThreeMember 2021-09-30 0000278165 OMQS:OctoberFourteenTwoThousandTwentyThreeMember 2020-09-30 0000278165 OMQS:OctoberSixTwoThousandTwentyFourMember 2021-09-30 0000278165 OMQS:OctoberSixTwoThousandTwentyFourMember 2020-09-30 0000278165 OMQS:SeptemberOneTwoThoousandTwentyFiveMember 2021-09-30 0000278165 OMQS:SeptemberOneTwoThoousandTwentyFiveMember 2020-09-30 0000278165 OMQS:JuneFourTwoThousandTwentySixMember 2021-09-30 0000278165 OMQS:JuneFourTwoThousandTwentySixMember 2020-09-30 0000278165 OMQS:JulyEightTwoThousandTwentySixMember 2021-09-30 0000278165 OMQS:JulyEightTwoThousandTwentySixMember 2020-09-30 0000278165 OMQS:DecemberFourTwoThousandTwentySevenMember 2021-09-30 0000278165 OMQS:DecemberFourTwoThousandTwentySevenMember 2020-09-30 0000278165 us-gaap:EmployeeStockOptionMember 2020-09-29 2020-09-30 0000278165 OMQS:ExercisePriceRangeOneMember OMQS:StockOptionsMember 2021-01-01 2021-09-30 0000278165 OMQS:ExercisePriceRangeOneMember OMQS:StockOptionsMember 2021-09-30 0000278165 OMQS:ExercisePriceRangeTwoMember OMQS:StockOptionsMember 2021-01-01 2021-09-30 0000278165 OMQS:ExercisePriceRangeTwoMember OMQS:StockOptionsMember 2021-09-30 0000278165 OMQS:ExercisePriceRangeThreeMember OMQS:StockOptionsMember 2021-01-01 2021-09-30 0000278165 OMQS:ExercisePriceRangeThreeMember OMQS:StockOptionsMember 2021-09-30 0000278165 OMQS:ExercisePriceRangeFourMember OMQS:StockOptionsMember 2021-01-01 2021-09-30 0000278165 OMQS:ExercisePriceRangeFourMember OMQS:StockOptionsMember 2021-09-30 0000278165 OMQS:ExercisePriceRangeFiveMember OMQS:StockOptionsMember 2021-01-01 2021-09-30 0000278165 OMQS:ExercisePriceRangeFiveMember OMQS:StockOptionsMember 2021-09-30 0000278165 OMQS:ExercisePriceRangeSixMember OMQS:StockOptionsMember 2021-01-01 2021-09-30 0000278165 OMQS:ExercisePriceRangeSixMember OMQS:StockOptionsMember 2021-09-30 0000278165 OMQS:ExercisePriceRangeSevenMember OMQS:StockOptionsMember 2021-01-01 2021-09-30 0000278165 OMQS:ExercisePriceRangeSevenMember OMQS:StockOptionsMember 2021-09-30 0000278165 OMQS:ExercisePriceRangeEightMember OMQS:StockOptionsMember 2021-01-01 2021-09-30 0000278165 OMQS:ExercisePriceRangeEightMember OMQS:StockOptionsMember 2021-09-30 0000278165 OMQS:ExercisePriceRangeNineMember OMQS:StockOptionsMember 2021-01-01 2021-09-30 0000278165 OMQS:ExercisePriceRangeNineMember OMQS:StockOptionsMember 2021-09-30 0000278165 srt:MinimumMember OMQS:StockOptionsMember 2021-01-01 2021-09-30 0000278165 srt:MaximumMember OMQS:StockOptionsMember 2021-01-01 2021-09-30 0000278165 OMQS:StockOptionsMember 2021-01-01 2021-09-30 0000278165 OMQS:StockOptionsMember 2021-09-30 0000278165 OMQS:AugustTwoTwoThousandTwentyOneMember 2021-01-01 2021-09-30 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoMember 2021-01-01 2021-09-30 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoMember 2021-09-30 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoMember 2020-09-30 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoOneMember 2021-01-01 2021-09-30 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoOneMember 2021-09-30 0000278165 OMQS:FebruarySeventeenTwoThoudsandTwentyTwoOneMember 2020-09-30 0000278165 OMQS:FebruaryTwentyEightTwoThoudsandTwentyThreeMember 2021-01-01 2021-09-30 0000278165 OMQS:FebruaryTwentyEightTwoThoudsandTwentyThreeMember 2021-09-30 0000278165 OMQS:FebruaryTwentyEightTwoThoudsandTwentyThreeMember 2020-09-30 0000278165 OMQS:MarchZeroFiveTwoThousandTwentyThreeMember 2021-01-01 2021-09-30 0000278165 OMQS:MarchZeroFiveTwoThousandTwentyThreeMember 2021-09-30 0000278165 OMQS:MarchZeroFiveTwoThousandTwentyThreeMember 2020-09-30 0000278165 OMQS:JulyThirtyOneTwoThousandTwentyThreeMember 2021-01-01 2021-09-30 0000278165 OMQS:JulyThirtyOneTwoThousandTwentyThreeMember 2021-09-30 0000278165 OMQS:JulyThirtyOneTwoThousandTwentyThreeMember 2020-09-30 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentyThreeMember 2021-01-01 2021-09-30 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentyThreeMember 2021-09-30 0000278165 OMQS:OctoberThirtyFirstTwoThousandTwentyThreeMember 2020-09-30 0000278165 OMQS:NovemberThirtyTwoThousandTwentyThreeMember 2021-01-01 2021-09-30 0000278165 OMQS:NovemberThirtyTwoThousandTwentyThreeMember 2021-09-30 0000278165 OMQS:NovemberThirtyTwoThousandTwentyThreeMember 2020-09-30 0000278165 OMQS:NovemberTwentyThousandTwentyFourMember 2021-01-01 2021-09-30 0000278165 OMQS:NovemberTwentyThousandTwentyFourMember 2021-09-30 0000278165 OMQS:NovemberTwentyThousandTwentyFourMember 2020-09-30 0000278165 OMQS:AprilTwentyTwoThousandTwentyFiveMember 2021-01-01 2021-09-30 0000278165 OMQS:AprilTwentyTwoThousandTwentyFiveMember 2021-09-30 0000278165 OMQS:AprilTwentyTwoThousandTwentyFiveMember 2020-09-30 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyMember 2021-01-01 2021-09-30 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyMember 2021-09-30 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyMember 2020-09-30 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyOneMember 2021-01-01 2021-09-30 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyOneMember 2021-09-30 0000278165 OMQS:SeptemberThirtyTwoThousandThirtyOneMember 2020-09-30 0000278165 us-gaap:EmployeeStockOptionMember 2021-09-30 0000278165 us-gaap:EmployeeStockOptionMember 2020-09-30 0000278165 OMQS:AkronMember 2021-01-01 2021-09-30 0000278165 OMQS:AkronMember 2021-09-30 0000278165 OMQS:VehicleLeaseMember 2021-01-01 2021-09-30 0000278165 OMQS:VehicleLeaseMember 2021-09-30 0000278165 OMQS:SaltLackCityMember 2021-01-01 2021-09-30 0000278165 OMQS:SaltLakeCityUTMember 2021-09-30 0000278165 srt:MinimumMember OMQS:YadHaruzimMember 2021-01-01 2021-09-30 0000278165 srt:MaximumMember OMQS:YadHaruzimMember 2021-01-01 2021-09-30 0000278165 OMQS:YadHaruzimMember 2021-09-30 0000278165 srt:MinimumMember OMQS:GamdanOfficeMember 2021-01-01 2021-09-30 0000278165 srt:MaximumMember OMQS:GamdanOfficeMember 2021-01-01 2021-09-30 0000278165 OMQS:GamdanOfficeMember 2021-09-30 0000278165 srt:MinimumMember OMQS:RivalWareHouseMember 2021-01-01 2021-09-30 0000278165 srt:MaximumMember OMQS:RivalWareHouseMember 2021-01-01 2021-09-30 0000278165 OMQS:RivalWareHouseMember 2021-09-30 0000278165 OMQS:HofmanMember 2021-01-01 2021-09-30 0000278165 OMQS:HofmanMember 2021-09-30 0000278165 OMQS:RentalCarsMember 2021-01-01 2021-09-30 0000278165 OMQS:RentalCarsMember OMQS:SixtyFiveEmployeesMember 2021-01-01 2021-09-30 iso4217:USD shares iso4217:USD shares pure utr:D iso4217:ILS 0000278165 false --12-31 Q3 P5Y P5Y 10-Q true 2021-09-30 2021 false 000-09047 OMNIQ Corp. DE 20-3454263 1865 West 2100 South Salt Lake City UT 84119 (801) 244-9577 Yes Yes Non-accelerated Filer true false false 7459286 9993000 4594000 20629000 9661000 6794000 1507000 1809000 670000 10000 10000 39235000 16442000 767000 555000 888000 289000 16453000 14695000 3714000 1156000 2570000 1028000 9279000 4885000 6450000 4479000 1402000 1104000 931000 1042000 533000 3749000 76000 2322000 74000 72598000 38658000 38619000 26811000 5839000 4914000 2061000 1717000 390000 433000 5641000 6449000 1310000 31000 2796000 1412000 56656000 41767000 390000 683000 63000 56000 2327000 1000 2472000 48000 2057000 1146000 63965000 43701000 0.001 0.001 1000000 1000000 0 0 0 0 0.001 0.001 1 1 0 0 0 0 0.001 0.001 5000000 5000000 745030 745030 745030 745030 1000 2000 0.001 0.001 15000000 15000000 7448597 7448597 4684736 4684736 20000 5000 70276000 51842000 -67883000 -56726000 -190000 -166000 2224000 -5043000 6409000 8633000 -5043000 72598000 38658000 20513000 15833000 53383000 42309000 15842000 13024000 42778000 33886000 4671000 2809000 10605000 8423000 474000 428000 1437000 1260000 6801000 4808000 15348000 11838000 82000 44000 167000 134000 1528000 550000 2575000 1562000 8885000 5830000 19527000 14794000 -4214000 -3021000 -8922000 -6371000 587000 744000 1890000 1957000 -159000 -16000 2000 -318000 -746000 -760000 -1888000 -2275000 -4960000 -3781000 -10810000 -8646000 -117000 -119000 117000 119000 -5076000 -3781000 -10929000 -8646000 166000 166000 -5242000 -3781000 -11095000 -8646000 -5076000 -3781000 -10929000 -8646000 58000 16000 24000 30000 -5134000 -3797000 -10953000 -8676000 -5076000 -3781000 -10929000 -8646000 12000 32000 57000 158000 -5064000 -3813000 -10872000 -8804000 166000 166000 -5230000 -3813000 -11038000 -8804000 -0.73 -0.83 -1.86 -2.03 7224958000 4588944000 5971440000 4339634000 4829000 5000 3960000 4000 46861000 -45063000 1000 1808000 72000 72000 -17000 -17000 190000 190000 440000 440000 65000 354000 354000 14000 14000 -2873000 -2873000 4829000 5000 4025000 4000 47845000 -47994000 -16000 -156000 54000 54000 3000 3000 105000 105000 80000 67000 547000 547000 34000 -2684000 -3000 3000 822000 822000 -1992000 -1992000 2145000 2000 4206000 4000 49322000 -50040000 -13000 -725000 2145000 2000 4685000 5000 51842000 -56726000 -166000 -5043000 31000 31000 1000 1000 786000 786000 25000 188000 188000 6000 2000 2000 105000 105000 -4000 -4000 -3343000 -3343000 2145000 2000 4716000 5000 52819000 -60104000 -61000 -7339000 14000 14000 1000 4000 4000 786000 786000 240000 304000 304000 -71000 -71000 -1400000 -1000 70000 1000 25000 203000 203000 -2510000 -2510000 745000 1000 5052000 5000 54117000 -62628000 -132000 -8637000 12000 12000 1000 9000 8000 653000 653000 2143000 15000 13280000 13295000 33000 132000 132000 220000 2084000 2084000 6508000 -1000 -325000 -58000 1000 -5242000 -5076000 745000 1000 7449000 20000 70276000 -67883000 -190000 8633000 -10929000 -8646000 2620000 2275000 53000 40000 3544000 1696000 -2502000 3193000 1139000 116000 671000 -218000 -1104000 9673000 7000 -26000 345000 -14000 -428000 -48000 920000 -39000 1632000 -420000 -1792000 1496000 4392000 66000 976000 5000 -5368000 61000 13295000 14000 926000 1870000 279000 156000 2172000 898000 4793000 874000 -12049000 1894000 4889000 3451000 5127000 1615000 -23000 9993000 5066000 1101000 77000 110000 1276000 188000 1971000 13052000 885000 281000 171000 304000 <p id="xdx_80C_eus-gaap--NatureOfOperations_zde7awn8PIv2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 1 – <span id="xdx_820_zYlhqkO1Tw84">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">OMNIQ Corp., a Delaware corporation, formerly Quest Solution, Inc., together with its wholly owned subsidiaries, referred to herein as “we,” “us,” and “our” (“OMNIQ” or the “Company”), was incorporated in 1973. Since its incorporation, the Company has been involved in various lines of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">From 2008 and to 2013, we were in the business of developing oil and gas reserves. In January 2014, we determined it was in the best interest of our stockholders to focus on operating companies with a track record of positive cash flows and larger existing revenue bases. Our strategy developed into leveraging management’s relationships in the business world for investments for the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Since 2014, we have made the following acquisitions resulting in us becoming a leading provider of computerized and machine vision image processing solutions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Quest Solution, Inc. (January 2014)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Bar Code Specialties, Inc. (November 2014)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ViascanQdata, Inc (October 2015 – later sold in September 2016)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">HTS Image Processing, Inc. (October 2018)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">EyepaxIT Consulting LLC. (February 2021)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We use patented and proprietary artificial intelligence (AI) technology to deliver data collection, real time surveillance and monitoring for supply chain management, homeland security, public safety, traffic &amp; parking management and access control applications. The technology and services we provide helps our clients move people, assets and data safely and securely through airports, warehouses, schools, national borders, and many other applications and environments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We offer end-to-end solutions that include hardware, software, communications, and full lifecycle management services. We are an established manufacturer and distributor of barcode labels, tags, and ribbons, as well as RFID labels and tags. Our highly tenured team of professionals has the knowledge and expertise to simplify the integration process for our customers, and our team delivers proven problem-solving solutions backed by numerous customer references. We offer comprehensive packaged and configurable software, and we are a leading provider of best-in-class mobile and wireless equipment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our customers include government agencies and leading Fortune 500 companies from diverse sectors, including healthcare, food and beverage, manufacturing, retail, distribution, transportation and logistics, and oil, gas, and chemicals.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">COVID-19</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The outbreak of the COVID-19 pandemic continues to affect the United States of America and the world, including in the primary regions we operate. Many State Governors issued temporary Executive Orders in 2020, that, among other stipulations, effectively limited in-person work activities for most industries and businesses having the effect of suspending or severely curtailing operations. Many of these orders are in the process of being lifted. To date, we have not incurred any significant interruptions to our day-to-day operations or supply chain, except some of our employees have or are working remotely. In response to the COVID-19 pandemic, we proactively implemented certain measures to strengthen cash flow, manage costs, strengthen liquidity, and enhance employee safety. These measures included the reduction of payroll costs, a reduction in capital expenditures and other discretionary spending, the elimination of most business travel and restriction of visitors to our corporate office, enhanced cleaning and disinfection procedures at our corporate office and branch locations, promotion of social distancing and the wearing of face coverings (masks) at our corporate office and branch locations, and requirements for employees to work from home where possible.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The extent of the ultimate impact of the pandemic on our operational and financial performance will depend on various developments, including the duration and spread of the outbreak, the impact on capital and financial markets, governmental limitations on business operations generally, and its and their impact on potential customers, employees, vendors, and distribution partners, all of which cannot be reasonably predicted at this time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_80F_eus-gaap--SignificantAccountingPoliciesTextBlock_zbqN5VSRQjDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 2 –<span id="xdx_82E_zGpB1V0pnQn6">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We describe our significant accounting policies in Note 2 of the notes to consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020. During the nine-month period ended September 30, 2021, there were no significant changes to those accounting policies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_z6guVEpST6Cd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_863_zLZFGPilvJfl">Principles of Consolidation and Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our unaudited condensed consolidated financial statements include the financial position and results of operations of OMNIQ Corp. and its wholly owned subsidiaries Quest Marketing, Inc., Quest Exchange Ltd., OmniQ Technologies Ltd., HTS Image Ltd., and HTS Image Processing, Inc., collectively referred to herein as “we” or “us” or “our” or the “Company.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">All significant intercompany accounts and transactions have been eliminated in these unaudited condensed consolidated financial statements. Business combinations are included in the unaudited condensed consolidated financial statements from their respective dates of acquisition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have prepared the interim unaudited condensed consolidated financial statements included herein, in accordance with accounting principles generally accepted in the United States of America, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although we believe the disclosures are adequate to make the information presented not misleading.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. It is suggested that these interim financial statements be read in conjunction with our financial statements for the year ended December 31, 2020 and notes thereto included in our Form 10-K filed with the SEC on March 31, 2021. The Company operates in one segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Operating results for the nine months ended September 30, 2021, are not necessarily indicative of the results that may be expected for the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_840_eus-gaap--UseOfEstimates_zROZT7WaBwv3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_864_zARUyPj5SAm4">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We prepare our unaudited condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, which requires management to use its judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reported period. These assumptions and estimates could have a material effect on our unaudited condensed consolidated financial statements. Actual results may differ materially from those estimates. We review our estimates on an ongoing basis based on information currently available, and changes in facts and circumstances may cause us to revise these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zVDhfBHWtz5h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_869_zaMnygDc26S8">Goodwill and Intangibles</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have made acquisitions in the past that resulted in the recognition of goodwill. Goodwill is the excess of the consideration transferred plus the fair value of any non-controlling interest in the acquiree at the acquisition date over the fair values of the identifiable net assets acquired. We evaluate goodwill for impairment annually or more frequently, if triggering events occur or other impairment indicators arise which might impair recoverability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Application of the goodwill impairment test requires judgment. We performed a Step 1 quantitative assessment of goodwill impairment as of December 31, 2020, our annual impairment test date. We compared the carrying value inclusive of goodwill and definite-lived intangible assets, to its fair value. We estimated the fair value of these reporting units by weighting results from the income approach and the market approach, as further described in Note 2 in our Annual Report on Form 10-K for the year ended December 31, 2020. Based on this quantitative test, we determined there was <span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_pn3n3_do_c20200101__20201231_z65xfWicGMb8" title="Impairment of goodwill">no</span> impairment as of the December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangible assets with a limited life</span><span style="font: 10pt Times New Roman, Times, Serif"> are being amortized on the straight-line method over useful lives ranging from <span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20210930__srt--RangeAxis__srt--MinimumMember_zgAGXYU0Ludb">3 </span></span><span style="font: 10pt Times New Roman, Times, Serif">to <span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20210930__srt--RangeAxis__srt--MaximumMember_zmm5WHSBxP2l">11 </span></span><span style="font: 10pt Times New Roman, Times, Serif">years. No events or indicators have occurred subsequent to December 31, 2020 that would affect the intangible assets. <span id="xdx_901_eus-gaap--GoodwillImpairmentLoss_pn3n3_do_c20210101__20210930_zRzW2FHnnXm1">No </span></span><span style="font: 10pt Times New Roman, Times, Serif">impairment expense was recognized for the nine months ended September 30, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84D_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zn1GLHiqP4C8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_866_zX52D8CcRwU3">Foreign Currency Translation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our unaudited condensed consolidated financial statements are presented in U.S. dollars. The functional currency for the Company is U.S. dollars. Transactions in currencies other than the functional currency are recorded using the appropriate exchange rate at the time of the transaction. All of our continuing operations are conducted in U.S. dollars except its subsidiary located in Israel. The records of the Israeli operation were maintained in the local currency and re-measured to the functional currency as follows: monetary assets and liabilities are converted using the balance sheet period-end date exchange rate, while the non-monetary assets and liabilities are converted using the historical exchange rate. Expenses and income items are converted using the weighted average exchange rates for the reporting period. Foreign transaction gains and losses are reported on the unaudited condensed consolidated statement of operations and were included in the amount of loss from comprehensive income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zRgOWFvw2Nee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86C_zhWWS1k1t25l">Net Loss Per Common Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Net loss per share is provided in accordance with FASB ASC 260-10, “Earnings per Share”. Basic net loss per common share (“EPS”) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued, unless doing so is anti-dilutive. The weighted-average number of common shares outstanding for computing basic EPS for the nine-months ended September 30, 2021 and 2020 were <span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20210930_zOSGXDFqg756" title="Weighted average number of diluted shares outstanding">5,971,440</span> and <span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20200101__20200930_z2hhHxdlYjdi" title="Weighted average number of diluted shares outstanding">4,339,634</span>, respectively. Diluted net loss per share of common stock is the same as basic net loss per share of common stock because the effects of potentially dilutive securities are antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z5mhmkxgvKH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported as of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BB_zOBaHElXGsBk" style="display: none">SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-style: italic">In thousands</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Options to purchase common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z8YNH5t4sTF1" style="width: 16%; text-align: right" title="Potential shares excluded from diluted net loss per share">1,654</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20200101__20201231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z6wMOiMBnKd6" style="width: 16%; text-align: right" title="Potential shares excluded from diluted net loss per share">1,553</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Convertible preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember_zmgfrf1rXsPl" style="text-align: right" title="Potential shares excluded from diluted net loss per share"><span style="-sec-ix-hidden: xdx2ixbrl1197">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20200101__20201231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember_z2tIinqzUKUe" style="text-align: right" title="Potential shares excluded from diluted net loss per share"><span style="-sec-ix-hidden: xdx2ixbrl1199">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants to purchase common stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zIt7lROtSo5h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potential shares excluded from diluted net loss per share">1,404</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20200101__20201231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zV2umkU9TPyf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potential shares excluded from diluted net loss per share">75</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Potential shares excluded from diluted net loss per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20210101__20210930_zSRAbkFHv2Cj" style="border-bottom: Black 2.5pt double; text-align: right" title="Potential shares excluded from diluted net loss per share">3,058</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20200101__20201231_zL8fWHEYWp37" style="border-bottom: Black 2.5pt double; text-align: right" title="Potential shares excluded from diluted net loss per share">1,628</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zfIwF420wYQb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84A_eus-gaap--BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_zhG2wy5f82Sd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_862_zi7hKsf2cN5k">Purchase Accounting and Business Combinations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We account for our business combinations using the purchase method of accounting which requires that intangible assets be recognized apart from goodwill if they are contractual in nature or separately identifiable. Acquisitions are measured on the fair value of consideration exchanged and, if the consideration given is not cash, measurement is based on the fair value of the consideration given or the fair value of the assets acquired, whichever is more reliably measurable. The excess of cost of an acquired entity over the fair value of identifiable acquired assets and liabilities assumed is allocated to goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The valuation and allocation processes rely on significant assumptions made by management. In certain situations, the allocations of excess purchase price are based upon preliminary estimates and assumptions. Accordingly, the allocations are subject to revision when we receive updated information, including appraisals and other analyses, which are completed within one year of the acquisition. Revisions to the fair values, which may be significant, are recorded when pending information is finalized, within one year from the acquisition date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_843_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zi45tugxFqX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_862_zVqFYQ5IXyMk">Revenue Recognition.</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">When entering into contracts with our customers, we review follow the five steps outline in <i>Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606)</i>:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identify the contract with our customer.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identify the performance obligations in the contract.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Determine the transaction price.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iv.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Allocate the transaction price to the performance obligations. And</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">v.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Evaluate the satisfaction of the performance obligations,</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We account for contracts, with our customers, when we have approval and commitment from both parties, the rights of the parties are identified, payment terms are established, the contract has commercial substance and collectability of consideration is probable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We evaluate, in accordance with Topic 606, whether we meet the criteria to be a principal or an agent and record the revenue on a gross or net basis. We are considered a principal if we obtain control of any one of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A good or another asset from another party that we then transfer to our customer. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A right to a service to be performed by another party, which gives the us the ability to direct that party to provide the service to the customer on our behalf, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A good or service from another party that we then combine with other goods or services in providing the specified good or service to our customer. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have certain relationships with manufacturers and suppliers to sell us products or provide services. Our contracts may transfer to our customer a right to a future service or product to be provided by our manufacturer or supplier. When a specified good or service is a right to a good or service is provided by a manufacturer or supplier, we evaluate whether we control the right to the goods or services before that right is transferred to the customer rather than whether we control the underlying goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicators that we control the specified good or service before it is transferred to the customer (and we are therefore a principal) include, but are not limited to, the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We are responsible for fulfilling the promise to provide the specified good or service. This typically includes responsibility for the acceptability of the specified good or service. If we are primarily responsible for fulfilling the promise to provide the specified good or service, this may indicate that the other party involved in providing the specified good or service is acting on our behalf. Often, we provide value added services (combining hardware, integrating hardware to software, etc.) to the products and services purchased from our manufacturers and suppliers.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have inventory risk before the specified good or service has been transferred to a customer. Our purchases of products or services from our manufactures and suppliers is evidenced by our issuing a binding purchase order contract with the negotiated terms including specifications, pricing, delivery among other things. Our obligation for purchased products and services is mutually exclusive of our customers’ performance (failure to take acceptance, make payment, etc.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have sole discretion in establishing our price for the specified good or service. Establishing the price our customer pays for a specified good or service may indicate we have the ability to direct the use of that good or service and obtain substantially all of the remaining benefits. We control and set the pricing for the product or services to be provided to our customers.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If the terms of a transaction do not indicate we are acting as a principal in the transaction, we are then considered acting as an agent and the associated revenues would be recognized on a net basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As principal, when (or as) we satisfy a performance obligation, we recognize revenue in the gross amount of consideration which we expect to be entitled in exchange for the specified good or service transferred. We are an agent if our performance obligation is to arrange for the provision of the specified good or service by another party. As an agent, we do not control the specified good or service provided by another party before that good or service is transferred to our customer. As an agent, when (or as) we satisfy a performance obligation, we recognize revenue in the amount of any fee or commission which we expect to be entitled in exchange for arranging for the specified goods or services to be provided by another party to our customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Under Topic 606, we recognize revenue (on either a gross or net basis previously discussed) only when we satisfy a performance obligation by transferring a promised good or service to our customer. A good or service is considered to be transferred when the customer obtains control. The standard defines control as an entity’s ability to direct the use of, and obtain substantially all of the remaining benefits from, an asset. We recognize revenue (either gross or net) once control has passed to the customer. The following indicators are evaluated in determining when control has passed to the customer:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have a right to payment for the product or service,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The customer has legal title to the product,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have transferred physical possession of the product to the customer,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iv.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The customer has the risk and rewards of ownership of the product, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">v.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The customer has accepted the product. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Revenue Recognition for Hardware. </i>Revenues from sales of hardware products are recognized on a gross basis as we are acting as a principal in these transactions, with the selling price to the customer recorded as sales and the acquisition cost of the product recorded as cost of sales. We recognize revenue from these transactions when control has passed to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Manufacturers and suppliers, from whom we purchase hardware, often provide their warranties only providing assurance the products and services will conform to their specifications. These assurance type warranties are not sold separately and are not considered separate performance obligations. In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Revenue Recognition for Software. </i>Sales of software licenses are generally considered a single performance obligation. When we are considered to be the principal, we recognize revenues on a gross basis at the point the software is delivered to and accepted by our customer. Generally, software licenses are sold with accompanying third-party delivered software assurance, which is a product that allows customers to upgrade, at no additional cost, to the latest technology if new capabilities are introduced during the period that the software assurance is in effect.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As explained above, we evaluate whether the software assurance is a separate performance obligation by assessing if the third-party delivered software assurance is critical or essential to the core functionality of the software itself. This involves considering:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If the software provides its original intended functionality to the customer without the updates, </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If the customer would ascribe a higher value to the upgrades versus the up-front deliverable, </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If the customer would expect frequent intelligence updates to the software (such as updates that maintain the original functionality), and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iv.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If the customer chooses to not delay or always install upgrades. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If we determine the accompanying third-party delivered software assurance is critical or essential to the core functionality of the software license, the software license and the accompanying third-party delivered software assurance are recognized as a single performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Revenue Recognition for Services. </i>We provide professional services, which include project managers and consultants recommending, designing and implementing IT solutions. Revenue from professional services is recognized either on a time and materials basis or proportionally, as costs are incurred for fixed fee project work. Revenue is recognized on a gross basis each month as work is performed and we transfer those services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenues from the sale of professional and support services, provided by us, are recognized over the period the service is provided. As the customer receives the benefit of the service each month, we recognize the respective revenue on a gross basis as we are acting as a principal in the transaction. Additionally, we manage services team provides project support to customers that are billed on a fixed fee basis. We are acting as the principal in the transaction and recognize revenue on a gross basis based on the total number of hours incurred for the period over the total expected hours for the project. Total expected hours to complete the project is updated for each period and best represents the transfer of control of the service to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Contract Asset. The Company recognizes revenue as explained in accordance with ASC 606. The Company has entered into contracts with customers that only allow us to invoice the customer once the total project is completed, creating a contract asset which is presented on a separate line item on the balance sheet as a current asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Freight Costs. </i>We record both the freight billed to its customers and the related freight costs as cost of sales when the underlying product revenue is recognized. For freight not billed to its customers, we record the freight costs as cost of sales. The Company considers shipping to be a fulfillment activity and not a separate performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z1QzijBzx7g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86A_z9aEjgZtfRM4">Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We periodically issue stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. We account for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by Financial Accounting Standards Board (the “FASB”) where the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We record stock-based compensation expense according to the provisions of ASC Topic 718, Compensation – Stock Compensation. ASC Topic 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Under the provisions of ASC Topic 718, the Company determines the appropriate fair value model to be used for valuing share-based payments and the amortization method for compensation cost. The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We account for equity instruments issued to parties other than employees for acquiring goods or services under guidance of section 505-50-30 of the FASB Accounting Standards Codification (“FASB ASC Section 505-50-30”). Pursuant to FASB ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z2j6D4uaYgrk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_864_z3N872tDkvMl">Recent Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have evaluated the recent pronouncements and believe their adoption will not have a material effect on our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zz5vOcL5MUFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_860_zBBYs54OSYO1">Reclassifications and Comparability</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Certain amounts in the financial statements of prior years have been reclassified to conform to the current year presentation for comparative purposes. This had no effect on total assets or net income.</span></p> <p id="xdx_857_z24IuOslePIl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_z6guVEpST6Cd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_863_zLZFGPilvJfl">Principles of Consolidation and Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our unaudited condensed consolidated financial statements include the financial position and results of operations of OMNIQ Corp. and its wholly owned subsidiaries Quest Marketing, Inc., Quest Exchange Ltd., OmniQ Technologies Ltd., HTS Image Ltd., and HTS Image Processing, Inc., collectively referred to herein as “we” or “us” or “our” or the “Company.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">All significant intercompany accounts and transactions have been eliminated in these unaudited condensed consolidated financial statements. Business combinations are included in the unaudited condensed consolidated financial statements from their respective dates of acquisition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have prepared the interim unaudited condensed consolidated financial statements included herein, in accordance with accounting principles generally accepted in the United States of America, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although we believe the disclosures are adequate to make the information presented not misleading.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. It is suggested that these interim financial statements be read in conjunction with our financial statements for the year ended December 31, 2020 and notes thereto included in our Form 10-K filed with the SEC on March 31, 2021. The Company operates in one segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Operating results for the nine months ended September 30, 2021, are not necessarily indicative of the results that may be expected for the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_840_eus-gaap--UseOfEstimates_zROZT7WaBwv3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_864_zARUyPj5SAm4">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We prepare our unaudited condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, which requires management to use its judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reported period. These assumptions and estimates could have a material effect on our unaudited condensed consolidated financial statements. Actual results may differ materially from those estimates. We review our estimates on an ongoing basis based on information currently available, and changes in facts and circumstances may cause us to revise these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zVDhfBHWtz5h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_869_zaMnygDc26S8">Goodwill and Intangibles</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have made acquisitions in the past that resulted in the recognition of goodwill. Goodwill is the excess of the consideration transferred plus the fair value of any non-controlling interest in the acquiree at the acquisition date over the fair values of the identifiable net assets acquired. We evaluate goodwill for impairment annually or more frequently, if triggering events occur or other impairment indicators arise which might impair recoverability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Application of the goodwill impairment test requires judgment. We performed a Step 1 quantitative assessment of goodwill impairment as of December 31, 2020, our annual impairment test date. We compared the carrying value inclusive of goodwill and definite-lived intangible assets, to its fair value. We estimated the fair value of these reporting units by weighting results from the income approach and the market approach, as further described in Note 2 in our Annual Report on Form 10-K for the year ended December 31, 2020. Based on this quantitative test, we determined there was <span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_pn3n3_do_c20200101__20201231_z65xfWicGMb8" title="Impairment of goodwill">no</span> impairment as of the December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangible assets with a limited life</span><span style="font: 10pt Times New Roman, Times, Serif"> are being amortized on the straight-line method over useful lives ranging from <span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20210930__srt--RangeAxis__srt--MinimumMember_zgAGXYU0Ludb">3 </span></span><span style="font: 10pt Times New Roman, Times, Serif">to <span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20210930__srt--RangeAxis__srt--MaximumMember_zmm5WHSBxP2l">11 </span></span><span style="font: 10pt Times New Roman, Times, Serif">years. No events or indicators have occurred subsequent to December 31, 2020 that would affect the intangible assets. <span id="xdx_901_eus-gaap--GoodwillImpairmentLoss_pn3n3_do_c20210101__20210930_zRzW2FHnnXm1">No </span></span><span style="font: 10pt Times New Roman, Times, Serif">impairment expense was recognized for the nine months ended September 30, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 0 P3Y P11Y 0 <p id="xdx_84D_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zn1GLHiqP4C8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_866_zX52D8CcRwU3">Foreign Currency Translation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our unaudited condensed consolidated financial statements are presented in U.S. dollars. The functional currency for the Company is U.S. dollars. Transactions in currencies other than the functional currency are recorded using the appropriate exchange rate at the time of the transaction. All of our continuing operations are conducted in U.S. dollars except its subsidiary located in Israel. The records of the Israeli operation were maintained in the local currency and re-measured to the functional currency as follows: monetary assets and liabilities are converted using the balance sheet period-end date exchange rate, while the non-monetary assets and liabilities are converted using the historical exchange rate. Expenses and income items are converted using the weighted average exchange rates for the reporting period. Foreign transaction gains and losses are reported on the unaudited condensed consolidated statement of operations and were included in the amount of loss from comprehensive income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zRgOWFvw2Nee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86C_zhWWS1k1t25l">Net Loss Per Common Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Net loss per share is provided in accordance with FASB ASC 260-10, “Earnings per Share”. Basic net loss per common share (“EPS”) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued, unless doing so is anti-dilutive. The weighted-average number of common shares outstanding for computing basic EPS for the nine-months ended September 30, 2021 and 2020 were <span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20210101__20210930_zOSGXDFqg756" title="Weighted average number of diluted shares outstanding">5,971,440</span> and <span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20200101__20200930_z2hhHxdlYjdi" title="Weighted average number of diluted shares outstanding">4,339,634</span>, respectively. Diluted net loss per share of common stock is the same as basic net loss per share of common stock because the effects of potentially dilutive securities are antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z5mhmkxgvKH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported as of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BB_zOBaHElXGsBk" style="display: none">SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-style: italic">In thousands</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Options to purchase common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z8YNH5t4sTF1" style="width: 16%; text-align: right" title="Potential shares excluded from diluted net loss per share">1,654</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20200101__20201231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z6wMOiMBnKd6" style="width: 16%; text-align: right" title="Potential shares excluded from diluted net loss per share">1,553</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Convertible preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember_zmgfrf1rXsPl" style="text-align: right" title="Potential shares excluded from diluted net loss per share"><span style="-sec-ix-hidden: xdx2ixbrl1197">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20200101__20201231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember_z2tIinqzUKUe" style="text-align: right" title="Potential shares excluded from diluted net loss per share"><span style="-sec-ix-hidden: xdx2ixbrl1199">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants to purchase common stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zIt7lROtSo5h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potential shares excluded from diluted net loss per share">1,404</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20200101__20201231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zV2umkU9TPyf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potential shares excluded from diluted net loss per share">75</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Potential shares excluded from diluted net loss per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20210101__20210930_zSRAbkFHv2Cj" style="border-bottom: Black 2.5pt double; text-align: right" title="Potential shares excluded from diluted net loss per share">3,058</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20200101__20201231_zL8fWHEYWp37" style="border-bottom: Black 2.5pt double; text-align: right" title="Potential shares excluded from diluted net loss per share">1,628</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zfIwF420wYQb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 5971440 4339634 <p id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z5mhmkxgvKH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported as of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BB_zOBaHElXGsBk" style="display: none">SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-style: italic">In thousands</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Options to purchase common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z8YNH5t4sTF1" style="width: 16%; text-align: right" title="Potential shares excluded from diluted net loss per share">1,654</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20200101__20201231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z6wMOiMBnKd6" style="width: 16%; text-align: right" title="Potential shares excluded from diluted net loss per share">1,553</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Convertible preferred stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember_zmgfrf1rXsPl" style="text-align: right" title="Potential shares excluded from diluted net loss per share"><span style="-sec-ix-hidden: xdx2ixbrl1197">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20200101__20201231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertiblePreferredStockMember_z2tIinqzUKUe" style="text-align: right" title="Potential shares excluded from diluted net loss per share"><span style="-sec-ix-hidden: xdx2ixbrl1199">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants to purchase common stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zIt7lROtSo5h" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potential shares excluded from diluted net loss per share">1,404</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20200101__20201231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zV2umkU9TPyf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potential shares excluded from diluted net loss per share">75</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Potential shares excluded from diluted net loss per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20210101__20210930_zSRAbkFHv2Cj" style="border-bottom: Black 2.5pt double; text-align: right" title="Potential shares excluded from diluted net loss per share">3,058</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pn3n3_c20200101__20201231_zL8fWHEYWp37" style="border-bottom: Black 2.5pt double; text-align: right" title="Potential shares excluded from diluted net loss per share">1,628</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1654000 1553000 1404000 75000 3058000 1628000 <p id="xdx_84A_eus-gaap--BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_zhG2wy5f82Sd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_862_zi7hKsf2cN5k">Purchase Accounting and Business Combinations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We account for our business combinations using the purchase method of accounting which requires that intangible assets be recognized apart from goodwill if they are contractual in nature or separately identifiable. Acquisitions are measured on the fair value of consideration exchanged and, if the consideration given is not cash, measurement is based on the fair value of the consideration given or the fair value of the assets acquired, whichever is more reliably measurable. The excess of cost of an acquired entity over the fair value of identifiable acquired assets and liabilities assumed is allocated to goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The valuation and allocation processes rely on significant assumptions made by management. In certain situations, the allocations of excess purchase price are based upon preliminary estimates and assumptions. Accordingly, the allocations are subject to revision when we receive updated information, including appraisals and other analyses, which are completed within one year of the acquisition. Revisions to the fair values, which may be significant, are recorded when pending information is finalized, within one year from the acquisition date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_843_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zi45tugxFqX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_862_zVqFYQ5IXyMk">Revenue Recognition.</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">When entering into contracts with our customers, we review follow the five steps outline in <i>Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606)</i>:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identify the contract with our customer.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identify the performance obligations in the contract.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Determine the transaction price.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iv.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Allocate the transaction price to the performance obligations. And</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">v.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Evaluate the satisfaction of the performance obligations,</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We account for contracts, with our customers, when we have approval and commitment from both parties, the rights of the parties are identified, payment terms are established, the contract has commercial substance and collectability of consideration is probable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We evaluate, in accordance with Topic 606, whether we meet the criteria to be a principal or an agent and record the revenue on a gross or net basis. We are considered a principal if we obtain control of any one of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A good or another asset from another party that we then transfer to our customer. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A right to a service to be performed by another party, which gives the us the ability to direct that party to provide the service to the customer on our behalf, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A good or service from another party that we then combine with other goods or services in providing the specified good or service to our customer. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have certain relationships with manufacturers and suppliers to sell us products or provide services. Our contracts may transfer to our customer a right to a future service or product to be provided by our manufacturer or supplier. When a specified good or service is a right to a good or service is provided by a manufacturer or supplier, we evaluate whether we control the right to the goods or services before that right is transferred to the customer rather than whether we control the underlying goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicators that we control the specified good or service before it is transferred to the customer (and we are therefore a principal) include, but are not limited to, the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We are responsible for fulfilling the promise to provide the specified good or service. This typically includes responsibility for the acceptability of the specified good or service. If we are primarily responsible for fulfilling the promise to provide the specified good or service, this may indicate that the other party involved in providing the specified good or service is acting on our behalf. Often, we provide value added services (combining hardware, integrating hardware to software, etc.) to the products and services purchased from our manufacturers and suppliers.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have inventory risk before the specified good or service has been transferred to a customer. Our purchases of products or services from our manufactures and suppliers is evidenced by our issuing a binding purchase order contract with the negotiated terms including specifications, pricing, delivery among other things. Our obligation for purchased products and services is mutually exclusive of our customers’ performance (failure to take acceptance, make payment, etc.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have sole discretion in establishing our price for the specified good or service. Establishing the price our customer pays for a specified good or service may indicate we have the ability to direct the use of that good or service and obtain substantially all of the remaining benefits. We control and set the pricing for the product or services to be provided to our customers.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If the terms of a transaction do not indicate we are acting as a principal in the transaction, we are then considered acting as an agent and the associated revenues would be recognized on a net basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As principal, when (or as) we satisfy a performance obligation, we recognize revenue in the gross amount of consideration which we expect to be entitled in exchange for the specified good or service transferred. We are an agent if our performance obligation is to arrange for the provision of the specified good or service by another party. As an agent, we do not control the specified good or service provided by another party before that good or service is transferred to our customer. As an agent, when (or as) we satisfy a performance obligation, we recognize revenue in the amount of any fee or commission which we expect to be entitled in exchange for arranging for the specified goods or services to be provided by another party to our customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Under Topic 606, we recognize revenue (on either a gross or net basis previously discussed) only when we satisfy a performance obligation by transferring a promised good or service to our customer. A good or service is considered to be transferred when the customer obtains control. The standard defines control as an entity’s ability to direct the use of, and obtain substantially all of the remaining benefits from, an asset. We recognize revenue (either gross or net) once control has passed to the customer. The following indicators are evaluated in determining when control has passed to the customer:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have a right to payment for the product or service,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The customer has legal title to the product,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have transferred physical possession of the product to the customer,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iv.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The customer has the risk and rewards of ownership of the product, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">v.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The customer has accepted the product. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Revenue Recognition for Hardware. </i>Revenues from sales of hardware products are recognized on a gross basis as we are acting as a principal in these transactions, with the selling price to the customer recorded as sales and the acquisition cost of the product recorded as cost of sales. We recognize revenue from these transactions when control has passed to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Manufacturers and suppliers, from whom we purchase hardware, often provide their warranties only providing assurance the products and services will conform to their specifications. These assurance type warranties are not sold separately and are not considered separate performance obligations. In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Revenue Recognition for Software. </i>Sales of software licenses are generally considered a single performance obligation. When we are considered to be the principal, we recognize revenues on a gross basis at the point the software is delivered to and accepted by our customer. Generally, software licenses are sold with accompanying third-party delivered software assurance, which is a product that allows customers to upgrade, at no additional cost, to the latest technology if new capabilities are introduced during the period that the software assurance is in effect.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As explained above, we evaluate whether the software assurance is a separate performance obligation by assessing if the third-party delivered software assurance is critical or essential to the core functionality of the software itself. This involves considering:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If the software provides its original intended functionality to the customer without the updates, </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If the customer would ascribe a higher value to the upgrades versus the up-front deliverable, </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If the customer would expect frequent intelligence updates to the software (such as updates that maintain the original functionality), and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iv.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If the customer chooses to not delay or always install upgrades. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If we determine the accompanying third-party delivered software assurance is critical or essential to the core functionality of the software license, the software license and the accompanying third-party delivered software assurance are recognized as a single performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Revenue Recognition for Services. </i>We provide professional services, which include project managers and consultants recommending, designing and implementing IT solutions. Revenue from professional services is recognized either on a time and materials basis or proportionally, as costs are incurred for fixed fee project work. Revenue is recognized on a gross basis each month as work is performed and we transfer those services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenues from the sale of professional and support services, provided by us, are recognized over the period the service is provided. As the customer receives the benefit of the service each month, we recognize the respective revenue on a gross basis as we are acting as a principal in the transaction. Additionally, we manage services team provides project support to customers that are billed on a fixed fee basis. We are acting as the principal in the transaction and recognize revenue on a gross basis based on the total number of hours incurred for the period over the total expected hours for the project. Total expected hours to complete the project is updated for each period and best represents the transfer of control of the service to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Contract Asset. The Company recognizes revenue as explained in accordance with ASC 606. The Company has entered into contracts with customers that only allow us to invoice the customer once the total project is completed, creating a contract asset which is presented on a separate line item on the balance sheet as a current asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Freight Costs. </i>We record both the freight billed to its customers and the related freight costs as cost of sales when the underlying product revenue is recognized. For freight not billed to its customers, we record the freight costs as cost of sales. The Company considers shipping to be a fulfillment activity and not a separate performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z1QzijBzx7g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_86A_z9aEjgZtfRM4">Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We periodically issue stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. We account for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by Financial Accounting Standards Board (the “FASB”) where the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We record stock-based compensation expense according to the provisions of ASC Topic 718, Compensation – Stock Compensation. ASC Topic 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Under the provisions of ASC Topic 718, the Company determines the appropriate fair value model to be used for valuing share-based payments and the amortization method for compensation cost. The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We account for equity instruments issued to parties other than employees for acquiring goods or services under guidance of section 505-50-30 of the FASB Accounting Standards Codification (“FASB ASC Section 505-50-30”). Pursuant to FASB ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84D_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z2j6D4uaYgrk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_864_z3N872tDkvMl">Recent Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have evaluated the recent pronouncements and believe their adoption will not have a material effect on our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zz5vOcL5MUFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_860_zBBYs54OSYO1">Reclassifications and Comparability</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Certain amounts in the financial statements of prior years have been reclassified to conform to the current year presentation for comparative purposes. This had no effect on total assets or net income.</span></p> <p id="xdx_800_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zkCu9P8ugGfa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 3 – <span id="xdx_826_zUC3Jr8e73Sf">GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements have been prepared assuming that we will continue as a going concern. As of September 30, 2021, we had a working capital deficit of $<span id="xdx_907_ecustom--WorkingCapitalDeficit_iI_pn5n6_c20210930_zP0AtIzhsRFk" title="Working capital deficit">16.6</span> million and an accumulated deficit of $<span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20210930_znpQ96N7XyAi" title="Accumulated deficit">67.9</span> million. These facts and others have in the past raised concerns about the Company’s ability to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, which we have successfully accomplished to date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0">Management has evaluated and assessed the Company’s ability to continue as a going concern. We believe that the achievements of the following positive factors alleviated the substantial doubt about our ability to continue as a going concern (not all inclusive):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"/> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The successful capital raise of $<span id="xdx_907_ecustom--ProceedsFromCapitalRaise_pn6n6_c20210101__20210930_zE9xn4Leyhi3" title="Raise capital">15</span> million.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s cash balance at September 30, 2021 of $<span id="xdx_903_eus-gaap--Cash_iI_pn4n6_c20210930_zSkVvO8jJon8" title="Cash">9.99</span> million.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s acquisition of Dangot Computers, Ltd. has improved the balance sheet, profitability and cash flow.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s favorable settlement with a major creditor. Reference note 8 supplier note.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s up-listing to the NASDAQ stock exchange enhancing the potential to issue additional stock.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s historical ability to continue operations and meet cash flow requirements.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management considers these factors in the aggregate and believes that the Company has alleviated the substantial doubt about its ability to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 16600000 -67900000 15000000 9990000 <p id="xdx_80E_eus-gaap--ConcentrationRiskDisclosureTextBlock_zEnJa982aP8e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 4 – <span id="xdx_821_zyaGOaD3FdMd">CONCENTRATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For the nine-months ended September 30, 2021 and the year ended December 31, 2020, two customers accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_z8vm8u1wUBzd">26.1</span></span><span style="font: 10pt Times New Roman, Times, Serif">% </span><span style="font: 10pt Times New Roman, Times, Serif">and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zP83EngpyCmk">37.2</span></span><span style="font: 10pt Times New Roman, Times, Serif">%, respectively, of the Company’s consolidated revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accounts receivable at September 30, 2021 and December 31, 2020 are made up of trade receivables due from customers in the ordinary course of business. Four customers made up <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zEogD3cDQCdl">20.2</span></span><span style="font: 10pt Times New Roman, Times, Serif">% </span><span style="font: 10pt Times New Roman, Times, Serif">of the accounts receivable balance at September 30, 2021 and one customer represented <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomersMember_zc2yTlyiIgFh">46</span></span><span style="font: 10pt Times New Roman, Times, Serif">% of the balance of accounts receivable at December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accounts payable are made up of amounts due to suppliers in the ordinary course of business at September 30, 2021 and December 31, 2020. One vendor made up <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_zmhfded1Qvti">71</span></span><span style="font: 10pt Times New Roman, Times, Serif">% </span><span style="font: 10pt Times New Roman, Times, Serif">and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_z8BKXOBx1e8c">92.4</span></span><span style="font: 10pt Times New Roman, Times, Serif">% of our accounts payable on September 30, 2021 and December 31, 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 0.261 0.372 0.202 0.46 0.71 0.924 <p id="xdx_808_eus-gaap--BusinessCombinationDisclosureTextBlock_zJPD0NYJ8Fee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 5 – <span id="xdx_822_zscjBPDKMl85">BUSINESS ACQUISITION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In February 2020, OMNIQ entered in an asset purchase agreement with Eyepax IT Consulting LLC, a California limited liability company, (“Eyepax”) and its principal owners (collectively the “Sellers”), pursuant to which we purchased certain assets from the Sellers at a cash purchase price of $<span id="xdx_90D_eus-gaap--PaymentsToAcquireBusinessesGross_pn3n3_c20200201__20200228__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--EyepaxITConsultingLLCMember_zsoxljIKFMHj" title="Cash purchase price">245</span>,000. As additional consideration, the Company issued to the Sellers <span id="xdx_905_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20200201__20200228__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--EyepaxITConsultingLLCMember_zA99Fe9oUKai" title="Number of shares will be issued">80,000</span> shares of the Company’s common stock and an option to purchase <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20200201__20200228__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--EyepaxITConsultingLLCMember_zL0pqyMRlZji" title="Number of options granted to purchase common stock">20,000</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20200201__20200228__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--EyepaxITConsultingLLCMember_zhJ96MlDIpJc" title="Weighted average exercise price, stock options granted">5.00</span> per share, subject to adjustment, which shall vest quarterly in four (4) equal installments and expire on <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20200201__20200228__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--EyepaxITConsultingLLCMember_zcy9fvtAGPnj" title="Stock options, expiration date">February 28, 2023</span>. The Company entered into an employment agreement with Mr. Lalith Caldera, a principal owner of Eyepax, agreeing to pay Mr. Caldera an annual salary of $<span id="xdx_90F_eus-gaap--OfficersCompensation_pn3n3_c20200201__20200228__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--MrCalderaMember_zJSxeCCuFnr1" title="Annual salary">100</span>,000.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On May 3, 2021, the Company and Omniq Technologies Ltd., a wholly owned subsidiary of the Company (“Omniq Technologies”) entered into a share purchase agreement (the “Dangot Share Purchase Agreement”) with Mr. Haim Dangot. Pursuant to the Dangot Share Purchase Agreement, Omniq Technologies agreed to purchase <span id="xdx_907_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20210503__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAcquisitionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DangotComputersLtdMember_zkARAQoLHGq" title="Acquisition percentage">51</span>%, or <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210502__20210503__dei--LegalEntityAxis__custom--OmniqTechnologiesMember_zPipdmm98B1k" title="Stock issued">5,100</span> shares, of the capital stock of Dangot Computers Ltd., an Israel company (“Dangot”), from Dangot’s sole shareholder, Haim Dangot, for consideration equivalent to <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_uIsraelinewsheqel_c20210707__20210708__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAcquisitionAgreementMember__dei--LegalEntityAxis__custom--OmniqTechnologiesMember_zUS7NuRdfVSa" title="Stock Issued During Period, Value, New Issues">23,740,500</span> NIS (New Israeli Shekel), which is equal to US$<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn5n6_c20210707__20210708__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAcquisitionAgreementMember__dei--LegalEntityAxis__custom--OmniqTechnologiesMember_zPo6mhBBDA74" title="Stock Issued During Period, Value, New Issues">7.6</span> million (the “Closing Consideration”), based on the then current exchange rate at the date of acquisition of NIS to dollars.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Closing Consideration was paid on July 8, 2021 in the following manner: (a) the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210707__20210708__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zqoEleR4WV36" title="Stock Issued During Period, Shares">220,103</span> shares of its common stock having a share value of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210706__20210708__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAcquisitionAgreementMember_z03NEYvz1Vmf" title="Stock issued during period, restricted shares">2,000,000</span> based on the average of the last <span id="xdx_909_ecustom--NumberofTradingDays_iI_uTradingdays_c20210708__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAcquisitionAgreementMember_zTRJu24bg2Ui" title="Number of trading days">30</span> trading days prior to signing (May 3 ,2021); and (b) cash in the amount of $<span id="xdx_901_eus-gaap--Cash_iI_c20210708__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAcquisitionAgreementMember_zUfvQHciHFq6" title="Cash">5,600,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Haim Dangot also granted Omniq Technologies an irrevocable option to purchase the remaining <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210502__20210503__dei--LegalEntityAxis__custom--HaimDagotMember_z0KwJXqvT84a" title="Stock issued">4,900</span> shares, or <span id="xdx_907_ecustom--RemainingAcquiredPercentage_iI_pid_dp_uPure_c20210503__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAcquisitionAgreementMember_zzjzpjUey945" title="Remaining acquired percentage">49</span>%, of Dangot’s capital stock (the “Dangot Option”) in the 12-month period following the closing date (the “Dangot Option Period”) at a share purchase price of<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_uIsraelinewsheqel_c20210707__20210708__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAcquisitionAgreementMember__dei--LegalEntityAxis__custom--HaimDangotMember_zeFQywFAeSUi"> 465,500</span> NIS (US$<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210707__20210708__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAcquisitionAgreementMember__dei--LegalEntityAxis__custom--HaimDangotMember_zSgmgQiEBxnc" title="Stock issued during period, new issues">143,142</span> per each <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_dp_c20200201__20200228__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--HaimDangotMember_zdTQICSU9qx1">1</span>% of Dangot’s remaining shares on a fully diluted basis) which is the same valuation per share as the purchase price for the <span id="xdx_902_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20210503__us-gaap--TypeOfArrangementAxis__custom--DefinitiveAcquisitionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--HaimDangotMember_z5i0j2jS0VR4">51</span>%. In the event that Omniq Technologies chooses to exercise the Dangot Option, it must do so in whole or by an exercise pursuant to which Omniq Technologies shall purchase at least 26% of the additional Dangot shares on a fully diluted basis (the “Specific Partial Exercise”). Should Omniq Technologies exercise the Specific Partial Exercise, it shall have the right to complete the purchase of the remaining 23% of the Dangot shares on a fully diluted basis in a single exercise until the lapse of the Dangot Option Period. No other partial exercise shall be allowed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table summarizes the consideration given and the purchase price allocation:</span></p> <p id="xdx_89F_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zq7EHknSeF73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B1_zi9HCjwxZjWi" style="display: none">SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold">Purchase Price Consideration (in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20210502__20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_ze20Mimbqx08" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total Consideration</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_maBCCTz3sb_zrvr6CD4OQb9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Cash payments</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">5,058</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--AccruedPayableToOwner_maBCCTz3sb_z85X8TVf2ux9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued payable to owner</td><td> </td> <td style="text-align: left"/><td style="text-align: right">600</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--BusinessCombinationConsiderationFairValue_maBCCTz3sb_zKcthRsZrOi2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Fair value of stock issued (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFQ09HTklaRUQgRkFJUiBWQUxVRVMgT0YgQVNTRVRTIEFDUVVJUkVEIEFORCBMSUFCSUxJVElFUyBBU1NVTUVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20210502__20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zmACVdhltRSi" title="Business acquisition stock issued, shares">220,103</span> shares)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,084</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NoncashOrPartNoncashAcquisitionDebtAssumed1_maBCCTz3sb_zPCes8j5mAe8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Debt assumed</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,310</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationConsiderationTransferred1_iT_pn3n3_mtBCCTz3sb_zzY7zln7W7W" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Total consideration</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,052</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Cash</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_ziTiVDqzH7rk" style="text-align: right" title="Cash">666</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts Receivable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zer2ZwMBuVid" style="text-align: right" title="Accounts Receivable">13,470</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Inventory</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zONJ0Dr1I4Ji" style="text-align: right" title="Inventory">4,616</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other Assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zsW2j7qbCATd" style="text-align: right" title="Other Assets">5,392</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_z9KvboclbMGa" style="text-align: right" title="Property and equipment">638</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Goodwill</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zdTWFhIkIOOc" style="text-align: right" title="Goodwill">1,758</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Trade name</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zfV4jhtQv2Yc" style="text-align: right" title="Trade name">1,893</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer relationship</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationship_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zjzaAmMyRfW3" style="text-align: right" title="Customer relationship">3,139</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Other intangible assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zt9IyHnB9nEj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other intangible assets">899</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Assets acquired</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zxxIVqpB97cc" style="text-align: right" title="Assets acquired">32,471</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current liabilities assumed</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iNI_pn3n3_di_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zwG3kjZJXlme" style="text-align: right" title="Current liabilities assumed">(12,911</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Non-controlling interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iNI_pn3n3_di_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zNifhkG7DzK9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Non-controlling interest">(6,508</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Net assets acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zaDrm2sH3Nc9" style="border-bottom: Black 2.5pt double; text-align: right" title="Net assets acquired">13,052</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_ziHzPPDw6Qq7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_892_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_z7EK6XotXZDk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following proforma unaudited revenue and earnings as if the acquisition had been included in the consolidated results of the company for the full year ending December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BE_zKnlhZLxifH8" style="display: none">SCHEDULE OF PROFORMA UNAUDITED REVENUE AND EARNINGS</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49B_20210101__20210930_zsrRI3vSsjmk" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_490_20200101__20200930_zQbe3i1H1iAh" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2020</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">September 30,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2020</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-style: italic"> </td> <td colspan="6" style="text-align: center; font-style: italic">(in thousands/unaudited)</td><td style="text-align: center; font-style: italic"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_zBiAy4bymFE7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">72,940</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">66,110</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_zgorTBhFgAD5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net income (loss)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(9,233</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(7,892</td><td style="text-align: left">)</td></tr> </table> <p id="xdx_8AC_zCLD9zLDTXw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Individual pro forma results for each acquisition are not disclosed, as individually these acquisitions would not have a material impact on the Company’s financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> 245000 80000 20000 5.00 2023-02-28 100000 0.51 5100 23740500 7600000 220103 2000000 30 5600000 4900 0.49 465500 143142 0.01 0.51 <p id="xdx_89F_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zq7EHknSeF73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B1_zi9HCjwxZjWi" style="display: none">SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold">Purchase Price Consideration (in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20210502__20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_ze20Mimbqx08" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total Consideration</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_maBCCTz3sb_zrvr6CD4OQb9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Cash payments</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">5,058</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--AccruedPayableToOwner_maBCCTz3sb_z85X8TVf2ux9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued payable to owner</td><td> </td> <td style="text-align: left"/><td style="text-align: right">600</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--BusinessCombinationConsiderationFairValue_maBCCTz3sb_zKcthRsZrOi2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Fair value of stock issued (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFJFQ09HTklaRUQgRkFJUiBWQUxVRVMgT0YgQVNTRVRTIEFDUVVJUkVEIEFORCBMSUFCSUxJVElFUyBBU1NVTUVEIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20210502__20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zmACVdhltRSi" title="Business acquisition stock issued, shares">220,103</span> shares)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,084</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NoncashOrPartNoncashAcquisitionDebtAssumed1_maBCCTz3sb_zPCes8j5mAe8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Debt assumed</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,310</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationConsiderationTransferred1_iT_pn3n3_mtBCCTz3sb_zzY7zln7W7W" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Total consideration</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,052</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Cash</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_ziTiVDqzH7rk" style="text-align: right" title="Cash">666</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts Receivable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zer2ZwMBuVid" style="text-align: right" title="Accounts Receivable">13,470</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Inventory</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zONJ0Dr1I4Ji" style="text-align: right" title="Inventory">4,616</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other Assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zsW2j7qbCATd" style="text-align: right" title="Other Assets">5,392</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_z9KvboclbMGa" style="text-align: right" title="Property and equipment">638</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Goodwill</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zdTWFhIkIOOc" style="text-align: right" title="Goodwill">1,758</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Trade name</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zfV4jhtQv2Yc" style="text-align: right" title="Trade name">1,893</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer relationship</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationship_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zjzaAmMyRfW3" style="text-align: right" title="Customer relationship">3,139</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Other intangible assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zt9IyHnB9nEj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other intangible assets">899</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Assets acquired</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zxxIVqpB97cc" style="text-align: right" title="Assets acquired">32,471</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current liabilities assumed</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iNI_pn3n3_di_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zwG3kjZJXlme" style="text-align: right" title="Current liabilities assumed">(12,911</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Non-controlling interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iNI_pn3n3_di_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zNifhkG7DzK9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Non-controlling interest">(6,508</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Net assets acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iI_pn3n3_c20210503__us-gaap--BusinessAcquisitionAxis__custom--DangotSharesMember_zaDrm2sH3Nc9" style="border-bottom: Black 2.5pt double; text-align: right" title="Net assets acquired">13,052</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 5058000 600000 220103 2084000 5310000 13052000 666000 13470000 4616000 5392000 638000 1758000 1893000 3139000 899000 32471000 12911000 6508000 13052000 <p id="xdx_892_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_z7EK6XotXZDk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following proforma unaudited revenue and earnings as if the acquisition had been included in the consolidated results of the company for the full year ending December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BE_zKnlhZLxifH8" style="display: none">SCHEDULE OF PROFORMA UNAUDITED REVENUE AND EARNINGS</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49B_20210101__20210930_zsrRI3vSsjmk" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_490_20200101__20200930_zQbe3i1H1iAh" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2020</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">September 30,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2020</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-style: italic"> </td> <td colspan="6" style="text-align: center; font-style: italic">(in thousands/unaudited)</td><td style="text-align: center; font-style: italic"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaRevenue_pn3n3_zBiAy4bymFE7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">72,940</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">66,110</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pn3n3_zgorTBhFgAD5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net income (loss)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(9,233</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(7,892</td><td style="text-align: left">)</td></tr> </table> 72940000 66110000 -9233000 -7892000 <p id="xdx_800_eus-gaap--ShortTermDebtTextBlock_zjUEAoZAWfl1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 6 – <span id="xdx_82C_z2lAeI06njC">CREDIT FACILITIES AND LINE OF CREDIT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We maintain operating lines of credit, factoring and revolving credit facilities with banks and finance companies to provide us working capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In July 2016, we entered into a Factoring and Security Agreement (the “FASA”) with Action Capital Corporation (“Action”) to establish a sale of accounts receivable credit facility, whereby we may obtain short-term financing by selling and assigning acceptable accounts receivable to Action. Pursuant to the FASA, the outstanding principal amount of advances made by Action at any time shall not exceed $<span id="xdx_90E_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn5n6_c20160731__us-gaap--TypeOfArrangementAxis__custom--FactoringAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ActionCapitalCorporationMember_zcrjCH9C2AIb" title="Line of credit, maximum borrowing capacity">6.0 </span></span><span style="font: 10pt Times New Roman, Times, Serif">million. Action reserves and withholds up to <span id="xdx_903_ecustom--PercentageOfReserveAccount_pid_dp_uPure_c20160701__20160731__us-gaap--TypeOfArrangementAxis__custom--FactoringAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ActionCapitalCorporationMember_zpcRrNQLQMtg">5</span></span><span style="font: 10pt Times New Roman, Times, Serif">% of the face amount of each account purchased in a reserve account. As of September 30, 2021 and December 31, 2020, the balance outstanding was $<span id="xdx_900_eus-gaap--LineOfCredit_iI_pn5n6_c20210930_zMqC2chdJTP7" title="Line of credit">5.8</span> million and $<span id="xdx_901_eus-gaap--LineOfCredit_iI_pn5n6_c20201231_zXeEClB1NX2g" title="Line of credit">4.9</span></span> <span style="font: 10pt Times New Roman, Times, Serif">million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The annual interest rate with respect to the daily average balance of unpaid advances outstanding under the FASA (computed on a monthly basis) is equal to the “Prime Rate” of Wells Fargo Bank N.A. plus <span id="xdx_904_eus-gaap--LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_pid_dp_uPure_c20160701__20160731__us-gaap--TypeOfArrangementAxis__custom--FactoringAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ActionCapitalCorporationMember__us-gaap--VariableRateAxis__us-gaap--PrimeRateMember_z6D8CSO7bf22" title="Line of credit facility, unused capacity, commitment fee percentage">2.0</span>%, plus a monthly fee equal to <span id="xdx_90F_eus-gaap--LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_pid_dp_uPure_c20160701__20160731__us-gaap--TypeOfArrangementAxis__custom--FactoringAndSecurityAgreementMember__dei--LegalEntityAxis__custom--ActionCapitalCorporationMember_zH41oNr6UQ41" title="Line of credit facility, unused capacity, commitment fee percentage">0.75</span>% of the average outstanding balance. We also pay all other costs incurred by Action under the FASA, including all bank fees. The FASA continues in full force and effect unless terminated by either party upon 30 days’ prior written notice. The FASA credit facility is collateralized with a security interest in certain assets of the Company. The FASA includes customary representations and warranties and default provisions for transactions of this type.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 6000000.0 0.05 5800000 4900000 0.020 0.0075 <p id="xdx_809_ecustom--NotesPayableRelatedPartiesTextBlock_zn9oeTqP9Df8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 7 – <span id="xdx_822_zbdaRZg5Pud5">RELATED PARTY NOTES PAYABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zYPXQxbjmGB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Related party notes payable, consisted of the following as of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_zLpoOfDSBTV8" style="display: none">SCHEDULE OF NOTES PAYABLE, RELATED PARTIES</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-style: italic; text-align: left">In thousands</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Note payable –Marin</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20210930__us-gaap--DebtInstrumentAxis__custom--NotePayableMarinMember_zoTV6s1n9NM2" style="width: 16%; text-align: right" title="Total notes payable">480</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20201231__us-gaap--DebtInstrumentAxis__custom--NotePayableMarinMember_zkP5PdvE56Q6" style="width: 16%; text-align: right" title="Total notes payable">660</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Note payable –Thomet</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20210930__us-gaap--DebtInstrumentAxis__custom--NotePayableThometMember_zbzKjVQ3acQb" style="text-align: right" title="Total notes payable">300</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20201231__us-gaap--DebtInstrumentAxis__custom--NotePayableThometMember_ztSf4YPdnfS4" style="text-align: right" title="Total notes payable">413</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Note payable–Shareholder Convertible Note</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20210930__us-gaap--DebtInstrumentAxis__custom--NotePayableShareholderConvertibleNoteMember_zks9cnimf1hd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total notes payable"><span style="-sec-ix-hidden: xdx2ixbrl1349">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20201231__us-gaap--DebtInstrumentAxis__custom--NotePayableShareholderConvertibleNoteMember_zhTLnZrypcCj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total notes payable">43</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total notes payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20210930_zgKvVkCF9Lbc" style="text-align: right" title="Total notes payable">780</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20201231_zqSJTJWtIse1" style="text-align: right" title="Total notes payable">1,116</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Less current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iNI_pn3n3_di_c20210930_zSkNIv5Jzxre" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: current portion">(390</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iNI_pn3n3_di_c20201231_zym0XGBmDgxb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: current portion">(433</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayableRelatedPartiesNoncurrent_iI_pn3n3_c20210930_z3iMoHInuKof" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Notes Payable">390</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayableRelatedPartiesNoncurrent_iI_pn3n3_c20201231_zdOf89OR96M7" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Notes Payable">683</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zXrphdyXnHW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note Payable -Marin</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In December 2017, we entered into a $<span id="xdx_90A_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20171231__us-gaap--DebtInstrumentAxis__custom--MarinNoteMember_zRvdjzJ1GYT5">660 </span></span><span style="font: 10pt Times New Roman, Times, Serif">thousand, <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20171231__us-gaap--DebtInstrumentAxis__custom--MarinNoteMember_zJj1qOHZBKO6">1.89</span></span><span style="font: 10pt Times New Roman, Times, Serif">% annual interest rate note payable (the “Marin Note”) with two individuals from whom we previously acquired their company (in 2014). The Marin Note is payable in 60 monthly principal payments of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20181001__20181031__us-gaap--DebtInstrumentAxis__custom--MarinNoteMember_zAeZQfswZFS2">20 </span></span><span style="font: 10pt Times New Roman, Times, Serif">thousand beginning in October 2018. Accrued interest payable as of September 30, 2021, was $<span id="xdx_902_eus-gaap--AccountsPayableAndAccruedLiabilitiesNoncurrent_iI_pn3n3_c20210930_zMQak5ZpTNw7" title="Accrued interest payable">63 </span></span><span style="font: 10pt Times New Roman, Times, Serif">thousand. Accrued interest is payable at maturity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note Payable – Thomet</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In December 2017, we entered into a $<span id="xdx_90C_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20171231__us-gaap--DebtInstrumentAxis__custom--ThometNoteMember_zUmYBB03CpK4" title="Note payable, related parties">750</span> thousand, zero percent annual interest rate note payable (the “Thomet Note”) with an individual from whom we previously acquired his company (in 2014). The Thomet Note is payable in 60 monthly principal payments of $<span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20181001__20181031__us-gaap--DebtInstrumentAxis__custom--ThometNoteMember_zr8fdkHInxqf" title="Monthly principal payments">13</span> thousand beginning in October 2018.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note Payable – Shareholder Convertible Note</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In October 2018, we entered into a $<span id="xdx_906_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20181031__us-gaap--DebtInstrumentAxis__custom--ShareholderConvertibleNoteMember_zzXSbHZlIEG9" title="Note payable, related parties">700</span> thousand, <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20181031__us-gaap--DebtInstrumentAxis__custom--ShareholderConvertibleNoteMember_zU5w49GWkSuc" title="Debt instruments interest rate">6</span>% annual interest rate convertible note payable (the “Shareholder Convertible Note”) with Walefar and Campbeltown (collectively the “Holders”), in connection with the HTS Image Processing, Inc. Mr. Shai Lustgarten, our Chief executive Officer and Director is the principal shareholder in Walefar. Mr. Carlos J. Nissensohn, a consultant and significant shareholder in OMNIQ, is the principal shareholder in Campbeltown. The Shareholder Convertible Note was retired in 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_895_ecustom--ScheduleOfFutureMaturitiesOfNotesPayableRelatedPartiesTableTextBlock_zdxCar2JgWKg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Future maturities of related party notes payable as of September 30, 2021, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BB_zfkTQwOoCQxk" style="display: none">SCHEDULE OF FUTURE MATURITIES OF NOTES PAYABLE, RELATED PARTIES</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>In thousands </i></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20210930_zVfAq2u9KgHf" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_pn3n3_zGX08h8vRFwe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify">2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">97</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pn3n3_zIzzzBcGeCv9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">390</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pn3n3_zip22Z9EnInc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">293</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_pn3n3_zNxgKsMUiXS6" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1386">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pn3n3_zElZZeYWFOPk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Thereafter</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1388">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LongTermDebt_iI_pn3n3_z9pArYZhrDQb" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">780</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AF_zfE7EcWD4oCh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_893_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zYPXQxbjmGB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Related party notes payable, consisted of the following as of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_zLpoOfDSBTV8" style="display: none">SCHEDULE OF NOTES PAYABLE, RELATED PARTIES</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-style: italic; text-align: left">In thousands</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Note payable –Marin</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20210930__us-gaap--DebtInstrumentAxis__custom--NotePayableMarinMember_zoTV6s1n9NM2" style="width: 16%; text-align: right" title="Total notes payable">480</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20201231__us-gaap--DebtInstrumentAxis__custom--NotePayableMarinMember_zkP5PdvE56Q6" style="width: 16%; text-align: right" title="Total notes payable">660</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Note payable –Thomet</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20210930__us-gaap--DebtInstrumentAxis__custom--NotePayableThometMember_zbzKjVQ3acQb" style="text-align: right" title="Total notes payable">300</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20201231__us-gaap--DebtInstrumentAxis__custom--NotePayableThometMember_ztSf4YPdnfS4" style="text-align: right" title="Total notes payable">413</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Note payable–Shareholder Convertible Note</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20210930__us-gaap--DebtInstrumentAxis__custom--NotePayableShareholderConvertibleNoteMember_zks9cnimf1hd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total notes payable"><span style="-sec-ix-hidden: xdx2ixbrl1349">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20201231__us-gaap--DebtInstrumentAxis__custom--NotePayableShareholderConvertibleNoteMember_zhTLnZrypcCj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total notes payable">43</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total notes payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20210930_zgKvVkCF9Lbc" style="text-align: right" title="Total notes payable">780</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pn3n3_c20201231_zqSJTJWtIse1" style="text-align: right" title="Total notes payable">1,116</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Less current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iNI_pn3n3_di_c20210930_zSkNIv5Jzxre" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: current portion">(390</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iNI_pn3n3_di_c20201231_zym0XGBmDgxb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: current portion">(433</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayableRelatedPartiesNoncurrent_iI_pn3n3_c20210930_z3iMoHInuKof" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Notes Payable">390</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayableRelatedPartiesNoncurrent_iI_pn3n3_c20201231_zdOf89OR96M7" style="border-bottom: Black 2.5pt double; text-align: right" title="Long Term Notes Payable">683</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 480000 660000 300000 413000 43000 780000 1116000 390000 433000 390000 683000 660000 0.0189 20000 63000 750000 13000 700000 0.06 <p id="xdx_895_ecustom--ScheduleOfFutureMaturitiesOfNotesPayableRelatedPartiesTableTextBlock_zdxCar2JgWKg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Future maturities of related party notes payable as of September 30, 2021, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BB_zfkTQwOoCQxk" style="display: none">SCHEDULE OF FUTURE MATURITIES OF NOTES PAYABLE, RELATED PARTIES</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>In thousands </i></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20210930_zVfAq2u9KgHf" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_pn3n3_zGX08h8vRFwe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify">2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">97</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pn3n3_zIzzzBcGeCv9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">390</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pn3n3_zip22Z9EnInc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">293</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_pn3n3_zNxgKsMUiXS6" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1386">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pn3n3_zElZZeYWFOPk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Thereafter</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1388">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LongTermDebt_iI_pn3n3_z9pArYZhrDQb" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">780</td><td style="text-align: left"> </td></tr> </table> 97000 390000 293000 780000 <p id="xdx_80A_eus-gaap--DebtDisclosureTextBlock_zqvgIMMAspf1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 8 – <span id="xdx_820_zGKIXB6GQ5R3">OTHER NOTES PAYABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfDebtTableTextBlock_zAi03KQt3sua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Other notes payable at September 30, 2021 and December 31, 2020, consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B4_zrw8O9C7IYmk" style="display: none">SCHEDULE OF OTHER NOTES PAYABLE</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: justify">(In thousands)</td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2021</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: justify">Note Payable- Supplier</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherNotesPayable_iI_pn3n3_c20210930__us-gaap--DebtInstrumentAxis__custom--NotePayableSupplierMember_zdZYjYr4kNc5" style="width: 18%; text-align: right" title="Total notes payable">2,843</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--OtherNotesPayable_iI_pn3n3_c20201231__us-gaap--DebtInstrumentAxis__custom--NotePayableSupplierMember_ziQ6bWbFzoY4" style="width: 18%; text-align: right" title="Total notes payable">6,443</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Total notes payable"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Total notes payable"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">All Other</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--OtherNotesPayable_iI_pn3n3_c20210930__us-gaap--DebtInstrumentAxis__custom--AllOtherMember_zUdNcoHCuKYj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total notes payable">5,125</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherNotesPayable_iI_pn3n3_c20201231__us-gaap--DebtInstrumentAxis__custom--AllOtherMember_z36vY8UPVmUa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total notes payable">7</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Total</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--OtherNotesPayable_iI_pn3n3_c20210930_zZ8h1Xpzajyd" style="text-align: right" title="Total notes payable">7,968</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--OtherNotesPayable_iI_pn3n3_c20201231_zWIWQUx20Ao7" style="text-align: right" title="Total notes payable">6,450</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Less current portion</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--OtherNotesPayableCurrent_iNI_pn3n3_di_c20210930_zrx08MgQEKh8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less current portion">(5,641</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--OtherNotesPayableCurrent_iNI_pn3n3_di_c20201231_z2hOJ3uCqej5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less current portion">(6,449</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Long Term Notes Payable</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--OtherLongTermNotesPayable_iI_pn3n3_c20210930_zYLBfd0Jywo2" style="border-bottom: Black 2.5pt double; text-align: right" title="Total notes payable">2,327</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--OtherLongTermNotesPayable_iI_pn3n3_c20201231_zU6Ew2vMI2d8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total notes payable">1</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A2_zfKr0P3CDAK1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note Payable - Supplier </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On July 18, 2016, the Company and the Supplier entered into a certain secured promissory note, with an effective date of July 1, 2016, in the principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20160718__us-gaap--LongtermDebtTypeAxis__custom--SecuredPromissoryNoteMember_zMzDGTRBciek" title="Debt instrument face amount">12.5</span> million (the “Secured Promissory Note”). The USD Note accrues interest at <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20160718__us-gaap--LongtermDebtTypeAxis__custom--SecuredPromissoryNoteMember_zgtxyYMzYXY2" title="Debt instruments interest rate">18</span>% per annum and is payable in six consecutive monthly installments of principal and accrued interest in a minimum principal amount of $<span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPayment_pn3n3_c20160717__20160718__us-gaap--LongtermDebtTypeAxis__custom--SecuredPromissoryNoteMember_zEGpi9yHBLOc" title="Debt instruments periodic payment">250</span> thousand each, with any remaining principal and accrued interest due and payable on December 31, 2016.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On September 7, 2018, the Company entered into a Sixth Amendment to the Secured Promissory Note (the “Sixth Amendment”) extending the maturity date to January 31, 2019. The Sixth Amendment also increases the principal amount to $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20180907__us-gaap--LongtermDebtTypeAxis__custom--SecuredPromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--SixthAmendmentAgreementMember_z406gYd0qHw9" title="Debt instrument face amount">8.7</span> million, an increase of $<span id="xdx_902_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn5n6_c20180906__20180907__us-gaap--LongtermDebtTypeAxis__custom--SecuredPromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--SixthAmendmentAgreementMember_zjsdUvkahDk7" title="Debt instrument, increase, accrued interest">6.8</span> million, by rolling the Company’s then existing and outstanding accounts payable into the note by the previously mentioned amount of increase. The Company will continue to make monthly payments in the amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentPeriodicPayment_pn3n3_c20180906__20180907__us-gaap--LongtermDebtTypeAxis__custom--SecuredPromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--SixthAmendmentAgreementMember__us-gaap--DebtInstrumentAxis__custom--FirstThreeMonthlyPaymentsMember_zoemqkI4CTR8" title="Debt instruments periodic payment">300</span> thousand for the first three monthly payments, and also in the amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentPeriodicPayment_pn3n3_c20180906__20180907__us-gaap--LongtermDebtTypeAxis__custom--SecuredPromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--SixthAmendmentAgreementMember__us-gaap--DebtInstrumentAxis__custom--LastTwoMonthlyPaymentsMember_z4Jgi67icNp2" title="Debt instruments periodic payment">500</span> thousand for the last two monthly payments prior to the note’s maturity.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On April 30, 2019, the Company entered into a Seventh Amendment to the Secured Promissory Note (the “Seventh Amendment”) extending the maturity date to July 31, 2019. The Seventh Amendment also provides that the Company will continue to make monthly installments of principal and accrued interest in a minimum principal amount of $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPayment_pn3n3_c20190401__20190430__srt--StatementScenarioAxis__custom--FirstMinimumPaymentMember_zGE0PxH2in9g" title="Debt instruments periodic payment">350</span> thousand each. The Company has made partial payments towards the required monthly installments under the terms of the Seventh Amendment.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 20, 2021, the Company entered into the Eighth Amendment to the Secured Promissory Note (the “Eighth Amendment”) extending the maturity date to August 15, 2022 and reducing the interest rate from <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20210719__20210720__srt--StatementScenarioAxis__custom--EighthAmendmentMember__srt--RangeAxis__srt--MaximumMember_zNUfRfaz04B5" title="Interest rate">18</span>% to <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20210719__20210720__srt--StatementScenarioAxis__custom--EighthAmendmentMember__srt--RangeAxis__srt--MinimumMember_zRCbYsLrfSRb" title="Interest rate">10</span>%. The Eighth Amendment also provides that the Company will continue to make monthly installments of principal and accrued interest at a minimum of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPayment_pn3n3_c20210719__20210720__srt--StatementScenarioAxis__custom--EighthAmendmentMember_zkeL7ZD5B869" title="Debt instruments periodic payment">300</span> thousand each month. As has been the case with each previous amendment, the Company is in continual negotiations with the holder of the Secured Promissory Note to extend the maturity date and establish a new schedule of payments.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_893_eus-gaap--ScheduleOfDebtTableTextBlock_zAi03KQt3sua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Other notes payable at September 30, 2021 and December 31, 2020, consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B4_zrw8O9C7IYmk" style="display: none">SCHEDULE OF OTHER NOTES PAYABLE</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: justify">(In thousands)</td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2021</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: justify">Note Payable- Supplier</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--OtherNotesPayable_iI_pn3n3_c20210930__us-gaap--DebtInstrumentAxis__custom--NotePayableSupplierMember_zdZYjYr4kNc5" style="width: 18%; text-align: right" title="Total notes payable">2,843</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--OtherNotesPayable_iI_pn3n3_c20201231__us-gaap--DebtInstrumentAxis__custom--NotePayableSupplierMember_ziQ6bWbFzoY4" style="width: 18%; text-align: right" title="Total notes payable">6,443</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Total notes payable"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Total notes payable"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">All Other</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--OtherNotesPayable_iI_pn3n3_c20210930__us-gaap--DebtInstrumentAxis__custom--AllOtherMember_zUdNcoHCuKYj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total notes payable">5,125</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherNotesPayable_iI_pn3n3_c20201231__us-gaap--DebtInstrumentAxis__custom--AllOtherMember_z36vY8UPVmUa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total notes payable">7</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify">Total</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--OtherNotesPayable_iI_pn3n3_c20210930_zZ8h1Xpzajyd" style="text-align: right" title="Total notes payable">7,968</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--OtherNotesPayable_iI_pn3n3_c20201231_zWIWQUx20Ao7" style="text-align: right" title="Total notes payable">6,450</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Less current portion</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--OtherNotesPayableCurrent_iNI_pn3n3_di_c20210930_zrx08MgQEKh8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less current portion">(5,641</td><td style="text-align: left">)</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--OtherNotesPayableCurrent_iNI_pn3n3_di_c20201231_z2hOJ3uCqej5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less current portion">(6,449</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Long Term Notes Payable</td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--OtherLongTermNotesPayable_iI_pn3n3_c20210930_zYLBfd0Jywo2" style="border-bottom: Black 2.5pt double; text-align: right" title="Total notes payable">2,327</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--OtherLongTermNotesPayable_iI_pn3n3_c20201231_zU6Ew2vMI2d8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total notes payable">1</td><td style="text-align: left"> </td></tr> </table> 2843000 6443000 5125000 7000 7968000 6450000 5641000 6449000 2327000 1000 12500000 0.18 250000 8700000 6800000 300000 500000 350000 0.18 0.10 300000 <p id="xdx_80D_eus-gaap--OtherLiabilitiesDisclosureTextBlock_znnuiMV7lhoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 9 – <span id="xdx_82D_zjQX5L3hDw63">OTHER LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89E_eus-gaap--OtherLiabilitiesTableTextBlock_zVvFrVpmj8ei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">At September 30, 2021 and December 31, 2020, other liabilities consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B5_zoREnKWSnHp" style="display: none">SCHEDULE OF OTHER LIABILITIES</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: justify">(In thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20210930_zONJ3Y4Wq2D2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20201231_z4KILtD9wpab" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pn3n3_maOLzdZp_zjTIijp8Wfc3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Other vendor payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">801</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">801</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_pn3n3_maOLzdZp_z4xQJgXP0Lq2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Dividend payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,164</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">253</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--BonusPayableCurrentandNoncurrent_iI_pn3n3_maOLzdZp_zHbgQtCoIoaj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Bonus payable</td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1448"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherSundryLiabilities_iI_pn3n3_maOLzdZp_zHseYUFaB5T" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,888</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,477</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OtherLiabilities_iTI_pn3n3_mtOLzdZp_zpnLLvmMEq07" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Total other liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,853</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,558</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OtherLiabilitiesCurrent_iNI_pn3n3_di_zL2sBbHPDJy5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Less Current Portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,796</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,412</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--OtherLiabilitiesNoncurrent_iI_pn3n3_zb86TasEXxT7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total long term other liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,057</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,146</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zBXlsJEnRd85" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89E_eus-gaap--OtherLiabilitiesTableTextBlock_zVvFrVpmj8ei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">At September 30, 2021 and December 31, 2020, other liabilities consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B5_zoREnKWSnHp" style="display: none">SCHEDULE OF OTHER LIABILITIES</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: justify">(In thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20210930_zONJ3Y4Wq2D2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20201231_z4KILtD9wpab" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--AccountsPayableTradeCurrentAndNoncurrent_iI_pn3n3_maOLzdZp_zjTIijp8Wfc3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Other vendor payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">801</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">801</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_pn3n3_maOLzdZp_z4xQJgXP0Lq2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Dividend payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,164</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">253</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--BonusPayableCurrentandNoncurrent_iI_pn3n3_maOLzdZp_zHbgQtCoIoaj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Bonus payable</td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1448"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherSundryLiabilities_iI_pn3n3_maOLzdZp_zHseYUFaB5T" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,888</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,477</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OtherLiabilities_iTI_pn3n3_mtOLzdZp_zpnLLvmMEq07" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Total other liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,853</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,558</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OtherLiabilitiesCurrent_iNI_pn3n3_di_zL2sBbHPDJy5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Less Current Portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,796</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,412</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--OtherLiabilitiesNoncurrent_iI_pn3n3_zb86TasEXxT7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total long term other liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,057</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,146</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 801000 801000 1164000 253000 27000 2888000 1477000 4853000 2558000 2796000 1412000 2057000 1146000 <p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zoZvD8rSD2T3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 10 – <span id="xdx_829_zC2zwOIKQbnl">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>PREFERRED STOCK</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Series A</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of September 30, 2021, there were <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z1lN7JHoFGt1" title="Preferred stock shares authorized">1,000,000</span> Series A preferred shares designated and <span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zKiiCLM0mgke" title="Preferred stock shares outstanding">no</span> Series A preferred shares outstanding. <span id="xdx_907_eus-gaap--PreferredStockVotingRights_c20210101__20210930__srt--TitleOfIndividualAxis__srt--DirectorMember_zmC3KR7gtyZd" title="Preferred stock voting rights">The board of directors of the Company (the “Board”) had previously set the voting rights for the Series A preferred stock at 1 share of preferred to 250 common shares.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Series B</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of September 30, 2021, there was <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zPXDTxcN0El6" title="Preferred stock shares authorized">1</span> preferred share designated and <span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zRLDQKq33TEg" title="Preferred stock shares outstanding">no</span> preferred shares outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Series C</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of September 30, 2021, there were <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zhz21oDzQlQf" title="Preferred stock shares authorized">3,000,000</span> Series C Preferred Shares (“Series C”) authorized with <span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_pid_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zGsSz66FDRAg" title="Preferred stock, shares issued"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zrapuI6LJUMe" title="Preferred stock, shares outstanding">745,030</span></span> issued and outstanding. The Series C shares have preferential rights above common shares and the Series B Preferred Shares and is entitled to receive a quarterly dividend at a rate of $<span id="xdx_90F_eus-gaap--DividendsPayableAmountPerShare_iI_pid_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zINDZ8BytPKj" title="Dividends payable, amount per share">0.06</span> per share per annum and have a liquidation preference of $<span id="xdx_900_eus-gaap--PreferredStockLiquidationPreference_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zwh2HxRrDgmg" title="Preferred stock, liquidation preference per share">1</span> per share. Series C shares outstanding are convertible into common stock at the rate of 20 preferred shares to one share of common stock. As of September 30, 2021, the accrued dividends on the Series C Preferred Stock was $<span id="xdx_907_eus-gaap--Dividends_pn3n3_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zsxhv3rEugPk" title="Dividends">106</span> thousand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--PreferredStockConversionBasis_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zbbKfs6CNUEk" title="Preferred stock conversion, description">The Series C Preferred Stock has a liquidation value and conversion price of $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) and automatically converts into Common Stock at $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) in the event that the Company’s common stock has a closing price of $30 per share for 20 consecutive trading days.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>COMMON STOCK</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In August 2020, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain existing employees and attract new employees, directors, officers, consultants, and advisors to the Company. Pursuant to the Plan, one million (<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20200801__20200831__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDlSzeEPQo3" title="Number of stock issued">1,000,000</span>) shares of the Company’s common stock, par value $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20200831__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8oGGZ9BhoIi" title="Common stock, price per share">0.001</span> (the “Shares”), were set aside and reserved for issuance. As of September 30, 2021, we had issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20210101__20210930__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--ConsultantsAndAdvisorsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQZjAXQHyOLj" title="Number of shares for services">361,146</span> shares or $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn5n6_c20210101__20210930__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--ConsultantsAndAdvisorsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgxaaM5ACCZ7" title="Number of shares for services, value">1.8</span> million to consultants and advisors for services rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In December 2015, our Board of Directors approved the OMNIQ. Employee Stock Purchase Plan (the “ESPP”). For the nine months ending September 30, 2021 employees purchased <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_pid_c20210101__20210930__us-gaap--PlanNameAxis__custom--EmployeeStockPurchasePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDU6KmXK7RX9">1,376 </span></span><span style="font: 10pt Times New Roman, Times, Serif">or $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_pn3n3_c20210101__20210930__us-gaap--PlanNameAxis__custom--EmployeeStockPurchasePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTDA2xSyjsHl">14 </span></span><span style="font: 10pt Times New Roman, Times, Serif">thousand shares of commons stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On February 15, 2021 the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20210214__20210215__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__dei--LegalEntityAxis__custom--OrionFourLLCMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zvBCNBhyUXNc" title="Number of shares for services">25,000</span> shares to Orion 4, LLC as part of a consulting agreement. The shares were valued at $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_c20210214__20210215__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__dei--LegalEntityAxis__custom--OrionFourLLCMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zZmzhbNkMpr6" title="Number of shares for services, value">188</span> thousand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For the nine months ending September 30, 2021, <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zuyHiKvjxJ7k" title="Stock options and warrants exercised">342,667 </span></span><span style="font: 10pt Times New Roman, Times, Serif">in stock options and stock warrants were exercised in exchange for <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzxgGFxn34D3">2,784,096</span> shares of OMNIQ common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 8, 2021, the Company entered into a form of Securities Purchase Agreement (the “Securities Purchase Agreement”) with accredited investors. Pursuant to the Securities Purchase Agreement, on July 8, 2021 (the Closing Date”), the Company sold an aggregate gross proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20210707__20210708__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z2Lb2rrUs81b" title="Proceeds from offering">15</span> million of units (the “Units”) before deducting placement agent fees, consultant and legal fees and other offering expenses (the “Offering”). The per Unit purchase price was $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210708__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zPg4MrHaxvng" title="Common stock, price per share">7.00</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Each Unit is comprised of one share of the Company’s common stock, $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210930_zkOqAi7vUgb5" title="Common stock, par value">0.001</span> par value per share. As a result of the Offering, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210707__20210708__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9A3uHxvXEoc">2,142,857</span> shares of common Stock (the “Shares”) and warrants (the “Warrants”) to purchase <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211108__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zphtoZXb0cM6" title="Number of warrants issued for purchase of common stock">171,429</span> shares of Common Stock (the “Warrant Shares”) at an exercise price equal to $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210708__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zh5O9wu51GI6" title="Warrants exercise price">7.70</span> per Warrant Share, which</span> <span style="font: 10pt Times New Roman, Times, Serif">Warrants are exercisable for a period of <span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20210708__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zXoNo1zUQoYj" title="Warrants exercisable period::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1517">five years</span></span> from the issuance date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ThinkEquity, a division of Fordham Financial Management, Inc. (the “Placement Agent”), acted as the sole placement agent for the Offering. In connection with the Offering, the Company entered into a Placement Agency Agreement with the Placement Agent, pursuant to which it paid the Placement Agent $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20210707__20210708__us-gaap--TypeOfArrangementAxis__custom--PlacementAgencyAgreementMember_zDERgWWHQ1Ak" title="Proceeds from placement">1.2</span> million (eight percent of the gross proceeds) in commissions and reimbursed it for $<span id="xdx_909_eus-gaap--DeferredOfferingCosts_iI_pn3n3_c20211108__us-gaap--TypeOfArrangementAxis__custom--PlacementAgencyAgreementMember_zdoPJGz2nZad" title="Offering cost">150</span> thousand of expenses incurred in connection with the Offering plus other miscellaneous expenses. The Company also issued the Placement Agent a warrant (the “Placement Agent Warrant”) to purchase <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210708__us-gaap--TypeOfArrangementAxis__custom--PlacementAgencyAgreementMember_zhWZ9IvuX06c" title="Number of warrants issued for purchase of common stock">171,429</span> shares of the Company’s common stock (the “Placement Agent Warrant Shares”) at an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210708__us-gaap--TypeOfArrangementAxis__custom--PlacementAgencyAgreementMember_zXmZ2tatFSX9" title="Warrants exercise price">7.70</span> per share. The Placement Agent Warrant terminates <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20210708__us-gaap--TypeOfArrangementAxis__custom--PlacementAgencyAgreementMember_zC7QKpMV0nIf" title="Warrants exercisable period"><span style="-sec-ix-hidden: xdx2ixbrl1527">five years</span></span> from the Closing Date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_896_ecustom--ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingTableTextBlock_zGGothrQvhu5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company paid additional legal and other fees directly related to the Offering. The cash fees paid were netted against the Offering proceeds, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8BC_z3dkwmkKnzX2" style="display: none">SCHEDULE OF ADDITIONAL LEGAL AND OTHER FEES RELATED TO OFFERING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-style: italic; text-align: justify">(In thousands)</td><td> </td> <td colspan="2" id="xdx_49D_20210101__20210930_zLkuaZDWFhM7" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_409_eus-gaap--ProceedsFromIssuanceOfWarrants_hus-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zV6bYaanTC6d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">Total proceeds from issuance of Common Stock and Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">15,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--PlacementAgentFees_zzd0ywqMCke2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Placement Agent fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,455</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--LegalFees_iN_di_z1lYtlewwGb9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Commission, Legal and other fees</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(264</td><td style="text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--ProceedsFromIssuanceOfWarrants_zdXTqW3F0pI3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Total</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,281</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AF_zhO2dEAyQuxa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The fair value of the Warrants issued to the Placement Agent and Consultant are included in the Warrants Paid in Capital account in stockholder’s equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Warrants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zozsECdgrkK" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table summarizes information about warrants granted during the nine-month periods ended September 30, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_ztxDkt5Gzksl" style="display: none">SCHEDULE OF WARRANTS ACTIVITY</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>warrants</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>warrants</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify">Balance, beginning of period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20210101__20210930_z1GVdvtPPEX8" style="width: 11%; text-align: right" title="Number of warrants, Outstanding, Beginning of period">1,366,667</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20210930_zGu8M5YCKEQ9" style="width: 11%; text-align: right" title="Weighted Average Exercise Price balance, Outstanding, Beginning of period">7.19</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20200101__20200930_zqeB8cC0n3R1" style="width: 11%; text-align: right" title="Number of warrants, Outstanding, Beginning of period">1,166,667</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20200101__20200930_zQZ2vpUowtYe" style="width: 11%; text-align: right" title="Weighted Average Exercise Price balance, Outstanding, Beginning of period">6.42</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Warrants granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20210101__20210930_zCH3FVpc2yv1" style="text-align: right" title="Number of warrants, Warrants granted">171,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20200101__20200930_zckrmFmkba6j" style="text-align: right" title="Number of warrants, Warrants granted">325,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_pid_c20200101__20200930_zR8hMLnpvY33" style="text-align: right" title="Weighted Average Exercise Price, Warrants granted">8.20</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Warrants expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20210101__20210930_zjHialk2whah" style="text-align: right" title="Number of warrants, Warrants expired">(15,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice_pid_c20210101__20210930_zXNR9O1ENFcc" style="text-align: right" title="Weighted Average Exercise Price, Warrants expired">14.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20200101__20200930_zetYbw1782W9" style="text-align: right" title="Number of warrants, Warrants expired">(10,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice_pid_c20200101__20200930_zhFVoM4fr069" style="text-align: right" title="Weighted Average Exercise Price, Warrants expired">5.60</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Warrants cancelled, forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20210101__20210930_zzwAi6GC2Gu" style="text-align: right" title="Number of warrants, Warrants cancelled, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1563">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20210101__20210930_z8ZPEndUK96l" style="text-align: right" title="Weighted Average Exercise Price, Warrants cancelled, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1565">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20200101__20200930_zS4v7LpRW996" style="text-align: right" title="Number of warrants, Warrants cancelled, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1567">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20200101__20200930_z3rHaRs4zDzh" style="text-align: right" title="Weighted Average Exercise Price, Warrants cancelled, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1569">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Warrants exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20210101__20210930_z5oAIp1u2Tl2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants, Warrants exercised">(119,167</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20210930_z5tPWKmyvjQj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants exercised">3.98</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20200101__20200930_z1sX3uAiuYv9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants, Warrants exercised">(150,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_pid_c20200101__20200930_zRp2L5Ccggl6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants exercised">4.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Balance, end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20210101__20210930_zMvR0xmssxKk" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Outstanding, End of period">1,403,929</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20210930_zGhpHBVXliUg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, End of period">7.45</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20200101__20200930_z6V5fpC7CZp9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Outstanding, End of period">1,331,667</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20200101__20200930_zwfHKWf39L6d" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, End of period">7.14</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Exercisable warrants</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20210101__20210930_z1phlrbFUCo7" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Exercisable warrants">1,320,596</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20210930_znmsqH6xmGq1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable warrants">7.45</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20200101__20200930_zWeBMRZ0Pb09" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Exercisable warrants">1,165,001</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iE_pid_c20200101__20200930_zRLZr9mFdavh" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable warrants">7.08</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zmDEufWUVZuj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89F_ecustom--ScheduleOfOutstandingWarrantsTableTextBlock_zY73rrnS8TKl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding warrants as of September 30, 2021 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B3_zWdv72UAW8I2" style="display: none">SCHEDULE OF OUTSTANDING WARRANTS</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">Weighted Average</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Range of</td><td> </td> <td colspan="2" style="text-align: center">residual life</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Average</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Average</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Exercise</td><td> </td> <td colspan="2" style="text-align: center">span</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Outstanding</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercisable</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Prices</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(in years)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zyDBxSGqJoL3" style="width: 35%; text-align: right">7.00</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zQss35QMTQog" title="Weighted Average residual life span (in years)">3.27</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zhSjGToOKMEj" style="width: 9%; text-align: right">847,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zlpkLLfaSRck" style="width: 9%; text-align: right" title="Weighted Average Exercise Price">7.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_ziB37ElGYskd" style="width: 9%; text-align: right" title="Exercisable Warrants">847,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z8OYUPqu14Bl" style="width: 9%; text-align: right" title="Weighted Average Exercise Price">7.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zdkT9UUa9jal" style="text-align: right">7.50</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zicfxsFcJq5h" title="Weighted Average residual life span (in years)">4.93</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zhnfM4ci3uB2" style="text-align: right">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_znqZbzZXfkP8" style="text-align: right" title="Weighted Average Exercise Price">7.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zIub7Nn698Nc" style="text-align: right" title="Exercisable Warrants">166,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zrJGcuWgzmwh" style="text-align: right" title="Weighted Average Exercise Price">7.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zzIPhgfvUe3j" style="text-align: right">7.70</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zIBSnq0BPkP7" title="Weighted Average residual life span (in years)">4.77</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zL2TQr1NOsY1" style="text-align: right">171,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zpyrNQN2ZnT3" style="text-align: right" title="Weighted Average Exercise Price">7.70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zSglUZZNwfz7" style="text-align: right" title="Exercisable Warrants">171,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zV5OgG0oooEh" style="text-align: right" title="Weighted Average Exercise Price">7.70</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zdaVUiIpvJU2" style="text-align: right">8.00</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zoibQ0Mo6jIe" title="Weighted Average residual life span (in years)">0.41</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zUTueE1GjUmh" style="text-align: right">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zngywIfNOIU2" style="text-align: right" title="Weighted Average Exercise Price">8.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zlLBjwymJfb" style="text-align: right" title="Exercisable Warrants">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zGOaoup1hD8l" style="text-align: right" title="Weighted Average Exercise Price">8.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zaFFFrBR9z3i" style="border-bottom: Black 1.5pt solid; text-align: right">10.00</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zemQFFvNu9Fj" title="Weighted Average residual life span (in years)">1.23</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zELvfXhVCxYi" style="border-bottom: Black 1.5pt solid; text-align: right">125,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_z6gH22Mu4ril" style="border-bottom: Black 1.5pt solid; text-align: right">10.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_z0GTVrK0wYI3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercisable Warrants">125,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zri5ZjwedNNd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price">10.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zWqMro99EGK2" title="Range of Exercise Prices">7.00</span> to <span id="xdx_90E_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zmqHaIV4VKdd" title="Range of Exercise Prices">10.00</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBX9gh5pn0Z5" title="Weighted Average residual life span (in years)">3.42</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpLEHQVhUZRb" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding Warrants">1,403,929</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_znezotPLsu2c" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price">7.45</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcq1mWUKFvy5" style="border-bottom: Black 2.5pt double; text-align: right" title="Exercisable Warrants">1,320,596</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zp3mfSfcXUU5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price">7.45</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_ziAIB1WEs9T4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_899_ecustom--ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesTableTextBlock_zfGumlxfg1L4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Warrants outstanding at September 30, 2021 and 2020 have the following expiry date and exercise prices:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B8_zroamGJOnSQb" style="display: none">SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Expiry Date</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Prices</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyMember_zX295f8ivDia" style="width: 52%; text-align: center" title="Warrant expiry date">October 10, 2020</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyMember_zhfzcXV0oj8f" style="width: 12%; text-align: right" title="Warrant Exercise Prices">12.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyMember_zPtNf8DEa31e" style="width: 12%; text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1666">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyMember_zjH7iWSB06o5" style="width: 12%; text-align: right" title="Warrant Outstanding">15,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyMember_z4ruAGuhTCG7" style="text-align: center">December 30, 2020</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyMember_zHxhewmps2s9" style="text-align: right">4.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyMember_zRKHn7DC0op5" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1672">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyMember_zUX92yG11kq7" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1674">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwoThousandTwentyOneMember_zGtC45cG3ic2" style="text-align: center">February 02, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwoThousandTwentyOneMember_zLhbVURnTYnf" style="text-align: right">14.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwoThousandTwentyOneMember_zgv4rDbx0hxk" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1678">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--FebruaryTwoThousandTwentyOneMember_zr8GA7DuKcfl" style="text-align: right" title="Warrant Outstanding">15,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_zlHU140doNjk" style="text-align: center">August 02, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_zalkuYgM0Pv2" style="text-align: right">2.20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_zmt40HJFILr6" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1684">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_zTynm98FE7K3" style="text-align: right" title="Warrant Outstanding">75,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyOneMember_zA7w8hz0eumb" style="text-align: center">October 10, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyOneMember_zSah09Jg09y7" style="text-align: right">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyOneMember_zlVBqLF4w7Q6" style="text-align: right" title="Warrant Outstanding">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyOneMember_zskTmMVwGZp9" style="text-align: right" title="Warrant Outstanding">25,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_zyb4nVw1l3Vf" style="text-align: center">February 27, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_zdidyNQefRsc" style="text-align: right">8.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_zsCUIyLoZzNb" style="text-align: right" title="Warrant Outstanding">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_z2Lj7LlTSLUg" style="text-align: right" title="Warrant Outstanding">10,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zN7KCPaV5NE3" style="text-align: center">May 18, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zjCwdOyyhDXb" style="text-align: right">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zDHHZ4CwERhh" style="text-align: right" title="Warrant Outstanding">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zCWNkKPjkLM6" style="text-align: right" title="Warrant Outstanding">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_zxu8gTXyA7Fe" style="text-align: center">October 14, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_zwo9NdJTyrii" style="text-align: right">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_z2yHBW6iGfRk" style="text-align: right" title="Warrant Outstanding">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_zH42qY71qXOc" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1710">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_z4sR9gdwza8k" style="text-align: center">October 06, 2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_zoZer5lVdYc8" style="text-align: right">7.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_zd8ZiZf9ekZ6" style="text-align: right" title="Warrant Outstanding">793,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_zlPUyGgW5np9" style="text-align: right" title="Warrant Outstanding">891,667</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThoousandTwentyFiveMember_zcalGZEaMbsc" style="text-align: center">September 01, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThoousandTwentyFiveMember_zp40gqZzPLah" style="text-align: right">7.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThoousandTwentyFiveMember_zpmFsVWpvy9b" style="text-align: right" title="Warrant Outstanding">83,334</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThoousandTwentyFiveMember_zzSnmiZppTCg" style="text-align: right" title="Warrant Outstanding">83,334</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_zUmmNk6enCu5" style="text-align: center">June 04, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_zS3NZAM1jBnj" style="text-align: right">7.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_zk8oZFoTxFPd" style="text-align: right" title="Warrant Outstanding">83,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_zUEE0HYDDqj5" style="text-align: right" title="Warrant Outstanding">83,333</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--JulyEightTwoThousandTwentySixMember_zUEV5xFL3W75" style="text-align: center">July 8, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--JulyEightTwoThousandTwentySixMember_z9dymAzIUVyg" style="text-align: right">7.70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--JulyEightTwoThousandTwentySixMember_zwTsMclojoP" style="text-align: right" title="Warrant Outstanding">171429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--JulyEightTwoThousandTwentySixMember_zd1LJKwnqEM5" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1734">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zNXYmfUbMsZ9" style="text-align: center; padding-bottom: 1.5pt">December 04, 2027</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zkKk64lH2zq8" style="padding-bottom: 1.5pt; text-align: right">7.50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zqidog8khp17" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrant Outstanding">83,333</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zTf7u7c431x1" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">83,333</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930_zcbOi8Dnjoy2" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant Outstanding">1,403,929</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930_zuWeUAtEy0c1" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant Outstanding">1,231,667</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_z6pAfaLttUu8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Stock Options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zJPrFPhOzrT5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table summarizes information about stock options granted during the nine months ended September 30, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B8_zyyKcDmSrmu8" style="display: none">SCHEDULE OF STOCK OPTIONS GRANTED</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>stock options</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>stock options</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify">Balance, beginning of period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20210930_znbFnggxXwj2" style="width: 11%; text-align: right" title="Number of stock options, Outstanding, Beginning of period">1,811,550</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20210930_zstoQjjVFyo3" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning of period">4.32</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20200101__20200930_zyAtBsGplA7i" style="width: 11%; text-align: right" title="Number of stock options, Outstanding, Beginning of period">1,133,550</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20200101__20200930_zWhk2YULeYy8" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning of period">4.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Stock options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20210930_zpj5hKtSH58b" style="text-align: right" title="Number of stock options, Stock options granted"><span style="-sec-ix-hidden: xdx2ixbrl1755">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20200101__20200930_zOl0LRdqigR8" style="text-align: right" title="Number of stock options, Stock options granted">775,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20200101__20200930_zeg9pNsDAWWg" style="text-align: right" title="Weighted Average Exercise Price, Stock options granted">4.63</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Stock options expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pid_di_c20210101__20210930_zOm4jtZyPQjd" style="text-align: right" title="Number of stock options, Stock options expired"><span style="-sec-ix-hidden: xdx2ixbrl1761">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pid_di_c20200101__20200930_zmPRaRSXBQL1" style="text-align: right" title="Number of stock options, Stock options expired">(30,250</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20200101__20200930_zR557q9IisC4" style="text-align: right" title="Weighted Average Exercise Price, Stock options expired">3.98</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Stock options cancelled, forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20210101__20210930_z7b5c4lwWSh9" style="text-align: right" title="Number of stock options, Stock options cancelled, forfeited">(28,750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20200101__20200930_zfwWQ687krUf" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1768">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Stock options exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20210101__20210930_zCqMiAVyW3h8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Stock options exercised">(223,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20200101__20200930_zXCPRZ2OuGq6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Stock options exercised">(66,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20200101__20200930_z0bIJ9K7ivF5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Stock options exercised">2.51</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Balance, end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20210930_zaqcj6iHlLWd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Outstanding, End of period">1,559,300</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20210930_zeQntMIyLwL5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, End of period">4.58</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20200101__20200930_z1kXWyRDTYRf" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Outstanding, End of period">1,811,550</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20200101__20200930_zzzcwGS2gOh6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, End of period">4.32</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Exercisable stock options</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20210930_zD7DFub9WLX2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Exercisable stock options">1,070,133</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20210930_zeDszcW4ZGkb" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable stock options">4.56</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20200101__20200930_zvfsK1dVsxWf" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Exercisable stock options">959,550</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20200101__20200930_zPBn1Zushxz9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable stock options">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zR0c6PJjigXc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On September 30, 2020, the Company granted <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pid_c20200929__20200930__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--EmployeeStockOptionMember_zLzmnxEpqyye" title="Stock options granted">775,000</span> stock options. These options were granted as part of the asset acquisition described in Note 4, and to a member of the board of advisors, and to certain employees as part of the Company’s Equity Incentive Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_zlvEADI6JUhh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding stock options as of September 30, 2021 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span/><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B0_zvtQ8OOZJv52" style="display: none">SCHEDULE OF OUTSTANDING STOCK OPTIONS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Range of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Prices</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>residual life</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>span</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>(in years)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Outstanding Stock Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Exercisable Stock</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z1LQMMQCrBnc" style="width: 23%; text-align: right">1.50</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z08FGgbpdyKb" title="Weighted Average residual life span (in years)">0.38</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zDjInRhwuss7" style="width: 12%; text-align: right" title="Outstanding Stock Options">38,017</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zLkqCj0eMoUf" style="width: 12%; text-align: right" title="Weighted Average Exercise Price">1.50</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zC1v5vLGbCJ5" style="width: 12%; text-align: right" title="Exercisable Stock Options">38,017</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zFof52n6wxTh" style="width: 12%; text-align: right" title="Weighted Average Exercise Price">1.50</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zUK8ewk6CmN7" style="text-align: right" title="Range of Exercise Prices, Upper Range Limit">1.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z7A6a37Nvu78" title="Weighted Average residual life span (in years)">0.38</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zCGMNeLVeyT2" style="text-align: right" title="Outstanding Stock Options">76,033</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z4n9RLFO2wQb" style="text-align: right" title="Weighted Average Exercise Price">1.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z2LJHPdiu8I3" style="text-align: right" title="Exercisable Stock Options">76,033</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z0WYuRPPI5b4" style="text-align: right" title="Weighted Average Exercise Price">1.80</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td style="text-align: right"/><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zzsdaFLDa2ka" style="text-align: right" title="Range of Exercise Prices, Upper Range Limit">2.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zEFzrUsCGKHl" title="Weighted Average residual life span (in years)">1.43</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zH1HNyhBDihd" style="text-align: right" title="Outstanding Stock Options">247,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_z2B5jaeXnrN2" style="text-align: right" title="Weighted Average Exercise Price">2.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zZbmE90HNtK2" style="text-align: right" title="Exercisable Stock Options">247,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zeqWD8zD1sN8" style="text-align: right" title="Weighted Average Exercise Price">2.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zj4fgsCG9oX9" style="text-align: right" title="Range of Exercise Prices, Upper Range Limit">4.20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zOTvrh7GItui" title="Weighted Average residual life span (in years)">3.55</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zX0HDh2kxNy4" style="text-align: right" title="Outstanding Stock Options">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zBwqVwe5u6Ih" style="text-align: right" title="Weighted Average Exercise Price">4.20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zqg6bKz9cIK7" style="text-align: right" title="Exercisable Stock Options">7,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zlAMHytBQZoh" style="text-align: right" title="Weighted Average Exercise Price">4.20</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zWREiZh8dDj5" style="text-align: right" title="Range of Exercise Prices, Upper Range Limit">4.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zcuPBmyhkYC3" title="Weighted Average residual life span (in years)">8.24</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_z6u0uE0zMEQl" style="text-align: right" title="Outstanding Stock Options">404,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zGmFcVg2vqyc" style="text-align: right" title="Weighted Average Exercise Price">4.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zRTGKJVgExCd" style="text-align: right" title="Exercisable Stock Options">170,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zFqhEjq3TwW2" style="text-align: right" title="Weighted Average Exercise Price">4.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_ze9OJHDY1YSf" style="text-align: right" title="Range of Exercise Prices, Upper Range Limit">4.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zEHpTDvoY4k8" title="Weighted Average residual life span (in years)">9.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zqjFMRVnJpua" style="text-align: right" title="Outstanding Stock Options">380,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zDqld2u78wC9" style="text-align: right" title="Weighted Average Exercise Price">4.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zaXSUZLOzDSe" style="text-align: right" title="Exercisable Stock Options">126,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zO67qcgmc12j" style="text-align: right" title="Weighted Average Exercise Price">4.84</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_z5OPk4oU4JZh" style="text-align: right" title="Range of Exercise Prices, Upper Range Limit">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_ztoqWyGIGozl" title="Weighted Average residual life span (in years)">1.77</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zaxXWMov9oNf" style="text-align: right" title="Outstanding Stock Options">147,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zNW7niUawdSf" style="text-align: right" title="Weighted Average Exercise Price">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zQhxyPRgSnr5" style="text-align: right" title="Exercisable Stock Options">142,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_z8Qq5CMXEzb3" style="text-align: right" title="Weighted Average Exercise Price">5.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zU8BgTCCVMv8" style="text-align: right" title="Range of Exercise Prices, Upper Range Limit">5.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_z261dSd01hTb" title="Weighted Average residual life span (in years)">2.17</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zhktHx1Ga8Dl" style="text-align: right" title="Outstanding Stock Options">131,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_z5VemaqUYswh" style="text-align: right" title="Weighted Average Exercise Price">5.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zASh9GB542Yb" style="text-align: right" title="Exercisable Stock Options">131,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_z75Iujys7hZf" style="text-align: right" title="Weighted Average Exercise Price">5.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zknbJF3Kx79i" style="border-bottom: Black 1.5pt solid; text-align: right" title="Range of Exercise Prices, Upper Range Limit">10.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zETrLscZB28d" title="Weighted Average residual life span (in years)">3.14</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zU23HQ2sMVO6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Outstanding Stock Options">125,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zI4wtCV7FhBl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price">10.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zjPMynRLeoMj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercisable Stock Options">125,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zCfmDLtzzQ3b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price">10.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"> <span id="xdx_907_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__srt--RangeAxis__srt--MinimumMember_zY2GpQwlBgCj" title="Range of Exercise Prices">1.50</span> to <span id="xdx_908_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__srt--RangeAxis__srt--MaximumMember_zh14igZRMUfa" title="Range of Exercise Prices">10.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zfBSGwBF2jM4" title="Weighted Average residual life span (in years)">5.16</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zYPJvqhZSZ29" style="border-bottom: Black 2.5pt double; text-align: right">1,564,300</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zMcPY8ZO7uE" style="border-bottom: Black 2.5pt double; text-align: right">4.58</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zX91NoksECAl" style="border-bottom: Black 2.5pt double; text-align: right">1,032,116</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zxbUJuqpdVwl" style="border-bottom: Black 2.5pt double; text-align: right">4.73</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_8A8_z87N7e3drPG9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zrauNlopceQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Stock options outstanding at September 30, 2021, and 2020 have the following expiration date and exercise prices:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B5_zrWAx4xsJBNe" style="display: none">SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expiration Date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Prices</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_z1IlAIWdfa1" title="Stock option expiration date">August 2, 2021</span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_zrggXVySU6ph" style="width: 12%; text-align: right" title="Stock option exercise prices">2.20</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_pdd" style="width: 12%; text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1919">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_pdd" style="width: 12%; text-align: right" title="Stock option outstanding">175,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_zXc37wkgoZK" title="Stock option expiration date">February 17, 2022</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_zZE8pbIBOnmc" style="text-align: right" title="Stock option exercise prices">1.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_pdd" style="text-align: right" title="Stock option outstanding">38,017</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_pdd" style="text-align: right" title="Stock option outstanding">38,017</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_zeBsTXZpZHJh" title="Stock option expiration date">February 17, 2022</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_zMqhEWifdtc9" style="text-align: right" title="Stock option exercise prices">1.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_pdd" style="text-align: right" title="Stock option outstanding">76,033</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_pdd" style="text-align: right" title="Stock option outstanding">76,033</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_znFSQlcVz1T2" title="Stock option expiration date">February 28, 2023</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_zqlqxKu6caGl" style="text-align: right" title="Stock option exercise prices">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">20,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1945">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_zBjSIsiMIa6l" title="Stock option expiration date">March 5, 2023</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_zscgH1ebwl72" style="text-align: right" title="Stock option exercise prices">2.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">247,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">340,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_z5zVLF7Lqke2" title="Stock option expiration date">July 31, 2023</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_z4bDXPbJ0JU" style="text-align: right" title="Stock option exercise prices">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">127,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">127,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_zCRPbWpdnPt9" title="Stock option expiration date">October 31, 2023</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_z4erTfIOxWv6" style="text-align: right" title="Stock option exercise prices">4.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">59,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">108,250</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_zgWtCQ0J4Vde" title="Stock option expiration date">November 30, 2023</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_zbj8ki2ACPC6" style="text-align: right" title="Stock option exercise prices">5.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">131,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">143,750</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_zpANdmODQKc9" title="Stock option expiration date">November 20, 2024</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_zKLWwwzeNdN7" style="text-align: right" title="Stock option exercise prices">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_pdd" style="text-align: right" title="Stock option outstanding">125,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_pdd" style="text-align: right" title="Stock option outstanding">125,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_zjm66tRPqfa5" title="Stock option expiration date">April 20, 2025</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_zNtKE4gb4Cvi" style="text-align: right" title="Stock option exercise prices">4.20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_pdd" style="text-align: right" title="Stock option outstanding">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_pdd" style="text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1993">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_zopHbAAZC5Fg" title="Stock option expiration date">September 30, 2030</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_zKg1dgWB3jg6" style="text-align: right" title="Stock option exercise prices">4.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_pdd" style="text-align: right" title="Stock option outstanding">350,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_pdd" style="text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2001">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right; padding-bottom: 1.5pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_zKACuqSxp0ra" title="Stock option expiration date">September 30, 2030</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_ziZ1usaKjjFa" style="padding-bottom: 1.5pt; text-align: right" title="Stock option exercise prices">4.84</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Stock option outstanding">380,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2009">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20210930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z8NBXotTRIW8" style="border-bottom: Black 2.5pt double; text-align: right">1,564,300</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20200930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zR9rNJpflasc" style="border-bottom: Black 2.5pt double; text-align: right">1,073,300</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zADBHBYLlzO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> 1000000 0 The board of directors of the Company (the “Board”) had previously set the voting rights for the Series A preferred stock at 1 share of preferred to 250 common shares. 1 0 3000000 745030 745030 0.06 1 106000 The Series C Preferred Stock has a liquidation value and conversion price of $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) and automatically converts into Common Stock at $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) in the event that the Company’s common stock has a closing price of $30 per share for 20 consecutive trading days. 1000000 0.001 361146 1800000 1376 14000 25000 188000 342667 2784096 15 7.00 0.001 2142857 171429 7.70 1200000 150000 171429 7.70 <p id="xdx_896_ecustom--ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingTableTextBlock_zGGothrQvhu5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company paid additional legal and other fees directly related to the Offering. The cash fees paid were netted against the Offering proceeds, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8BC_z3dkwmkKnzX2" style="display: none">SCHEDULE OF ADDITIONAL LEGAL AND OTHER FEES RELATED TO OFFERING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-style: italic; text-align: justify">(In thousands)</td><td> </td> <td colspan="2" id="xdx_49D_20210101__20210930_zLkuaZDWFhM7" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_409_eus-gaap--ProceedsFromIssuanceOfWarrants_hus-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zV6bYaanTC6d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">Total proceeds from issuance of Common Stock and Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">15,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--PlacementAgentFees_zzd0ywqMCke2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Placement Agent fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,455</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--LegalFees_iN_di_z1lYtlewwGb9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Commission, Legal and other fees</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(264</td><td style="text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--ProceedsFromIssuanceOfWarrants_zdXTqW3F0pI3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Total</td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,281</td><td style="text-align: left"> </td></tr> </table> 15000000 -1455000 264000 13281000 <p id="xdx_892_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zozsECdgrkK" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table summarizes information about warrants granted during the nine-month periods ended September 30, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_ztxDkt5Gzksl" style="display: none">SCHEDULE OF WARRANTS ACTIVITY</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>warrants</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>warrants</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify">Balance, beginning of period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20210101__20210930_z1GVdvtPPEX8" style="width: 11%; text-align: right" title="Number of warrants, Outstanding, Beginning of period">1,366,667</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20210930_zGu8M5YCKEQ9" style="width: 11%; text-align: right" title="Weighted Average Exercise Price balance, Outstanding, Beginning of period">7.19</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20200101__20200930_zqeB8cC0n3R1" style="width: 11%; text-align: right" title="Number of warrants, Outstanding, Beginning of period">1,166,667</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20200101__20200930_zQZ2vpUowtYe" style="width: 11%; text-align: right" title="Weighted Average Exercise Price balance, Outstanding, Beginning of period">6.42</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Warrants granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20210101__20210930_zCH3FVpc2yv1" style="text-align: right" title="Number of warrants, Warrants granted">171,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20200101__20200930_zckrmFmkba6j" style="text-align: right" title="Number of warrants, Warrants granted">325,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_pid_c20200101__20200930_zR8hMLnpvY33" style="text-align: right" title="Weighted Average Exercise Price, Warrants granted">8.20</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Warrants expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20210101__20210930_zjHialk2whah" style="text-align: right" title="Number of warrants, Warrants expired">(15,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice_pid_c20210101__20210930_zXNR9O1ENFcc" style="text-align: right" title="Weighted Average Exercise Price, Warrants expired">14.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_pid_di_c20200101__20200930_zetYbw1782W9" style="text-align: right" title="Number of warrants, Warrants expired">(10,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice_pid_c20200101__20200930_zhFVoM4fr069" style="text-align: right" title="Weighted Average Exercise Price, Warrants expired">5.60</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Warrants cancelled, forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20210101__20210930_zzwAi6GC2Gu" style="text-align: right" title="Number of warrants, Warrants cancelled, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1563">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20210101__20210930_z8ZPEndUK96l" style="text-align: right" title="Weighted Average Exercise Price, Warrants cancelled, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1565">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20200101__20200930_zS4v7LpRW996" style="text-align: right" title="Number of warrants, Warrants cancelled, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1567">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20200101__20200930_z3rHaRs4zDzh" style="text-align: right" title="Weighted Average Exercise Price, Warrants cancelled, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1569">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Warrants exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20210101__20210930_z5oAIp1u2Tl2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants, Warrants exercised">(119,167</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20210930_z5tPWKmyvjQj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants exercised">3.98</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20200101__20200930_z1sX3uAiuYv9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants, Warrants exercised">(150,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_pid_c20200101__20200930_zRp2L5Ccggl6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Warrants exercised">4.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Balance, end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20210101__20210930_zMvR0xmssxKk" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Outstanding, End of period">1,403,929</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20210930_zGhpHBVXliUg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, End of period">7.45</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20200101__20200930_z6V5fpC7CZp9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Outstanding, End of period">1,331,667</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20200101__20200930_zwfHKWf39L6d" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, End of period">7.14</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Exercisable warrants</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20210101__20210930_z1phlrbFUCo7" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Exercisable warrants">1,320,596</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20210930_znmsqH6xmGq1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable warrants">7.45</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20200101__20200930_zWeBMRZ0Pb09" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, Exercisable warrants">1,165,001</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iE_pid_c20200101__20200930_zRLZr9mFdavh" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable warrants">7.08</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1366667 7.19 1166667 6.42 171429 325000 8.20 15000 14.00 10000 5.60 119167 3.98 150000 4.00 1403929 7.45 1331667 7.14 1320596 7.45 1165001 7.08 <p id="xdx_89F_ecustom--ScheduleOfOutstandingWarrantsTableTextBlock_zY73rrnS8TKl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding warrants as of September 30, 2021 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B3_zWdv72UAW8I2" style="display: none">SCHEDULE OF OUTSTANDING WARRANTS</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">Weighted Average</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Range of</td><td> </td> <td colspan="2" style="text-align: center">residual life</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Average</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Average</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Exercise</td><td> </td> <td colspan="2" style="text-align: center">span</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Outstanding</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercisable</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Prices</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(in years)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zyDBxSGqJoL3" style="width: 35%; text-align: right">7.00</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zQss35QMTQog" title="Weighted Average residual life span (in years)">3.27</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zhSjGToOKMEj" style="width: 9%; text-align: right">847,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zlpkLLfaSRck" style="width: 9%; text-align: right" title="Weighted Average Exercise Price">7.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_ziB37ElGYskd" style="width: 9%; text-align: right" title="Exercisable Warrants">847,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z8OYUPqu14Bl" style="width: 9%; text-align: right" title="Weighted Average Exercise Price">7.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zdkT9UUa9jal" style="text-align: right">7.50</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zicfxsFcJq5h" title="Weighted Average residual life span (in years)">4.93</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zhnfM4ci3uB2" style="text-align: right">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_znqZbzZXfkP8" style="text-align: right" title="Weighted Average Exercise Price">7.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zIub7Nn698Nc" style="text-align: right" title="Exercisable Warrants">166,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zrJGcuWgzmwh" style="text-align: right" title="Weighted Average Exercise Price">7.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zzIPhgfvUe3j" style="text-align: right">7.70</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zIBSnq0BPkP7" title="Weighted Average residual life span (in years)">4.77</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zL2TQr1NOsY1" style="text-align: right">171,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zpyrNQN2ZnT3" style="text-align: right" title="Weighted Average Exercise Price">7.70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zSglUZZNwfz7" style="text-align: right" title="Exercisable Warrants">171,429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zV5OgG0oooEh" style="text-align: right" title="Weighted Average Exercise Price">7.70</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zdaVUiIpvJU2" style="text-align: right">8.00</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zoibQ0Mo6jIe" title="Weighted Average residual life span (in years)">0.41</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zUTueE1GjUmh" style="text-align: right">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zngywIfNOIU2" style="text-align: right" title="Weighted Average Exercise Price">8.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zlLBjwymJfb" style="text-align: right" title="Exercisable Warrants">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zGOaoup1hD8l" style="text-align: right" title="Weighted Average Exercise Price">8.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zaFFFrBR9z3i" style="border-bottom: Black 1.5pt solid; text-align: right">10.00</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zemQFFvNu9Fj" title="Weighted Average residual life span (in years)">1.23</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zELvfXhVCxYi" style="border-bottom: Black 1.5pt solid; text-align: right">125,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_z6gH22Mu4ril" style="border-bottom: Black 1.5pt solid; text-align: right">10.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_z0GTVrK0wYI3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercisable Warrants">125,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zri5ZjwedNNd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price">10.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zWqMro99EGK2" title="Range of Exercise Prices">7.00</span> to <span id="xdx_90E_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zmqHaIV4VKdd" title="Range of Exercise Prices">10.00</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBX9gh5pn0Z5" title="Weighted Average residual life span (in years)">3.42</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpLEHQVhUZRb" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding Warrants">1,403,929</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_znezotPLsu2c" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price">7.45</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcq1mWUKFvy5" style="border-bottom: Black 2.5pt double; text-align: right" title="Exercisable Warrants">1,320,596</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zp3mfSfcXUU5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price">7.45</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 7.00 P3Y3M7D 847500 7.00 847500 7.00 7.50 P4Y11M4D 250000 7.50 166667 7.50 7.70 P4Y9M7D 171429 7.70 171429 7.70 8.00 P0Y4M28D 10000 8.00 10000 8.00 10.00 P1Y2M23D 125000 10.00 125000 10.00 7.00 10.00 P3Y5M1D 1403929 7.45 1320596 7.45 <p id="xdx_899_ecustom--ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesTableTextBlock_zfGumlxfg1L4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Warrants outstanding at September 30, 2021 and 2020 have the following expiry date and exercise prices:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B8_zroamGJOnSQb" style="display: none">SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center">Expiry Date</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Prices</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2020</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyMember_zX295f8ivDia" style="width: 52%; text-align: center" title="Warrant expiry date">October 10, 2020</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyMember_zhfzcXV0oj8f" style="width: 12%; text-align: right" title="Warrant Exercise Prices">12.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyMember_zPtNf8DEa31e" style="width: 12%; text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1666">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyMember_zjH7iWSB06o5" style="width: 12%; text-align: right" title="Warrant Outstanding">15,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_989_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyMember_z4ruAGuhTCG7" style="text-align: center">December 30, 2020</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyMember_zHxhewmps2s9" style="text-align: right">4.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyMember_zRKHn7DC0op5" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1672">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--DecemberThirtyTwoThousandTwentyMember_zUX92yG11kq7" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1674">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwoThousandTwentyOneMember_zGtC45cG3ic2" style="text-align: center">February 02, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwoThousandTwentyOneMember_zLhbVURnTYnf" style="text-align: right">14.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwoThousandTwentyOneMember_zgv4rDbx0hxk" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1678">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--FebruaryTwoThousandTwentyOneMember_zr8GA7DuKcfl" style="text-align: right" title="Warrant Outstanding">15,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_zlHU140doNjk" style="text-align: center">August 02, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_zalkuYgM0Pv2" style="text-align: right">2.20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_zmt40HJFILr6" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1684">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_zTynm98FE7K3" style="text-align: right" title="Warrant Outstanding">75,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyOneMember_zA7w8hz0eumb" style="text-align: center">October 10, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyOneMember_zSah09Jg09y7" style="text-align: right">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyOneMember_zlVBqLF4w7Q6" style="text-align: right" title="Warrant Outstanding">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--OctoberTenTwoThousandTwentyOneMember_zskTmMVwGZp9" style="text-align: right" title="Warrant Outstanding">25,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_zyb4nVw1l3Vf" style="text-align: center">February 27, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_zdidyNQefRsc" style="text-align: right">8.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_zsCUIyLoZzNb" style="text-align: right" title="Warrant Outstanding">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--FebruaryTwentySevenThousandTwentyTwoMember_z2Lj7LlTSLUg" style="text-align: right" title="Warrant Outstanding">10,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zN7KCPaV5NE3" style="text-align: center">May 18, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zjCwdOyyhDXb" style="text-align: right">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zDHHZ4CwERhh" style="text-align: right" title="Warrant Outstanding">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--MayEighteenTwoThousandTwentyThreeMember_zCWNkKPjkLM6" style="text-align: right" title="Warrant Outstanding">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_zxu8gTXyA7Fe" style="text-align: center">October 14, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_zwo9NdJTyrii" style="text-align: right">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_z2yHBW6iGfRk" style="text-align: right" title="Warrant Outstanding">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--OctoberFourteenTwoThousandTwentyThreeMember_zH42qY71qXOc" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1710">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_z4sR9gdwza8k" style="text-align: center">October 06, 2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_zoZer5lVdYc8" style="text-align: right">7.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_zd8ZiZf9ekZ6" style="text-align: right" title="Warrant Outstanding">793,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--OctoberSixTwoThousandTwentyFourMember_zlPUyGgW5np9" style="text-align: right" title="Warrant Outstanding">891,667</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThoousandTwentyFiveMember_zcalGZEaMbsc" style="text-align: center">September 01, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThoousandTwentyFiveMember_zp40gqZzPLah" style="text-align: right">7.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThoousandTwentyFiveMember_zpmFsVWpvy9b" style="text-align: right" title="Warrant Outstanding">83,334</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--SeptemberOneTwoThoousandTwentyFiveMember_zzSnmiZppTCg" style="text-align: right" title="Warrant Outstanding">83,334</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_986_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_zUmmNk6enCu5" style="text-align: center">June 04, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_zS3NZAM1jBnj" style="text-align: right">7.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_zk8oZFoTxFPd" style="text-align: right" title="Warrant Outstanding">83,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--JuneFourTwoThousandTwentySixMember_zUEE0HYDDqj5" style="text-align: right" title="Warrant Outstanding">83,333</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--JulyEightTwoThousandTwentySixMember_zUEV5xFL3W75" style="text-align: center">July 8, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--JulyEightTwoThousandTwentySixMember_z9dymAzIUVyg" style="text-align: right">7.70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--JulyEightTwoThousandTwentySixMember_zwTsMclojoP" style="text-align: right" title="Warrant Outstanding">171429</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--JulyEightTwoThousandTwentySixMember_zd1LJKwnqEM5" style="text-align: right" title="Warrant Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1734">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_c20210930__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zNXYmfUbMsZ9" style="text-align: center; padding-bottom: 1.5pt">December 04, 2027</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zkKk64lH2zq8" style="padding-bottom: 1.5pt; text-align: right">7.50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zqidog8khp17" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrant Outstanding">83,333</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930__us-gaap--AwardDateAxis__custom--DecemberFourTwoThousandTwentySevenMember_zTf7u7c431x1" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">83,333</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210930_zcbOi8Dnjoy2" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant Outstanding">1,403,929</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20200930_zuWeUAtEy0c1" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant Outstanding">1,231,667</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2020-10-10 12.00 15000 2020-12-30 4.00 2021-02-02 14.00 15000 2021-08-02 2.20 75000 2021-10-10 10.00 25000 25000 2022-02-27 8.00 10000 10000 2023-05-18 10.00 50000 50000 2023-10-14 10.00 50000 2024-10-06 7.00 793667 891667 2025-09-01 7.50 83334 83334 2026-06-04 7.50 83333 83333 2026-07-08 7.70 171429 2027-12-04 7.50 83333 83333 1403929 1231667 <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zJPrFPhOzrT5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table summarizes information about stock options granted during the nine months ended September 30, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B8_zyyKcDmSrmu8" style="display: none">SCHEDULE OF STOCK OPTIONS GRANTED</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>stock options</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>stock options</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: justify">Balance, beginning of period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20210930_znbFnggxXwj2" style="width: 11%; text-align: right" title="Number of stock options, Outstanding, Beginning of period">1,811,550</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20210930_zstoQjjVFyo3" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning of period">4.32</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20200101__20200930_zyAtBsGplA7i" style="width: 11%; text-align: right" title="Number of stock options, Outstanding, Beginning of period">1,133,550</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20200101__20200930_zWhk2YULeYy8" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding, Beginning of period">4.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Stock options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20210930_zpj5hKtSH58b" style="text-align: right" title="Number of stock options, Stock options granted"><span style="-sec-ix-hidden: xdx2ixbrl1755">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20200101__20200930_zOl0LRdqigR8" style="text-align: right" title="Number of stock options, Stock options granted">775,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20200101__20200930_zeg9pNsDAWWg" style="text-align: right" title="Weighted Average Exercise Price, Stock options granted">4.63</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Stock options expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pid_di_c20210101__20210930_zOm4jtZyPQjd" style="text-align: right" title="Number of stock options, Stock options expired"><span style="-sec-ix-hidden: xdx2ixbrl1761">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pid_di_c20200101__20200930_zmPRaRSXBQL1" style="text-align: right" title="Number of stock options, Stock options expired">(30,250</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20200101__20200930_zR557q9IisC4" style="text-align: right" title="Weighted Average Exercise Price, Stock options expired">3.98</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Stock options cancelled, forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20210101__20210930_z7b5c4lwWSh9" style="text-align: right" title="Number of stock options, Stock options cancelled, forfeited">(28,750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20200101__20200930_zfwWQ687krUf" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1768">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Stock options exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20210101__20210930_zCqMiAVyW3h8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Stock options exercised">(223,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20200101__20200930_zXCPRZ2OuGq6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Stock options exercised">(66,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20200101__20200930_z0bIJ9K7ivF5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Stock options exercised">2.51</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Balance, end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20210930_zaqcj6iHlLWd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Outstanding, End of period">1,559,300</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20210930_zeQntMIyLwL5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, End of period">4.58</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20200101__20200930_z1kXWyRDTYRf" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Outstanding, End of period">1,811,550</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20200101__20200930_zzzcwGS2gOh6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding, End of period">4.32</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Exercisable stock options</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20210930_zD7DFub9WLX2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Exercisable stock options">1,070,133</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20210930_zeDszcW4ZGkb" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable stock options">4.56</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20200101__20200930_zvfsK1dVsxWf" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of stock options, Exercisable stock options">959,550</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20200101__20200930_zPBn1Zushxz9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable stock options">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1811550 4.32 1133550 4.00 775000 4.63 30250 3.98 28750 223500 66750 2.51 1559300 4.58 1811550 4.32 1070133 4.56 959550 4.02 775000 <p id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_zlvEADI6JUhh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Outstanding stock options as of September 30, 2021 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span/><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B0_zvtQ8OOZJv52" style="display: none">SCHEDULE OF OUTSTANDING STOCK OPTIONS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Range of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Prices</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>residual life</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>span</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>(in years)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Outstanding Stock Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Exercisable Stock</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z1LQMMQCrBnc" style="width: 23%; text-align: right">1.50</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z08FGgbpdyKb" title="Weighted Average residual life span (in years)">0.38</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zDjInRhwuss7" style="width: 12%; text-align: right" title="Outstanding Stock Options">38,017</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zLkqCj0eMoUf" style="width: 12%; text-align: right" title="Weighted Average Exercise Price">1.50</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zC1v5vLGbCJ5" style="width: 12%; text-align: right" title="Exercisable Stock Options">38,017</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zFof52n6wxTh" style="width: 12%; text-align: right" title="Weighted Average Exercise Price">1.50</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zUK8ewk6CmN7" style="text-align: right" title="Range of Exercise Prices, Upper Range Limit">1.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z7A6a37Nvu78" title="Weighted Average residual life span (in years)">0.38</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zCGMNeLVeyT2" style="text-align: right" title="Outstanding Stock Options">76,033</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z4n9RLFO2wQb" style="text-align: right" title="Weighted Average Exercise Price">1.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z2LJHPdiu8I3" style="text-align: right" title="Exercisable Stock Options">76,033</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z0WYuRPPI5b4" style="text-align: right" title="Weighted Average Exercise Price">1.80</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td style="text-align: right"/><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zzsdaFLDa2ka" style="text-align: right" title="Range of Exercise Prices, Upper Range Limit">2.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zEFzrUsCGKHl" title="Weighted Average residual life span (in years)">1.43</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zH1HNyhBDihd" style="text-align: right" title="Outstanding Stock Options">247,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_z2B5jaeXnrN2" style="text-align: right" title="Weighted Average Exercise Price">2.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zZbmE90HNtK2" style="text-align: right" title="Exercisable Stock Options">247,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zeqWD8zD1sN8" style="text-align: right" title="Weighted Average Exercise Price">2.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zj4fgsCG9oX9" style="text-align: right" title="Range of Exercise Prices, Upper Range Limit">4.20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zOTvrh7GItui" title="Weighted Average residual life span (in years)">3.55</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zX0HDh2kxNy4" style="text-align: right" title="Outstanding Stock Options">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zBwqVwe5u6Ih" style="text-align: right" title="Weighted Average Exercise Price">4.20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zqg6bKz9cIK7" style="text-align: right" title="Exercisable Stock Options">7,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zlAMHytBQZoh" style="text-align: right" title="Weighted Average Exercise Price">4.20</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zWREiZh8dDj5" style="text-align: right" title="Range of Exercise Prices, Upper Range Limit">4.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zcuPBmyhkYC3" title="Weighted Average residual life span (in years)">8.24</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_z6u0uE0zMEQl" style="text-align: right" title="Outstanding Stock Options">404,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zGmFcVg2vqyc" style="text-align: right" title="Weighted Average Exercise Price">4.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zRTGKJVgExCd" style="text-align: right" title="Exercisable Stock Options">170,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zFqhEjq3TwW2" style="text-align: right" title="Weighted Average Exercise Price">4.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_ze9OJHDY1YSf" style="text-align: right" title="Range of Exercise Prices, Upper Range Limit">4.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zEHpTDvoY4k8" title="Weighted Average residual life span (in years)">9.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zqjFMRVnJpua" style="text-align: right" title="Outstanding Stock Options">380,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zDqld2u78wC9" style="text-align: right" title="Weighted Average Exercise Price">4.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zaXSUZLOzDSe" style="text-align: right" title="Exercisable Stock Options">126,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zO67qcgmc12j" style="text-align: right" title="Weighted Average Exercise Price">4.84</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_z5OPk4oU4JZh" style="text-align: right" title="Range of Exercise Prices, Upper Range Limit">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_ztoqWyGIGozl" title="Weighted Average residual life span (in years)">1.77</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zaxXWMov9oNf" style="text-align: right" title="Outstanding Stock Options">147,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zNW7niUawdSf" style="text-align: right" title="Weighted Average Exercise Price">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zQhxyPRgSnr5" style="text-align: right" title="Exercisable Stock Options">142,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_z8Qq5CMXEzb3" style="text-align: right" title="Weighted Average Exercise Price">5.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zU8BgTCCVMv8" style="text-align: right" title="Range of Exercise Prices, Upper Range Limit">5.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_z261dSd01hTb" title="Weighted Average residual life span (in years)">2.17</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zhktHx1Ga8Dl" style="text-align: right" title="Outstanding Stock Options">131,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_z5VemaqUYswh" style="text-align: right" title="Weighted Average Exercise Price">5.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zASh9GB542Yb" style="text-align: right" title="Exercisable Stock Options">131,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_z75Iujys7hZf" style="text-align: right" title="Weighted Average Exercise Price">5.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zknbJF3Kx79i" style="border-bottom: Black 1.5pt solid; text-align: right" title="Range of Exercise Prices, Upper Range Limit">10.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zETrLscZB28d" title="Weighted Average residual life span (in years)">3.14</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zU23HQ2sMVO6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Outstanding Stock Options">125,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zI4wtCV7FhBl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price">10.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zjPMynRLeoMj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercisable Stock Options">125,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zCfmDLtzzQ3b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price">10.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"> <span id="xdx_907_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__srt--RangeAxis__srt--MinimumMember_zY2GpQwlBgCj" title="Range of Exercise Prices">1.50</span> to <span id="xdx_908_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember__srt--RangeAxis__srt--MaximumMember_zh14igZRMUfa" title="Range of Exercise Prices">10.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zfBSGwBF2jM4" title="Weighted Average residual life span (in years)">5.16</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zYPJvqhZSZ29" style="border-bottom: Black 2.5pt double; text-align: right">1,564,300</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zMcPY8ZO7uE" style="border-bottom: Black 2.5pt double; text-align: right">4.58</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zX91NoksECAl" style="border-bottom: Black 2.5pt double; text-align: right">1,032,116</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20210930__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zxbUJuqpdVwl" style="border-bottom: Black 2.5pt double; text-align: right">4.73</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> 1.50 P0Y4M17D 38017 1.50 38017 1.50 1.80 P0Y4M17D 76033 1.80 76033 1.80 2.40 P1Y5M4D 247000 2.40 247000 2.40 4.20 P3Y6M18D 10000 4.20 7500 4.20 4.40 P8Y2M26D 404000 4.40 170667 4.40 4.84 P9Y 380000 4.84 126667 4.84 5.00 P1Y9M7D 147500 5.00 142500 5.00 5.40 P2Y2M1D 131750 5.40 131750 5.40 10.00 P3Y1M20D 125000 10.00 125000 10.00 1.50 10.00 P5Y1M28D 1564300 4.58 1032116 4.73 <p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zrauNlopceQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Stock options outstanding at September 30, 2021, and 2020 have the following expiration date and exercise prices:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B5_zrWAx4xsJBNe" style="display: none">SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expiration Date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Prices</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_z1IlAIWdfa1" title="Stock option expiration date">August 2, 2021</span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_zrggXVySU6ph" style="width: 12%; text-align: right" title="Stock option exercise prices">2.20</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_pdd" style="width: 12%; text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1919">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--AugustTwoTwoThousandTwentyOneMember_pdd" style="width: 12%; text-align: right" title="Stock option outstanding">175,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_zXc37wkgoZK" title="Stock option expiration date">February 17, 2022</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_zZE8pbIBOnmc" style="text-align: right" title="Stock option exercise prices">1.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_pdd" style="text-align: right" title="Stock option outstanding">38,017</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoMember_pdd" style="text-align: right" title="Stock option outstanding">38,017</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_zeBsTXZpZHJh" title="Stock option expiration date">February 17, 2022</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_zMqhEWifdtc9" style="text-align: right" title="Stock option exercise prices">1.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_pdd" style="text-align: right" title="Stock option outstanding">76,033</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--FebruarySeventeenTwoThoudsandTwentyTwoOneMember_pdd" style="text-align: right" title="Stock option outstanding">76,033</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_znFSQlcVz1T2" title="Stock option expiration date">February 28, 2023</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_zqlqxKu6caGl" style="text-align: right" title="Stock option exercise prices">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">20,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--FebruaryTwentyEightTwoThoudsandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1945">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_zBjSIsiMIa6l" title="Stock option expiration date">March 5, 2023</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_zscgH1ebwl72" style="text-align: right" title="Stock option exercise prices">2.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">247,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--MarchZeroFiveTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">340,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_z5zVLF7Lqke2" title="Stock option expiration date">July 31, 2023</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_z4bDXPbJ0JU" style="text-align: right" title="Stock option exercise prices">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">127,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--JulyThirtyOneTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">127,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_zCRPbWpdnPt9" title="Stock option expiration date">October 31, 2023</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_z4erTfIOxWv6" style="text-align: right" title="Stock option exercise prices">4.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">59,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--OctoberThirtyFirstTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">108,250</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_zgWtCQ0J4Vde" title="Stock option expiration date">November 30, 2023</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_zbj8ki2ACPC6" style="text-align: right" title="Stock option exercise prices">5.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">131,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--NovemberThirtyTwoThousandTwentyThreeMember_pdd" style="text-align: right" title="Stock option outstanding">143,750</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_zpANdmODQKc9" title="Stock option expiration date">November 20, 2024</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_zKLWwwzeNdN7" style="text-align: right" title="Stock option exercise prices">10.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_pdd" style="text-align: right" title="Stock option outstanding">125,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--NovemberTwentyThousandTwentyFourMember_pdd" style="text-align: right" title="Stock option outstanding">125,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_zjm66tRPqfa5" title="Stock option expiration date">April 20, 2025</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_zNtKE4gb4Cvi" style="text-align: right" title="Stock option exercise prices">4.20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_pdd" style="text-align: right" title="Stock option outstanding">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--AprilTwentyTwoThousandTwentyFiveMember_pdd" style="text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1993">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_zopHbAAZC5Fg" title="Stock option expiration date">September 30, 2030</span></td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_zKg1dgWB3jg6" style="text-align: right" title="Stock option exercise prices">4.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_pdd" style="text-align: right" title="Stock option outstanding">350,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyMember_pdd" style="text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2001">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right; padding-bottom: 1.5pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20210101__20210930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_zKACuqSxp0ra" title="Stock option expiration date">September 30, 2030</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20210930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_ziZ1usaKjjFa" style="padding-bottom: 1.5pt; text-align: right" title="Stock option exercise prices">4.84</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20210930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Stock option outstanding">380,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200930__us-gaap--AwardDateAxis__custom--SeptemberThirtyTwoThousandThirtyOneMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Stock option outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2009">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20210930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z8NBXotTRIW8" style="border-bottom: Black 2.5pt double; text-align: right">1,564,300</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20200930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zR9rNJpflasc" style="border-bottom: Black 2.5pt double; text-align: right">1,073,300</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2021-08-02 2.20 175000 2022-02-17 1.50 38017 38017 2022-02-17 1.80 76033 76033 2023-02-28 5.00 20000 2023-03-05 2.40 247000 340000 2023-07-31 5.00 127500 127500 2023-10-31 4.40 59000 108250 2023-11-30 5.40 131750 143750 2024-11-20 10.00 125000 125000 2025-04-20 4.20 10000 2030-09-30 4.40 350000 2030-09-30 4.84 380000 1564300000 1073300000 <p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z0br1i5Tueia" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 11 – <span id="xdx_821_zJVMAxM73MW8">COMMITMENTS AND CONTINGENCIES</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Profit Sharing Plan</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We maintain a contributory profit-sharing plan covering substantially all fulltime employees within the requirements of the Employee Retirement Income Security Act of 1974 (“ERISA”). In 2016, the Safe Harbor element was removed from the plan and the employer may make a discretionary matching contribution equal to a uniform percentage or dollar amount of participants’ elective deferrals for each Plan Year. In 2015, we were required to make a safe harbor non-elective contribution equal to 3 percent of a participant’s compensation. The plan also includes a 401(k) savings plan feature that allows substantially all employees to make voluntary contributions and provides for discretionary matching contributions determined annually by the Board of Directors. For the nine months ending September 30, 2021, we elected to forgo the match.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Operating Leases</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of September 30, 2021, we had 8 operating leases as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Office space in Akron, Ohio, with monthly payments of $<span id="xdx_902_ecustom--RentalExpenseMonthlyPayments_pn3n3_c20210101__20210930__srt--StatementGeographicalAxis__custom--AkronMember_zzYPEaCOAFg6">3 </span></span><span style="font: 10pt Times New Roman, Times, Serif">thousand and an incremental borrowing rate of <span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20210930__srt--StatementGeographicalAxis__custom--AkronMember_zj1JuCrquoIl">14.55</span></span><span style="font: 10pt Times New Roman, Times, Serif">%. As of September 30, 2021, we had <span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20210930__srt--StatementGeographicalAxis__custom--AkronMember_zzScLLlqnay4">20 </span></span><span style="font: 10pt Times New Roman, Times, Serif">months remaining on the lease.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A vehicle with monthly payments of less than $<span id="xdx_90D_ecustom--RentalExpenseMonthlyPayments_pn3n3_c20210101__20210930__us-gaap--TypeOfArrangementAxis__custom--VehicleLeaseMember_zfmx52Te21k1">1 </span></span><span style="font: 10pt Times New Roman, Times, Serif">thousand. As of September 30, 2021, the Company had <span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20210930__us-gaap--TypeOfArrangementAxis__custom--VehicleLeaseMember_zEckofXJnr5i">5 </span></span><span style="font: 10pt Times New Roman, Times, Serif">months remaining on the lease.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Office space in Salt Lake City, UT, with monthly payments of $<span id="xdx_904_ecustom--RentalExpenseMonthlyPayments_pn3n3_c20210101__20210930__srt--StatementGeographicalAxis__custom--SaltLackCityMember_zWe3ZfZmGz9c" title="Rental expense monthly payments">22 </span></span><span style="font: 10pt Times New Roman, Times, Serif">thousand. As of September 30, 2021 the company had <span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20210930__srt--StatementGeographicalAxis__custom--SaltLakeCityUTMember_zGGFrAUvHIee">58</span> months remaining on the lease. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Yad haruzim</b> -Dangot main office in Tel-Aviv . with monthly payments of between <span id="xdx_900_ecustom--RentalExpenseMonthlyPayments_uIsraelinewsheqel_c20210101__20210930__srt--StatementGeographicalAxis__custom--YadHaruzimMember__srt--RangeAxis__srt--MinimumMember_zU0E7cyUxA0b" title="Rental expense monthly expenses">62500</span> NIS to <span id="xdx_90F_ecustom--RentalExpenseMonthlyPayments_uIsraelinewsheqel_c20210101__20210930__srt--StatementGeographicalAxis__custom--YadHaruzimMember__srt--RangeAxis__srt--MaximumMember_z0hEMIkYCi6e">65365 </span></span><span style="font: 10pt Times New Roman, Times, Serif">NIS . As of September 30, 2021, we had <span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20210930__srt--StatementGeographicalAxis__custom--YadHaruzimMember_zdSl3fHRf6ma">38 </span></span><span style="font: 10pt Times New Roman, Times, Serif">months remaining on the lease.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Gamdan </b>office in Tel-Aviv. with monthly payments of between <span id="xdx_90B_ecustom--RentalExpenseMonthlyPayments_uIsraelinewsheqel_c20210101__20210930__srt--StatementGeographicalAxis__custom--GamdanOfficeMember__srt--RangeAxis__srt--MinimumMember_zh6t9ehdPxC3">21,080</span> NIS to <span id="xdx_903_ecustom--RentalExpenseMonthlyPayments_uIsraelinewsheqel_c20210101__20210930__srt--StatementGeographicalAxis__custom--GamdanOfficeMember__srt--RangeAxis__srt--MaximumMember_zPZbyp9c5UK9">22,134</span> NIS . As of September 30, 2021, we had <span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20210930__srt--StatementGeographicalAxis__custom--GamdanOfficeMember_z2SFand24XXf">27</span> months remaining on the lease.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Rival </b>warehouse in Tel Aviv. . with monthly payments of between <span id="xdx_902_ecustom--RentalExpenseMonthlyPayments_uIsraelinewsheqel_c20210101__20210930__srt--StatementGeographicalAxis__custom--RivalWareHouseMember__srt--RangeAxis__srt--MinimumMember_zOAGmNX88GIe">40,000</span> NIS to <span id="xdx_909_ecustom--RentalExpenseMonthlyPayments_uIsraelinewsheqel_c20210101__20210930__srt--StatementGeographicalAxis__custom--RivalWareHouseMember__srt--RangeAxis__srt--MaximumMember_zBR5JMv002r4">41,200</span> NIS. As of September 30, 2021, we had <span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20210930__srt--StatementGeographicalAxis__custom--RivalWareHouseMember_zrnW2k8YicPf">45</span> months remaining on the lease.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Hofman </b>warehouse in Tel Aviv. . with monthly payments of between <span id="xdx_906_ecustom--RentalExpenseMonthlyPayments_uIsraelinewsheqel_c20210101__20210930__srt--StatementGeographicalAxis__custom--HofmanMember_z2QfhV0leBR4">3,500</span> NIS. As of September 30, 2021, we had <span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtM_c20210930__srt--StatementGeographicalAxis__custom--HofmanMember_zEBezxCy29Y9">33</span> months remaining on the lease.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Rental cars</b>- Variable payments, between NIS <span id="xdx_906_ecustom--RentalExpenseMonthlyPayments_uIsraelinewsheqel_c20210101__20210930__srt--StatementGeographicalAxis__custom--RentalCarsMember_zJjc0EEzRYAh">2,000</span> and NIS <span id="xdx_902_ecustom--RentalExpenseMonthlyPayments_uIsraelinewsheqel_c20210101__20210930__srt--StatementGeographicalAxis__custom--RentalCarsMember__srt--TitleOfIndividualAxis__custom--SixtyFiveEmployeesMember_znaXvwWqMnE3">6,000</span> for about 65 employees with 36 payments.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 3000 0.1455 P20M 1000 P5M 22000 P58M 62500000 65365000 P38M 21080000 22134000 P27M 40000000 41200000 P45M 3500000 P33M 2000000 6000000 <p id="xdx_80B_eus-gaap--LegalMattersAndContingenciesTextBlock_z7f7B3MI2YA4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 12 – <span id="xdx_826_zb8KFo8S68N3">LITIGATION</span></b> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In September 2020 the Company was named as a defendant in a Mississippi state lawsuit (the “Mississippi case”) filed by Riverland Technologies LLC (“Riverland”) in the Circuit Court of Rankin County, Mississippi. The subject matter of the Mississippi case directly relates to the RedLPR case, to which Riverland was also a party. Subject to a settlement between the Company and Riverland, all of Riverland’s claims against the Company in the Mississippi case have been dismissed, and the Company is no longer a party to the Mississippi case.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company was named a defendant in a case involving a former employee who claims he is owed approximately $<span id="xdx_90A_eus-gaap--AccruedLiabilitiesForCommissionsExpenseAndTaxes_iI_pn3n3_c20210930_z4rmI5SA9hM2" title="Accrued Liabilities for Commissions, Expense and Taxes">60</span> thousand in unpaid commissions. This case was filed in the Superior Court of the State of California, County of San Diego on October 21, 2020. The Company believes the claim is without merit and intends to defend itself against said claim.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company is not a party to any other pending material legal proceeding. To the knowledge of management, no federal, state or local governmental agency is presently contemplating any proceeding against the Company. To the knowledge of management, no director, executive officer or affiliate of the Company, any owner of record or beneficially of more than five percent of the Company’s Common Stock is a party adverse to the Company or has a material interest adverse to the Company in any proceeding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 60000 <p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zvcxYAEKENfe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 13 – <span id="xdx_820_zEqbphnQ3Wl9">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Related party transactions are discussed in Note 7.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_zeZiP4mEQom1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTE 14 – <span id="xdx_822_z8hj6cwBxYa4">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company assessed potential subsequent events and there were none as of the filing date.</span></p> XML 11 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover - shares
9 Months Ended
Sep. 30, 2021
Nov. 15, 2021
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2021  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2021  
Current Fiscal Year End Date --12-31  
Entity File Number 000-09047  
Entity Registrant Name OMNIQ Corp.  
Entity Central Index Key 0000278165  
Entity Tax Identification Number 20-3454263  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 1865 West 2100 South  
Entity Address, City or Town Salt Lake City  
Entity Address, State or Province UT  
Entity Address, Postal Zip Code 84119  
City Area Code (801)  
Local Phone Number 244-9577  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   7,459,286
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 9,993 $ 4,594
Accounts receivable, net 20,629 9,661
Inventory 6,794 1,507
Prepaid expenses 1,809 670
Other current assets 10 10
Total current assets 39,235 16,442
Property and equipment, net of accumulated depreciation of $767 and $555 respectively 888 289
Goodwill 16,453 14,695
Trade name, net of accumulated amortization of $3,714 and $1,156, respectively 2,570 1,028
Customer relationships, net of accumulated amortization of $9,279 and $4,885, respectively 6,450 4,479
Other intangibles, net of accumulated amortization of $1,402 and $1,104, respectively 931 1,042
Restricted Cash 533
Right of use lease asset 3,749 76
Other assets 2,322 74
Total assets 72,598 38,658
Current liabilities    
Accounts payable and accrued liabilities 38,619 26,811
Line of credit 5,839 4,914
Accrued payroll and sales tax 2,061 1,717
Notes payable, related parties – current portion 390 433
Notes payable – current portion 5,641 6,449
Lease liability – current portion 1,310 31
Other current liabilities 2,796 1,412
Total current liabilities 56,656 41,767
Long term liabilities    
Notes payable, related party, less current portion 390 683
Accrued interest and accrued liabilities, related party 63 56
Notes payable, less current portion 2,327 1
Lease liability 2,472 48
Other long-term liabilities 2,057 1,146
Total liabilities 63,965 43,701
Stockholders’ equity (deficit)    
Common stock; $0.001 par value; 15,000,000 shares authorized; 7,448,597 and 4,684,736 shares issued and outstanding, respectively. 20 5
Additional paid-in capital 70,276 51,842
Accumulated (deficit) (67,883) (56,726)
Cumulative Translation Adjustment (190) (166)
Total OmniQ stockholders’ equity (deficit) 2,224 (5,043)
Non-controlling interest 6,409
TOTAL EQUITY (DEFICIT) 8,633 (5,043)
Total liabilities and equity (deficit) 72,598 38,658
Series A Preferred Stock [Member]    
Stockholders’ equity (deficit)    
Preferred Stock Value
Series B Preferred Stock [Member]    
Stockholders’ equity (deficit)    
Preferred Stock Value
Series C Preferred Stock [Member]    
Stockholders’ equity (deficit)    
Preferred Stock Value $ 1 $ 2
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Property and equipment, accumulated depreciation $ 767 $ 555
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 15,000,000 15,000,000
Common stock, shares, issued 7,448,597 4,684,736
Common stock, shares, outstanding 7,448,597 4,684,736
Series A Preferred Stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares designated 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Series B Preferred Stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares designated 1 1
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Series C Preferred Stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares designated 5,000,000 5,000,000
Preferred stock, shares issued 745,030 745,030
Preferred stock, shares outstanding 745,030 745,030
Trade Names [Member]    
Finite-Lived Intangible Assets, Accumulated Amortization $ 3,714 $ 1,156
Customer Relationships [Member]    
Finite-Lived Intangible Assets, Accumulated Amortization 9,279 4,885
Other Intangible Assets [Member]    
Finite-Lived Intangible Assets, Accumulated Amortization $ 1,402 $ 1,104
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues        
Total Revenues $ 20,513 $ 15,833 $ 53,383 $ 42,309
Cost of goods sold        
Cost of goods sold 15,842 13,024 42,778 33,886
Gross profit 4,671 2,809 10,605 8,423
Operating expenses        
Research & Development 474 428 1,437 1,260
Selling, general and administrative 6,801 4,808 15,348 11,838
Depreciation 82 44 167 134
Amortization 1,528 550 2,575 1,562
Total operating expenses 8,885 5,830 19,527 14,794
Loss from operations (4,214) (3,021) (8,922) (6,371)
Other income (expenses):        
Interest expense (587) (744) (1,890) (1,957)
Other (expenses) income (159) (16) 2 (318)
Total other expenses (746) (760) (1,888) (2,275)
Net Loss Before Income Taxes (4,960) (3,781) (10,810) (8,646)
Provision for Income Taxes        
Current (117) (119)
Total Provision for Income Taxes (117) (119)
Net Loss (5,076) (3,781) (10,929) (8,646)
Net income attributable to noncontrolling interest 166 166
Net Loss attributable to OmniQ Corp (5,242) (3,781) (11,095) (8,646)
Net loss (5,076) (3,781) (10,929) (8,646)
Foreign currency translation adjustment (58) (16) (24) (30)
Comprehensive loss (5,134) (3,797) (10,953) (8,676)
Reconciliation of net loss to net loss attributable to common shareholders        
Less: Preferred stock – Series C dividend (12) (32) (57) (158)
Net loss less series C dividend (5,064) (3,813) (10,872) (8,804)
Net income after series C dividend attributable to noncontrolling interest 166 166
Net loss after series C dividend attributable to common stockholders’ of OmniQ Corp $ (5,230) $ (3,813) $ (11,038) $ (8,804)
Net (loss) per share - basic attributable to common stockholders’ of OmniQ Corp $ (0.73) $ (0.83) $ (1.86) $ (2.03)
Weighted average number of common shares outstanding - basic 7,224,958 4,588,944 5,971,440 4,339,634
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Series C Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 5 $ 4 $ 46,861 $ (45,063) $ 1 $ 1,808
Shares, Outstanding, Beginning Balance at Dec. 31, 2019 4,829 3,960          
Dividend on Class C Shares (72) (72)
Accumulated other comprehensive loss (17) (17)
Stock-based compensation – options and warrants 190 190
Subscribed common stock     440 440
Professional fees – restricted shares 354 354
Stock Issued During Period, Shares, Restricted Stock Award, Gross 65          
Other misc. items 14 14
Net (loss) income (2,873) (2,873)
Ending balance, value at Mar. 31, 2020 $ 5 $ 4 47,845 (47,994) (16) (156)
Shares, Outstanding, Ending Balance at Mar. 31, 2020 4,829 4,025          
Dividend on Class C Shares (54) (54)
Accumulated other comprehensive loss 3 3
Stock-based compensation – options and warrants 105 105
Subscribed common stock    
Subscribed common stock, shares   80          
Professional fees – restricted shares 547 547
Stock Issued During Period, Shares, Restricted Stock Award, Gross   67          
Exercise of stock options and warrants
exercise of stock options and warrants, shares   34          
Conversion agreements - preferred shares $ (3) 3
Converion agreements - preferred shares, shares (2,684)            
Conversion agreements - debt 822 822
Net (loss) income (1,992) (1,992)
Ending balance, value at Jun. 30, 2020 $ 2 $ 4 49,322 (50,040) (13) (725)
Shares, Outstanding, Ending Balance at Jun. 30, 2020 2,145 4,206          
Beginning balance, value at Dec. 31, 2020 $ 2 $ 5 51,842 (56,726) (166) (5,043)
Shares, Outstanding, Beginning Balance at Dec. 31, 2020 2,145 4,685          
Dividend on Class C Shares (31) (31)
Exercise of stock options and warrants 2 2
exercise of stock options and warrants, shares   6          
ESPP Stock Issuance 1 1
Stock-based compensation – options, warrants, issuances 786 786
Stock and Warrant issued for services 188 188
Stock and Warrant issued for service, shares   25          
Cumulative translation adjustment 105 105
Other misc. items (4) (4)
Conversion of Equity
Net (loss) income (3,343) (3,343)
Ending balance, value at Mar. 31, 2021 $ 2 $ 5 52,819 (60,104) (61) (7,339)
Shares, Outstanding, Ending Balance at Mar. 31, 2021 2,145 4,716          
Beginning balance, value at Dec. 31, 2020 $ 2 $ 5 51,842 (56,726) (166) (5,043)
Shares, Outstanding, Beginning Balance at Dec. 31, 2020 2,145 4,685          
Net (loss) income             (10,929)
Ending balance, value at Sep. 30, 2021 $ 1 $ 20 70,276 (67,883) (190) 8,633
Shares, Outstanding, Ending Balance at Sep. 30, 2021 745 7,449          
Beginning balance, value at Mar. 31, 2021 $ 2 $ 5 52,819 (60,104) (61) (7,339)
Shares, Outstanding, Beginning Balance at Mar. 31, 2021 2,145 4,716          
Dividend on Class C Shares (14) (14)
Exercise of stock options and warrants 304 304
exercise of stock options and warrants, shares   240          
ESPP Stock Issuance 4 4
ESPP Stock Issuance, shares   1          
Stock-based compensation – options, warrants, issuances 786 786
Cumulative translation adjustment (71) (71)
Other misc. items    
Conversion of Equity $ (1) 1
Conversion of Equity, shares (1,400) 70          
Conversion of debt 203 203
Conversion of debt, Shares   25          
Net (loss) income (2,510) (2,510)
Ending balance, value at Jun. 30, 2021 $ 1 $ 5 54,117 (62,628) (132) (8,637)
Shares, Outstanding, Ending Balance at Jun. 30, 2021 745 5,052          
Dividend on Class C Shares (12) (12)
Exercise of stock options and warrants 132 132
exercise of stock options and warrants, shares   33          
ESPP Stock Issuance 9 8
ESPP Stock Issuance, shares   1          
Stock-based compensation – options, warrants, issuances 653 653
Stock and warrant issuances, net of issuance costs $ 15 13,280 13,295
Stock and warrant issuances, net of issuance costs, shares   2,143          
Stock and warrant issuance for Acquisition 2,084   2,084
Stock and warrant issuance for Acquisition, shares   220          
Cumulative translation adjustment (58) 1
Post acquisition adjustment (1) (325)
Dangot Acquisition 6,508
Net (loss) income (5,242) (5,076)
Ending balance, value at Sep. 30, 2021 $ 1 $ 20 $ 70,276 $ (67,883) $ (190) $ 8,633
Shares, Outstanding, Ending Balance at Sep. 30, 2021 745 7,449          
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from continuing operating activities:    
Net loss $ (10,929) $ (8,646)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Stock based compensation 2,620 2,275
Amortization of ROU lease asset 53 40
Depreciation and amortization 3,544 1,696
Changes in operating assets and liabilities:    
Accounts receivable 2,502 (3,193)
Prepaid expenses (1,139) (116)
Inventory (671) 218
Accounts payable and accrued liabilities (1,104) 9,673
Accrued interest and accrued liabilities, related party 7 (26)
Accrued payroll and sales taxes payable 345 (14)
Other Current assets 428 48
Lease liability 920 (39)
Other liabilities 1,632 (420)
Net cash (used in) provided by operating activities (1,792) 1,496
Cash flows from investing activities:    
Payments for acquisition, net of cash acquired (4,392)
Other assets 66
Purchase of property and equipment (976) (5)
Net cash provided by (used in) investing activities (5,368) 61
Cash flows from financing activities:    
Proceeds from private placement 13,295
Proceeds from ESPP stock issuance 14
Proceeds from / (payments on) line of credit 926 1,870
Net proceeds from Warrant exercise 279
Net Proceeds from Options Exercise 156
Proceeds from notes/loans payable 2,172 898
Payment on notes/loans payable (4,793) (874)
Net cash provided by (used in) financing activities (12,049) 1,894
Net increase (decrease) in cash 4,889 3,451
Cash and restricted cash, beginning of period 5,127 1,615
Foreign currency Exchange (23)
Cash and restricted cash, end of period 9,993 5,066
Cash paid for interest 1,101 77
Cash paid for taxes 110
Supplementary for non-cash flow information:    
Right of use lease asset 1,276
Stock issued for services 188 1,971
Net assets acquired in business combination 13,052
Intangible assets acquired in non-cash exchange 885
Conversion of notes payable 281
Stock options and warrants issued $ 171 $ 304
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
NATURE OF OPERATIONS
9 Months Ended
Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
NATURE OF OPERATIONS

NOTE 1 – NATURE OF OPERATIONS

 

OMNIQ Corp., a Delaware corporation, formerly Quest Solution, Inc., together with its wholly owned subsidiaries, referred to herein as “we,” “us,” and “our” (“OMNIQ” or the “Company”), was incorporated in 1973. Since its incorporation, the Company has been involved in various lines of business.

 

From 2008 and to 2013, we were in the business of developing oil and gas reserves. In January 2014, we determined it was in the best interest of our stockholders to focus on operating companies with a track record of positive cash flows and larger existing revenue bases. Our strategy developed into leveraging management’s relationships in the business world for investments for the Company.

 

Since 2014, we have made the following acquisitions resulting in us becoming a leading provider of computerized and machine vision image processing solutions:

 

  Quest Solution, Inc. (January 2014)
  Bar Code Specialties, Inc. (November 2014)
  ViascanQdata, Inc (October 2015 – later sold in September 2016)
  HTS Image Processing, Inc. (October 2018)
  EyepaxIT Consulting LLC. (February 2021)

 

We use patented and proprietary artificial intelligence (AI) technology to deliver data collection, real time surveillance and monitoring for supply chain management, homeland security, public safety, traffic & parking management and access control applications. The technology and services we provide helps our clients move people, assets and data safely and securely through airports, warehouses, schools, national borders, and many other applications and environments.

 

We offer end-to-end solutions that include hardware, software, communications, and full lifecycle management services. We are an established manufacturer and distributor of barcode labels, tags, and ribbons, as well as RFID labels and tags. Our highly tenured team of professionals has the knowledge and expertise to simplify the integration process for our customers, and our team delivers proven problem-solving solutions backed by numerous customer references. We offer comprehensive packaged and configurable software, and we are a leading provider of best-in-class mobile and wireless equipment.

 

Our customers include government agencies and leading Fortune 500 companies from diverse sectors, including healthcare, food and beverage, manufacturing, retail, distribution, transportation and logistics, and oil, gas, and chemicals.

 

COVID-19

 

The outbreak of the COVID-19 pandemic continues to affect the United States of America and the world, including in the primary regions we operate. Many State Governors issued temporary Executive Orders in 2020, that, among other stipulations, effectively limited in-person work activities for most industries and businesses having the effect of suspending or severely curtailing operations. Many of these orders are in the process of being lifted. To date, we have not incurred any significant interruptions to our day-to-day operations or supply chain, except some of our employees have or are working remotely. In response to the COVID-19 pandemic, we proactively implemented certain measures to strengthen cash flow, manage costs, strengthen liquidity, and enhance employee safety. These measures included the reduction of payroll costs, a reduction in capital expenditures and other discretionary spending, the elimination of most business travel and restriction of visitors to our corporate office, enhanced cleaning and disinfection procedures at our corporate office and branch locations, promotion of social distancing and the wearing of face coverings (masks) at our corporate office and branch locations, and requirements for employees to work from home where possible.

 

The extent of the ultimate impact of the pandemic on our operational and financial performance will depend on various developments, including the duration and spread of the outbreak, the impact on capital and financial markets, governmental limitations on business operations generally, and its and their impact on potential customers, employees, vendors, and distribution partners, all of which cannot be reasonably predicted at this time.

 

 

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 –SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES 

 

We describe our significant accounting policies in Note 2 of the notes to consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020. During the nine-month period ended September 30, 2021, there were no significant changes to those accounting policies.

 

Principles of Consolidation and Basis of Presentation

 

Our unaudited condensed consolidated financial statements include the financial position and results of operations of OMNIQ Corp. and its wholly owned subsidiaries Quest Marketing, Inc., Quest Exchange Ltd., OmniQ Technologies Ltd., HTS Image Ltd., and HTS Image Processing, Inc., collectively referred to herein as “we” or “us” or “our” or the “Company.”

 

All significant intercompany accounts and transactions have been eliminated in these unaudited condensed consolidated financial statements. Business combinations are included in the unaudited condensed consolidated financial statements from their respective dates of acquisition.

 

We have prepared the interim unaudited condensed consolidated financial statements included herein, in accordance with accounting principles generally accepted in the United States of America, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although we believe the disclosures are adequate to make the information presented not misleading.

 

These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. It is suggested that these interim financial statements be read in conjunction with our financial statements for the year ended December 31, 2020 and notes thereto included in our Form 10-K filed with the SEC on March 31, 2021. The Company operates in one segment.

 

Operating results for the nine months ended September 30, 2021, are not necessarily indicative of the results that may be expected for the year ended December 31, 2021.

 

Use of Estimates

 

We prepare our unaudited condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, which requires management to use its judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reported period. These assumptions and estimates could have a material effect on our unaudited condensed consolidated financial statements. Actual results may differ materially from those estimates. We review our estimates on an ongoing basis based on information currently available, and changes in facts and circumstances may cause us to revise these estimates.

 

Goodwill and Intangibles

 

We have made acquisitions in the past that resulted in the recognition of goodwill. Goodwill is the excess of the consideration transferred plus the fair value of any non-controlling interest in the acquiree at the acquisition date over the fair values of the identifiable net assets acquired. We evaluate goodwill for impairment annually or more frequently, if triggering events occur or other impairment indicators arise which might impair recoverability.

 

 

Application of the goodwill impairment test requires judgment. We performed a Step 1 quantitative assessment of goodwill impairment as of December 31, 2020, our annual impairment test date. We compared the carrying value inclusive of goodwill and definite-lived intangible assets, to its fair value. We estimated the fair value of these reporting units by weighting results from the income approach and the market approach, as further described in Note 2 in our Annual Report on Form 10-K for the year ended December 31, 2020. Based on this quantitative test, we determined there was no impairment as of the December 31, 2020.

 

Intangible assets with a limited life are being amortized on the straight-line method over useful lives ranging from 3 to 11 years. No events or indicators have occurred subsequent to December 31, 2020 that would affect the intangible assets. No impairment expense was recognized for the nine months ended September 30, 2021.

 

Foreign Currency Translation

 

Our unaudited condensed consolidated financial statements are presented in U.S. dollars. The functional currency for the Company is U.S. dollars. Transactions in currencies other than the functional currency are recorded using the appropriate exchange rate at the time of the transaction. All of our continuing operations are conducted in U.S. dollars except its subsidiary located in Israel. The records of the Israeli operation were maintained in the local currency and re-measured to the functional currency as follows: monetary assets and liabilities are converted using the balance sheet period-end date exchange rate, while the non-monetary assets and liabilities are converted using the historical exchange rate. Expenses and income items are converted using the weighted average exchange rates for the reporting period. Foreign transaction gains and losses are reported on the unaudited condensed consolidated statement of operations and were included in the amount of loss from comprehensive income.

 

Net Loss Per Common Share

 

Net loss per share is provided in accordance with FASB ASC 260-10, “Earnings per Share”. Basic net loss per common share (“EPS”) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued, unless doing so is anti-dilutive. The weighted-average number of common shares outstanding for computing basic EPS for the nine-months ended September 30, 2021 and 2020 were 5,971,440 and 4,339,634, respectively. Diluted net loss per share of common stock is the same as basic net loss per share of common stock because the effects of potentially dilutive securities are antidilutive.

 

The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported as of:

 

In thousands  September 30, 2021   December 31, 2020 
Options to purchase common stock   1,654    1,553 
Convertible preferred stock   -    - 
Warrants to purchase common stock   1,404    75 
Potential shares excluded from diluted net loss per share   3,058    1,628 

 

Purchase Accounting and Business Combinations

 

We account for our business combinations using the purchase method of accounting which requires that intangible assets be recognized apart from goodwill if they are contractual in nature or separately identifiable. Acquisitions are measured on the fair value of consideration exchanged and, if the consideration given is not cash, measurement is based on the fair value of the consideration given or the fair value of the assets acquired, whichever is more reliably measurable. The excess of cost of an acquired entity over the fair value of identifiable acquired assets and liabilities assumed is allocated to goodwill.

 

 

The valuation and allocation processes rely on significant assumptions made by management. In certain situations, the allocations of excess purchase price are based upon preliminary estimates and assumptions. Accordingly, the allocations are subject to revision when we receive updated information, including appraisals and other analyses, which are completed within one year of the acquisition. Revisions to the fair values, which may be significant, are recorded when pending information is finalized, within one year from the acquisition date.

 

Revenue Recognition.

 

When entering into contracts with our customers, we review follow the five steps outline in Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606):

 

  i. Identify the contract with our customer.
     
  ii. Identify the performance obligations in the contract.
     
  iii. Determine the transaction price.
     
  iv. Allocate the transaction price to the performance obligations. And
     
  v. Evaluate the satisfaction of the performance obligations,

 

We account for contracts, with our customers, when we have approval and commitment from both parties, the rights of the parties are identified, payment terms are established, the contract has commercial substance and collectability of consideration is probable.

 

We evaluate, in accordance with Topic 606, whether we meet the criteria to be a principal or an agent and record the revenue on a gross or net basis. We are considered a principal if we obtain control of any one of the following:

 

  i. A good or another asset from another party that we then transfer to our customer.
     
  ii. A right to a service to be performed by another party, which gives the us the ability to direct that party to provide the service to the customer on our behalf, and
     
  iii. A good or service from another party that we then combine with other goods or services in providing the specified good or service to our customer.

 

We have certain relationships with manufacturers and suppliers to sell us products or provide services. Our contracts may transfer to our customer a right to a future service or product to be provided by our manufacturer or supplier. When a specified good or service is a right to a good or service is provided by a manufacturer or supplier, we evaluate whether we control the right to the goods or services before that right is transferred to the customer rather than whether we control the underlying goods or services.

 

Indicators that we control the specified good or service before it is transferred to the customer (and we are therefore a principal) include, but are not limited to, the following:

 

  i. We are responsible for fulfilling the promise to provide the specified good or service. This typically includes responsibility for the acceptability of the specified good or service. If we are primarily responsible for fulfilling the promise to provide the specified good or service, this may indicate that the other party involved in providing the specified good or service is acting on our behalf. Often, we provide value added services (combining hardware, integrating hardware to software, etc.) to the products and services purchased from our manufacturers and suppliers.
     
  ii. We have inventory risk before the specified good or service has been transferred to a customer. Our purchases of products or services from our manufactures and suppliers is evidenced by our issuing a binding purchase order contract with the negotiated terms including specifications, pricing, delivery among other things. Our obligation for purchased products and services is mutually exclusive of our customers’ performance (failure to take acceptance, make payment, etc.

 

 

  iii. We have sole discretion in establishing our price for the specified good or service. Establishing the price our customer pays for a specified good or service may indicate we have the ability to direct the use of that good or service and obtain substantially all of the remaining benefits. We control and set the pricing for the product or services to be provided to our customers.

 

If the terms of a transaction do not indicate we are acting as a principal in the transaction, we are then considered acting as an agent and the associated revenues would be recognized on a net basis.

 

As principal, when (or as) we satisfy a performance obligation, we recognize revenue in the gross amount of consideration which we expect to be entitled in exchange for the specified good or service transferred. We are an agent if our performance obligation is to arrange for the provision of the specified good or service by another party. As an agent, we do not control the specified good or service provided by another party before that good or service is transferred to our customer. As an agent, when (or as) we satisfy a performance obligation, we recognize revenue in the amount of any fee or commission which we expect to be entitled in exchange for arranging for the specified goods or services to be provided by another party to our customer.

 

Under Topic 606, we recognize revenue (on either a gross or net basis previously discussed) only when we satisfy a performance obligation by transferring a promised good or service to our customer. A good or service is considered to be transferred when the customer obtains control. The standard defines control as an entity’s ability to direct the use of, and obtain substantially all of the remaining benefits from, an asset. We recognize revenue (either gross or net) once control has passed to the customer. The following indicators are evaluated in determining when control has passed to the customer:

 

  i. We have a right to payment for the product or service,
  ii. The customer has legal title to the product,
  iii. We have transferred physical possession of the product to the customer,
  iv. The customer has the risk and rewards of ownership of the product, and
  v. The customer has accepted the product.

 

Revenue Recognition for Hardware. Revenues from sales of hardware products are recognized on a gross basis as we are acting as a principal in these transactions, with the selling price to the customer recorded as sales and the acquisition cost of the product recorded as cost of sales. We recognize revenue from these transactions when control has passed to the customer.

 

Manufacturers and suppliers, from whom we purchase hardware, often provide their warranties only providing assurance the products and services will conform to their specifications. These assurance type warranties are not sold separately and are not considered separate performance obligations. In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.

 

Revenue Recognition for Software. Sales of software licenses are generally considered a single performance obligation. When we are considered to be the principal, we recognize revenues on a gross basis at the point the software is delivered to and accepted by our customer. Generally, software licenses are sold with accompanying third-party delivered software assurance, which is a product that allows customers to upgrade, at no additional cost, to the latest technology if new capabilities are introduced during the period that the software assurance is in effect.

 

 

As explained above, we evaluate whether the software assurance is a separate performance obligation by assessing if the third-party delivered software assurance is critical or essential to the core functionality of the software itself. This involves considering:

 

  i. If the software provides its original intended functionality to the customer without the updates,
  ii. If the customer would ascribe a higher value to the upgrades versus the up-front deliverable,
  iii. If the customer would expect frequent intelligence updates to the software (such as updates that maintain the original functionality), and
  iv. If the customer chooses to not delay or always install upgrades.

 

If we determine the accompanying third-party delivered software assurance is critical or essential to the core functionality of the software license, the software license and the accompanying third-party delivered software assurance are recognized as a single performance obligation.

 

In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.

 

Revenue Recognition for Services. We provide professional services, which include project managers and consultants recommending, designing and implementing IT solutions. Revenue from professional services is recognized either on a time and materials basis or proportionally, as costs are incurred for fixed fee project work. Revenue is recognized on a gross basis each month as work is performed and we transfer those services.

 

Revenues from the sale of professional and support services, provided by us, are recognized over the period the service is provided. As the customer receives the benefit of the service each month, we recognize the respective revenue on a gross basis as we are acting as a principal in the transaction. Additionally, we manage services team provides project support to customers that are billed on a fixed fee basis. We are acting as the principal in the transaction and recognize revenue on a gross basis based on the total number of hours incurred for the period over the total expected hours for the project. Total expected hours to complete the project is updated for each period and best represents the transfer of control of the service to the customer.

 

Contract Asset. The Company recognizes revenue as explained in accordance with ASC 606. The Company has entered into contracts with customers that only allow us to invoice the customer once the total project is completed, creating a contract asset which is presented on a separate line item on the balance sheet as a current asset.

 

Freight Costs. We record both the freight billed to its customers and the related freight costs as cost of sales when the underlying product revenue is recognized. For freight not billed to its customers, we record the freight costs as cost of sales. The Company considers shipping to be a fulfillment activity and not a separate performance obligation.

 

Stock-Based Compensation

 

We periodically issue stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. We account for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by Financial Accounting Standards Board (the “FASB”) where the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period.

 

We record stock-based compensation expense according to the provisions of ASC Topic 718, Compensation – Stock Compensation. ASC Topic 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Under the provisions of ASC Topic 718, the Company determines the appropriate fair value model to be used for valuing share-based payments and the amortization method for compensation cost. The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model.

 

We account for equity instruments issued to parties other than employees for acquiring goods or services under guidance of section 505-50-30 of the FASB Accounting Standards Codification (“FASB ASC Section 505-50-30”). Pursuant to FASB ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.

 

 

Recent Accounting Pronouncements

 

We have evaluated the recent pronouncements and believe their adoption will not have a material effect on our financial statements.

 

Reclassifications and Comparability

 

Certain amounts in the financial statements of prior years have been reclassified to conform to the current year presentation for comparative purposes. This had no effect on total assets or net income.

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.21.2
GOING CONCERN
9 Months Ended
Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN

NOTE 3 – GOING CONCERN

 

The accompanying unaudited condensed consolidated financial statements have been prepared assuming that we will continue as a going concern. As of September 30, 2021, we had a working capital deficit of $16.6 million and an accumulated deficit of $67.9 million. These facts and others have in the past raised concerns about the Company’s ability to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, which we have successfully accomplished to date.

 

Management has evaluated and assessed the Company’s ability to continue as a going concern. We believe that the achievements of the following positive factors alleviated the substantial doubt about our ability to continue as a going concern (not all inclusive):

 

The successful capital raise of $15 million.
  The Company’s cash balance at September 30, 2021 of $9.99 million.
  The Company’s acquisition of Dangot Computers, Ltd. has improved the balance sheet, profitability and cash flow.
  The Company’s favorable settlement with a major creditor. Reference note 8 supplier note.
  The Company’s up-listing to the NASDAQ stock exchange enhancing the potential to issue additional stock.
  The Company’s historical ability to continue operations and meet cash flow requirements.

 

Management considers these factors in the aggregate and believes that the Company has alleviated the substantial doubt about its ability to continue as a going concern.

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.21.2
CONCENTRATIONS
9 Months Ended
Sep. 30, 2021
Risks and Uncertainties [Abstract]  
CONCENTRATIONS

NOTE 4 – CONCENTRATIONS

 

For the nine-months ended September 30, 2021 and the year ended December 31, 2020, two customers accounted for 26.1% and 37.2%, respectively, of the Company’s consolidated revenues.

 

Accounts receivable at September 30, 2021 and December 31, 2020 are made up of trade receivables due from customers in the ordinary course of business. Four customers made up 20.2% of the accounts receivable balance at September 30, 2021 and one customer represented 46% of the balance of accounts receivable at December 31, 2020.

 

 

Accounts payable are made up of amounts due to suppliers in the ordinary course of business at September 30, 2021 and December 31, 2020. One vendor made up 71% and 92.4% of our accounts payable on September 30, 2021 and December 31, 2020, respectively.

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.21.2
BUSINESS ACQUISITION
9 Months Ended
Sep. 30, 2021
Business Combination and Asset Acquisition [Abstract]  
BUSINESS ACQUISITION

NOTE 5 – BUSINESS ACQUISITION

 

In February 2020, OMNIQ entered in an asset purchase agreement with Eyepax IT Consulting LLC, a California limited liability company, (“Eyepax”) and its principal owners (collectively the “Sellers”), pursuant to which we purchased certain assets from the Sellers at a cash purchase price of $245,000. As additional consideration, the Company issued to the Sellers 80,000 shares of the Company’s common stock and an option to purchase 20,000 shares of the Company’s common stock at an exercise price of $5.00 per share, subject to adjustment, which shall vest quarterly in four (4) equal installments and expire on February 28, 2023. The Company entered into an employment agreement with Mr. Lalith Caldera, a principal owner of Eyepax, agreeing to pay Mr. Caldera an annual salary of $100,000.

 

On May 3, 2021, the Company and Omniq Technologies Ltd., a wholly owned subsidiary of the Company (“Omniq Technologies”) entered into a share purchase agreement (the “Dangot Share Purchase Agreement”) with Mr. Haim Dangot. Pursuant to the Dangot Share Purchase Agreement, Omniq Technologies agreed to purchase 51%, or 5,100 shares, of the capital stock of Dangot Computers Ltd., an Israel company (“Dangot”), from Dangot’s sole shareholder, Haim Dangot, for consideration equivalent to 23,740,500 NIS (New Israeli Shekel), which is equal to US$7.6 million (the “Closing Consideration”), based on the then current exchange rate at the date of acquisition of NIS to dollars.

 

The Closing Consideration was paid on July 8, 2021 in the following manner: (a) the Company issued 220,103 shares of its common stock having a share value of $2,000,000 based on the average of the last 30 trading days prior to signing (May 3 ,2021); and (b) cash in the amount of $5,600,000.

 

Haim Dangot also granted Omniq Technologies an irrevocable option to purchase the remaining 4,900 shares, or 49%, of Dangot’s capital stock (the “Dangot Option”) in the 12-month period following the closing date (the “Dangot Option Period”) at a share purchase price of 465,500 NIS (US$143,142 per each 1% of Dangot’s remaining shares on a fully diluted basis) which is the same valuation per share as the purchase price for the 51%. In the event that Omniq Technologies chooses to exercise the Dangot Option, it must do so in whole or by an exercise pursuant to which Omniq Technologies shall purchase at least 26% of the additional Dangot shares on a fully diluted basis (the “Specific Partial Exercise”). Should Omniq Technologies exercise the Specific Partial Exercise, it shall have the right to complete the purchase of the remaining 23% of the Dangot shares on a fully diluted basis in a single exercise until the lapse of the Dangot Option Period. No other partial exercise shall be allowed.

 

The following table summarizes the consideration given and the purchase price allocation:

Purchase Price Consideration (in thousands)  Total Consideration 
Cash payments  $5,058 
Accrued payable to owner  600 
Fair value of stock issued (220,103 shares)   2,084 
Debt assumed   5,310 
Total consideration  $13,052 
      
Cash  $666 
Accounts Receivable   13,470 
Inventory   4,616 
Other Assets   5,392 
Property and equipment   638 
Goodwill   1,758 
Trade name   1,893 
Customer relationship   3,139 
Other intangible assets   899 
Assets acquired  $32,471 
Current liabilities assumed   (12,911)
Non-controlling interest   (6,508)
Net assets acquired  $13,052 

 

The following proforma unaudited revenue and earnings as if the acquisition had been included in the consolidated results of the company for the full year ending December 31, 2020.

 

   2021   2020 
   September 30, 
   2021   2020 
   (in thousands/unaudited) 
Revenue  $72,940   $66,110 
Net income (loss)  $(9,233)  $(7,892)

 

Individual pro forma results for each acquisition are not disclosed, as individually these acquisitions would not have a material impact on the Company’s financial statements.

 

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.21.2
CREDIT FACILITIES AND LINE OF CREDIT
9 Months Ended
Sep. 30, 2021
Debt Disclosure [Abstract]  
CREDIT FACILITIES AND LINE OF CREDIT

NOTE 6 – CREDIT FACILITIES AND LINE OF CREDIT

 

We maintain operating lines of credit, factoring and revolving credit facilities with banks and finance companies to provide us working capital.

 

In July 2016, we entered into a Factoring and Security Agreement (the “FASA”) with Action Capital Corporation (“Action”) to establish a sale of accounts receivable credit facility, whereby we may obtain short-term financing by selling and assigning acceptable accounts receivable to Action. Pursuant to the FASA, the outstanding principal amount of advances made by Action at any time shall not exceed $6.0 million. Action reserves and withholds up to 5% of the face amount of each account purchased in a reserve account. As of September 30, 2021 and December 31, 2020, the balance outstanding was $5.8 million and $4.9 million, respectively.

 

The annual interest rate with respect to the daily average balance of unpaid advances outstanding under the FASA (computed on a monthly basis) is equal to the “Prime Rate” of Wells Fargo Bank N.A. plus 2.0%, plus a monthly fee equal to 0.75% of the average outstanding balance. We also pay all other costs incurred by Action under the FASA, including all bank fees. The FASA continues in full force and effect unless terminated by either party upon 30 days’ prior written notice. The FASA credit facility is collateralized with a security interest in certain assets of the Company. The FASA includes customary representations and warranties and default provisions for transactions of this type.

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.21.2
RELATED PARTY NOTES PAYABLE
9 Months Ended
Sep. 30, 2021
Related Party Notes Payable  
RELATED PARTY NOTES PAYABLE

NOTE 7 – RELATED PARTY NOTES PAYABLE

 

Related party notes payable, consisted of the following as of:

 

   September 30, 2021   December 31, 2020 
In thousands        
Note payable –Marin  $480   $660 
Note payable –Thomet   300    413 
           
Note payable–Shareholder Convertible Note   -    43 
Total notes payable   780    1,116 
Less current portion   (390)   (433)
Long-term portion  $390   $683 

 

Note Payable -Marin

 

In December 2017, we entered into a $660 thousand, 1.89% annual interest rate note payable (the “Marin Note”) with two individuals from whom we previously acquired their company (in 2014). The Marin Note is payable in 60 monthly principal payments of $20 thousand beginning in October 2018. Accrued interest payable as of September 30, 2021, was $63 thousand. Accrued interest is payable at maturity.

 

Note Payable – Thomet

 

In December 2017, we entered into a $750 thousand, zero percent annual interest rate note payable (the “Thomet Note”) with an individual from whom we previously acquired his company (in 2014). The Thomet Note is payable in 60 monthly principal payments of $13 thousand beginning in October 2018.

 

Note Payable – Shareholder Convertible Note

 

In October 2018, we entered into a $700 thousand, 6% annual interest rate convertible note payable (the “Shareholder Convertible Note”) with Walefar and Campbeltown (collectively the “Holders”), in connection with the HTS Image Processing, Inc. Mr. Shai Lustgarten, our Chief executive Officer and Director is the principal shareholder in Walefar. Mr. Carlos J. Nissensohn, a consultant and significant shareholder in OMNIQ, is the principal shareholder in Campbeltown. The Shareholder Convertible Note was retired in 2021.

 

Future maturities of related party notes payable as of September 30, 2021, are as follows:

 

In thousands

      
2021   97 
2022   390 
2023   293 
2024   - 
Thereafter   - 
Total  $780 

 

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.21.2
OTHER NOTES PAYABLE
9 Months Ended
Sep. 30, 2021
Debt Disclosure [Abstract]  
OTHER NOTES PAYABLE

NOTE 8 – OTHER NOTES PAYABLE

 

Other notes payable at September 30, 2021 and December 31, 2020, consists of the following:

 

(In thousands)  September 30, 2021   December 31, 2020 
Note Payable- Supplier  $2,843   $6,443 
           
All Other   5,125    7 
Total   7,968    6,450 
Less current portion   (5,641)   (6,449)
Long Term Notes Payable  $2,327   $1 

 

Note Payable - Supplier

 

On July 18, 2016, the Company and the Supplier entered into a certain secured promissory note, with an effective date of July 1, 2016, in the principal amount of $12.5 million (the “Secured Promissory Note”). The USD Note accrues interest at 18% per annum and is payable in six consecutive monthly installments of principal and accrued interest in a minimum principal amount of $250 thousand each, with any remaining principal and accrued interest due and payable on December 31, 2016.

 

  On September 7, 2018, the Company entered into a Sixth Amendment to the Secured Promissory Note (the “Sixth Amendment”) extending the maturity date to January 31, 2019. The Sixth Amendment also increases the principal amount to $8.7 million, an increase of $6.8 million, by rolling the Company’s then existing and outstanding accounts payable into the note by the previously mentioned amount of increase. The Company will continue to make monthly payments in the amount of $300 thousand for the first three monthly payments, and also in the amount of $500 thousand for the last two monthly payments prior to the note’s maturity.
     
  On April 30, 2019, the Company entered into a Seventh Amendment to the Secured Promissory Note (the “Seventh Amendment”) extending the maturity date to July 31, 2019. The Seventh Amendment also provides that the Company will continue to make monthly installments of principal and accrued interest in a minimum principal amount of $350 thousand each. The Company has made partial payments towards the required monthly installments under the terms of the Seventh Amendment.
     
  On July 20, 2021, the Company entered into the Eighth Amendment to the Secured Promissory Note (the “Eighth Amendment”) extending the maturity date to August 15, 2022 and reducing the interest rate from 18% to 10%. The Eighth Amendment also provides that the Company will continue to make monthly installments of principal and accrued interest at a minimum of $300 thousand each month. As has been the case with each previous amendment, the Company is in continual negotiations with the holder of the Secured Promissory Note to extend the maturity date and establish a new schedule of payments.

 

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.21.2
OTHER LIABILITIES
9 Months Ended
Sep. 30, 2021
Other Liabilities Disclosure [Abstract]  
OTHER LIABILITIES

NOTE 9 – OTHER LIABILITIES

 

At September 30, 2021 and December 31, 2020, other liabilities consisted of the following:

 

(In thousands)  September 30, 2021   December 31, 2020 
Other vendor payable  $801   $801 
Dividend payable   1,164    253 
Bonus payable   -    27 
Others   2,888    1,477 
Total other liabilities   4,853    2,558 
Less Current Portion   (2,796)   (1,412)
Total long term other liabilities  $2,057   $1,146 

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.21.2
STOCKHOLDERS’ EQUITY
9 Months Ended
Sep. 30, 2021
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 10 – STOCKHOLDERS’ EQUITY

 

PREFERRED STOCK

 

Series A

 

As of September 30, 2021, there were 1,000,000 Series A preferred shares designated and no Series A preferred shares outstanding. The board of directors of the Company (the “Board”) had previously set the voting rights for the Series A preferred stock at 1 share of preferred to 250 common shares.

 

Series B

 

As of September 30, 2021, there was 1 preferred share designated and no preferred shares outstanding.

 

Series C

 

As of September 30, 2021, there were 3,000,000 Series C Preferred Shares (“Series C”) authorized with 745,030 issued and outstanding. The Series C shares have preferential rights above common shares and the Series B Preferred Shares and is entitled to receive a quarterly dividend at a rate of $0.06 per share per annum and have a liquidation preference of $1 per share. Series C shares outstanding are convertible into common stock at the rate of 20 preferred shares to one share of common stock. As of September 30, 2021, the accrued dividends on the Series C Preferred Stock was $106 thousand.

 

The Series C Preferred Stock has a liquidation value and conversion price of $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) and automatically converts into Common Stock at $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) in the event that the Company’s common stock has a closing price of $30 per share for 20 consecutive trading days.

 

COMMON STOCK

 

In August 2020, OMNIQ’ Board of Directors adopted an Equity Incentive Plan (the “Plan”), as an incentive to retain existing employees and attract new employees, directors, officers, consultants, and advisors to the Company. Pursuant to the Plan, one million (1,000,000) shares of the Company’s common stock, par value $0.001 (the “Shares”), were set aside and reserved for issuance. As of September 30, 2021, we had issued 361,146 shares or $1.8 million to consultants and advisors for services rendered.

 

In December 2015, our Board of Directors approved the OMNIQ. Employee Stock Purchase Plan (the “ESPP”). For the nine months ending September 30, 2021 employees purchased 1,376 or $14 thousand shares of commons stock.

 

On February 15, 2021 the Company issued 25,000 shares to Orion 4, LLC as part of a consulting agreement. The shares were valued at $188 thousand.

 

For the nine months ending September 30, 2021, 342,667 in stock options and stock warrants were exercised in exchange for 2,784,096 shares of OMNIQ common stock.

 

On July 8, 2021, the Company entered into a form of Securities Purchase Agreement (the “Securities Purchase Agreement”) with accredited investors. Pursuant to the Securities Purchase Agreement, on July 8, 2021 (the Closing Date”), the Company sold an aggregate gross proceeds of $15 million of units (the “Units”) before deducting placement agent fees, consultant and legal fees and other offering expenses (the “Offering”). The per Unit purchase price was $7.00.

 

Each Unit is comprised of one share of the Company’s common stock, $0.001 par value per share. As a result of the Offering, the Company issued 2,142,857 shares of common Stock (the “Shares”) and warrants (the “Warrants”) to purchase 171,429 shares of Common Stock (the “Warrant Shares”) at an exercise price equal to $7.70 per Warrant Share, which Warrants are exercisable for a period of five years from the issuance date.

 

ThinkEquity, a division of Fordham Financial Management, Inc. (the “Placement Agent”), acted as the sole placement agent for the Offering. In connection with the Offering, the Company entered into a Placement Agency Agreement with the Placement Agent, pursuant to which it paid the Placement Agent $1.2 million (eight percent of the gross proceeds) in commissions and reimbursed it for $150 thousand of expenses incurred in connection with the Offering plus other miscellaneous expenses. The Company also issued the Placement Agent a warrant (the “Placement Agent Warrant”) to purchase 171,429 shares of the Company’s common stock (the “Placement Agent Warrant Shares”) at an exercise price of $7.70 per share. The Placement Agent Warrant terminates five years from the Closing Date.

 

The Company paid additional legal and other fees directly related to the Offering. The cash fees paid were netted against the Offering proceeds, as follows:

 

(In thousands)    
Total proceeds from issuance of Common Stock and Warrants  $15,000 
      
Placement Agent fees   (1,455)
Commission, Legal and other fees   (264)
Total  $13,281 

 

The fair value of the Warrants issued to the Placement Agent and Consultant are included in the Warrants Paid in Capital account in stockholder’s equity.

 

 

Warrants

 

The following table summarizes information about warrants granted during the nine-month periods ended September 30, 2021 and 2020:

 

   September 30, 2021   September 30, 2020 
  

Number of

warrants

  

Weighted

Average

Exercise

Price

  

Number of

warrants

  

Weighted

Average

Exercise

Price

 
                 
Balance, beginning of period   1,366,667   $7.19    1,166,667   $6.42 
                     
Warrants granted   171,429         325,000    8.20 
Warrants expired   (15,000)   14.00    (10,000)   5.60 
Warrants cancelled, forfeited   -    -    -    - 
Warrants exercised   (119,167)   3.98    (150,000)   4.00 
                     
Balance, end of period   1,403,929   $7.45    1,331,667   $7.14 
                     
Exercisable warrants   1,320,596   $7.45    1,165,001   $7.08 

 

Outstanding warrants as of September 30, 2021 are as follows:

 

   Weighted Average       Weighted       Weighted 
Range of  residual life       Average       Average 
Exercise  span   Outstanding   Exercise   Exercisable   Exercise 
Prices  (in years)   Warrants   Price   Warrants   Price 
                     
7.00   3.27    847,500    7.00    847,500    7.00 
7.50   4.93    250,000    7.50    166,667    7.50 
7.70   4.77    171,429    7.70    171,429    7.70 
8.00   0.41    10,000    8.00    10,000    8.00 
10.00   1.23    125,000    10.00    125,000    10.00 
                          
7.00 to 10.00   3.42    1,403,929   $7.45    1,320,596   $7.45 

 

Warrants outstanding at September 30, 2021 and 2020 have the following expiry date and exercise prices:

 

   Exercise         
Expiry Date  Prices   2021   2020 
             
October 10, 2020   12.00    -    15,000 
December 30, 2020   4.00    -    - 
February 02, 2021   14.00    -    15,000 
August 02, 2021   2.20    -    75,000 
October 10, 2021   10.00    25,000    25,000 
February 27, 2022   8.00    10,000    10,000 
May 18, 2023   10.00    50,000    50,000 
October 14, 2023   10.00    50,000    - 
October 06, 2024   7.00    793,667    891,667 
September 01, 2025   7.50    83,334    83,334 
June 04, 2026   7.50    83,333    83,333 
July 8, 2026   7.70    171429    - 
December 04, 2027   7.50    83,333    83,333 
                
         1,403,929    1,231,667 

 

 

Stock Options

 

The following table summarizes information about stock options granted during the nine months ended September 30, 2021 and 2020:

 

   September 30, 2021   September 30, 2020 
  

Number of

stock options

  

Weighted

Average

Exercise Price

  

Number of

stock options

  

Weighted

Average

Exercise Price

 
                 
Balance, beginning of period   1,811,550   $4.32    1,133,550   $4.00 
                     
Stock options granted   -         775,000    4.63 
Stock options expired   -         (30,250)   3.98 
Stock options cancelled, forfeited   (28,750)        -      
Stock options exercised   (223,500)        (66,750)   2.51 
                     
Balance, end of period   1,559,300   $4.58    1,811,550   $4.32 
                     
Exercisable stock options   1,070,133   $4.56    959,550   $4.02 

 

On September 30, 2020, the Company granted 775,000 stock options. These options were granted as part of the asset acquisition described in Note 4, and to a member of the board of advisors, and to certain employees as part of the Company’s Equity Incentive Plan.

 

Outstanding stock options as of September 30, 2021 are as follows:

 

Range of

Exercise

Prices

  

Weighted

Average

residual life

span

(in years)

   Outstanding Stock Options  

Weighted

Average

Exercise

Price

  

Exercisable Stock

Options

  

Weighted

Average

Exercise

Price

 
                      
$1.50    0.38    38,017   $1.50    38,017   $1.50 
$1.80    0.38    76,033   $1.80    76,033   $1.80 
$                          
$2.40    1.43    247,000   $2.40    247,000   $2.40 
$4.20    3.55    10,000   $4.20    7,500   $4.20 
$4.40    8.24    404,000   $4.40    170,667   $4.40 
$4.84    9.00    380,000   $4.84    126,667   $4.84 
$5.00    1.77    147,500   $5.00    142,500   $5.00 
$5.40    2.17    131,750   $5.40    131,750   $5.40 
$10.00    3.14    125,000   $10.00    125,000   $10.00 
                            
$ 1.50 to 10.00    5.16    1,564,300   $4.58    1,032,116   $4.73 

 

Stock options outstanding at September 30, 2021, and 2020 have the following expiration date and exercise prices:

 

Expiration Date  Exercise Prices   September 30, 2021   September 30, 2020 
August 2, 2021  $2.20    -    175,000 
February 17, 2022  $1.50    38,017    38,017 
February 17, 2022  $1.80    76,033    76,033 
February 28, 2023  $5.00    20,000    - 
March 5, 2023  $2.40    247,000    340,000 
July 31, 2023  $5.00    127,500    127,500 
October 31, 2023  $4.40    59,000    108,250 
November 30, 2023  $5.40    131,750    143,750 
November 20, 2024  $10.00    125,000    125,000 
April 20, 2025  $4.20    10,000    - 
September 30, 2030  $4.40    350,000    - 
September 30, 2030  $4.84    380,000    - 
                
         1,564,300    1,073,300 

 

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 11 – COMMITMENTS AND CONTINGENCIES

 

Profit Sharing Plan

 

We maintain a contributory profit-sharing plan covering substantially all fulltime employees within the requirements of the Employee Retirement Income Security Act of 1974 (“ERISA”). In 2016, the Safe Harbor element was removed from the plan and the employer may make a discretionary matching contribution equal to a uniform percentage or dollar amount of participants’ elective deferrals for each Plan Year. In 2015, we were required to make a safe harbor non-elective contribution equal to 3 percent of a participant’s compensation. The plan also includes a 401(k) savings plan feature that allows substantially all employees to make voluntary contributions and provides for discretionary matching contributions determined annually by the Board of Directors. For the nine months ending September 30, 2021, we elected to forgo the match.

 

Operating Leases

 

As of September 30, 2021, we had 8 operating leases as follows:

 

  Office space in Akron, Ohio, with monthly payments of $3 thousand and an incremental borrowing rate of 14.55%. As of September 30, 2021, we had 20 months remaining on the lease.
     
  A vehicle with monthly payments of less than $1 thousand. As of September 30, 2021, the Company had 5 months remaining on the lease.
     
  Office space in Salt Lake City, UT, with monthly payments of $22 thousand. As of September 30, 2021 the company had 58 months remaining on the lease.

 

  Yad haruzim -Dangot main office in Tel-Aviv . with monthly payments of between 62500 NIS to 65365 NIS . As of September 30, 2021, we had 38 months remaining on the lease.
     
  Gamdan office in Tel-Aviv. with monthly payments of between 21,080 NIS to 22,134 NIS . As of September 30, 2021, we had 27 months remaining on the lease.
     
  Rival warehouse in Tel Aviv. . with monthly payments of between 40,000 NIS to 41,200 NIS. As of September 30, 2021, we had 45 months remaining on the lease.
     
  Hofman warehouse in Tel Aviv. . with monthly payments of between 3,500 NIS. As of September 30, 2021, we had 33 months remaining on the lease.
     
  Rental cars- Variable payments, between NIS 2,000 and NIS 6,000 for about 65 employees with 36 payments.

 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.21.2
LITIGATION
9 Months Ended
Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
LITIGATION

NOTE 12 – LITIGATION 

 

In September 2020 the Company was named as a defendant in a Mississippi state lawsuit (the “Mississippi case”) filed by Riverland Technologies LLC (“Riverland”) in the Circuit Court of Rankin County, Mississippi. The subject matter of the Mississippi case directly relates to the RedLPR case, to which Riverland was also a party. Subject to a settlement between the Company and Riverland, all of Riverland’s claims against the Company in the Mississippi case have been dismissed, and the Company is no longer a party to the Mississippi case.

 

The Company was named a defendant in a case involving a former employee who claims he is owed approximately $60 thousand in unpaid commissions. This case was filed in the Superior Court of the State of California, County of San Diego on October 21, 2020. The Company believes the claim is without merit and intends to defend itself against said claim.

 

The Company is not a party to any other pending material legal proceeding. To the knowledge of management, no federal, state or local governmental agency is presently contemplating any proceeding against the Company. To the knowledge of management, no director, executive officer or affiliate of the Company, any owner of record or beneficially of more than five percent of the Company’s Common Stock is a party adverse to the Company or has a material interest adverse to the Company in any proceeding.

 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.21.2
RELATED PARTY TRANSACTIONS
9 Months Ended
Sep. 30, 2021
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 13 – RELATED PARTY TRANSACTIONS

 

Related party transactions are discussed in Note 7.

 

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.21.2
SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2021
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 14 – SUBSEQUENT EVENTS

 

The Company assessed potential subsequent events and there were none as of the filing date.

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Principles of Consolidation and Basis of Presentation

Principles of Consolidation and Basis of Presentation

 

Our unaudited condensed consolidated financial statements include the financial position and results of operations of OMNIQ Corp. and its wholly owned subsidiaries Quest Marketing, Inc., Quest Exchange Ltd., OmniQ Technologies Ltd., HTS Image Ltd., and HTS Image Processing, Inc., collectively referred to herein as “we” or “us” or “our” or the “Company.”

 

All significant intercompany accounts and transactions have been eliminated in these unaudited condensed consolidated financial statements. Business combinations are included in the unaudited condensed consolidated financial statements from their respective dates of acquisition.

 

We have prepared the interim unaudited condensed consolidated financial statements included herein, in accordance with accounting principles generally accepted in the United States of America, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although we believe the disclosures are adequate to make the information presented not misleading.

 

These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. It is suggested that these interim financial statements be read in conjunction with our financial statements for the year ended December 31, 2020 and notes thereto included in our Form 10-K filed with the SEC on March 31, 2021. The Company operates in one segment.

 

Operating results for the nine months ended September 30, 2021, are not necessarily indicative of the results that may be expected for the year ended December 31, 2021.

 

Use of Estimates

Use of Estimates

 

We prepare our unaudited condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, which requires management to use its judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reported period. These assumptions and estimates could have a material effect on our unaudited condensed consolidated financial statements. Actual results may differ materially from those estimates. We review our estimates on an ongoing basis based on information currently available, and changes in facts and circumstances may cause us to revise these estimates.

 

Goodwill and Intangibles

Goodwill and Intangibles

 

We have made acquisitions in the past that resulted in the recognition of goodwill. Goodwill is the excess of the consideration transferred plus the fair value of any non-controlling interest in the acquiree at the acquisition date over the fair values of the identifiable net assets acquired. We evaluate goodwill for impairment annually or more frequently, if triggering events occur or other impairment indicators arise which might impair recoverability.

 

 

Application of the goodwill impairment test requires judgment. We performed a Step 1 quantitative assessment of goodwill impairment as of December 31, 2020, our annual impairment test date. We compared the carrying value inclusive of goodwill and definite-lived intangible assets, to its fair value. We estimated the fair value of these reporting units by weighting results from the income approach and the market approach, as further described in Note 2 in our Annual Report on Form 10-K for the year ended December 31, 2020. Based on this quantitative test, we determined there was no impairment as of the December 31, 2020.

 

Intangible assets with a limited life are being amortized on the straight-line method over useful lives ranging from 3 to 11 years. No events or indicators have occurred subsequent to December 31, 2020 that would affect the intangible assets. No impairment expense was recognized for the nine months ended September 30, 2021.

 

Foreign Currency Translation

Foreign Currency Translation

 

Our unaudited condensed consolidated financial statements are presented in U.S. dollars. The functional currency for the Company is U.S. dollars. Transactions in currencies other than the functional currency are recorded using the appropriate exchange rate at the time of the transaction. All of our continuing operations are conducted in U.S. dollars except its subsidiary located in Israel. The records of the Israeli operation were maintained in the local currency and re-measured to the functional currency as follows: monetary assets and liabilities are converted using the balance sheet period-end date exchange rate, while the non-monetary assets and liabilities are converted using the historical exchange rate. Expenses and income items are converted using the weighted average exchange rates for the reporting period. Foreign transaction gains and losses are reported on the unaudited condensed consolidated statement of operations and were included in the amount of loss from comprehensive income.

 

Net Loss Per Common Share

Net Loss Per Common Share

 

Net loss per share is provided in accordance with FASB ASC 260-10, “Earnings per Share”. Basic net loss per common share (“EPS”) is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average shares outstanding, assuming all dilutive potential common shares were issued, unless doing so is anti-dilutive. The weighted-average number of common shares outstanding for computing basic EPS for the nine-months ended September 30, 2021 and 2020 were 5,971,440 and 4,339,634, respectively. Diluted net loss per share of common stock is the same as basic net loss per share of common stock because the effects of potentially dilutive securities are antidilutive.

 

The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported as of:

 

In thousands  September 30, 2021   December 31, 2020 
Options to purchase common stock   1,654    1,553 
Convertible preferred stock   -    - 
Warrants to purchase common stock   1,404    75 
Potential shares excluded from diluted net loss per share   3,058    1,628 

 

Purchase Accounting and Business Combinations

Purchase Accounting and Business Combinations

 

We account for our business combinations using the purchase method of accounting which requires that intangible assets be recognized apart from goodwill if they are contractual in nature or separately identifiable. Acquisitions are measured on the fair value of consideration exchanged and, if the consideration given is not cash, measurement is based on the fair value of the consideration given or the fair value of the assets acquired, whichever is more reliably measurable. The excess of cost of an acquired entity over the fair value of identifiable acquired assets and liabilities assumed is allocated to goodwill.

 

 

The valuation and allocation processes rely on significant assumptions made by management. In certain situations, the allocations of excess purchase price are based upon preliminary estimates and assumptions. Accordingly, the allocations are subject to revision when we receive updated information, including appraisals and other analyses, which are completed within one year of the acquisition. Revisions to the fair values, which may be significant, are recorded when pending information is finalized, within one year from the acquisition date.

 

Revenue Recognition.

Revenue Recognition.

 

When entering into contracts with our customers, we review follow the five steps outline in Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606):

 

  i. Identify the contract with our customer.
     
  ii. Identify the performance obligations in the contract.
     
  iii. Determine the transaction price.
     
  iv. Allocate the transaction price to the performance obligations. And
     
  v. Evaluate the satisfaction of the performance obligations,

 

We account for contracts, with our customers, when we have approval and commitment from both parties, the rights of the parties are identified, payment terms are established, the contract has commercial substance and collectability of consideration is probable.

 

We evaluate, in accordance with Topic 606, whether we meet the criteria to be a principal or an agent and record the revenue on a gross or net basis. We are considered a principal if we obtain control of any one of the following:

 

  i. A good or another asset from another party that we then transfer to our customer.
     
  ii. A right to a service to be performed by another party, which gives the us the ability to direct that party to provide the service to the customer on our behalf, and
     
  iii. A good or service from another party that we then combine with other goods or services in providing the specified good or service to our customer.

 

We have certain relationships with manufacturers and suppliers to sell us products or provide services. Our contracts may transfer to our customer a right to a future service or product to be provided by our manufacturer or supplier. When a specified good or service is a right to a good or service is provided by a manufacturer or supplier, we evaluate whether we control the right to the goods or services before that right is transferred to the customer rather than whether we control the underlying goods or services.

 

Indicators that we control the specified good or service before it is transferred to the customer (and we are therefore a principal) include, but are not limited to, the following:

 

  i. We are responsible for fulfilling the promise to provide the specified good or service. This typically includes responsibility for the acceptability of the specified good or service. If we are primarily responsible for fulfilling the promise to provide the specified good or service, this may indicate that the other party involved in providing the specified good or service is acting on our behalf. Often, we provide value added services (combining hardware, integrating hardware to software, etc.) to the products and services purchased from our manufacturers and suppliers.
     
  ii. We have inventory risk before the specified good or service has been transferred to a customer. Our purchases of products or services from our manufactures and suppliers is evidenced by our issuing a binding purchase order contract with the negotiated terms including specifications, pricing, delivery among other things. Our obligation for purchased products and services is mutually exclusive of our customers’ performance (failure to take acceptance, make payment, etc.

 

 

  iii. We have sole discretion in establishing our price for the specified good or service. Establishing the price our customer pays for a specified good or service may indicate we have the ability to direct the use of that good or service and obtain substantially all of the remaining benefits. We control and set the pricing for the product or services to be provided to our customers.

 

If the terms of a transaction do not indicate we are acting as a principal in the transaction, we are then considered acting as an agent and the associated revenues would be recognized on a net basis.

 

As principal, when (or as) we satisfy a performance obligation, we recognize revenue in the gross amount of consideration which we expect to be entitled in exchange for the specified good or service transferred. We are an agent if our performance obligation is to arrange for the provision of the specified good or service by another party. As an agent, we do not control the specified good or service provided by another party before that good or service is transferred to our customer. As an agent, when (or as) we satisfy a performance obligation, we recognize revenue in the amount of any fee or commission which we expect to be entitled in exchange for arranging for the specified goods or services to be provided by another party to our customer.

 

Under Topic 606, we recognize revenue (on either a gross or net basis previously discussed) only when we satisfy a performance obligation by transferring a promised good or service to our customer. A good or service is considered to be transferred when the customer obtains control. The standard defines control as an entity’s ability to direct the use of, and obtain substantially all of the remaining benefits from, an asset. We recognize revenue (either gross or net) once control has passed to the customer. The following indicators are evaluated in determining when control has passed to the customer:

 

  i. We have a right to payment for the product or service,
  ii. The customer has legal title to the product,
  iii. We have transferred physical possession of the product to the customer,
  iv. The customer has the risk and rewards of ownership of the product, and
  v. The customer has accepted the product.

 

Revenue Recognition for Hardware. Revenues from sales of hardware products are recognized on a gross basis as we are acting as a principal in these transactions, with the selling price to the customer recorded as sales and the acquisition cost of the product recorded as cost of sales. We recognize revenue from these transactions when control has passed to the customer.

 

Manufacturers and suppliers, from whom we purchase hardware, often provide their warranties only providing assurance the products and services will conform to their specifications. These assurance type warranties are not sold separately and are not considered separate performance obligations. In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.

 

Revenue Recognition for Software. Sales of software licenses are generally considered a single performance obligation. When we are considered to be the principal, we recognize revenues on a gross basis at the point the software is delivered to and accepted by our customer. Generally, software licenses are sold with accompanying third-party delivered software assurance, which is a product that allows customers to upgrade, at no additional cost, to the latest technology if new capabilities are introduced during the period that the software assurance is in effect.

 

 

As explained above, we evaluate whether the software assurance is a separate performance obligation by assessing if the third-party delivered software assurance is critical or essential to the core functionality of the software itself. This involves considering:

 

  i. If the software provides its original intended functionality to the customer without the updates,
  ii. If the customer would ascribe a higher value to the upgrades versus the up-front deliverable,
  iii. If the customer would expect frequent intelligence updates to the software (such as updates that maintain the original functionality), and
  iv. If the customer chooses to not delay or always install upgrades.

 

If we determine the accompanying third-party delivered software assurance is critical or essential to the core functionality of the software license, the software license and the accompanying third-party delivered software assurance are recognized as a single performance obligation.

 

In some transactions, a third-party will provide the customer with an extended warranty. These extended warranties are sold separately and provide the customer with a service in addition to assurance that the product will function as expected. We consider these warranties to be separate performance obligations from the underlying product. For warranties, where we are arranging those services be provided by a third-party, we are acting as an agent in the transaction and records revenue on a net basis at the point of sale.

 

Revenue Recognition for Services. We provide professional services, which include project managers and consultants recommending, designing and implementing IT solutions. Revenue from professional services is recognized either on a time and materials basis or proportionally, as costs are incurred for fixed fee project work. Revenue is recognized on a gross basis each month as work is performed and we transfer those services.

 

Revenues from the sale of professional and support services, provided by us, are recognized over the period the service is provided. As the customer receives the benefit of the service each month, we recognize the respective revenue on a gross basis as we are acting as a principal in the transaction. Additionally, we manage services team provides project support to customers that are billed on a fixed fee basis. We are acting as the principal in the transaction and recognize revenue on a gross basis based on the total number of hours incurred for the period over the total expected hours for the project. Total expected hours to complete the project is updated for each period and best represents the transfer of control of the service to the customer.

 

Contract Asset. The Company recognizes revenue as explained in accordance with ASC 606. The Company has entered into contracts with customers that only allow us to invoice the customer once the total project is completed, creating a contract asset which is presented on a separate line item on the balance sheet as a current asset.

 

Freight Costs. We record both the freight billed to its customers and the related freight costs as cost of sales when the underlying product revenue is recognized. For freight not billed to its customers, we record the freight costs as cost of sales. The Company considers shipping to be a fulfillment activity and not a separate performance obligation.

 

Stock-Based Compensation

Stock-Based Compensation

 

We periodically issue stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. We account for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by Financial Accounting Standards Board (the “FASB”) where the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period.

 

We record stock-based compensation expense according to the provisions of ASC Topic 718, Compensation – Stock Compensation. ASC Topic 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. Under the provisions of ASC Topic 718, the Company determines the appropriate fair value model to be used for valuing share-based payments and the amortization method for compensation cost. The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model.

 

We account for equity instruments issued to parties other than employees for acquiring goods or services under guidance of section 505-50-30 of the FASB Accounting Standards Codification (“FASB ASC Section 505-50-30”). Pursuant to FASB ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.

 

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

We have evaluated the recent pronouncements and believe their adoption will not have a material effect on our financial statements.

 

Reclassifications and Comparability

Reclassifications and Comparability

 

Certain amounts in the financial statements of prior years have been reclassified to conform to the current year presentation for comparative purposes. This had no effect on total assets or net income.

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE

The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share because such securities have an anti-dilutive impact due to losses reported as of:

 

In thousands  September 30, 2021   December 31, 2020 
Options to purchase common stock   1,654    1,553 
Convertible preferred stock   -    - 
Warrants to purchase common stock   1,404    75 
Potential shares excluded from diluted net loss per share   3,058    1,628 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.21.2
BUSINESS ACQUISITION (Tables)
9 Months Ended
Sep. 30, 2021
Business Combination and Asset Acquisition [Abstract]  
SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED

Purchase Price Consideration (in thousands)  Total Consideration 
Cash payments  $5,058 
Accrued payable to owner  600 
Fair value of stock issued (220,103 shares)   2,084 
Debt assumed   5,310 
Total consideration  $13,052 
      
Cash  $666 
Accounts Receivable   13,470 
Inventory   4,616 
Other Assets   5,392 
Property and equipment   638 
Goodwill   1,758 
Trade name   1,893 
Customer relationship   3,139 
Other intangible assets   899 
Assets acquired  $32,471 
Current liabilities assumed   (12,911)
Non-controlling interest   (6,508)
Net assets acquired  $13,052 
SCHEDULE OF PROFORMA UNAUDITED REVENUE AND EARNINGS

The following proforma unaudited revenue and earnings as if the acquisition had been included in the consolidated results of the company for the full year ending December 31, 2020.

 

   2021   2020 
   September 30, 
   2021   2020 
   (in thousands/unaudited) 
Revenue  $72,940   $66,110 
Net income (loss)  $(9,233)  $(7,892)
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.21.2
RELATED PARTY NOTES PAYABLE (Tables)
9 Months Ended
Sep. 30, 2021
Related Party Notes Payable  
SCHEDULE OF NOTES PAYABLE, RELATED PARTIES

Related party notes payable, consisted of the following as of:

 

   September 30, 2021   December 31, 2020 
In thousands        
Note payable –Marin  $480   $660 
Note payable –Thomet   300    413 
           
Note payable–Shareholder Convertible Note   -    43 
Total notes payable   780    1,116 
Less current portion   (390)   (433)
Long-term portion  $390   $683 
SCHEDULE OF FUTURE MATURITIES OF NOTES PAYABLE, RELATED PARTIES

Future maturities of related party notes payable as of September 30, 2021, are as follows:

 

In thousands

      
2021   97 
2022   390 
2023   293 
2024   - 
Thereafter   - 
Total  $780 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.21.2
OTHER NOTES PAYABLE (Tables)
9 Months Ended
Sep. 30, 2021
Debt Disclosure [Abstract]  
SCHEDULE OF OTHER NOTES PAYABLE

Other notes payable at September 30, 2021 and December 31, 2020, consists of the following:

 

(In thousands)  September 30, 2021   December 31, 2020 
Note Payable- Supplier  $2,843   $6,443 
           
All Other   5,125    7 
Total   7,968    6,450 
Less current portion   (5,641)   (6,449)
Long Term Notes Payable  $2,327   $1 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.21.2
OTHER LIABILITIES (Tables)
9 Months Ended
Sep. 30, 2021
Other Liabilities Disclosure [Abstract]  
SCHEDULE OF OTHER LIABILITIES

At September 30, 2021 and December 31, 2020, other liabilities consisted of the following:

 

(In thousands)  September 30, 2021   December 31, 2020 
Other vendor payable  $801   $801 
Dividend payable   1,164    253 
Bonus payable   -    27 
Others   2,888    1,477 
Total other liabilities   4,853    2,558 
Less Current Portion   (2,796)   (1,412)
Total long term other liabilities  $2,057   $1,146 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.21.2
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Sep. 30, 2021
Equity [Abstract]  
SCHEDULE OF ADDITIONAL LEGAL AND OTHER FEES RELATED TO OFFERING

The Company paid additional legal and other fees directly related to the Offering. The cash fees paid were netted against the Offering proceeds, as follows:

 

(In thousands)    
Total proceeds from issuance of Common Stock and Warrants  $15,000 
      
Placement Agent fees   (1,455)
Commission, Legal and other fees   (264)
Total  $13,281 
SCHEDULE OF WARRANTS ACTIVITY

The following table summarizes information about warrants granted during the nine-month periods ended September 30, 2021 and 2020:

 

   September 30, 2021   September 30, 2020 
  

Number of

warrants

  

Weighted

Average

Exercise

Price

  

Number of

warrants

  

Weighted

Average

Exercise

Price

 
                 
Balance, beginning of period   1,366,667   $7.19    1,166,667   $6.42 
                     
Warrants granted   171,429         325,000    8.20 
Warrants expired   (15,000)   14.00    (10,000)   5.60 
Warrants cancelled, forfeited   -    -    -    - 
Warrants exercised   (119,167)   3.98    (150,000)   4.00 
                     
Balance, end of period   1,403,929   $7.45    1,331,667   $7.14 
                     
Exercisable warrants   1,320,596   $7.45    1,165,001   $7.08 
SCHEDULE OF OUTSTANDING WARRANTS

Outstanding warrants as of September 30, 2021 are as follows:

 

   Weighted Average       Weighted       Weighted 
Range of  residual life       Average       Average 
Exercise  span   Outstanding   Exercise   Exercisable   Exercise 
Prices  (in years)   Warrants   Price   Warrants   Price 
                     
7.00   3.27    847,500    7.00    847,500    7.00 
7.50   4.93    250,000    7.50    166,667    7.50 
7.70   4.77    171,429    7.70    171,429    7.70 
8.00   0.41    10,000    8.00    10,000    8.00 
10.00   1.23    125,000    10.00    125,000    10.00 
                          
7.00 to 10.00   3.42    1,403,929   $7.45    1,320,596   $7.45 
SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES

Warrants outstanding at September 30, 2021 and 2020 have the following expiry date and exercise prices:

 

   Exercise         
Expiry Date  Prices   2021   2020 
             
October 10, 2020   12.00    -    15,000 
December 30, 2020   4.00    -    - 
February 02, 2021   14.00    -    15,000 
August 02, 2021   2.20    -    75,000 
October 10, 2021   10.00    25,000    25,000 
February 27, 2022   8.00    10,000    10,000 
May 18, 2023   10.00    50,000    50,000 
October 14, 2023   10.00    50,000    - 
October 06, 2024   7.00    793,667    891,667 
September 01, 2025   7.50    83,334    83,334 
June 04, 2026   7.50    83,333    83,333 
July 8, 2026   7.70    171429    - 
December 04, 2027   7.50    83,333    83,333 
                
         1,403,929    1,231,667 
SCHEDULE OF STOCK OPTIONS GRANTED

The following table summarizes information about stock options granted during the nine months ended September 30, 2021 and 2020:

 

   September 30, 2021   September 30, 2020 
  

Number of

stock options

  

Weighted

Average

Exercise Price

  

Number of

stock options

  

Weighted

Average

Exercise Price

 
                 
Balance, beginning of period   1,811,550   $4.32    1,133,550   $4.00 
                     
Stock options granted   -         775,000    4.63 
Stock options expired   -         (30,250)   3.98 
Stock options cancelled, forfeited   (28,750)        -      
Stock options exercised   (223,500)        (66,750)   2.51 
                     
Balance, end of period   1,559,300   $4.58    1,811,550   $4.32 
                     
Exercisable stock options   1,070,133   $4.56    959,550   $4.02 
SCHEDULE OF OUTSTANDING STOCK OPTIONS

Outstanding stock options as of September 30, 2021 are as follows:

 

Range of

Exercise

Prices

  

Weighted

Average

residual life

span

(in years)

   Outstanding Stock Options  

Weighted

Average

Exercise

Price

  

Exercisable Stock

Options

  

Weighted

Average

Exercise

Price

 
                      
$1.50    0.38    38,017   $1.50    38,017   $1.50 
$1.80    0.38    76,033   $1.80    76,033   $1.80 
$                          
$2.40    1.43    247,000   $2.40    247,000   $2.40 
$4.20    3.55    10,000   $4.20    7,500   $4.20 
$4.40    8.24    404,000   $4.40    170,667   $4.40 
$4.84    9.00    380,000   $4.84    126,667   $4.84 
$5.00    1.77    147,500   $5.00    142,500   $5.00 
$5.40    2.17    131,750   $5.40    131,750   $5.40 
$10.00    3.14    125,000   $10.00    125,000   $10.00 
                            
$ 1.50 to 10.00    5.16    1,564,300   $4.58    1,032,116   $4.73 

SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES

Stock options outstanding at September 30, 2021, and 2020 have the following expiration date and exercise prices:

 

Expiration Date  Exercise Prices   September 30, 2021   September 30, 2020 
August 2, 2021  $2.20    -    175,000 
February 17, 2022  $1.50    38,017    38,017 
February 17, 2022  $1.80    76,033    76,033 
February 28, 2023  $5.00    20,000    - 
March 5, 2023  $2.40    247,000    340,000 
July 31, 2023  $5.00    127,500    127,500 
October 31, 2023  $4.40    59,000    108,250 
November 30, 2023  $5.40    131,750    143,750 
November 20, 2024  $10.00    125,000    125,000 
April 20, 2025  $4.20    10,000    - 
September 30, 2030  $4.40    350,000    - 
September 30, 2030  $4.84    380,000    - 
                
         1,564,300    1,073,300 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares
shares in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential shares excluded from diluted net loss per share 3,058 1,628
Share-based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential shares excluded from diluted net loss per share 1,654 1,553
Convertible Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential shares excluded from diluted net loss per share
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential shares excluded from diluted net loss per share 1,404 75
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Property, Plant and Equipment [Line Items]      
Impairment of goodwill $ 0   $ 0
Weighted average number of diluted shares outstanding 5,971,440 4,339,634  
Minimum [Member]      
Property, Plant and Equipment [Line Items]      
Finite-Lived Intangible Asset, Useful Life 3 years    
Maximum [Member]      
Property, Plant and Equipment [Line Items]      
Finite-Lived Intangible Asset, Useful Life 11 years    
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.21.2
GOING CONCERN (Details Narrative) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Working capital deficit $ 16,600  
Accumulated deficit 67,883 $ 56,726
Raise capital 15,000  
Cash $ 9,990  
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.21.2
CONCENTRATIONS (Details Narrative) - Customer Concentration Risk [Member]
9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Revenue Benchmark [Member] | Two Customers [Member]    
Concentration Risk [Line Items]    
Concentration Risk, Percentage 26.10% 37.20%
Accounts Receivable [Member] | Four Customers [Member]    
Concentration Risk [Line Items]    
Concentration Risk, Percentage 20.20%  
Accounts Receivable [Member] | One Customers [Member]    
Concentration Risk [Line Items]    
Concentration Risk, Percentage   46.00%
Accounts Payable [Member] | One Vendor [Member]    
Concentration Risk [Line Items]    
Concentration Risk, Percentage 71.00% 92.40%
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) - USD ($)
$ in Thousands
9 Months Ended
May 03, 2021
Sep. 30, 2021
Sep. 30, 2020
Business Acquisition [Line Items]      
Cash payments   $ 4,392
Dangot Shares [Member]      
Business Acquisition [Line Items]      
Cash payments $ 5,058    
Accrued payable to owner 600    
Fair value of stock issued (220,103 shares) 2,084    
Debt assumed 5,310    
Total consideration 13,052    
Cash 666    
Accounts Receivable 13,470    
Inventory 4,616    
Other Assets 5,392    
Property and equipment 638    
Goodwill 1,758    
Trade name 1,893    
Customer relationship 3,139    
Other intangible assets 899    
Assets acquired 32,471    
Current liabilities assumed (12,911)    
Non-controlling interest (6,508)    
Net assets acquired $ 13,052    
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)
May 03, 2021
shares
Dangot Shares [Member]  
Business Acquisition [Line Items]  
Business acquisition stock issued, shares 220,103
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF PROFORMA UNAUDITED REVENUE AND EARNINGS (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Business Combination and Asset Acquisition [Abstract]    
Revenue $ 72,940 $ 66,110
Net income (loss) $ (9,233) $ (7,892)
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.21.2
BUSINESS ACQUISITION (Details Narrative)
1 Months Ended 9 Months Ended
Jul. 08, 2021
USD ($)
d
shares
Jul. 08, 2021
ILS (₪)
shares
Jul. 08, 2021
USD ($)
d
shares
May 03, 2021
shares
Feb. 28, 2020
USD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
shares
Sep. 30, 2020
$ / shares
shares
Business Acquisition [Line Items]              
Number of options granted to purchase common stock           775,000
Weighted average exercise price, stock options granted | $ / shares             $ 4.63
Cash | $           $ 9,990,000  
Omniq Technologies [Member]              
Business Acquisition [Line Items]              
Stock issued       5,100      
Haim Dagot [Member]              
Business Acquisition [Line Items]              
Stock issued       4,900      
Asset Purchase Agreement [Member] | Eyepax I T Consulting L L C [Member]              
Business Acquisition [Line Items]              
Cash purchase price | $         $ 245,000    
Number of shares will be issued         80,000    
Number of options granted to purchase common stock         20,000    
Weighted average exercise price, stock options granted | $ / shares         $ 5.00    
Stock options, expiration date         Feb. 28, 2023    
Asset Purchase Agreement [Member] | Haim Dangot [Member]              
Business Acquisition [Line Items]              
Weighted average exercise price, stock options granted | $ / shares         $ 0.01    
Employment Agreement [Member] | Mr Caldera [Member]              
Business Acquisition [Line Items]              
Annual salary | $         $ 100,000    
Definitive Acquisition Agreement [Member]              
Business Acquisition [Line Items]              
Stock issued during period, restricted shares     2,000,000        
Number of trading days | d 30   30        
Cash | $ $ 5,600,000   $ 5,600,000        
Remaining acquired percentage       49.00%      
Definitive Acquisition Agreement [Member] | Omniq Technologies [Member]              
Business Acquisition [Line Items]              
Stock issued during period, new issues 7,600,000 ₪ 23,740,500          
Definitive Acquisition Agreement [Member] | Haim Dangot [Member]              
Business Acquisition [Line Items]              
Stock issued during period, new issues $ 143,142 ₪ 465,500          
Definitive Acquisition Agreement [Member] | Dangot Computers Ltd [Member]              
Business Acquisition [Line Items]              
Acquisition percentage       51.00%      
Definitive Acquisition Agreement [Member] | Haim Dangot [Member]              
Business Acquisition [Line Items]              
Acquisition percentage       51.00%      
Securities Purchase Agreement [Member]              
Business Acquisition [Line Items]              
Stock issued 220,103 220,103          
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.21.2
CREDIT FACILITIES AND LINE OF CREDIT (Details Narrative) - USD ($)
$ in Millions
1 Months Ended
Jul. 31, 2016
Sep. 30, 2021
Dec. 31, 2020
Debt Instrument [Line Items]      
Line of credit   $ 5.8 $ 4.9
Factoring and Security Agreement [Member] | Document and Entity Information      
Debt Instrument [Line Items]      
Line of credit, maximum borrowing capacity $ 6.0    
Percentage of reserve account 5.00%    
Line of credit facility, unused capacity, commitment fee percentage 0.75%    
Factoring and Security Agreement [Member] | Document and Entity Information | Prime Rate [Member]      
Debt Instrument [Line Items]      
Line of credit facility, unused capacity, commitment fee percentage 2.00%    
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF NOTES PAYABLE, RELATED PARTIES (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Short-term Debt [Line Items]    
Total notes payable $ 780 $ 1,116
Less: current portion (390) (433)
Long Term Notes Payable 390 683
Note Payable Marin [Member]    
Short-term Debt [Line Items]    
Total notes payable 480 660
Note Payable Thomet [Member]    
Short-term Debt [Line Items]    
Total notes payable 300 413
Note Payable - Shareholder Convertible Note [Member]    
Short-term Debt [Line Items]    
Total notes payable $ 43
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF FUTURE MATURITIES OF NOTES PAYABLE, RELATED PARTIES (Details)
$ in Thousands
Sep. 30, 2021
USD ($)
Related Party Notes Payable  
2021 $ 97
2022 390
2023 293
2024
Thereafter
Total $ 780
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.21.2
RELATED PARTY NOTES PAYABLE (Details Narrative) - USD ($)
$ in Thousands
1 Months Ended
Oct. 31, 2018
Sep. 30, 2021
Dec. 31, 2020
Dec. 31, 2017
Short-term Debt [Line Items]        
Note payable, related parties   $ 780 $ 1,116  
Accrued interest payable   $ 63 $ 56  
Marin Note [Member]        
Short-term Debt [Line Items]        
Note payable, related parties       $ 660
Debt instruments interest rate       1.89%
Monthly principal payments $ 20      
Thomet Note [Member]        
Short-term Debt [Line Items]        
Note payable, related parties       $ 750
Monthly principal payments 13      
Share holder Convertible Note [Member]        
Short-term Debt [Line Items]        
Note payable, related parties $ 700      
Debt instruments interest rate 6.00%      
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF OTHER NOTES PAYABLE (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Short-term Debt [Line Items]    
Total notes payable $ 7,968 $ 6,450
Less current portion (5,641) (6,449)
Total notes payable 2,327 1
Note Payable- Supplier [Member]    
Short-term Debt [Line Items]    
Total notes payable 2,843 6,443
All Other [Member]    
Short-term Debt [Line Items]    
Total notes payable $ 5,125 $ 7
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.21.2
OTHER NOTES PAYABLE (Details Narrative) - USD ($)
$ in Thousands
1 Months Ended
Jul. 20, 2021
Sep. 07, 2018
Jul. 18, 2016
Apr. 30, 2019
First Minimum Payment [Member].        
Debt Instrument [Line Items]        
Debt instruments periodic payment       $ 350
Eighth Amendment [Member]        
Debt Instrument [Line Items]        
Debt instruments periodic payment $ 300      
Eighth Amendment [Member] | Maximum [Member]        
Debt Instrument [Line Items]        
Interest rate 18.00%      
Eighth Amendment [Member] | Minimum [Member]        
Debt Instrument [Line Items]        
Interest rate 10.00%      
Secured Promissory Note [Member]        
Debt Instrument [Line Items]        
Debt instrument face amount     $ 12,500  
Debt instruments interest rate     18.00%  
Debt instruments periodic payment     $ 250  
Secured Promissory Note [Member] | Sixth Amendment Agreement [Member]        
Debt Instrument [Line Items]        
Debt instrument face amount   $ 8,700    
Debt instrument, increase, accrued interest   6,800    
Secured Promissory Note [Member] | Sixth Amendment Agreement [Member] | First Three Monthly Payments [Member]        
Debt Instrument [Line Items]        
Debt instruments periodic payment   300    
Secured Promissory Note [Member] | Sixth Amendment Agreement [Member] | Last Two Monthly Payments [Member]        
Debt Instrument [Line Items]        
Debt instruments periodic payment   $ 500    
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF OTHER LIABILITIES (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Other Liabilities Disclosure [Abstract]    
Other vendor payable $ 801 $ 801
Dividend payable 1,164 253
Bonus payable 27
Others 2,888 1,477
Total other liabilities 4,853 2,558
Less Current Portion (2,796) (1,412)
Total long term other liabilities $ 2,057 $ 1,146
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF ADDITIONAL LEGAL AND OTHER FEES RELATED TO OFFERING (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2021
USD ($)
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Total $ 13,281
Placement Agent fees (1,455)
Commission, Legal and other fees (264)
Common Stock [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Total $ 15,000
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF WARRANTS ACTIVITY (Details) - $ / shares
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Equity [Abstract]    
Number of warrants, Outstanding, Beginning of period 1,366,667 1,166,667
Weighted Average Exercise Price balance, Outstanding, Beginning of period $ 7.19 $ 6.42
Number of warrants, Warrants granted 171,429 325,000
Weighted Average Exercise Price, Warrants granted   $ 8.20
Number of warrants, Warrants expired (15,000) (10,000)
Weighted Average Exercise Price, Warrants expired $ 14.00 $ 5.60
Number of warrants, Warrants cancelled, forfeited
Weighted Average Exercise Price, Warrants cancelled, forfeited
Number of warrants, Warrants exercised (119,167) (150,000)
Weighted Average Exercise Price, Warrants exercised $ 3.98 $ 4.00
Number of warrants, Outstanding, End of period 1,403,929 1,331,667
Weighted Average Exercise Price, Outstanding, End of period $ 7.45 $ 7.14
Number of warrants, Exercisable warrants 1,320,596 1,165,001
Weighted Average Exercise Price, Exercisable warrants $ 7.45 $ 7.08
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF OUTSTANDING WARRANTS (Details) - Warrant [Member]
9 Months Ended
Sep. 30, 2021
$ / shares
shares
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Weighted Average residual life span (in years) 3 years 5 months 1 day
Outstanding Warrants | shares 1,403,929
Weighted Average Exercise Price $ 7.45
Exercisable Warrants | shares 1,320,596
Weighted Average Exercise Price $ 7.45
Minimum [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices 7.00
Maximum [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices 10.00
Exercise Price Range 1 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit $ 7.00
Weighted Average residual life span (in years) 3 years 3 months 7 days
Outstanding Warrants | shares 847,500
Weighted Average Exercise Price $ 7.00
Exercisable Warrants | shares 847,500
Weighted Average Exercise Price $ 7.00
Exercise Price Range 2 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit $ 7.50
Weighted Average residual life span (in years) 4 years 11 months 4 days
Outstanding Warrants | shares 250,000
Weighted Average Exercise Price $ 7.50
Exercisable Warrants | shares 166,667
Weighted Average Exercise Price $ 7.50
Exercise Price Range 3 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit $ 7.70
Weighted Average residual life span (in years) 4 years 9 months 7 days
Outstanding Warrants | shares 171,429
Weighted Average Exercise Price $ 7.70
Exercisable Warrants | shares 171,429
Weighted Average Exercise Price $ 7.70
Exercise Price Range 4 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit $ 8.00
Weighted Average residual life span (in years) 4 months 28 days
Outstanding Warrants | shares 10,000
Weighted Average Exercise Price $ 8.00
Exercisable Warrants | shares 10,000
Weighted Average Exercise Price $ 8.00
Exercise Price Range Five [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit $ 10.00
Weighted Average residual life span (in years) 1 year 2 months 23 days
Outstanding Warrants | shares 125,000
Weighted Average Exercise Price $ 10.00
Exercisable Warrants | shares 125,000
Weighted Average Exercise Price $ 10.00
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES (Details) - $ / shares
Sep. 30, 2021
Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrant Outstanding 1,403,929 1,231,667
October 10, 2020 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrant expiry date Oct. 10, 2020  
Warrant Exercise Prices $ 12.00  
Warrant Outstanding 15,000
December 30, 2020 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrant expiry date Dec. 30, 2020  
Warrant Exercise Prices $ 4.00  
Warrant Outstanding
February 02, 2021 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrant expiry date Feb. 02, 2021  
Warrant Exercise Prices $ 14.00  
Warrant Outstanding 15,000
August 2, 2021 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrant expiry date Aug. 02, 2021  
Warrant Exercise Prices $ 2.20  
Warrant Outstanding 75,000
October 10, 2021 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrant expiry date Oct. 10, 2021  
Warrant Exercise Prices $ 10.00  
Warrant Outstanding 25,000 25,000
February 27, 2022 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrant expiry date Feb. 27, 2022  
Warrant Exercise Prices $ 8.00  
Warrant Outstanding 10,000 10,000
May 18, 2023 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrant expiry date May 18, 2023  
Warrant Exercise Prices $ 10.00  
Warrant Outstanding 50,000 50,000
October 14, 2023 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrant expiry date Oct. 14, 2023  
Warrant Exercise Prices $ 10.00  
Warrant Outstanding 50,000
October 6, 2024 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrant expiry date Oct. 06, 2024  
Warrant Exercise Prices $ 7.00  
Warrant Outstanding 793,667 891,667
September 1, 2025 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrant expiry date Sep. 01, 2025  
Warrant Exercise Prices $ 7.50  
Warrant Outstanding 83,334 83,334
June 4, 2026 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrant expiry date Jun. 04, 2026  
Warrant Exercise Prices $ 7.50  
Warrant Outstanding 83,333 83,333
July 8, 2026 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrant expiry date Jul. 08, 2026  
Warrant Exercise Prices $ 7.70  
Warrant Outstanding 171,429
December 4, 2027 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrant expiry date Dec. 04, 2027  
Warrant Exercise Prices $ 7.50  
Warrant Outstanding 83,333 83,333
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF STOCK OPTIONS GRANTED (Details) - $ / shares
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Equity [Abstract]    
Number of stock options, Outstanding, Beginning of period 1,811,550 1,133,550
Weighted Average Exercise Price, Outstanding, Beginning of period $ 4.32 $ 4.00
Number of stock options, Stock options granted 775,000
Weighted Average Exercise Price, Stock options granted   $ 4.63
Number of stock options, Stock options expired (30,250)
Weighted Average Exercise Price, Stock options expired   $ 3.98
Number of stock options, Stock options cancelled, forfeited (28,750)
Number of stock options, Stock options exercised (223,500) (66,750)
Weighted Average Exercise Price, Stock options exercised   $ 2.51
Number of stock options, Outstanding, End of period 1,559,300 1,811,550
Weighted Average Exercise Price, Outstanding, End of period $ 4.58 $ 4.32
Number of stock options, Exercisable stock options 1,070,133 959,550
Weighted Average Exercise Price, Exercisable stock options $ 4.56 $ 4.02
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF OUTSTANDING STOCK OPTIONS (Details) - Stock Options [Member]
9 Months Ended
Sep. 30, 2021
$ / shares
shares
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Weighted Average residual life span (in years) 5 years 1 month 28 days
Outstanding Stock Options | shares 1,564,300
Weighted Average Exercise Price $ 4.58
Exercisable Stock Options | shares 1,032,116
Weighted Average Exercise Price $ 4.73
Minimum [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices 1.50
Maximum [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices 10.00
Exercise Price Range 1 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, Upper Range Limit $ 1.50
Weighted Average residual life span (in years) 4 months 17 days
Outstanding Stock Options | shares 38,017
Weighted Average Exercise Price $ 1.50
Exercisable Stock Options | shares 38,017
Weighted Average Exercise Price $ 1.50
Exercise Price Range 2 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, Upper Range Limit $ 1.80
Weighted Average residual life span (in years) 4 months 17 days
Outstanding Stock Options | shares 76,033
Weighted Average Exercise Price $ 1.80
Exercisable Stock Options | shares 76,033
Weighted Average Exercise Price $ 1.80
Exercise Price Range 3 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, Upper Range Limit $ 2.40
Weighted Average residual life span (in years) 1 year 5 months 4 days
Outstanding Stock Options | shares 247,000
Weighted Average Exercise Price $ 2.40
Exercisable Stock Options | shares 247,000
Weighted Average Exercise Price $ 2.40
Exercise Price Range 4 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, Upper Range Limit $ 4.20
Weighted Average residual life span (in years) 3 years 6 months 18 days
Outstanding Stock Options | shares 10,000
Weighted Average Exercise Price $ 4.20
Exercisable Stock Options | shares 7,500
Weighted Average Exercise Price $ 4.20
Exercise Price Range Five [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, Upper Range Limit $ 4.40
Weighted Average residual life span (in years) 8 years 2 months 26 days
Outstanding Stock Options | shares 404,000
Weighted Average Exercise Price $ 4.40
Exercisable Stock Options | shares 170,667
Weighted Average Exercise Price $ 4.40
Exercise Price Range 6 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, Upper Range Limit $ 4.84
Weighted Average residual life span (in years) 9 years
Outstanding Stock Options | shares 380,000
Weighted Average Exercise Price $ 4.84
Exercisable Stock Options | shares 126,667
Weighted Average Exercise Price $ 4.84
Exercise Price Range 7 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, Upper Range Limit $ 5.00
Weighted Average residual life span (in years) 1 year 9 months 7 days
Outstanding Stock Options | shares 147,500
Weighted Average Exercise Price $ 5.00
Exercisable Stock Options | shares 142,500
Weighted Average Exercise Price $ 5.00
Exercise Price Range 8 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, Upper Range Limit $ 5.40
Weighted Average residual life span (in years) 2 years 2 months 1 day
Outstanding Stock Options | shares 131,750
Weighted Average Exercise Price $ 5.40
Exercisable Stock Options | shares 131,750
Weighted Average Exercise Price $ 5.40
Exercise Price Range 9 [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Range of Exercise Prices, Upper Range Limit $ 10.00
Weighted Average residual life span (in years) 3 years 1 month 20 days
Outstanding Stock Options | shares 125,000
Weighted Average Exercise Price $ 10.00
Exercisable Stock Options | shares 125,000
Weighted Average Exercise Price $ 10.00
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES (Details) - $ / shares
9 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Sep. 30, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option exercise prices $ 4.58 $ 4.32 $ 4.32 $ 4.00
Stock option outstanding 1,559,300 1,811,550 1,811,550 1,133,550
Share-based Payment Arrangement, Option [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option outstanding 1,564,300,000   1,073,300,000  
August 2, 2021 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option expiration date Aug. 02, 2021      
Stock option exercise prices $ 2.20      
Stock option outstanding   175,000  
February 17, 2022 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option expiration date Feb. 17, 2022      
Stock option exercise prices $ 1.50      
Stock option outstanding 38,017   38,017  
February 17, 2022 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option expiration date Feb. 17, 2022      
Stock option exercise prices $ 1.80      
Stock option outstanding 76,033   76,033  
February 28, 2023 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option expiration date Feb. 28, 2023      
Stock option exercise prices $ 5.00      
Stock option outstanding 20,000    
March 05, 2023 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option expiration date Mar. 05, 2023      
Stock option exercise prices $ 2.40      
Stock option outstanding 247,000   340,000  
July 31, 2023 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option expiration date Jul. 31, 2023      
Stock option exercise prices $ 5.00      
Stock option outstanding 127,500   127,500  
October 31, 2023 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option expiration date Oct. 31, 2023      
Stock option exercise prices $ 4.40      
Stock option outstanding 59,000   108,250  
November 30, 2023 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option expiration date Nov. 30, 2023      
Stock option exercise prices $ 5.40      
Stock option outstanding 131,750   143,750  
November 20, 2024 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option expiration date Nov. 20, 2024      
Stock option exercise prices $ 10.00      
Stock option outstanding 125,000   125,000  
April 20, 2025 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option expiration date Apr. 20, 2025      
Stock option exercise prices $ 4.20      
Stock option outstanding 10,000    
September 30, 2030 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option expiration date Sep. 30, 2030      
Stock option exercise prices $ 4.40      
Stock option outstanding 350,000    
September 30, 2030 [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option expiration date Sep. 30, 2030      
Stock option exercise prices $ 4.84      
Stock option outstanding 380,000    
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.21.2
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 08, 2021
Feb. 15, 2021
Sep. 30, 2020
Aug. 31, 2020
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2021
Sep. 30, 2020
Nov. 08, 2021
Dec. 31, 2020
Class of Stock [Line Items]                      
Common stock, par value         $ 0.001     $ 0.001     $ 0.001
Number of shares for services, value             $ 188,000        
Stock Issued During Period, Value, Employee Stock Purchase Plan         $ 8,000 $ 4,000 $ 1,000        
Stock options and warrants exercised               223,500 66,750    
Proceeds from placement               $ 13,295,000    
Share-based Payment Arrangement, Option [Member]                      
Class of Stock [Line Items]                      
Stock options granted     775,000                
Securities Purchase Agreement [Member]                      
Class of Stock [Line Items]                      
Number of stock issued 220,103                    
Common stock, par value $ 7.00                    
Proceeds from offering $ 15                    
Placement Agency Agreement [Member]                      
Class of Stock [Line Items]                      
Number of warrants issued for purchase of common stock 171,429                    
Warrants exercise price $ 7.70                    
Warrants exercisable period 5 years                    
Proceeds from placement $ 1,200,000                    
Offering cost                   $ 150,000  
Common Stock [Member]                      
Class of Stock [Line Items]                      
Number of stock issued               2,784,096      
Number of shares for services             25,000        
Number of shares for services, value                    
Stock Issued During Period, Shares, Employee Stock Purchase Plans         1,000 1,000          
Stock Issued During Period, Value, Employee Stock Purchase Plan                
Stock options and warrants exercised               342,667      
Common Stock [Member] | Orion 4, LLC [Member] | Consulting Agreement [Member]                      
Class of Stock [Line Items]                      
Number of shares for services   25,000                  
Number of shares for services, value   $ 188,000                  
Common Stock [Member] | Equity Incentive Plan [Member]                      
Class of Stock [Line Items]                      
Number of stock issued       1,000,000              
Common stock, par value       $ 0.001              
Common Stock [Member] | Employee Stock Purchase Plan [Member]                      
Class of Stock [Line Items]                      
Stock Issued During Period, Shares, Employee Stock Purchase Plans               1,376      
Stock Issued During Period, Value, Employee Stock Purchase Plan               $ 14,000      
Warrant [Member]                      
Class of Stock [Line Items]                      
Stock options and warrants exercised 2,142,857                    
Number of warrants issued for purchase of common stock                   171,429  
Warrants exercise price $ 7.70                    
Warrants exercisable period 5 years                    
Director [Member]                      
Class of Stock [Line Items]                      
Preferred stock voting rights               The board of directors of the Company (the “Board”) had previously set the voting rights for the Series A preferred stock at 1 share of preferred to 250 common shares.      
Consultants and Advisors [Member] | Common Stock [Member] | Equity Incentive Plan [Member]                      
Class of Stock [Line Items]                      
Number of shares for services               361,146      
Number of shares for services, value               $ 1,800,000      
Series A Preferred Stock [Member]                      
Class of Stock [Line Items]                      
Preferred stock shares authorized         1,000,000     1,000,000     1,000,000
Preferred stock, shares outstanding         0     0     0
Preferred stock, shares issued         0     0     0
Series B Preferred Stock [Member]                      
Class of Stock [Line Items]                      
Preferred stock shares authorized         1     1     1
Preferred stock, shares outstanding         0     0     0
Preferred stock, shares issued         0     0     0
Series C Preferred Stock [Member]                      
Class of Stock [Line Items]                      
Preferred stock shares authorized         5,000,000     5,000,000     5,000,000
Preferred stock, shares outstanding         745,030     745,030     745,030
Preferred stock, shares issued         745,030     745,030     745,030
Dividends payable, amount per share         $ 0.06     $ 0.06      
Preferred stock, liquidation preference per share         $ 1     $ 1      
Dividends               $ 106,000      
Preferred stock conversion, description               The Series C Preferred Stock has a liquidation value and conversion price of $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) and automatically converts into Common Stock at $1.00 per share ($20.00 per 20 shares of preferred stock which convert to one share of common stock) in the event that the Company’s common stock has a closing price of $30 per share for 20 consecutive trading days.      
Series C Preferred Stock [Member] | Preferred Stock [Member]                      
Class of Stock [Line Items]                      
Preferred stock shares authorized         3,000,000     3,000,000      
Number of shares for services, value                    
Stock Issued During Period, Value, Employee Stock Purchase Plan                
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES (Details Narrative)
₪ in Thousands, $ in Thousands
9 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2021
ILS (₪)
Vehicle Lease [Member]    
Product Liability Contingency [Line Items]    
Rental expense monthly expenses | $ $ 1  
Operating Lease, Weighted Average Remaining Lease Term 5 months 5 months
Akron [Member]    
Product Liability Contingency [Line Items]    
Rental expense monthly expenses | $ $ 3  
Operating Lease, Weighted Average Discount Rate, Percent 14.55% 14.55%
Operating Lease, Weighted Average Remaining Lease Term 20 months 20 months
Salt Lack City [Member]    
Product Liability Contingency [Line Items]    
Rental expense monthly expenses | $ $ 22  
Salt Lake City UT [Member]    
Product Liability Contingency [Line Items]    
Operating Lease, Weighted Average Remaining Lease Term 58 months 58 months
Yad Haruzim [Member]    
Product Liability Contingency [Line Items]    
Operating Lease, Weighted Average Remaining Lease Term 38 months 38 months
Yad Haruzim [Member] | Minimum [Member]    
Product Liability Contingency [Line Items]    
Rental expense monthly expenses   ₪ 62,500
Yad Haruzim [Member] | Maximum [Member]    
Product Liability Contingency [Line Items]    
Rental expense monthly expenses   ₪ 65,365
Gamdan Office [Member]    
Product Liability Contingency [Line Items]    
Operating Lease, Weighted Average Remaining Lease Term 27 months 27 months
Gamdan Office [Member] | Minimum [Member]    
Product Liability Contingency [Line Items]    
Rental expense monthly expenses   ₪ 21,080
Gamdan Office [Member] | Maximum [Member]    
Product Liability Contingency [Line Items]    
Rental expense monthly expenses   ₪ 22,134
Rival Ware House [Member]    
Product Liability Contingency [Line Items]    
Operating Lease, Weighted Average Remaining Lease Term 45 months 45 months
Rival Ware House [Member] | Minimum [Member]    
Product Liability Contingency [Line Items]    
Rental expense monthly expenses   ₪ 40,000
Rival Ware House [Member] | Maximum [Member]    
Product Liability Contingency [Line Items]    
Rental expense monthly expenses   41,200
Hofman [Member]    
Product Liability Contingency [Line Items]    
Rental expense monthly expenses   ₪ 3,500
Operating Lease, Weighted Average Remaining Lease Term 33 months 33 months
Rental Cars [Member]    
Product Liability Contingency [Line Items]    
Rental expense monthly expenses   ₪ 2,000
Rental Cars [Member] | Sixty Five Employees [Member]    
Product Liability Contingency [Line Items]    
Rental expense monthly expenses   ₪ 6,000
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.21.2
LITIGATION (Details Narrative)
$ in Thousands
Sep. 30, 2021
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Accrued Liabilities for Commissions, Expense and Taxes $ 60
EXCEL 63 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( $J(;U,'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !*B&]3<:7.)>X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:L,P#(9?9?B>*'&W'4SJR\9.+0Q6V-C-R&IK%B?&UDCZ]G.R-F5L#S#01=*O M3[] #0:%?:3GV >*["C=C+[MDL*P%D?FH 2'LF;5&9%EYO[/GK#.8T'" 8_ MS(% 5M4]>&)C#1N8@$58B$(W%A5&,MS',][B@@^?L9UA%H%:\M1Q@KJL0>AI M8SB-;0-7P 1CBCY]%\@NQ+GZ)W;N@#@KQ^06U3 ,Y;":=?F&&MZVFY?YW,)U MB4V'E*>24WP*M!:7S:^KA\?=D]"RDG51Y[C;2:FJ'+?OD]#NH%??Z&_ %!+ P04 " !*B&]3F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M $J(;U-:-%+4PP0 (83 8 >&PO=V]R:W-H965T&UL MI9A=;Z,X%(:OI[_"RM6N-"G@D*]1&JG-M+O1]B-M.CN:7>V%"TY !U/=D*^9H%G"OR%D=)=M$)E$J_6%;F!3QFV;E( M>0)W5D+&3,&I7%M9*CGS35 <6=2V!U;,PJ0SG9AK"SF=B%Q%8<(7DF1Y'#/Y M?L4CL;WH.)W]A:=P'2A]P9I.4K;F2ZZ^I0L)9U:IXH+Q7OS&-A\:\L(S/1/0]]%5PT1EUB,]7+(_4D]C^SG<-ZFL]3T29^27; MXEG7[1 OSY2(=\% $(=)\<_>=HDX"*#T1 #=!="C .?4&WJ[@)YI:$%FFO65 M*3:=2+$E4C\-:OK Y,9$0VO"1'?C4DFX&T*DY[]F5";.C4\,SS\ M7FS.B=.O"_^ TROSTS-Z/30_?U^^9$K")_#@-!D>?W ME-=E' ]W[.XC0M$O*?JHS"4@^ ;C)F+K.@P\?L6BC",<@Y)CT"X;CSF3BLOH MG3SQ5$A5AX1+*9EC1,.2:-BR?R2#\0;N%Q;4'"UQQZ"Y-A56;/_%]0/ MSN1II :QAD0Y!\76085FN93'4%A7-LAUNP[M]E T6J%15.LZ4:%Z![*(D_L\ M?N&R%@@7L6V[:X]M=X@A5:77Z;5!>N+K4%=?R-L]B^OSA L]W-W/'\]F0J;G M&%A5P!V\!._ 9M"5$KIQ#M;W1O[@[[5HN!1DS*;#D3/H8V1547?PJKPC>V9O M9.X#7K@*/68J&-*GN"2UNSVW[](!.C"K /+%)GM^R5&R&,L/(' M!R_IQX1E9R^DV(2)5Y].7//;,S;7K&R"XI7]&&TA,@4C^J\P/?D%-BB.7,<9 M8VR56= &LS!DL#8[C8(+_#*RG5\QE,H<*%[7;X4Q]D DF#DTB%#7[8[[0\P; M:.4-M)4W[ VUF)^%R=I\7/4FWZ#XXWCY\Y&L,@?:RASF"4QFBT6JMG>V1ZTE MPQ4;R"ISH*W,05L\%%H8@VLA:SVK0>=>)%WF>; 4A_+-_4(0(ZS,@;8RAV7, MHHA+W:H M[ICNTHQ$? 6A]OD0WBZ+39_B1(G4[)N\"*5$; X#SGPN]0-P?R6$VI_H%Y1; M;]/_ %!+ P04 " !*B&]3]C[X#P8( -) & 'AL+W=O']] 5(A) *$Y-WNA\2D= "^YP#G/ #$LV?1?I5+SA7X M5E>-/)\ME5J]6RQDON0UDR=BQ1O]S8-H:Z;T;?NXD*N6LZ)K5%<+%$7QHF9E M,[LXZSZ[:2_.Q%I59<-O6B#7=\$L_G,SC[_L'G\G&IS >+B[,5>^2W M7'U9W;3Z;C'T4I0U;V0I&M#RA_/9)7QW1;L&G<4O)7^66]? N'(OQ%=S5:8GK>/73:>SX9FFX?;U]]Y_[)S7SMPSR:]$]<^R M4,OS63H#!7]@ZTI]%L]_YQN'J.DO%Y7L_@?/&]MH!O*U5*+>--8*ZK+I_[)O MFT!L-8!DH@':-$"'-L";!KASM%?6N?6!*79QUHIGT!IKW9NYZ&+3M=;>E(T9 MQEO5ZF]+W4Y=7(FFT(/""Z"OI*C*@BE]\YY5K,DYN#4=2_#F2\/61:F_>0N. MP9?;#^#-T5MP!,H&W"W%6K*FD&<+I?687A?YYMGO^V>CB6??\M4)P-$-H.B&M$:$8&HQV5 M9%!)@BHO\URLM2B=E#G7"N\K/@<-5SZ1?4]TZ_DHBE$V4NE:97$,_2KIH)(& M55XW3SIRHGWQR:+. ^-D*RR]*M<(TBCQJXH'57%0U4W+5ZPL /^V,DGD'=C8 M?6X:C4/F&L5)Y->6#-J2H+9/:LE;74*F)W6O+W'U12-U09,=<>D@+@V*NQ.* M50>(2YTGXPQA.M+G6L&8$.27F T2LSUCJUG9JIEUUU;+@&J%YR3HPZ>^.DCCIFAU12G5>R17O:%5Y9V_FJ$_3=.2A:X/2S.\? MC&SICX(>_DV(XKFL*F_ECGPQI>."Y#,C<48GI&U1"8;G1\L*#AI6= M$W)9KN1AKF9SE&2]JV2>IO0 5Y%;70AU7'6M"$FF)IEE( Q#L"]#9:-8\UAJ MMASH)9R3" T#&I$#O,0N=C <.^D:ZKE=U^+25A&)/#\G'%7LS: ML+D)H@YL*ZJJ"ZS4&P@)%/OF5>M!6A2/2Z#' M"B9P8B&,MC9/8:3]0R@^3()Y#[9.?&M&'_SU+RF"\'18\JU,O1>-UPT71#@; MT\IC1*:J(+*P0F%8[3CQ*LTN5VA,G-"[5GJ=.H%89.F#PO3YV)7K[[GV\BK= M+DP@=M;_'BL\E7V6."A,G-W]R9Y*@5R8Z%50/-;IV>,1.$%W9*&#PM#9W:SL M4^JRA<8Q=:2Z9@3J;<.$5DLAE 3+_$?1/ +%V_K 0H\L0%!XRQ9(\)>Y7C)( M>="$\^WHG/GF&L7I5');4J&]I.KJJ5Z+&GELZ,3Z M!UMDX3"R1H-P:-2Q2RB]+$I&BCU6$UF.+<1P&&*CVN05Y\$62<9K-H\5F5@4 M80LM'(967X,JG3/'X9S9*'6A@R+JA-&U@GI3/*%UZS QS*:^"NU3Z"$,SN+Q M@8G'C. DFAIM2R),@M7G5HG\ZU)4!6]E1Z'DM#LZT5!Z4_"',B_5V]#!JH4' M#L/C2M2UWBE*\[Q36+7FIP#2>11%YA^02Z:S';"U6HJV_(T7 MIR"9$Y+.:=8?TI!YG))Y@N/OIJ64IB28[\1:2;US+N*-OH=2X]KF ML9DX+<$64#@,J,M"KU]UZNOY88XCC\L&Y&Q5ZOGB5>G9_40H&1/*8T9A.K57 MQI90.+Q/NMS:]D],BHU.=R=T'"=IZAR*>^QHG*"IC+/$PV'B7?4Z]7B#NY8U MLC^J 9?%?]=2F<- KVJ775'\,//7Z[O_@7>?/CAQ^NKZSMOS(D+MS3&XXGNL0K%W%*0 MA"GHD&4X\MXW5XB+.M^9AL<9;X?^AHUU>++!)&UF;H MWO^NH;.L(>'=T!\=.HL*$D;%X4,7[.$S&ZZ7%UKL:YD69GUC[6#92;^4>=)OH M)-$IV?;OGO0W2JRZUS?NA5*B[BZ7G.FP& /]_8/0>\+-C7DC9'@#Z.)_4$L# M!!0 ( $J(;U-.;^ZK7 0 .03 8 >&PO=V]R:W-H965T&ULM9C?;YLZ%,?_%2O:0RMU!3L0DBF)U*::[J2[W:A9MX>K^^""$ZP" MSFS3;/OK[S&A_ B$T*CK0X/#.<6VDI&@\PICBQBVR,KICP9S*?9=TLYGXI41SQA M2XE4&L=4_KIED=C-!GCP\L4]WX3:?&'-IUNZ82NF'[9+"2.KB!+PF"6*BP1) MMIX-;O"'!?&,0V;QC;.=JEPCLY1'(9[,X%,P&]B&B$7,UR8$A8]GMF!19"(! MQX\\Z*"8TSA6KU^B?\P6#XMYI(HM1/2=!SJ<#<8#%+ U32-]+W9_L7Q!KHGG MBTAE_]$NM[4'R$^5%G'N# 0Q3_:?]&>>B(H#=HXXD-R!]'48Y@[#;*%[LFQ9 M=U33^52*'9+&&J*9BRPWF3>LAB?F9UQI"7>G<1IE>0H8-(_/J2G)M@7O M9QAE,YB.>IY[(V]J/5=7U;1Q7;>PJ:$/"_1A)_I"Q#'T"%2/_W2%ME2B9QJE MK(UP'\BKS&Y?VS8^8#QE5:-T"DKG%90JA+I2B*8Z%)+_9D$;[3Z@6^' KIW] M'0#W,*PQNP6S^VKF*\252MN!W0:'YSAC=W)8!$T[9S1VO.&H'7=4X([.P(7' MN=)0U3S9M#&/>C(W[3J9O8+9ZV1>,)>0:U 4^:U=_:):?M M:M#8+E7%/@O[>*/D :LLA[2=)G70BOSALT!/M$@>M9.VRZ1.6RH2[I:DO#5N MSVD-7(H'[E:/US4'[J<@)\WJL*6&X&X1.:]!<(L^' )WF=1A2_' W>IQ1ELT MA:%1:%TF==!2-G"W;IS;%DU):-!VF=1I2\' O11C<59;E)*!WU(S<#_1.&E6 MARUE _\)WIA6'_G+I6#O+5RD*8L>(YK#P^93]O5D4L-(7]$0TA3 M(-JY3]K5N2O[FVXU^2IIP- 7&@-KCTXAI8"0;@'YR!/8*[[_&S;H ?J40 XV M_#%BZ$8IV$U>H9O*#NHF%E+SW\=W4,/&]FCH8>2 M;<"91/Y!MN3]2V@^TV&:G,H]"0XEEER&#?I3& .ZOA= O W/04QSLS?\'4$L# M!!0 ( $J(;U,QR_P0O@< )0C 8 >&PO=V]R:W-H965T&ULK5IKD],V%/TKFI3IP S96)*?R^[.L$EHF8%"62B?O;&2N-A6:BE9 MZ*^O9#MQ(EUK0^'+)LX>/<[1U;W'LJ\>>/U%K!F3Z&M95.)ZM)9R5VF4EW6JXG8U"S-FD9E,2&>%T[*-*]&-U?-;^_KFRN^E45> ML?O027\YIH!LTB+]R]B".OB--Y9[S+_KB=78]\O2,6,$64G>1JH\= MF[*BT#VI>?S3=3HZC*D;'G_?]_ZJ(:_(W*>"37GQ.<_D^GH4CU#&ENFVD!_X MP^^L(]1,<,$+T?Q%#QW6&Z'%5DA>=HW5#,J\:C_3KYT01PU4/W #TC4@9@-_ MH 'M&M!S1_"[!OZY(P1=@X;ZI.7>"#=+97IS5?,'5&NTZDU_:=1O6BN]\DH' MRIVLU7]SU4[>3'F5J65G&5+?!"_R+)7JXDZJ#Q4/4B"^1.\VK$[UN@J45AI9 MJJ!?JK2;9:KIL_0&'VZFZ&G3YXAL4YK)E!>H8]KOA6JK7B. MGIQ<7TVD8J'G,EET,[YM9TP&9DS16U[)M4!S-?,,:#]SMT\<[2=*O8.$9"_A M+7%V>,:-,?'>CO ]NQ:LN$ MHRO_T)7?=.4/=/61R[1 <(?MNK3MPZ:]SHB[&^(%F%Y-=L?RVR@&@@"*>L0W%+11/HFBV%#01BF9XQ!6,#J0C9QD?ZMU$MK4?)E+B&9D M3RV,L,'2!I'X:&E;DC8(>Z$7&"1ME!*5PASC \?8&25=$JY6B'W=Z)3MVF/) MH=/$*=P')EA:+];HU[3V8$ M 2@_]DSV H'U#R=(&D2 R\P$X8$@& M>/:U%M,S*B1_)#%TG*F]K'$WA=@MS%H M'.>RYN6>NC*F(&7?&G_L$VQF+ A&&S-U2AJ Q0DA)FD %M*C8G-*NO<(V&T2 MWLDUJY5U7O"2H:?[E7YVZ2@"N/<*V&T67E>2*:.B*'%"TVR$"JT<@2 PBKCF(P!&"%'"?24V=ZRY:\9NAUNW$^IE\'J-MV8^PG)JLI!*-1;.4* (:]&%L!#N#BT!]P MPZ1W.<1S)HOW-=_ES5F.(N_@?MI];R&(VT),MW4]8!&)7=#'&)M9PMV_/AR[ M%)MTP:Y'RJL(5N_8Z :!]\;@<,;VG/^$X4Z5ZIT(<3N1=N>=NQR=A+99@"1T M#OP]$H+#61+^^'"G$O8FA[A-SGXG@U+9#F,<>)&9L2 8L&LA&/828FD!X!R[ MMO@UJ8AL0'%J*.&?R M/=%SQFCSGS#:J:2]:R+!>67 %/1=6>5_HBFO-Z"& 1!7Q#H7@6!07 $PK ++ MO$N <(ZXZMT=<;L[+4(QM(,@5P?L( &,84,&[2# )R#:6_LB-O8O5*E/E]5 M:-$4J,4WI&[I*U&D[3.)[.^MD$-G&P2P7H%Y2PB!+)\'@L1M]$Y/Y@?7'/!G4*X.(R&UKQW>B1YY,19 M9<9%7K0G&OK(L^KBO4F<^^]F E!IME3PYA'%FA<9JUW>B/;6B[H/F-XP(2Y5 MQ6=+IF(P0T+RQ1?TZR\QP?@%NF-US@2:HBS?Y1FKP$-9:I_\C+&9>R 0-4 S M"!28M^G@<,' 30?M32)UF\1]UD&%4@2)LX@#;B[P0C,P(1B-S7/_&013)CPR M;[H@7!Q[ \<4M/=^U.W]CLOY4M5K6X,?*?,4.%*RRKQ[AM]1YL\9;?X31CN5 M^NBAT^,>L=WE9PJ]W_UZ:?3''1S"4^BE)B'9%,(!D4I %/F M@)HWRA#.$:6]Z:2/F\ZG6KMG:*.ET_D0C?7#]WSQM6\WB$4WVTEVP?$AU\/KY"\;%Z<,'Z_Q9=3#/P^PY?S]@61OOOV M?96W:;W**UU*EFHH%35JMG7["DA[(?FF>0KE[*ZDN] M8JPQ_MBLM_7U9-4T3S].I_5BQ39Y_:%\8EO^EX>RVN0-?UD]3NNGBN7+KM%F M/;5-TY]N\F([N;GJ?G=;W5R5NV9=;-EM9=2[S2:O_OS$UN7+]<2:O/[B<_&X M:MI?3&^NGO)'=L>:WYYN*_YJ>D19%ANVK8MR:U3LX7KRT?HQ"[L&7<2_"O92 MG_QLM%VY+\LO[8N?EM<3L[TBMF:+IH7(^7_/;,[6ZQ:)7\?7 ^CDF+-M>/KS M*WK2=9YWYCZOV;Q<_UXLF]7U))P82_:0[];-Y_(E8X<.>2W>HES7W;_&RR'6 MG!B+7=V4FT-C?@6;8KO_/__C<"-.&GBAIH%]:&!+#6Q;T\ Y-'"D!HZO:> > M&KAR!E?3P#LT\.0&@::!?VC@RY>D:Q <&@12 \O1- @/#<)N=/?#T8UEE#?Y MS555OAA5&\W1VA\Z0G2M^1 6VY:[=TW%_UKP=LW-O-PN.1/9TN _U>6Z6.8- M?W'7\/\X19O:*!_XJW+Q956NEZRJ_V;$7W=%\Z?Q+F(/Q:)HWAOO?MOFNV7! MV[TW+HW?[B+CW0_OC7J55ZPVBJWQZZK7TT;WH7V0J:+P^5^ MVE^NK;G<.U85''1NW'**LZKJ+I5?G/'OG]GFGE7_T?T>2#7'4\W+S8:_N09A M(ASFXY+?&?XNS=?&;5XL+WG_Y_E3T?#7"&B,@_[*IZEZ5_TY?'4)#O29-7Q^ MXW_S'\R/C9-5=SOFOQ^S8RFY'VN.(LPU&R@JR6_5?UF M4\[Q(]'M(]'M#L?5X'QBC\6V[2*?ZM;Y=L$NC.=\O6-&WA@16WPP'.O"L$UK M!I%R#^UWT.UJ\'SC74V?3[FD1KC]B B(\$/?ZD?%:"?:A>S'^BE?L.L)7ZEJ M5CVSR8T!#;N:[=+U3-_IITO5,.F",B B-,-C4&\LG.-8..A8W'53PX7QRZZI M&SX1\%&Y,,0 ?=H/T%DCLT_DG=[5T)Y)@Z,&.3/?A/O@'OO@HGV(BN>"SYQ+ M@\\1\W5>MY/2OE_09:)8YP_KG @G(L*)B7 25QFAR\"6N$J4*\-S]:U?GR_;1>MD1@K,A[Y[8__J7T+:LOQOE4_NR M-O@<:+SD597S!RZ()VB:$3PAPHE\Y5Y9,U-:R8AR)40X*1%.AO>]QY/@R), MY\GNOE[PQZ8]3=JGSKIE#G3G W6]<^4[CR8;<>>)<%(BG SO>^_.A\<['Z)W M_K8J'UA=[Y_/'QB7%J]O37XI_$EVT<[HM7991\%'O"^)<*)0?=#QI.?0F"A7 M0H23$N%D>-][[)@=V3$;GK^-G^IZQUD0[:KVX?26*]!R>6&\/L-^%CS9AW_D M$SG_>UIIUGPTY0C.S)3^^A[<7O6IT MVP19,FR? "&R?W((Z2W_0>A*2#'>BS'CIN:[=(/93'D; W&6+XD+,,CS-6,B M?!3K#4;*8:!.7)3A$3K+1H&B3%NWZ @CQ:)T4G"P,5,.E9="!113 2468''( MSX$I5;9L(%N?%<)1L;Z/I8+#CN$'E:E"!113 2540*FEFB:.//-A(7UN"%O% M^C_Y*GB>,62A0YQVB; D54$H%E WTOU]R%GZ*C?LIW\- FMNJW/=U5RKDOHW+_?@/ M5BV*FK7;/;JWU-EK* X\@LM40!$54$P%E% !I51 &0%0GVDG^S!P'X&=Q31L M1K=5,>UH](8MI+2-2^EYN7UF5;XG&U#*MA_JN"NT MLHUK91UWE^R^ :^#2B-3 46VJA)#VY9I3:5_J8!2*J!LH/]]7@B=;.,Z^2P/ M'\<80P8J#4P%%%,!);:J2B^MV4S>H425+QO,UR>$T,$VKH.U'OX_=ML/AF/J M'>(#\.D29\LKG!JB[($$2O@S1WVC4TEG(-^E9YKRCHD4BK-D)PL*"G3VMRTD MK3T@:<_S\(='2-6YMB671^9 E&N;FD*$+?2PC>OA,W?7:JY\-LPM-<23N04H M."MT%6Y1:5@@WZ7G![8O((?>K@^G12I@%(JH&R@ M_WV""*'O#!2\SR (NO"I6E>G=!VA=!UI8@8ZGVV%,!151 ,1500@64.JH[H.P^R0:"^N00#H*#.PAG;3W',<:0@:IN M3@444P$E#N DR'O_J))E>++^P5KA6;BX9W%2SN!/[ON/&X#8@,.,.55+=1"! M"BBF DJH@%(JH(P J,\KX2&Y!$<:<(PQI**RCJB 8BJ@Q(7,',>5CS10YPCE^!(@P6R1#VO(%O60(AL6;NJZ>'9H27MNX_Q7HP9-^ 4@F]:IKP\ M@''R!T- 08'CS#2#(EP;E_Q, SQ$JG<#V-5 E!M8&H'FGGPX!&[R?%,]Y("- MDDL-4[;"\G#4_YP(1D(429.H) ,KT >91T9!QLA!JB (BJ@F HH\8"'<^6L.U6V M;"!;GQ5""'C?JXZ, X]A"%4=V0-V1\MS24R5+:$"2JF LH'^]QDB5(GWO6O) M'J!'=!]?XPFAX9%4DW&4,32EJB9[Z@.^0E(J:4(%E%(!96CO^U0X^0PZ7-H M5$#YJ H334';$ZK$HSF8>W9!&\\WAK=4]4I/U51J09LJ6T(%E%(!90/][Q-' M"$H/%Y1O*@WBF&/(000440'%5$ )%5#J0;N?9?4Q$-0GA]"U'JYKSRH-XAAC MR$!5)Z8"BJF 4@*@_A *6>_ALO[2/UX[QGLQ9MR RJ!O^W8H#QQ49W2D>D & M186^H_O@;R'&_3?4&?%3?? 8 ?N'%:\<"/),3W-^PC_Y]')44YTCI@)*?*@@*Y\BILJ6#63KLT)(=7^@]OMFKQP''L,0*KWNJWI5F2)B MJFP)%5!*!90-]+_/$*'7?5RO?[M7[@,?YJU[>!,:U,@(ZWR /B ;9 Q;@"\(DR5"H IAOLR$RO>64!6EJ8!2*J ,O@,SC1L0"#<@ M&-@L.YH,Z#P';IG5,58HU !7J/J+[(ZC?5Q\W15U]R6)(%.I2M=40%&@:D;; M#.7J-56ZA HH&[KN_O *J1N<<8KYK.%%N0?LIK5UWZLD)&R 2]@WU15QS#&, MHU*R5$ Q%5!"!90&@$CU)"\G X)T#V GW[F%Z]A;/AL:N2#G$"FHQ"L54$0% M%%,!)0&T^UER-ZB295 R1^>O!T*\!KAXC?+M8]D,+DI4U68JH(@***8"2JB M4BJ@+%!M!=_3?9EM((R% #<6SBK)X!AC&$-E*U !Q51 20!]")HM'UE*J?)E M8#XST.QF"H6]$ [8"V\^'G, QDHR0(AR/ :(@8['X-T8,7! /O!X#!2G'H\! MHO3'8T+AN(0#C@O1\9A0E?5J208,4H['3.L58TV4-_G-U5/^R'[.J\=B6QMK M]L";F1_:A^*J>%P=7S3ET_6$0]^735-NNA]7+%^RJ@W@?W\HR^;UQ93COY35 MER['S?\ 4$L#!!0 ( $J(;U-$BTNXU0< (TB 8 >&PO=V]R:W-H M965T&ULK5I;;]NX$OXKA+$/*=#4(BE;5I $2-,6I\!V&]3; ML\^T3-L\E44M2>>ROWZ'E&+9(D4GP7E))'E(?G/A?#.4+A^D^J4WG!OTN"TK M?37:&%-?C,>ZV/ MTQ]DS2OX9275EAFX5>NQKA5G2S=H6XY)DDS'6R:JT?6E M>W:GKB_ESI2BXG<*Z=UVR]331U[*AZL1'CT_^"'6&V,?C*\O:[;F6'L% S^W?-;7I9V)L#Q=SOI:+^F'7AX_3S[%Z<\*+-@FM_*\B^Q-)NKT6R$ MEGS%=J7Y(1_^PUN%)G:^0I;:_44/K6PR0L5.&[EM!P."K:B:_^RQ-<3! )@G M/("T TA_0#HP@+8#J%.T0>;4^L0,N[Y4\@$I*PVSV0MG&S<:M!&5=>/<*/A5 MP#AS?2NK)3B%+Q%<:5F*)3-P,S?P#[QE-)(K=,OT!GT!CZ.SGQ7;+06(O$/G MZ.?\$SK[[1WZ#8D*_;F1.\VJI;X<&P!FIQ\7+8B/#0@R ")'WV1E-AI]!C#+ MX_%C4&BO%7G6ZB.)3CCG]0=$D_>() 0'\-R^?'@2@4/W1J9N/CID9&N_%=A/ MHY626U2 MJ+:B6J-8#\J9NR5"VAA!-<7D273_9*I6S(=6/(/R "EU$%G-".G M;J3=YO?7YSC)27XYOC^T44!L-DVG>ZDC7),]KDG4%#?+_T%0-Y%E)"0"L$4A M2HZJ%K!]:J\+:[.SG8U,4;U#M9+W H(#+9Y>;;/I'MLT:K.YD<4OEQ26X*(M M9$K-;*X)V;"9:7)@'#*UL7)DP8 0R29A V9[D%D4Y,U6*B/^<<#LWOSQ_23O M(71+5RC43)FP U(/8=97PA>+GH'321^T+G>-T '5'/3C./=_-ABMTNU,*8KK-/D&(/J>D9-:'&! :BNJ. M=W"<>'YW)/,Z08$#H_2!G'Z#JVP7&Z:>QW:G.%Z(-Z&=67.D_) M !WBCF5P?K(B>V51$]0A#X1?EGM*^&(X'6)*TE$725Y5R0K(P?H5I1CI^(>< MX!_VU%2)T*K"Y'_OA!:V='COJD,H?)PMW0^JWS.T+4* =E+J62J.P[;1%[IF M!;\:04&CN;KGHVL44[$C,!(GL"9FA_=Z?/B+D+4J^C0W'0J%CN5(G.7N=JK8 MV)0 OH! AO U3R[9&VZS9C M*)2#&@18:T*G_1P<$)OB 14Z;B/Q[JF__5:B8M ^O7S[=7Q$XGQTIV3!^;)= MIU90IAJ.ZA+";="U/NM@2O(^?\87?L-^ZQB,Q!GL6*?/\[L[I%W+)[3>@1V# M-0'QZ0KWJ['XNF]0J:,]$J>]8Y7&Z*Q^3IL20MI*NU0)&5*$?>9S74Z\W1B@ MS5DV0(BD(T1RFA#K(_Q_,:48E#_\D:M"Z+ _?&(C6;_CB*_\>H?0CB!IO+>S M2AT[Y7MM:4NCSQ&EJ-_$X4G?#?&5WZ!4Q\7T5"]XJ% E#=?C4K(J6DQ3GWX) MSOKL&Y":Y0.U*NV8E<:9M2T>8!.\&&V@7TRSO'].$A*;90/5/STX'XQSZ0EJ M"J7YH!*AYI$D:7][!.3P+!_2HB-8>II@107)QE8%9TO>7%EF=*?HV-16++;55:*P_:P%^AXM^%I4E3N?A>*&*R&#%2;U M6\$))OTV-R"%IWB@G*$=0],X0W^1BHLUF-;UC,43))C"G60%D?KQGT0Z#ES?]\&SD"3H1J8=O1+X_3K<+MC,MNE/)^:!&$& M.!0G_?.H@%26#8#L>);&>?88I#L$"2(,=(RXW[S'EWI]B*0=L:;QSG.^J^O2 MU9Y,/3E-*EF=%\\%,1B_>:<)7!M]?]*17AHG/?=&T\;>SAY[Q$_84Y_%( _T M"3R^X!N,U_%A&N?#^;[,Y4T4V-E%$0Z$U.F];>TL?BYT&0:WM:YD%D.'0.X0T0&PTF?2+CCB(-SCBX*U[&^Y M6KOO'>PNV%6F>1N^?[K_IN+&?4G0>_X17]PV7T9TTS0?:GQC"FH=#1EN!5,F M'S*PH&J^?6ANC*S=YP,+:8SB9^4) U%0 & 'AL+W=O>\6(2.[$S\[#8![94:A&F2 U) MN=WS]7NJ**D[F$PPP )!K*98Q;J<.E74R%/[T.J$GV&Y%[M NA*AUNX=[N^_VFNU<;.S$UF[#6+6LV)/%MX_\(_KZG2VSP:1I3*Q!HT_CW1!UK(BF/'' MH',V'LKO8WR MOUH->_=GJNQC\NT@# M:X_)?_33$X9\(' X"AV)W/DBL_*"3/CL)?J4"[X8V M?A!711K&&<=)N4L!;PWDTMFG\_NO7R[5S96ZN;W\^SEL._T?)6??0N-5%=NHJJ;^7W8-%DUN%HUOO#'RJ\HVY7'>W/U>'^X<$/ M]!U-;AZ)OJ._T7<3EMJ9/S4C8:XNO(O>FDIG8+A*W0:*Y%)>\+6Z,DZ[TFBK M[K!(0&&*ZC_GBY@"'!RK[YVD;CY^NOY<7/C0[ M@EVKSSW%I.Z\[?.+:U="+/DEI88"()L:91"A5>,MMON5HPIUOHBF,CH8BG,N M8 H!R\DKR)!!X*/8>+A_O**Y/!T<%\-*'\<5R<^PZOLPKCX;EL21<=$'!8/& MW1>^[;1;#R^?S]4*)QHWN@A;8,3!V]='N^H.RR0N;-ZSIP6K&_2H!N(+(H<] MC]X^9OE'^.?[J#@SD:&SZ",_QEUU%7Q;@!W?B OP^W#_X A6$/XAU!!F[>-^ MEJWH$339&;=4WE@16^+0(;-0>>W4O[7K09^L[(4HJRA1 #6P/6GP,6OFI!F' MMW@HH![A4V"4\@%IJBA$MJGV8!G%J.^(G<;1I?B+K.7$:L6@?X 5B$S%9G8^ M&B935>K8J!K$'L56J\,2<* G$T51@#NN)Z%-&'_3AX(+*-%R/;HJ0809%C^# M7K)4JQW: 9><(/CU,0? 2CYB8[KXE\"!]VW%8.7$P-5$B#B45WP'X;U^]?GN<:ZWXMM;4 ML^VL/Y_VOMA8:O<9Y*?G!;:J9S=E M\L/&EQ-K(.!8@GV"G1@.VU+[92%RNJ=-/U_<% MD_ 0VU]_O<#^*UJ$P&<")R'>@D\2X=DJF-<#1CW%JS M)"[B9^?7SU6BLG'>>@ -X*K( JU!L<_(D1U& B8E2"<,&2 K%)BQ5K,*R9QW M)OG 26(DQ;[KP&QE@SEG"Z%SU?@6X(1 I+(/)JWGJNL7UI0JZIKX)Q!?PU#U MDVZ[8_@3'KY%N1RG2XX>C',I8 C0.,V4&?.[ZKZA8LNC?%IX-"67*(T(!*U: M5 <7>6F-U$ +#*B.?&<)+!\CI5RH$@BVSX[:8#O_2$WP_1(U;Y@#4V3.#-2 MX!A8& D]YHUYX<0RQ&X!1@"1S >P@R2]=(1M^^4=N4<3O)/2W.7<^KIFJG#5 M3O([Q#:,I0 C-/-6:7MV2H>*;<#IOD[Y"676]F[4GP^O>VM!PC65Z]+2=GC' M4/&QBGN<=@HEII$DS$U5@:U]C:Z."(0<'=!7,(L>Z1="UZ'D&K-Z07!>);T< MSL2F13: \X#S\??+U?6'86NF?>P6ZE,-!D0.,2A1^B#I5L@T^)H+A^,9"^XQ MS$#<@":HVD1W'HM^QCZR]RL1EX1YA,4R/@XI8>7Y-"A M'*( AT1N8:G=008>&9I3)HH%>!^F+M;*]5#$?6Y4FALZ5UP.;,XG$R#PPD,[ M(P_BR$*N74"[-LL^(.ZTE4M^M1KR\A=.Y:;%76S'N)W2 L! ],+8')25 639 M7P)A=YSJW&(FMR<,+>%F<+G6F"2XM4F_&H[#?)]ZL/3+_?VMYE>C?0,+'"GB M"@$<$,FLDZ4:D$=J2O&B]CY[NVB^(F*]Q<&PI5;N" M%3)"T*[ZR$P@*M7/$GO/V8BQ%]RW/%Y!\O()M"-SQ(VP"&L&]V/J9P: P^#@ MY4 HB$C7V['@2>R').K)FM;D66X'QT?O"KX'YNN>29)(U$/K91:J>H[^D/YQ M@,!/# /L&ON5=7,D8A]Q]Q6?N0-P9OE 4"6G4I;SS"0D+3[G\ ,OF1<+O9GS MQNH42+,P:AAV@]T]\S%MAA+GA?YZ&9=9:S1+Q[U.NV&>"WTW4*67LJ[TFFD4 M?[9,4E/;*J1M(6Q/)?HXBJ_E>A5)),/Z->40L-E2B1S!/,"U'JUU+8,G9J$. M:H6#OHNQ^=",])@:)BKA8/A1$D?-%2UI]-H,0^2"W!*ZW&:2G _4#ZQ!H5?28G-+::1;CRX,#5?:):R<#AI80-!<(*1].=[R.KU&L[7C45IMWAHV MJ3,)/8[)%RA(HDQ*4A")0BY1U,S;P/*(E'G&$(/23;=) =\TKJ+F$9U"&@@Q M'"=[>$IDEAG3.MU4F%W1PN:CSP@GN,O)()H;EG'U\)U#<%9E8]-WU63P@WG* MIK!^ZJ(01+8'4Z*7R8K9BB_"PT'"!Z2#8+]6H#?.$^H""U$]:W5\B,__P;%J MZUBL(BO(;*#-X+Z!)4(A]2QLS,,6+IE\>\(=)!JTDCP=T1-/B2/[\5C9\L$ MH"ZGY8D+V448.)6*SE>M>KKTXX5\[V)XK3 5HF5R?EEPO.\-]Q8L=Y<*( MZ&_X/'\L&VT8B3KC9+1O [9O[0#!/A#KWW0P;3/CC37NMBZ04^D7Z')XQET\ MEXH9YCZ<:<+6J9WGL/%)6[/"%/NYPG10^7%^V.YCV:\!+*H BWN7\E>M M:77Z)GB>/X5MMN M#M[F#7B/II[&'WS ]*7T[']02P,$% @ 2HAO4Y@64F-(&@ ^D\ !@ M !X;"]W;W)K540;1> M;">;35PERW*BNMC26O+ZKJ[N P@,220@P.!%C/;77S_=/8,!"4F.MZ[VOM@4 M@9GIZ=>G>WKXP[9N?FM7SG7VCW59M3\>K+IN\_WSYVVVO_YADR[=C>L^;:X;^NMYF"4OUJYJB[JRC5O\ M>'!V_/V;%WB?7_A[X;9M]-EB)_.Z_@U_7.8_'AR!(%>ZK,,,*?UWY\Y=66(B M(N-WG?,@+(F!\6<_^SO>.^UEGK;NO"X_%WFW^O'@NP.;NT7:E]W'>ONST_V\ MQ'Q97;;\K]W*NR].#VS6MUV]UL%$P;JHY/_T#^5#-."[HP<&G.B $Z9;%F(J MWZ9=^OJ'IM[:!F_3;/C 6^711%Q102@W74-/"QK7O;[Y]/[]VGWVXM6?GYU>?/MQ>?OC)7E_]7'SP_..UL.HYYG._4;F/GE@ M[K_8]W75K5I[4>4N'X]_3G0&8D\\L6].'IWPQFUF]O0HL2=')\>/S'<:-G_* M\YT^,-]9EM5]U175TE[799$5KK7_?39ONX:4Y7\>6>!%6. %+_#B_X2[C\X- M:_V^W:29^_& S+%US9T[>/WAZO;"G-A__[?O3HZ/_VJ_?'W[V9GS+;8ED5BR)+JXY,)_!IX_E45/9#W3E[8NN%[5;.5O17:[O:9G75TEMYVKG< M+HHJK;(B+6W;T1=DSAV/Q1)G5=73@X]N4S>=)1.%G9GCH\/_L.1M>-)[ES;6 M07WL6Y>Y]=PU]O28%>!H9M_V#6CBU8D[AVNHF]VXIJAS'44JT^DPU9L$[S?. M;O%/5<<;-=DJK9:RBVY5MVYJYS-[3:MFQ:9TK:&]GX?MLI>IFKM,\+\(68E)-KDT]/LBLK^]SQ/H<7-G5;A"5I(7)#O"CYZX97 MY+^NWG^X_!O1V)#EX,6B:\UV59?EO:VW%:W8]O.VR(NT@5#_UKNVL^_3YC>' M/2?VLLIFB7Y]\8>PQ_[2Y?3EU;HJ_F9O7;:JZK)>8K@\^/GVQEZNT_ BEAV^ MNV[JS+4M9C,/I-BD'OI= MW^Y_1\H5?0FVZ8/S>KU)J_N9?WI6EB96]*+J7)/)2U[V+6^ 7$+5IIGP=97> M.3MWKK*N+,@IL^B(4EJ)=.:KA#PS;WIB"G&&WEW/,2R25D:*R?,*=9?N7S8A$@UP6; MX2:G=\D:"[+J3[=7)RK M*GTSL^>NZ0@%$7&"E;QM+NJZ@W.T>=%F9=WVQ'YR//0*]A0+=Y)Q008CAIF' M&6;_/,,BC1YD2J93KXL. V+^M7VV&AAH(@:2J9=@^W)%SI5F*PMW)UXKWCDT M.LW=[SW1@/G6Z6].]6O@VT8\)RU-G"/B^ K0I19I&1-F]C+JP[%>R$ZH!=B1=#]F;TD5],2)Y<4;#I^D';J/;R5 M3>H"Q68@;]!)L_[:5^R01!<04:<-_PMB*2NJ1G 027*)%1-S(SA;"6H1T.U: M\./#H9Q%0AKBQ5*P1>6DTNS=5!I^;F;S.KT'']T?<('P5A%[S#1[:#>?2.EH MM@O2IS7OA%RD6B9SYVN=XI?YP(=-VCSB Z'3M'?RZ["[09-A=3U4C2CXM<^7 M_CNV1!=V")5(6\K6-N(>F7OI8@%C$ZX"M]':Z9KC)/A#[SN-F&61SHMR\*.- M*YD1(U\@,X%#7E9?QT@.T1%-1FG"K UYH:I7*B!VFK.U^8 =PT8$.:J/&>V= MAP;.D(3*7'QF:O%5 W*KZNH0#KTAT IVLKL&.E9:F/+&.:_: MT4Y4S>][""'&W1L"6GG%8! MX)/2U.2?%O !+%B*<+124U#<8>V'9"?OAWB+9(?02K@6(!\Q3[\>-#W,)FX8P:(\6B(>7YP3 H]XL;9I[\$K4 M@*-BJ[$EK QESAU9-!G\84E/H9M>MU6*B4%0180+@A=YJG'D$QHGYB/^"33T M%2:8WQ.^@@3P58B;"N]!8;VF13>;IDY)5MXUKCFK,_[[!#Q:] U+W&?^>936 M/Y:DVS^1I+_QKJ9;D1G&P*LF#NRHO6 D>PV!42.'(114Y 8:9%V@65E ML7 , N:.,=T:C/J'7X^ !IDU.'6(ZHE9.W*:N9@@N:I%7UH(BS D5J'QS,13 M".KXV&!;Y+$^U,%,&AO9 WLKMARX#*318F7P?OOXBAW7EN-&%$+WE 3+F4@Q M-5PQ/]3-_2/"+!7OZG&0-(/$2%TJ<\[^/;NWM_!UY3];E@#;!YQ.ZO)I=C.S M.3E&YAOPWT(1*@W,_.*>=H\-22DPT P#XU2[\&&)BT[BGXB7(MVIZ4$5.-6 M&TBI)<:SVA.@@N-TOI !3.H=-1DA3,[PYX&"&6H$7%8A6X#C+ZJ>,XJARH(5 MP;<^F^ #QYQ-QX8?2BWWMJPS7S2X;)O4E<(O(;SU;E,>%<-B4K1"K5TS"HTZ MF"[F <.MP[5+ ;-RG_5.L@N(NRSK;?L]T+;K0)WHHME#<;)1LIYNQ-MY6C)^ ME5,$ 5&'#BYQC]N,2DNG!#8.#.U)+D2,L("NQ[-/Z-T70$>5[O$ M%Y)JKQ\F7WPI@@VBV'*'XI"1F,$->YRHAA7KBUV28'0?==LJUP+"K+^P@A/, M;*>BAXR;=6"W)B1X%V]C67%DB&.-6^$$Y<['!7(P% 1^P3O79$JH:1!--RM0 MB2<\FM8C87+I"?6'^J[(=^L/XHC?G=V\L6-+*Z;@HMBF!V?F ,1$D( O"74>K4KU M62;KZNRW55T2ON. &0OZT NZZME3$M-B$LC-]!UP+:_AW97*W+PM2J;#Q5L, MS)HD$YM54G'1:;Z9?*7;X^3%R^. M[(OD]/0OR:O3%Z#/B&-B,V7ILH>@=;3N$#A1W@_L:8?B'9FQF$B 1D)W*-3D M*LJ1,HHHYTZ2&12[3#2GY'S5F)N,)"FBYSUKH-K]D!X#BWYO;\Y_OGC[Z9<+ M<_7.GGVXO;1O+W_Y='OY]PL44#Y]O+S%*J]/;]Z?_WI M]NSV\NH#CG NSCY^N/SPTXV]OOAH;WX^^WAA+F']==\20]LI1N\!$7/EL_D: M53UR=*T;V8P]3EZ]?$'_OGQY:L[%73) V832O+QW: _-9P+'*;# ([.].'IA MOWUIKKVTO%*-Q?.(+$Z3HY??@:R3[^RU+F*BHSL^$XYI9936#T1 MPN>35?8A&(1=>*RXB"LR.R45!G5[&$ZJ= &KI91+=(8W.60J'-_O?4CB\T9. M22I+)/6H*='N45VB,("25I08HD809<>8(@1Z#2_C)&*4YQH?W'+P+5%*=G+A M)2EU!:>!TEJ6MI0LZ!(C%3AS$/ 1$X8P3!%NY8T1MI_5!L M@,>2U-P7_O5%J6?SJ1>[!63FU?A\-:HT^VL[, M"VLP%X0?)F@Q(=Y,$R266+^1XKH<6Q'N>K#U1]U@=RU,27CV5\YD MM-S# )7@!C(Z,@"'%*_?Y IT0YTI4?#"MDNP/"W:M)3U!=_3SLM[XI4O88J5 MK#>EZ[3NK&5D3CR]%L7G5Q^5'#W)=28JMOA9M0XYSBE\4R'97[_%P8 M24/?^@K!;H(F*DYOW7&JQI8Y_8Y/@QY8F(83N*99+K3 QK.T]+!=Z#2J:@], MD.S&FR#&9%J.:BJ"*9"?TL)26L5)(Q]-B3#F-=H:*(P43LV^ 7(+=4-])(?% MZM5(-)>$90"X5NB&N. KL>@Q!1=\N=*FT9;IYMKB,#.%P2V$R3Y6Z[N^Y O+ M5D8'1/H]=/_,P/L+5>JY$#Q$9OXKR.9>RS^<]PZE9NQPWTC.# L7#U.+MAY5 MW7E<%YW?CQ?P3FW)Y2Q.,>4_+S*:(*?XEFD)7:FJ?78GQ;*PF%BSDN5/-.9N ME98+/A$0FQSV[T<^M7,!7:H'\A:F:*,YV $(51Z3H5F!-=KNKD>4CA@83A%\ MN.1#)QCGJMBH*R.[[6'0A&8:B3IMCXHU_L+QMB-\UK,^HZ+#I'DF>1)GJ)I% M7AJA9$>H)G OM9$\%SVC.T^_S(UUO(1]LDT"QLYB8GGC2JJ$#2C(@[P!4HE5 M:>)YO%KZX%H<<<*I0V2RWDZ"0_(>=D^F9NX6P'%R?".'!VU\Y.)'!JZ18PFE MO@>6["F[;$JNS>\M",SD*[7&JV \^&&^*:G%DR0^@^YLQ:UPU9K'15[E&U^E M22CMZ(P_J_:UZZY.)IP*8@BCD'8#5P5LBEBRZ,M%(4=.[/')T/A\;<>"']H5 MX"FV<[]!S6QH.VF'A<1/^&*7'#-'#O^)Z2\7GA6T_;4]CU+HF<(,#8 MM SO0N.$C5U.4=W5I9S!?+$G@;5DTBL2>[N9N5I0WLHFX(F4!"+-83C!:3T3 MUX8)*&G-M\2)A \'E]+?$+YE'U,O.GG#==GLFP!,O,MAI^1-QV-Y391WO<*. M"Y,8XMT@<8)B94TXORG:WVRPPLC0A*'65T'IN2M#D9PHC$1?+^.V+J7!JG&"Q:H!Y;$^ M0U:,?WV)[A$SOHA'BDYRG(IV %JD*)Z:A[5H9*4>Y#X$2!RWH["3(7/>G8H3 M0T%FBDJUZ$?_^).2QN%0A"N2KG*+HFOU)%<\OLBI"SL:%78U ,<09"<8[^ T M1!<]*&)= TX0+AN MB6%X=#(QSAD$L&Y])Y81GG/)IA3?'O!L* MF4O4G(-6:$7CJ=BWA\7!U+"X'&^+/GP9_O!:9W;GM3&(FHA?._YZ#(S')/U9 M,9O'Q#P(&-G2PC&LS89FV1U!VR<$+9*(+72,"-K'+'6/9WN,^ 34:.(<=&IK MSXAN5TA.IWH=-?FA'"\-'1U M,/;VN0[KIF]-D?*_J[Y@>H_CM4$PI$:^'/-PY$D8O:&2'*2$94JWI$#!]K*# M%9,Q%H@%OEG=MWQ ON'SJ-B713EG3'?"1;2]U26](_@H)9GT46[=^(O8D9E2\OR[^3W0=^#Z#?[-#_R J#PZJ00XFX$8 CQJ?=2$VER5&;5^"( M?.^VQWC,(PQIG8FH$RW _\K/B)6"$U"4,'W>0*J :S%ZO1TMSJ$;)W M7-S=&KJ:XDJ%GXP"BJ,T7LH?6A@8(J4ONBB<#Z-4>"VW;=7DP'',RFZ M>,Z,&/)-8KA$?+=/3K:JZU;6@GLC^E-N4T[++9)*0B,=L('?-$\0MX?JN9K> MT!/#F]"E![3UG]0E4Y)M5ZU+QGS2;T.?[=>1YT\>?=, VQ;.7A^R+/A[\Z_R M]SOQROSK_'U$G?F7^?LX!3'_[_Q]*(GK&UJ8D]/-TFGY;B$044\@@:_0[^UW MF(SB6=\FNPH;>BST]G5\GA2=-' B&FN)T48!^59S@&!Y.H%#'SOWE.VD:Y)! MA,NL^X> GF/MHS48LR\'(E25%1D++RL=&5'JZ=+U$"GH S=#>,[A&#\K!0E%0EG%NM+?]4;=.5Y./C5K]*%8U M7"^51O9QO^,@5QD6;LW)J"B3P>;)=4R])5V9W+X1OPV]\.TAF(BE+,LRQI_+ M!1%M,6^'S2]\CV(XIAV?7N[D>KZ5P9Q)/HG?!^8-QB;^I@S]U;O'UVAW M?77T:CP/LAONX9";'WLM'$$5Y#"*DXZ4FS?DNA2029'M.-#:IR'"^XAMH1LF MH:#FY( A'GF$R M[8-&B[5OA-9HA*?C#CKDY'S^L-,(Z"]6\F;&WH)L3/0HR,S?-9FZ.J..)'@# MSPO?"?\9[?'.GT\5MM$T\HH]JECGKHD8V+] M*)KXTI^6(I]F01?YF8"$M;LCNM42-3>N:\*:2F??JE/'(VX'G^)& *]R@4K8 MK2VPON,[B &6I"6T4>X8S/7W(SDYHY]-^^*5-2GQM*%' I5*8Y M]$/4A;,AOF<(!)_AT"_^W:JFKNASIG?R?"%X*&$+1,8PK!&_*Q@K M_$@'<2'-U6YY363HC]]QG[["3D26!!>&6BBC.?9@_I*P_ZV4<$W_$1T5\%? MVAFNYT#^.M74KX0]CWZ/C8#"4U7EMP354)^W"&RFSGT2AZW+B11>EY(UG,:E'@+?K?ZVM+JZ1'R62%VDFC MP6(^CY:CD[-]M@\&?TC.E1KGP M"]O.=AA!VCAOJLZ9&%12M__BOM/A+0[CSF$<>+>! LMSX<5B9LT6+%L3&C^$ M5(,WD9.:BW+K+;V5Y.<7'Z\^77Z$U=7EZN+FC(?CT0Z\29_?).!-OH-W90NA MY3^"6V /5D8[HV0FVH[0&5Q;=*A]NV%R^""UT*D4"FYI$ZG]O(,_EVOG+370 M7SL8[?>,]@.C_?^K^$YW'M(35XL4YU'-W.T&H\7EU9>+P03>OSL>CT:G\"($ M?"F1FC\U52WT@]0%-%HTF?2806JH;-IA-DA[96@[[T5P3R*48H.P1M1 <6MA MR4XXFF5&]*7PL$7J7:48U$O=4% ' @K#!K27HM4Q+!VK3%4FV#7:OM1[Y#XH M!6&&,0X^HI:>.-",R51Z]OL!1H?Q(1P>Q=1X0M.IP=R(F@/<"-4$]EQ68H:. M\_*4_*I-/:AS=$JDUE))_P#>[.;ZE?-5$BGOD* /0I:\T4I"C'@O-XK.-G:M MC9-\RD!.S6(L82J%&\FT A/74",)"LEIF6;MB0N=E& :^T96\*,VGF%!ZE0U MCH+]=#)X_VYZ>#0]Y5(/7).FE'O>J%Y!*Z3#3K^#%\;_E285KJ133E'Y*;I_ MI5 MS#2>3G<"B?1;(UF,=JS.A2Z(-ULU'JW;@U]]%H?"R:JV9D-U8X$>0X<# M;8\ZS>240:<,%S80S$GN>&?X7&R,%6M%2.B]:MMD*WU)>E;B;V,AI0:65*,8 M;C!'BQR5I$4XIBK5-97=AO7N.$W]LY+.AQDP(8/+Y>WY\C<:')/> =ZG)66. M@+KDB0JC@M0F'MLF("=)0T1:9UD0*\PX.6U),8V5*UJ^U#5W9-IQH+FA6 M\>7>"T=7*97&MBT77P5VB)<[]3%IM&^O0/[W?X+8ME>G$_F[>?'9V$+ M28(IS,EU&!\=1&#;*[U=>%.':W1M/%W*X;&DKR"T;$#O&PO=V]R:W-H965T0,SA*33'$(RD+2'3@_"7D 3 M6W(E&<*_[TI^Q)F$3-N+K<=^WWZ[6JT&6ZF>]!K1P'.6"CWTUL;DYT&@XS5F M3/LR1T$[2ZDR9FBJ5H'.%;+$@;(TB,+P.,@8%]YHX-;NU6@@"Y-R@?<*=)%E M3.TN,97;H=?UZH497ZV-70A&@YRM<([F,;]7- L:EH1G*#27 A0NA]ZX>W[9 MM_;.X#O'K6Z-P4:RD/+)3FZ2H1=:09AB;"P#H]\&)YBFEHAD_*XXO<:E!;;' M-?M7%SO%LF :)S+]P1.S'GJG'B2X9$5J9G+[#:MXCBQ?+%/MOK M;7M''L2% M-C*KP*0@XZ+\L^1Z^C ;/]S<3>>#P!"GW0GB"G]9XJ,]^#.XE<*L-5R+ M!)/7^("T-(*B6M!E]"'A'',?>N$A1&'4_8"OUP38L#)_W&2=\YZ?]W%C_$VYMWKG,6X]"CJZ51;= ;3>\> MKCM]^/SI-.IV+^"U#Z":[)@U@B"J+UEY!FC/ "B#!K,%JB:-+GQKO$.F*JLK MC"NCKC,B4[.55)C++F=@YT2<7&F(IM$QYPBR1P@V* K4/XY)<$TF,?,,6*0(S^Z2_T0I, M(=V"!*'(G6=EQR]<&I("8:EDU@J("Z=0JH0+ZC\DK5 :.P1?%)JRJ$G75UIK M06H746A#[E0Q5IG1+8?4&5)&];4_B(X4V# 3TIVS2V__^(6ZIJ'I>UZ(_4TN M6LG,V:XT>YT=EI5$-B=&4O_-\Y3OSPBT,O(OA^)W[BA$.N&$ZJ5V?U)7S5GD M]\LX;8J;X&K)U*#_UL\AM"O/A_?N;]#JB)3OE>O[MAK):=DWTY,3)W_74A#1VN&Z[I>41E#6A_*:6I)]9! M\^"._@!02P,$% @ 2HAO4[IW*0:!!@ +PT !D !X;"]W;W)K&ULI5?;;N,V$'W75PS]VO[Y"2'7N;S4M?;(F7,S-GS@RIVST77V5"J8+O69K+ MNT:B5''3;LLHH1F1+5[0'&X[3:V>$Y8W[6S/V M(NYO>:E2EM,7 ;+,,B(.#S3E^[N&VS@.S-DV47J@?7];D"U=4+4J7@2^M4\H M,KU9\(71O3Q[!AW)FO.O^B6,[QJ.=HBF-%(:@>#? MCHYHFFH@=.-;C=DXF=0;SY^/Z(\F=HQE320=\?0/%JODKC%H0$PWI$S5G.\_ MT3J>KL:+>"K-+^RKM=U. Z)2*I[5F]&#C.75/_E>\W"V8>#\9(-7;_",WY4A MX^68*')_*_@>A%Z-:/K!A&IVHW,LUTE9*(&S#/>I^X?5(IQ.%@L(1I]7X2)< MAK/I;5LALIYO1S7*0X7B_01E",\\5XF$21[3^')_&STZN>4=W7KPW@5M? RI-4[&CC?CI;3JPN_/K+P'/= M#_"6)0ASZY&N18GEIIE$/F?/T_ ST%Q106-@F@0@AH.B%%&"^@:R%91BW2F4 MHDI@AK90&!$4H:-(6<$4I8QA9 I(VN6,G6 B&<% MR0\V-+6/GO.A0C(O[H=K2]//E(1"L#QB!4F![W,J)#11U*9J=S0]@$HHU + M+%Y<<$2PM<^R).BIXK!/6)3 GIX"B2&B0A%6!RAA(WAFX&H<(,HB$!&9O :/ MSD04^ :NP.MT8>#8CN,@=^:OV\*?5T('1IX^N#@ZRZUG<@"_4JQMS(PJ HS. M9EG.OL&21DG.4[YE5,*3BEN:Q'V"X1Y,\#$VQ[5D,=/XZ,0YRI'%_R(=^3BF MU6(Y\D% )D30M_+:/.-T3/(M5[ P:U^.:X/CVA.VT<*S:,$GPC*H=K7TAE," M-.@YFO5?-/LM'HQ?L48XN=IUH6MK6CW?[G<(IU5W8!CGF>[TO(SFJ[ ::Y/J"7R9EB6X@)VC9 M!T]GW&3=Q\3;O?I%1V_549)4/4T@=DCS">CV<=I^.=D#(]!.(B0'K1>)9=BUG>[ "J)(Z/3@A(D<633= C QUB-A G8D+4WEXID9?3VF MLWF>T$''&M.UTOV@S'"R:_NN8U5.7')W!:Z/=KW*FROH]7K:!5YJG^8THFQG MW,!5G;YCA3E2K3@6;.F,*78\P?6 M1\[C/4M3<.T^AKH4)*:0DPSA[<'0MT;F&H" @J;&/9FP EN-ZP]K2UCP*$FF M/:I[W6 XM&K[1!]NNMM?@>^ANRX"HBS1^+%7&['6G#1=SQZZ+EQ;4Y[_AJPH M@:+3DF.FNTAL'SU4YT"OH.IH[\Q(Q=P/>BT$-S=(*'-2QN:DP,J@.:;,$$*$ M+@'M!K"J[Y&S,SDA,:PIJAE/BK2,JY/KJ'B>LIA4@/IXDL?&69\_Z(2H6D") M%!_0$O;)6/LTQCQF:Z3/=TVS<%JG4K!0\"_SV>-L_AS :AJLQN$2-3^??)E, M5Q.C_4DPGX;3CPO+M!F]W<);BZH1'?ML_$+U[1,#U]:\IN *^LAZQS%*LUT4 MI:86@\6T0Q,;'M;*%32'MN?[8![[J P/'T,,9-G"TQW7284[3%&WX*V;5?OL$HMBWYJKN@13<]5]]C1Z M^AH(JDOPZ_+J4^*9B"U#IU.ZP:U.J]]M@*BNY]6+XH6Y$J^YPLHRCPE^T5"A M%^#\AG-U?-$&3M](]_\"4$L#!!0 ( $J(;U-974 B*@0 *T( 9 M>&PO=V]R:W-H965TD0%:2G4O3 MQ#;@V GJ19L&<7;SL-@'6AI;1"A2)2D[_ON=H637733!/NR#;5YFSIPYG"$] MV!C[[$I$#R^5TFX8E][7EVGJ\A(KX1)3HZ:=I;&5\#2UJ]35%D41G"J5]K/L M/*V$U/%H$-;N[6A@&J^DQGL+KJDJ8;?7J,QF&/?BW<*#7)6>%]+1H!8KG*/_ MH[ZW-$OW*(6L4#MI-%A<#N-Q[_+ZE.V#P9\2-^Y@#)S)PIAGGLR*89PQ(528 M>T80]+/&"2K%0$3C:X<9[T.RX^%XAWX;^8=/:GKR/(6^<-U7G3 PJJ=M?\=+I<.!PD;WBT.\<^H%W M&RBPG HO1@-K-F#9FM!X$%(-WD1.:CZ4N;>T*\G/CR8/-]/9(]R.)[-/L\?9 MS1S&=U/X-+N[@2^WT.X.4D^1V#[-.]3K%K7_"NH'^&RT+QW.&^I M1/Y^ _QT#WX:P$__9TW?1.7NO'2UR'$84_LYM&N,1W=?'F^B<_CUIXM^KW<% M_R4R/&'$W>KI ]3<5GBI5\#A')@EY!8+Z8]A26H8RUM"%]1_:Z/6/&OW>5LJ MZ24Y;:0OJ37TLPNF2ZF%SA%R4]5"LX$W4%NSE@5"XT*;$E"4BUIZH1*8Z>CW M1FWI;'OGQ[!!0.V1H@"1-"#@]CLF<\P;*_T6QBN+2/>#AR-?8M"@GUW=CN?C M,.Q=O6N9C=O^G[3A8&)L;3AI6COJG%J3G5M$4=%YL5#2E13?"86LC,ASTVCO M2(P9)%E232'+USZ:JQ M/7V6O#2J<-#4+.09_!)1.*9$(N$! Q1YN=,4ZL;F)=VN?.@D>0>YVZ90H3;I M&O!8+=#N[X(0&^G>1=(!?F4R7<2N:.\MG]$#\>H*EX,^ M44$YZAB[,G!-+0EWR3B!6E'?]9,,LN3]&?SHBDL/GI *[2H\E Z"^NUKLE_= MO\7C]@GZ9MX^Y)\IN-0.%"[)E2/&8-O'L9UX4X<':6$\/6]A6-+_";1L0/M+ M8_QNP@'V_U!&_P!02P,$% @ 2HAO4[OI8[ -! 2 D !D !X;"]W M;W)K&ULK59M;^(X$/Z>7S'*[9U:B4)>*- N(-&6 M:BNUVZK0.^U'DPS$VL3.VJ8L_W['3DA!VW+WX;XD?IEYYIGQS-C#C53?=89H MX&>1"SWR,V/*RTY')QD63+=EB8)VEE(5S-!4K3JZ5,A2IU3DG2@(>IV"<>&/ MAV[M28V'&X/U9"'E=SNY2T=^8 EACHFQ"(Q^ MKWB->6Z!B,:/&M-O3%K%_?$._=;Y3KXLF,9KF?_#4Y.-_($/*2[9.C?/R@SHVB7DYX9/T_O)_/I#3Q-GN??X.OC?#JC M\;?)U?UTV#%DP(IUDAKLJ@*+/@"[@ _)&WF#.#*3PQ9;;P51K4--ZR18Y'T+L->M>A=_^? M6!X%L\5XJ4N6X,BG:M.H7M$?6TRO#W_],8C"\#,<,0BUJU[I7!7.U;)RM06) MI*K2-A)R"29#6,JRE69P95T>Q_ BM M >Q,^35205GE5MW MPFM"$@5AOP4;!#* BHZ "R.!U4[O@M2"L#VX@#\])L2:Z'(GK TH.E5'ON%^ M8@_0>A\%=10M!;<0?CZE?F(R,!M)$"E_Y2FA:5@J6< FLQ\"4OC*R6R^I2;Y M8\TM*<+DBO*D*)G8>B<$2KR[IVV8D[$W*\#?8DA+O0 *VP$(J221A)=$G?:I MBQN;5^1D].8C+'#%A;!91[J/B9%U? 9MF"2)6E?!<7Y[.RLN/^'WG*.0TA8% M,6[P?T?9I\N,1TU]K;C9M@\/;5=>=;+]M\/KGU,&Q>\#' MW*Z)+^YHZ?0CP2+"-G=JN[U8;W?OLQ?GJ?P,*'?G2WQ?V\"UHNW M^G8]X*)O_Y&M##N((;J([: +9QXE$;T@EN2DG;AZ_.1J\+TNW-F[W0I4*W>' M4XW*M3#51=>L-L^$274[OHE7;PQ*7,HX#3DN235H]\]]4-6]74V,+-U=N9"& M;EXWS.BI@\H*T/Y24GSKB370/)[&OP!02P,$% @ 2HAO4U$2:]PO! MW@D !D !X;"]W;W)K&ULI59M;^(X$/Z>7S'* MKE:MQ$$2WEM HBVK[JK;HM*]T^ET'TPR@-7$SMI.*?_^QDZ@E&W1:N\+Q&// M,\\\GK$]6$OUJ%>(!IZS5.BAOS(F/VLT=+S"C.FZS%'0S$*JC!D:JF5#YPI9 MXIRRM!$%0:>1,2[\T<#9IFHTD(5)N<"I EUD&5.;"TSE>NB'_M9PSY#PDN6)&:>[F^QBJ?ML6+9:K=+ZS+M5'7A[C01F:5,S'(N"C_V7.EPYY# M+WC'(:H<(L>[#.187C'#1@,EUZ#L:D*S'RY5YTWDN+";,C.*9CGYF='=P_7D M'F[O'B8SF([_'E_<3 8-0\!VNA%7(!2U?X,([5A% M6U87T5' &>9U: 8UB((H/(+7W&79='C-=_"N<&[@BNLXE;I0"/^,Y]HHJHA_ MCX"W=N M!][Z?Q(>!;&]=Z9S%N/0I^;2J)[0'UE,KP>?/O2B,#R'-P+!G5FA M\H0TJ"%G&S9/$9@!$M!@-D>U4Q&82. *X\H:.BO-Q9(:3!L-<@&$!0N94J-R ML3R#V>7UY.J[#?+YK=C>R1=!+K+0!*U/WXKY4SSOEIC"M"3Z!\R*/$\YS7^$ MJ-9K->F_4VNUFMXX3#6E.+*(7"0"Z5 MZ_*3=JW3"N$43BQ0'TZ]&RF6\( J@UNG4A7\KT6Z M@;!GZ8>=FI/H4F8Y$QNGJ!WOEA,15)@ %T8"@QB5H6,1-!)+,N=*9EQKJ39@ M-ZQ&K6Y6A *X6* [G2!A) _M1!EU&Y0+S\;)%1)F4V9(\%^9*.@6J"HC[-?AP08\X,%2 M+8EC3/>-IKU[4P4"^PB]>AR_*X0A\Z_ M+(7=[ ,=?B+BE* *>N*)$X*:?#^1-:>.H5XV7!0.-&./%,H>R^G&XT)3]Z06 MR#7ZGH94PRR.55&*0&)H0Q^D!5TV/"NR=ZJN^;K:7 I1U?9')+83$WM1_J;& MA[Z_*O&X6-)="F';,8QN]R5]5@0!=M38> *ZJU+HK%WYV:HENYE M0>>1E:B\?G?6W>-E7-[9+\O+E\\WII:T0Y#B@ER#>K?M@RI?$^7 R-S=X'-I MZ#W@/E?T $-E%]#\0I).U< &V#WI1O\!4$L#!!0 ( $J(;U.6QUR_U@( M P& 9 >&PO=V]R:W-H965TX6^.>W-R!U?)6JFO3E@4 MHR!RA%!@;AT"H^,9;U (!T0TOATP@S:E"SR]']%O?>U4RYH9O%'B'U[8W2C( M BAPPVIA']7^#@_U]!U>KH3Q3]@WOFD40%X;J\I#,#$HN6Q.]OW0AY. [*V MY!"0>-Y-(L]RQBP;#[7:@W;>A.8NOE0?3>2X="]E9359.<79\?W3W?P1EHO) M=+%8';>RU9%.^'^*D'[FB*3,6"U ;("MLE*!QY7)[ M#:N;N_GLRW(.][.T["D\FM$2]]7O(];V6MAG65MNNNDDSX;_DMEP8$ M;B@TNACT ]#-[FD$JRH_[VME:7OXZX[6-6KG0/:-4O8HN 3M#V#\$U!+ P04 M " !*B&]3!Y2G0KD+ !W'P &0 'AL+W=OROWZKJMK$)26:TJ]'$=+NJNBY?71H^/*;9]WRE5 $_UG&2?SQ:%<7F MW?EY/E^IM&V>7 M'])M$4>)&F>0;]=KF3U=J3A]_'CD'I4;DVBY*FCC_/+#1B[55!5?-^,,5^>5 ME#!:JR2/T@0RM?AXU'/?705$SP2_1^HQKWT&LN0^3;_38AA^/')((16K>4$2 M)#X>5%_%,0E"-?XR,H^J(XFQ_KF4?L.VHRWW,E?]-/X6A<7JXU'W"$*UD-NX MF*2/GY6QIT7RYFF<\U]XU+0>GCC?YD6Z-LRX7D>)?LH?Q@\UAJ[S H-G&#S6 M6Q_$6E[+0EY^R-)'R(@:I=$'-I6Y4;DHH:!,BPS?1LA77$YGH_X_/X^^7 \F MT[__K>NYG?:\*G*J-#;YC@>=X[BOR_,I8G^7Y+\@;_+6-BB?X5^\^+S+$P[]? MD1E4,@.6&?Q?'/BJ+$K =_E&SM7'(\RP7&4/ZNCR;C0;"- ^E5E(C&&481*E60ZX0 [HI^N-3)[@A!:DA.>\OR)J_NR^/X65# %M>(C2 M;1X_08[EA6@?TB)*EI!1KN2 -85WM9[0(XZ%RC(5 @)__AUD 2[D*YDI4F/W MMDC!:SDP3]=KS&PFR.W2W*NWS94YRD4K#4?_YQSD5P[J!"W+\1UP;*>-DES\ MBPX3QHX^C"M-IVS'"@^4$$>(OU!R-7J0\5:!3$(T(GE0&1>Y31;-%?GXV+7Q ME TJPK;!R;'GE#N>8PR&ADNTPQY7T7PEM,B"W)0FRLA ZM)?1'K*A\LM%AC4 M:"YCC)+ARR%*D+6OJ:=E)'Y=*5%3"GY.J2AA1*@'E1!B9%''FX%[WN QSIW' M:4[0VOG0KRDK"&H>(2;)U7Q+G0"P!(3$$%O-OLH*LVFRQ]H!S&4]BO-@R,&09KJ,L<@WK =8/I M>%RZSH8;4SX2+*-BK5N/2CBFSS-YYRO8&/DA6N1WV@+%'(,;B&*%Q8J\M(.R M!EJND6;#*!$WZC[;XO@"9",+KA?$*,^W*-=KL9O<;I>4%*62\):2%OB!9[7; M'1&5Z$9@1:0!ZZ732689192+DE _5#:/R!B&#!J6+!575L_J= /+N6B3VO_8 M8GYW:T6M4AEQIS)FQ]!+XEP#U\+Y-HL*JF=5/'K+3*DU968]**]25@WA,2I6 M0L[G>%14\'$/*B=$/,?>JP()E%"W1NO2-^F/0Y#:)5?=SCR-.4'E$D4MD4PL MLS1'-&3I7*F0PXTP:$&'BMI 8AW]FD0%AI10@&6%?(PTC>+U5G&R4*1.%@]3 MQ;.ZK0ZX'=<*O L\I^/ -Q-,00)-+.5]K",HJ8!%*1^[H.+PI"2FT&P5)=]U MG;&$Q,S'G*;V@52(MG EUW 3)3*91S*&6YG@<*T]AT7)WB]%[3 6H^>M\4PH7J3F'&;XMT@>!5U347F3S6H58+V ME+4HCROK'8F2(6$5CT(TQ0B;F)$QI M(H %%1)=>2AD]XC)K+?*7I62B/$HDJV,%++/1YT6"J (FQI1$I MQGM3_@ZF_<^#ZZ]?!F)T [WKZ^%L.+KK?8$O@T_XMW=W#:/9Y\$$;@:#*4P& M7WJSP37,1C"ZP8EP>/=)G RIL^H"EY^*65J@/17V%UFZYN*%J&%@-YL_FET" ME7.$JIO8=S";>(*N;;7@E!RY1H'H/0N^''+>B=<.H%0$A?J6UW4Y!@L9969 M,BE6'6[JZZY)-32@$_I5RP-**6RL\3;4U;$A:4RQP,V^W$2D 9:F=(M,9>%= M8;E069G40G&ZV3M^5I2#0S$K.&?US3;ZCZ()2E^8^>9YC[?A7=E>T@,U"K<< M[K(YG'%S,!G//8+&Q^=]#(T4-)7L((%!AF^]R:1W-YM"KS\;_HZ7 7& ]=F6 M(^ZVM*;AM]+O&]]D\? >SFN8[# P+0;'6IJM?IU%7,F8@&7!O5I&24)FTYRH MBQLVX7:;FAZBH&.[%[CA5AMM._#$MWW7E1GLFT;;M=&4BDK]V$146TXT4.$4 MFSO5]!/7,>N6W:[1STFW.%:A155MH;@_G>E_=:EEHSUQW0M4L8."?/NB2^>4 M@NFX>7N@O*3<$@PHJ!NB:_,\ M'- MT&"1)K_=9[R[\X[M^>"6@Z'>JJ^TTOJ%CZ _")ENB.L5*PJUV<+D]X#2KTA;0$NKY*Y2_4F1I4+!C\,1Y._H1K[#K1-\[*AE-=,,KJ MQ>G&65I-Y8YG+':#!J^YSE6O/:P8^+:CW^Z=[)HXF/CHQ^X,K\-47B/4^B%N M)=X,]&3J&RD&7OJQ.RHX1'16O7?:_#[0T.U<^ S+[@47C%IQ=URF:VGX=GVL M*8%YX-"/LZJC#VK7"'SSJ-\*VA6V"=IG.V<;_LXA_AU&78 SX5"]?WJPV$V?2@&Q'P&O%(U/;WB,JV>08G:#5]OZ;[ MVQ[9P6YYXG6M#G."VRUW56R2PC3)>H/501F]!3[33VM^%;_$*>B6U:*&Z'?![UJ. MVP&SU5@Q7=?0==J6PX'BK<9*'".E9P?4/P-LU=C!'<8#[S67@D+K4??$"XBI MRF9+]WV]8+* 9\8 JQN)1T=@IC1\UA0"NP&<,$]N;N3B'NNUZXHNP%2MG23 MIUDA*(_3>WCMWRV9DE2WT1]I!,WLSU>+?L\4WTZL<+9#OPZD=M8B@G H,)K^SVMS*;KZ!5 MO6W V@_TR,!=VG>;(EQ/H\P\J[FA1L>0QK*GQY,NE71QESXT7.+O@\\-?'KN M"#W'#"+[T#-/T#[19H6Y8(.J'YKO_PO4$L#!!0 ( M $J(;U.MP^XT!@4 !\+ 9 >&PO=V]R:W-H965TG5J*0A)=EWY!8EFN1NNQJV5Y5G>Z#22;$6L=.;0?* M_?H;.Y#24Y?KAY. O'CFF6<>SPR^VBK];')$"U\+(VO.AV39)CP4Q' ME2AI)5.Z8)8>];IK2HTL]4Z%Z,9A..P6C,O6^,J_>]#C*U59P24^:#!543"] MNT&AMM>MJ'5X\]- MY+ATF[*TFE8Y^=GQ]/[N;OYT-UL\+6&RN(7I_>)IOG@W6TSGL^55UU((9]A- M]G W-5S\ MPYW"EI[Z5\55%P2U5E#3"9PI3HM,FZ# M9':'*F7OU1<8[T)*O/O9GM#>$2[7POF,E&$ ML<2DTMSN8))89QZ=G_7AM4LS#B]GC_/EQ-]'EV\Z,)=4*-&P[3&7+$-XS_1* M:: QX#!ARPS%+XAZ"IE6A3?TZ;AJ< ][RIJZ;$??9PP8I%07&MT8H<%%+VV2 MN\0;B=Q\H:28 *M(NDIR-RZA1)U04!IN0!12)033P I529](R;3E"2]).N-W M[>P2ZG&U03=94&LF#&2./DORP&_29V3ZD.>@#5NDCVXT31T!1YI8&)=^7JI*#><0@9.H9_8 M(D.B6M0T14DG)F7EXZYV?MMO%-.I2_V69$RHZ$T':.[[-4D>4-2##67J<&DN M62Q6J(/# T2?(>4LQ1& MH X^(&H?YNK!RW<1_/;J?'AV?@GW6<83#/Q$H'V R;-6L@WW.5=MWW:&*!C&O4[@P'\V@DF'N $\3@, M]G(1'(T3AZ+JYO=Y=!KNDV"#.4\$ODQ4H#&N;B11CAK*'7B11>#BT*"GVMUY M.H.?9?-O)9=,6/C@ZG!* Z@-'Y]."AK'/T'/Q0V28W:C)OYGE@;4L=7?O(!A M/ A#& YZPP$LYLO@1,('V7NC?94&_Y7H.U:D)"CYAJ.0>+>C7A_BLV;]D6^H M!/IA.R0._:@=N\N@67ZOLH+)H-=V%'N];VZ^=(*$:0.Q]QWZWQ_]A7:/#BT% MZK4_FKD90_U>GU^:M\WI;U(?>KZ9UT?'.Z;7G-I;8$:N8>=LT )='\?J!ZM* M?P1:*4L'*G^;TPD6M3.@]4PI>WAP 9HS\?@?4$L#!!0 ( $J(;U/3X& # M+ 0 ",) 9 >&PO=V]R:W-H965TQ)O6>^ZNQ-,_GUGUHY)$*"J M$@K[,O/,,V\[GM3./X0"D>"I-#9,DX*H.AL.0U9@J<+ 56CY9N5\J8BW?CT, ME4>51Z72#-/1Z..P5-HFLTD\N_6SB=N0T19O/81-62J_O43CZFDR3G8'"[TN M2 Z<FEUGB']%MUZWDW[%!R7:(-VEGPN)HF%^.SRV.1CP*_:ZS#WAK$DZ5S M#[*YRJ?)2 BAP8P$0?&_1YRC,0+$-/YI,9/.I"CNKW?H/T??V9>E"CAWY@^= M4S%-3A/(<:4VAA:N_A5;?TX$+W,FQ%^H&]F3-(%L$\B5K3(S*+5M_JNG-@Y[ M"J>C-Q325B&-O!M#D>5G16HV\:X&+]*,)HOH:M1FGPZS5O6QTTS=T?X(;9ZD(\,7FF!_J#YE'1R;=D;E,WP6\ MPVH 1Z,^I*-T_ [>4>?<4<0[>@-O[LI2$Y<0!5 VASG3U7:--M,8X+,.F7%A MXQ'^O%@&\EPA?[UC];BS>ARM'O^OD+ZK*RUX%BJ5X33A'@OH'S&9??UV_Z4W M3N&'[T[3\?@UQT C+)7J)V@BH0/:SK)3=0JT"6%5B#KQ04JQH [WEO:]O%<)F^3YW M'O1:SU\BQG#V7JF4EV42S6O[Z,PC]PX?R"1@?"PKX[:('$.W\XCM, =7"TY5 M>?>D.4_(:?@>/HX.#$:JM",9H\NGCIEZX(&3BRG1]5H9,+CF7\;+$.6&N3=. M/5A7)<*LMC1)+3ES"L,$>O3+^M;>UN'>X.*: M6L?QS/TAW=_,L.ZT^P*X: ;?LWCS^7"C_)HSP[6R8M71X--) KX9R^O M&%&IIRI\9;MI"D@DFZHK[6:CA+:JJAX>_=FE#F))'=6XDDX@=5488K ?)0UT2\SK#B;>SXSG%C3?>E,AMN$C5D MCQM47YJ5T)$[L!2T1B8I9R!P%SNI/YV-3;Y-^$JQE2=K,$ZVG#^9X*Z('<\( MP@IS91B(?CWC'*O*$&D9OWI.9RAI@*?K(_LGZUU[V1*)?L?=S;?AR7DG[A+;+#75R?I"*USU8*Z@IZ][DI;^'$\#$.P,(>D!@ M=7>%K,I;HD@2"=Z",-F:S2RL58O6XB@S'V6CA#ZE&J>2]>(^S1:WL$K7V7?( MUNERD\ZSN\?E)G*5YC=9;MYSS3JNX S7!WC@3)42%JS XF^\JW4-XH*CN%EP MD7"#S0A"[QT$7N!?X L'LZ'E"\^9Q8HH+&!%A'J%3! FB6T."3_2K51"1S\O MU!D/=<:VSOB_7.I%+C.44]F0'&-'3YU$\8Q.LGS,%E=^"&_?3 +?_PCG"T+O M^:JQGM6I9R(0"BIUETE]*93!DBN$FQ'\ZPKSM)$G(^8&IKMV&W6%8 MTZY'_Z1WD_Y Q)[J^A7N--0;W5P[(+KIZ0+%&]NQ6ZYT_]MEJ7\X*$R"/M]Q M+;0/3('A%Y;\!E!+ P04 " !*B&]3AK:P%BX" "\! &0 'AL+W=O MUY5"ECI06?AA$+SW2\:%%T=N;:7B M2-:FX )7"G1=EDR]SK&0S=0;>H>%>[[/C5WPXZAB>TS0;*J5HLCO65)>HM!< M"E"83;W9\&8^MODNX8%CHX_F8)ULI7RTP9=TZ@56$!:X,Y:!T>L9%U@4EHAD M/'6<7G^D!1[/#^R?G'?RLF4:%[+XSE.33[V)!REFK"[,O6P^8^?GTO+M9*'= M"$V;&UY[L*NUD64')@4E%^V;O73W< 28!"< 80<(G>[V(*?R(S,LCI1L0-EL M8K,39]6A21P7]J,D1M$N)YR)D\T\67[;+._6L'R@,8E\0[1VT]]U%/.6(CQ! M<0VW4IA2H$!H[""F0@" SNPH9 M)PE[2)G!P;^NP#^JJ!+5WO6-AIVLA6F+JU_M6W/65N3O]+:O;YG:#JT@/5]DH;&%FY^MQ*0]7NICG]7E#9!-K/)-GL GM _\.*?P%02P,$% M @ 2HAO4]:)$K/#&@ =50 !D !X;"]W;W)K&ULS5Q;<]M&EG[O7]&EK=JRJR!:%\MV$CM5LBPGJHDMQ9+'N[6U#R#0))& M: 0-B-'\^CVW;C1 D'*FF=?GLY.CHQ;-U6E0'/[ZF M[VZ:'U_;KBV+RMPTVG7K==H\O#6EW;PY.#[P7WPJEJL6OWCVX^LZ79I;TWZN M;QKXZUE8)2_6IG*%K71C%F\.SH^_?WM\BC?0%?\LS,9%GS4>96[M[_C'5?[F MX @I,J7)6EPBA?_NS84I2UP)Z/A#%CT(>^*-\6>_^GLZ/!QFGCIS8A?O>%KSYX?Z*QSK5W+S4#!NJCX__1/ M841TPZNC'3>-W>@&KX;5\ ,=E>X&XHH*I7+;-O!K M ?>U/]Y^_O#A_--_Z^OW^O;JIX]7[Z\NSC_>Z?.+B^O/'^^N/OZD;ZY_N;JX MNKS53VYL662%<4]?/VMA:US@62;;O.5M3G9L\YW^8*MVY?1EE9M\>/\S(#G0 M?>+I?GNR=\%;4\_TZ5&B3XY.CO>L=QKX<$KKG>Y8[SS+;%>U1;74_ICZ?\[G MKFU ;_YWSP;/PP;/:8/G.S:X:8HJ*^H2UK4+?6$K!]OD*:MFE>NWJ2OHIYO& M.%.U],L4H_=N@T;\O:O3S+PYJ'&AYMX<1'NKK]];7W>-ZJJTRXO6Y#JS(+G* M\2>Y'_Y8%%4*:Z>E=G"; 7MMG8;=RBXWNEV9Z(+:NB)L"1N!W="F@# -[4A_ M77_X>/4KT-B ?/'"HG5JL[)E^:#MIH(=73=W15ZD#8KHU\ZX5G](F]\-RB[1 M5U4V2^3KRS^S55HMC?ZES>'+ZW55_*KO3+:J;&F7>#O_\//=K;Y:I^%"W+;_ M[J:QF7$.5U>\.M@<@KDY.C'S:&/AS_ MH&WCO^O<]G>V:Z(OD6WRPX5=UVGU,/._GI>E&U-I4Q: (B0ZH!1V7C2H+35S7.,-I"AI]D=7L$;-]!>CZ(R@\W5*TE@9 M9DZQ_L;MPR%8J@D>!CG:T_5T3& M;>L/<;X&"K,TH>7 :6JB--%UU[@.!0Q:A3@F>*A3O)N""# .VI40(L$Q M9_H.;4Q%_ '$0/B O4M8]S?P\?1]0CI9.&(.G)09#E>#NT M3"JQ*BO#*(7A!P@5@;M4C!FNH8Y46'XK, ':@7;$6H^S-] M!5#C@)/+)0 K_9"V@A[>RB9U80ZJ"XQ .F'5W[J* (EU 4!OA^$+!CZ8M-$& M P;]#DZQGIM&GQZ3RS\B144E=4PDR"563%P;HS9]?'3X#]BEA*]I4[*7RPL- M1(#7 ,60!8])4%KP5GR2<;169;0S2Z1MIJ_9655+Y3V8I[8"CNDU1SE,]"VJ M,E,M@8J(!#3$BZ4@B\I!I0G=1!I^;6+S.GU /IH_$0(1K2+VJ&GVP&GVA"QG M(60YVQNR?'9$T"6HY!J9,16-[%UA.AJ!956\+(*W8 ;)[5OA^NO0>3?8J#WH MC-8&4@&/@XC0VQCB08=& !3\UN5+_QUAA DG1&5-'60^-0,WR35=+! &6-ZU M;7#O=$T>'/D#UQOQY661SHNR1_C&E,2( 4KQ2L@AKT7?QD@*'B*:E-"$JS: MCU4G5*!"PII.YQWAT^ @8":%S07]!F>G6P-G0$)ESFB>:ORJ07(,L\960X50 M?R4^T>=9VQ& LBVA&>4%+-R$?4 '),BP+A(7AA-X5,PI6G*0RE9+BP>> M4]B,.6&.OPP@%# ;J$ ENT^+,IV7AN-*=LVDK@N(SI@=6=%DW1IH!]5E0K,4 MM:ISJ$M(B3."MA&1>RS\1;#P%WLM_"=K\TV!?@BHN +4KY8%D#IIZ7M7FK9T MO[P:+1_"M37XU3B0<]ZAU:EKV4I8?'U$ /[00OSK?==2MICI<):"7 *H)R*L MMP7RK;DD&AP<<]RNZK+C&\@WWJ=E1P:$7J"RU2$ZPP8"?A0XN3K,+(06HKPQ MQAM?=!(QQ'O3C-8.% $U@$V+ G5#5:8-!L^+YJ2%!N_!E?PY"?T+<%)%0UB3 M5E5'B@Q?KRT@Z )1BE0/H@/8J2G 9Y-]HNVB&6>@G!0KH>.,UE+BAVR#,0^J M',/>&@L;/0 1E;7)3DO<*ARL$!J1&:+7 OXZ9&2C@A(@7:#X ?0 M:VI]K/_ T*UHV24B6YRC52)Y#WA //4^4/D0(2'C909MT8+BH>TI>?(90Y8V MS0/RBM6 (@HG?GD9VTIN ', D@Y+^!5UT^NV2#%1&)!@=! $S_(4\\TG-(X- MG!$4:>@J7&#^ +$I2@"_"C&'I$9(H5W#IG7=V!1DY<%[31FQ\M\GR*-%UY#$ M<^.RIIBS27W$./_$ATSGS*Q/1 -B6A1#?450-L-* H-ANP(SC.6HD.T)QMFY M 2M:]_&EWJ287D0 H<04V(MK3%F1966Q,!1 S0W%PVMDU+_\?A"D@5DCIPX1 MG-3: *SG;(( IHNNU"@LB+]Q%[B?F'B*@CH^5G@LP-2/-IA)HR-[(+0BRT'( MP!($6QGB\W9L2L"U(<\6.?DM)<'M5*28XE")'P)S_XKBO8I.M3_ W.L57@:O M\'*O5P"A@\95^H*<6/:@[Q NRYT5J;VK37L&V4)-;?$W"D^H''TF!DK]>78[ MTSG -TD7(_R%Y"!P8^8W]QSVT3^H+MZH^AOC8DKAW3L5"1E%0>*L@U/+(U4H MSP9EAD43CI7(."$P17@WOE2%68=W)P 5" R*/O<4S+ *1(4SL%AT3T754<[8 MU]%P1^1;ETWP@3QCW1(\A6+:@RYMYLM"5ZY)3@W XMN$&\* MGS.*;\3E8AY0V'JX-BF&J[FO:TRR"W.JLK0;]SWF4Z9%ZMABU%8TS <%&V\' MO)VG)>4!W-G@8/30('!O<9NB^Y(S>G3XHRVW _#&J*DM ? *@H\]6#]F;[T M@3+5,QFQ0;77N\EGQ$>7B+YV.:(XY)RJ=Q8^WO:V&^F+7H)@Y!S6.>%:B-3M M5];H@IF-:K984R$=&%?].&_ JW%;AEOTMHU985?GWGNOO9CU*F#6J[V8]1'$ M_ MN

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end XML 64 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 65 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 66 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 292 385 1 false 108 0 false 6 false false R1.htm 00000001 - Document - Cover Sheet http://omniqinc.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://omniqinc.com/role/BalanceSheets Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://omniqinc.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) Sheet http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flow (Unaudited) Sheet http://omniqinc.com/role/StatementsOfCashFlow Condensed Consolidated Statements of Cash Flow (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - NATURE OF OPERATIONS Sheet http://omniqinc.com/role/NatureOfOperations NATURE OF OPERATIONS Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://omniqinc.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - GOING CONCERN Sheet http://omniqinc.com/role/GoingConcern GOING CONCERN Notes 9 false false R10.htm 00000010 - Disclosure - CONCENTRATIONS Sheet http://omniqinc.com/role/Concentrations CONCENTRATIONS Notes 10 false false R11.htm 00000011 - Disclosure - BUSINESS ACQUISITION Sheet http://omniqinc.com/role/BusinessAcquisition BUSINESS ACQUISITION Notes 11 false false R12.htm 00000012 - Disclosure - CREDIT FACILITIES AND LINE OF CREDIT Sheet http://omniqinc.com/role/CreditFacilitiesAndLineOfCredit CREDIT FACILITIES AND LINE OF CREDIT Notes 12 false false R13.htm 00000013 - Disclosure - RELATED PARTY NOTES PAYABLE Notes http://omniqinc.com/role/RelatedPartyNotesPayable RELATED PARTY NOTES PAYABLE Notes 13 false false R14.htm 00000014 - Disclosure - OTHER NOTES PAYABLE Notes http://omniqinc.com/role/OtherNotesPayable OTHER NOTES PAYABLE Notes 14 false false R15.htm 00000015 - Disclosure - OTHER LIABILITIES Sheet http://omniqinc.com/role/OtherLiabilities OTHER LIABILITIES Notes 15 false false R16.htm 00000016 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://omniqinc.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 16 false false R17.htm 00000017 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://omniqinc.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 17 false false R18.htm 00000018 - Disclosure - LITIGATION Sheet http://omniqinc.com/role/Litigation LITIGATION Notes 18 false false R19.htm 00000019 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://omniqinc.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 19 false false R20.htm 00000020 - Disclosure - SUBSEQUENT EVENTS Sheet http://omniqinc.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 20 false false R21.htm 00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 21 false false R22.htm 00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://omniqinc.com/role/SummaryOfSignificantAccountingPolicies 22 false false R23.htm 00000023 - Disclosure - BUSINESS ACQUISITION (Tables) Sheet http://omniqinc.com/role/BusinessAcquisitionTables BUSINESS ACQUISITION (Tables) Tables http://omniqinc.com/role/BusinessAcquisition 23 false false R24.htm 00000024 - Disclosure - RELATED PARTY NOTES PAYABLE (Tables) Notes http://omniqinc.com/role/RelatedPartyNotesPayableTables RELATED PARTY NOTES PAYABLE (Tables) Tables http://omniqinc.com/role/RelatedPartyNotesPayable 24 false false R25.htm 00000025 - Disclosure - OTHER NOTES PAYABLE (Tables) Notes http://omniqinc.com/role/OtherNotesPayableTables OTHER NOTES PAYABLE (Tables) Tables http://omniqinc.com/role/OtherNotesPayable 25 false false R26.htm 00000026 - Disclosure - OTHER LIABILITIES (Tables) Sheet http://omniqinc.com/role/OtherLiabilitiesTables OTHER LIABILITIES (Tables) Tables http://omniqinc.com/role/OtherLiabilities 26 false false R27.htm 00000027 - Disclosure - STOCKHOLDERS??? EQUITY (Tables) Sheet http://omniqinc.com/role/StockholdersEquityTables STOCKHOLDERS??? EQUITY (Tables) Tables http://omniqinc.com/role/StockholdersEquity 27 false false R28.htm 00000028 - Disclosure - SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE (Details) Sheet http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE (Details) Details 28 false false R29.htm 00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesTables 29 false false R30.htm 00000030 - Disclosure - GOING CONCERN (Details Narrative) Sheet http://omniqinc.com/role/GoingConcernDetailsNarrative GOING CONCERN (Details Narrative) Details http://omniqinc.com/role/GoingConcern 30 false false R31.htm 00000031 - Disclosure - CONCENTRATIONS (Details Narrative) Sheet http://omniqinc.com/role/ConcentrationsDetailsNarrative CONCENTRATIONS (Details Narrative) Details http://omniqinc.com/role/Concentrations 31 false false R32.htm 00000032 - Disclosure - SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) Sheet http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) Details 32 false false R33.htm 00000033 - Disclosure - SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical) Sheet http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical) Details 33 false false R34.htm 00000034 - Disclosure - SCHEDULE OF PROFORMA UNAUDITED REVENUE AND EARNINGS (Details) Sheet http://omniqinc.com/role/ScheduleOfProformaUnauditedRevenueAndEarningsDetails SCHEDULE OF PROFORMA UNAUDITED REVENUE AND EARNINGS (Details) Details 34 false false R35.htm 00000035 - Disclosure - BUSINESS ACQUISITION (Details Narrative) Sheet http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative BUSINESS ACQUISITION (Details Narrative) Details http://omniqinc.com/role/BusinessAcquisitionTables 35 false false R36.htm 00000036 - Disclosure - CREDIT FACILITIES AND LINE OF CREDIT (Details Narrative) Sheet http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative CREDIT FACILITIES AND LINE OF CREDIT (Details Narrative) Details http://omniqinc.com/role/CreditFacilitiesAndLineOfCredit 36 false false R37.htm 00000037 - Disclosure - SCHEDULE OF NOTES PAYABLE, RELATED PARTIES (Details) Notes http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails SCHEDULE OF NOTES PAYABLE, RELATED PARTIES (Details) Details 37 false false R38.htm 00000038 - Disclosure - SCHEDULE OF FUTURE MATURITIES OF NOTES PAYABLE, RELATED PARTIES (Details) Notes http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotesPayableRelatedPartiesDetails SCHEDULE OF FUTURE MATURITIES OF NOTES PAYABLE, RELATED PARTIES (Details) Details 38 false false R39.htm 00000039 - Disclosure - RELATED PARTY NOTES PAYABLE (Details Narrative) Notes http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative RELATED PARTY NOTES PAYABLE (Details Narrative) Details http://omniqinc.com/role/RelatedPartyNotesPayableTables 39 false false R40.htm 00000040 - Disclosure - SCHEDULE OF OTHER NOTES PAYABLE (Details) Notes http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails SCHEDULE OF OTHER NOTES PAYABLE (Details) Details 40 false false R41.htm 00000041 - Disclosure - OTHER NOTES PAYABLE (Details Narrative) Notes http://omniqinc.com/role/OtherNotesPayableDetailsNarrative OTHER NOTES PAYABLE (Details Narrative) Details http://omniqinc.com/role/OtherNotesPayableTables 41 false false R42.htm 00000042 - Disclosure - SCHEDULE OF OTHER LIABILITIES (Details) Sheet http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails SCHEDULE OF OTHER LIABILITIES (Details) Details 42 false false R43.htm 00000043 - Disclosure - SCHEDULE OF ADDITIONAL LEGAL AND OTHER FEES RELATED TO OFFERING (Details) Sheet http://omniqinc.com/role/ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingDetails SCHEDULE OF ADDITIONAL LEGAL AND OTHER FEES RELATED TO OFFERING (Details) Details 43 false false R44.htm 00000044 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details) Sheet http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails SCHEDULE OF WARRANTS ACTIVITY (Details) Details 44 false false R45.htm 00000045 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details) Sheet http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails SCHEDULE OF OUTSTANDING WARRANTS (Details) Details 45 false false R46.htm 00000046 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES (Details) Sheet http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES (Details) Details 46 false false R47.htm 00000047 - Disclosure - SCHEDULE OF STOCK OPTIONS GRANTED (Details) Sheet http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails SCHEDULE OF STOCK OPTIONS GRANTED (Details) Details 47 false false R48.htm 00000048 - Disclosure - SCHEDULE OF OUTSTANDING STOCK OPTIONS (Details) Sheet http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails SCHEDULE OF OUTSTANDING STOCK OPTIONS (Details) Details 48 false false R49.htm 00000049 - Disclosure - SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES (Details) Sheet http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES (Details) Details 49 false false R50.htm 00000050 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://omniqinc.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://omniqinc.com/role/StockholdersEquityTables 50 false false R51.htm 00000051 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://omniqinc.com/role/CommitmentsAndContingencies 51 false false R52.htm 00000052 - Disclosure - LITIGATION (Details Narrative) Sheet http://omniqinc.com/role/LitigationDetailsNarrative LITIGATION (Details Narrative) Details http://omniqinc.com/role/Litigation 52 false false All Reports Book All Reports form10-q.htm ex31-1.htm ex31-2.htm ex32-1.htm omqs-20210930.xsd omqs-20210930_cal.xml omqs-20210930_def.xml omqs-20210930_lab.xml omqs-20210930_pre.xml http://xbrl.sec.gov/dei/2021 http://fasb.org/us-gaap/2021-01-31 http://fasb.org/srt/2021-01-31 true true JSON 69 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 22, "contextCount": 292, "dts": { "calculationLink": { "local": [ "omqs-20210930_cal.xml" ] }, "definitionLink": { "local": [ "omqs-20210930_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "omqs-20210930_lab.xml" ] }, "presentationLink": { "local": [ "omqs-20210930_pre.xml" ] }, "schema": { "local": [ "omqs-20210930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 552, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 211, "http://omniqinc.com/20210930": 71, "http://xbrl.sec.gov/dei/2021": 4, "total": 286 }, "keyCustom": 51, "keyStandard": 334, "memberCustom": 81, "memberStandard": 23, "nsprefix": "OMQS", "nsuri": "http://omniqinc.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://omniqinc.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - CONCENTRATIONS", "role": "http://omniqinc.com/role/Concentrations", "shortName": "CONCENTRATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - BUSINESS ACQUISITION", "role": "http://omniqinc.com/role/BusinessAcquisition", "shortName": "BUSINESS ACQUISITION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - CREDIT FACILITIES AND LINE OF CREDIT", "role": "http://omniqinc.com/role/CreditFacilitiesAndLineOfCredit", "shortName": "CREDIT FACILITIES AND LINE OF CREDIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "OMQS:NotesPayableRelatedPartiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - RELATED PARTY NOTES PAYABLE", "role": "http://omniqinc.com/role/RelatedPartyNotesPayable", "shortName": "RELATED PARTY NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "OMQS:NotesPayableRelatedPartiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - OTHER NOTES PAYABLE", "role": "http://omniqinc.com/role/OtherNotesPayable", "shortName": "OTHER NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - OTHER LIABILITIES", "role": "http://omniqinc.com/role/OtherLiabilities", "shortName": "OTHER LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "role": "http://omniqinc.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://omniqinc.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - LITIGATION", "role": "http://omniqinc.com/role/Litigation", "shortName": "LITIGATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://omniqinc.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)", "role": "http://omniqinc.com/role/BalanceSheets", "shortName": "Condensed Consolidated Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - SUBSEQUENT EVENTS", "role": "http://omniqinc.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - BUSINESS ACQUISITION (Tables)", "role": "http://omniqinc.com/role/BusinessAcquisitionTables", "shortName": "BUSINESS ACQUISITION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "OMQS:NotesPayableRelatedPartiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - RELATED PARTY NOTES PAYABLE (Tables)", "role": "http://omniqinc.com/role/RelatedPartyNotesPayableTables", "shortName": "RELATED PARTY NOTES PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "OMQS:NotesPayableRelatedPartiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - OTHER NOTES PAYABLE (Tables)", "role": "http://omniqinc.com/role/OtherNotesPayableTables", "shortName": "OTHER NOTES PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - OTHER LIABILITIES (Tables)", "role": "http://omniqinc.com/role/OtherLiabilitiesTables", "shortName": "OTHER LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "OMQS:ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)", "role": "http://omniqinc.com/role/StockholdersEquityTables", "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "OMQS:ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE (Details)", "role": "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails", "shortName": "SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "role": "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "role": "http://omniqinc.com/role/BalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-5", "first": true, "lang": null, "name": "OMQS:WorkingCapitalDeficit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - GOING CONCERN (Details Narrative)", "role": "http://omniqinc.com/role/GoingConcernDetailsNarrative", "shortName": "GOING CONCERN (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-5", "first": true, "lang": null, "name": "OMQS:WorkingCapitalDeficit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - CONCENTRATIONS (Details Narrative)", "role": "http://omniqinc.com/role/ConcentrationsDetailsNarrative", "shortName": "CONCENTRATIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)", "role": "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "shortName": "SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-05-022021-05-03_custom_DangotSharesMember", "decimals": "-3", "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-05-022021-05-03_custom_DangotSharesMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)", "role": "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical", "shortName": "SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-05-022021-05-03_custom_DangotSharesMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - SCHEDULE OF PROFORMA UNAUDITED REVENUE AND EARNINGS (Details)", "role": "http://omniqinc.com/role/ScheduleOfProformaUnauditedRevenueAndEarningsDetails", "shortName": "SCHEDULE OF PROFORMA UNAUDITED REVENUE AND EARNINGS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-012020-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - BUSINESS ACQUISITION (Details Narrative)", "role": "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "shortName": "BUSINESS ACQUISITION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-05-022021-05-03_custom_OmniqTechnologiesMember", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LineOfCredit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - CREDIT FACILITIES AND LINE OF CREDIT (Details Narrative)", "role": "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative", "shortName": "CREDIT FACILITIES AND LINE OF CREDIT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LineOfCredit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "OMQS:NotesPayableRelatedPartiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - SCHEDULE OF NOTES PAYABLE, RELATED PARTIES (Details)", "role": "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails", "shortName": "SCHEDULE OF NOTES PAYABLE, RELATED PARTIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "OMQS:NotesPayableRelatedPartiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30_custom_NotePayableMarinMember", "decimals": "-3", "lang": null, "name": "us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "OMQS:ScheduleOfFutureMaturitiesOfNotesPayableRelatedPartiesTableTextBlock", "OMQS:NotesPayableRelatedPartiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - SCHEDULE OF FUTURE MATURITIES OF NOTES PAYABLE, RELATED PARTIES (Details)", "role": "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotesPayableRelatedPartiesDetails", "shortName": "SCHEDULE OF FUTURE MATURITIES OF NOTES PAYABLE, RELATED PARTIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "OMQS:ScheduleOfFutureMaturitiesOfNotesPayableRelatedPartiesTableTextBlock", "OMQS:NotesPayableRelatedPartiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "OMQS:NotesPayableRelatedPartiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - RELATED PARTY NOTES PAYABLE (Details Narrative)", "role": "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative", "shortName": "RELATED PARTY NOTES PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "OMQS:NotesPayableRelatedPartiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2017-12-31_custom_MarinNoteMember", "decimals": "-3", "lang": null, "name": "us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-07-012021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "role": "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss", "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-07-012021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherNotesPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - SCHEDULE OF OTHER NOTES PAYABLE (Details)", "role": "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails", "shortName": "SCHEDULE OF OTHER NOTES PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherNotesPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2019-04-012019-04-30_custom_FirstMinimumPaymentMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentPeriodicPayment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - OTHER NOTES PAYABLE (Details Narrative)", "role": "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "shortName": "OTHER NOTES PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2019-04-012019-04-30_custom_FirstMinimumPaymentMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentPeriodicPayment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:OtherLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - SCHEDULE OF OTHER LIABILITIES (Details)", "role": "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails", "shortName": "SCHEDULE OF OTHER LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:OtherLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "OMQS:ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - SCHEDULE OF ADDITIONAL LEGAL AND OTHER FEES RELATED TO OFFERING (Details)", "role": "http://omniqinc.com/role/ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingDetails", "shortName": "SCHEDULE OF ADDITIONAL LEGAL AND OTHER FEES RELATED TO OFFERING (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "OMQS:ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details)", "role": "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails", "shortName": "SCHEDULE OF WARRANTS ACTIVITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "OMQS:ScheduleOfOutstandingWarrantsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-09-30_us-gaap_WarrantMember77397609", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details)", "role": "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails", "shortName": "SCHEDULE OF OUTSTANDING WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "OMQS:ScheduleOfOutstandingWarrantsTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-09-30_us-gaap_WarrantMember77397609", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "OMQS:ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES (Details)", "role": "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails", "shortName": "SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "OMQS:ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - SCHEDULE OF STOCK OPTIONS GRANTED (Details)", "role": "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails", "shortName": "SCHEDULE OF STOCK OPTIONS GRANTED (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-012020-09-30", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-09-30_custom_StockOptionsMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - SCHEDULE OF OUTSTANDING STOCK OPTIONS (Details)", "role": "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "shortName": "SCHEDULE OF OUTSTANDING STOCK OPTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-09-30_custom_StockOptionsMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES (Details)", "role": "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "shortName": "SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30_us-gaap_EmployeeStockOptionMember", "decimals": "-3", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2019-12-31_us-gaap_SeriesCPreferredStockMember_us-gaap_PreferredStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)", "role": "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit", "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2019-12-31_us-gaap_SeriesCPreferredStockMember_us-gaap_PreferredStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "role": "http://omniqinc.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-09-292020-09-30_us-gaap_EmployeeStockOptionMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-09-30_custom_VehicleLeaseMember", "decimals": "-3", "first": true, "lang": null, "name": "OMQS:RentalExpenseMonthlyPayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "role": "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-09-30_custom_VehicleLeaseMember", "decimals": "-3", "first": true, "lang": null, "name": "OMQS:RentalExpenseMonthlyPayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LegalMattersAndContingenciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - LITIGATION (Details Narrative)", "role": "http://omniqinc.com/role/LitigationDetailsNarrative", "shortName": "LITIGATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LegalMattersAndContingenciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flow (Unaudited)", "role": "http://omniqinc.com/role/StatementsOfCashFlow", "shortName": "Condensed Consolidated Statements of Cash Flow (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": "-3", "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - NATURE OF OPERATIONS", "role": "http://omniqinc.com/role/NatureOfOperations", "shortName": "NATURE OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://omniqinc.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - GOING CONCERN", "role": "http://omniqinc.com/role/GoingConcern", "shortName": "GOING CONCERN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 108, "tag": { "OMQS_AccruedPayableToOwner": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Payable to Owner.", "label": "Accrued payable to owner" } } }, "localname": "AccruedPayableToOwner", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_ActionCapitalCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Action Capital Corporation [Member]", "label": "Document and Entity Information" } } }, "localname": "ActionCapitalCorporationMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_AdjustmentsForPostAcquisitionToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments for post acquisition to additional paid in capital other.", "label": "Post acquisition adjustment" } } }, "localname": "AdjustmentsForPostAcquisitionToAdditionalPaidInCapitalOther", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "OMQS_AkronMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Akron [Member]", "label": "Akron [Member]" } } }, "localname": "AkronMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_AllOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All Other [Member]", "label": "All Other [Member]" } } }, "localname": "AllOtherMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "domainItemType" }, "OMQS_AprilTwentyTwoThousandTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "April 20, 2025 [Member]", "label": "April 20, 2025 [Member]" } } }, "localname": "AprilTwentyTwoThousandTwentyFiveMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_AssetPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset Purchase Agreement [Member].", "label": "Asset Purchase Agreement [Member]" } } }, "localname": "AssetPurchaseAgreementMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_AssetsObtainedNetOfCashIncludingNoncontrollingInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net assets obtained net of cash including noncontrolling interest.", "label": "Net assets acquired in business combination" } } }, "localname": "AssetsObtainedNetOfCashIncludingNoncontrollingInterest", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "OMQS_AugustTwoTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "August 2, 2021 [Member]", "label": "August 2, 2021 [Member]" } } }, "localname": "AugustTwoTwoThousandTwentyOneMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_BonusPayableCurrentandNoncurrent": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Bonus payable.", "label": "Bonus payable" } } }, "localname": "BonusPayableCurrentandNoncurrent", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_BusinessCombinationConsiderationFairValue": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of stock issued.", "label": "Fair value of stock issued (220,103 shares)" } } }, "localname": "BusinessCombinationConsiderationFairValue", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationship": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed customer relationship.", "label": "Customer relationship" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationship", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed goodwill.", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill", "verboseLabel": "Goodwill" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed trade name.", "label": "Trade name" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeName", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_ConsultantsAndAdvisorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consultants and Advisors [Member]", "label": "Consultants and Advisors [Member]" } } }, "localname": "ConsultantsAndAdvisorsMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_ConsultingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consulting Agreement [Member]", "label": "Consulting Agreement [Member]" } } }, "localname": "ConsultingAgreementMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_ConversionOfDebtShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of debt shares.", "label": "Conversion of debt, Shares" } } }, "localname": "ConversionOfDebtShares", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "OMQS_ConversionofNotesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of notes payable.", "label": "Conversion of notes payable" } } }, "localname": "ConversionofNotesPayable", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "OMQS_CumulativeTranslationAdjustment": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cumulative translation adjustment.", "label": "Cumulative Translation Adjustment" } } }, "localname": "CumulativeTranslationAdjustment", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "OMQS_DangotComputersLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dangot computers ltd member.", "label": "Dangot Computers Ltd [Member]" } } }, "localname": "DangotComputersLtdMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_DangotSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dangot Shares [Member]", "label": "Dangot Shares [Member]" } } }, "localname": "DangotSharesMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" ], "xbrltype": "domainItemType" }, "OMQS_DecemberFourTwoThousandTwentySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "December 4, 2027 [Member]", "label": "December 4, 2027 [Member]" } } }, "localname": "DecemberFourTwoThousandTwentySevenMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_DecemberThirtyTwoThousandTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "December 30, 2020 [Member]", "label": "December 30, 2020 [Member]" } } }, "localname": "DecemberThirtyTwoThousandTwentyMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_DefinitiveAcquisitionAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Definitive Acquisition Agreement [Member].", "label": "Definitive Acquisition Agreement [Member]" } } }, "localname": "DefinitiveAcquisitionAgreementMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_DisclosureRelatedPartyNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Notes Payable", "verboseLabel": "Schedule Of Future Maturities Of Notes Payable Related Parties" } } }, "localname": "DisclosureRelatedPartyNotesPayableAbstract", "nsuri": "http://omniqinc.com/20210930", "xbrltype": "stringItemType" }, "OMQS_EighthAmendmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eighth Amendment [Member]", "label": "Eighth Amendment [Member]" } } }, "localname": "EighthAmendmentMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_EmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Stock Purchase Plan [Member]", "label": "Employee Stock Purchase Plan [Member]" } } }, "localname": "EmployeeStockPurchasePlanMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_EmploymentAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note Payable- Supplier [Member].", "label": "Employment Agreement [Member]" } } }, "localname": "EmploymentAgreementMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_EquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Incentive Plan [Member]", "label": "Equity Incentive Plan [Member]" } } }, "localname": "EquityIncentivePlanMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_ExercisePriceRangeEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range 8 [Member]", "label": "Exercise Price Range 8 [Member]" } } }, "localname": "ExercisePriceRangeEightMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "domainItemType" }, "OMQS_ExercisePriceRangeFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range Five [Member]", "label": "Exercise Price Range Five [Member]" } } }, "localname": "ExercisePriceRangeFiveMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "OMQS_ExercisePriceRangeFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range 4 [Member]", "label": "Exercise Price Range 4 [Member]" } } }, "localname": "ExercisePriceRangeFourMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "OMQS_ExercisePriceRangeNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range 9 [Member]", "label": "Exercise Price Range 9 [Member]" } } }, "localname": "ExercisePriceRangeNineMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "domainItemType" }, "OMQS_ExercisePriceRangeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range 1 [Member]", "label": "Exercise Price Range 1 [Member]" } } }, "localname": "ExercisePriceRangeOneMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "OMQS_ExercisePriceRangeSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range 7 [Member]", "label": "Exercise Price Range 7 [Member]" } } }, "localname": "ExercisePriceRangeSevenMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "domainItemType" }, "OMQS_ExercisePriceRangeSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range 6 [Member]", "label": "Exercise Price Range 6 [Member]" } } }, "localname": "ExercisePriceRangeSixMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "domainItemType" }, "OMQS_ExercisePriceRangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range 3 [Member]", "label": "Exercise Price Range 3 [Member]" } } }, "localname": "ExercisePriceRangeThreeMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "OMQS_ExercisePriceRangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range 2 [Member]", "label": "Exercise Price Range 2 [Member]" } } }, "localname": "ExercisePriceRangeTwoMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "OMQS_EyepaxITConsultingLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eyepax IT Consulting, LLC [Member].", "label": "Eyepax I T Consulting L L C [Member]" } } }, "localname": "EyepaxITConsultingLLCMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_FactoringAndSecurityAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Factoring and Security Agreement [Member]", "label": "Factoring and Security Agreement [Member]" } } }, "localname": "FactoringAndSecurityAgreementMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_FebruarySeventeenTwoThoudsandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 17, 2022 [Member]", "label": "February 17, 2022 [Member]" } } }, "localname": "FebruarySeventeenTwoThoudsandTwentyTwoMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_FebruarySeventeenTwoThoudsandTwentyTwoOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 17, 2022 [Member]", "label": "February 17, 2022 [Member] [Default Label]", "verboseLabel": "February 17, 2022 [Member]" } } }, "localname": "FebruarySeventeenTwoThoudsandTwentyTwoOneMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_FebruaryTwentyEightTwoThoudsandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 28, 2023 [Member]", "label": "February 28, 2023 [Member]" } } }, "localname": "FebruaryTwentyEightTwoThoudsandTwentyThreeMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_FebruaryTwentySevenThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 27, 2022 [Member]", "label": "February 27, 2022 [Member]" } } }, "localname": "FebruaryTwentySevenThousandTwentyTwoMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_FebruaryTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 02, 2021 [Member]", "label": "February 02, 2021 [Member]" } } }, "localname": "FebruaryTwoThousandTwentyOneMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_FirstMinimumPaymentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Minimum Payment [Member]", "label": "First Minimum Payment [Member]." } } }, "localname": "FirstMinimumPaymentMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_FirstThreeMonthlyPaymentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Three Monthly Payments [Member]", "label": "First Three Monthly Payments [Member]" } } }, "localname": "FirstThreeMonthlyPaymentsMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_FourCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Four Customers [Member]", "label": "Four Customers [Member]" } } }, "localname": "FourCustomersMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_GamdanOfficeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gamdan Office [Member]", "label": "Gamdan Office [Member]" } } }, "localname": "GamdanOfficeMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_HaimDagotMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Haim Dagot [Member]", "label": "Haim Dagot [Member]" } } }, "localname": "HaimDagotMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_HaimDangotMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Haim Dangot [Member]", "label": "Haim Dangot [Member]" } } }, "localname": "HaimDangotMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_HofmanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hofman [Member]", "label": "Hofman [Member]" } } }, "localname": "HofmanMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_IncreaseDecreaseInOperatingLeaseLiabilities": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in operating lease liabilities.", "label": "IncreaseDecreaseInOperatingLeaseLiabilities", "verboseLabel": "Lease liability" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiabilities", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "OMQS_IncreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase in accounts payable and accrued liabilities related party.", "label": "IncreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty", "verboseLabel": "Accrued interest and accrued liabilities, related party" } } }, "localname": "IncreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "OMQS_IntangibleAssetsAcquiredInNoncashExchange": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Intangible assets acquired in noncash exchange.", "label": "Intangible assets acquired in non-cash exchange" } } }, "localname": "IntangibleAssetsAcquiredInNoncashExchange", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "OMQS_JulyEightTwoThousandTwentySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July 8, 2026 [Member]", "label": "July 8, 2026 [Member]" } } }, "localname": "JulyEightTwoThousandTwentySixMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_JulyThirtyOneTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July 31, 2023 [Member]", "label": "July 31, 2023 [Member]" } } }, "localname": "JulyThirtyOneTwoThousandTwentyThreeMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_JuneFourTwoThousandTwentySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June 4, 2026 [Member]", "label": "June 4, 2026 [Member]" } } }, "localname": "JuneFourTwoThousandTwentySixMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_LastTwoMonthlyPaymentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Last Two Monthly Payments [Member]", "label": "Last Two Monthly Payments [Member]" } } }, "localname": "LastTwoMonthlyPaymentsMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_MarchZeroFiveTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March 05, 2023 [Member]", "label": "March 05, 2023 [Member]" } } }, "localname": "MarchZeroFiveTwoThousandTwentyThreeMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_MarinNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Marin Note [Member]", "label": "Marin Note [Member]" } } }, "localname": "MarinNoteMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_MayEighteenTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May 18, 2023 [Member]", "label": "May 18, 2023 [Member]" } } }, "localname": "MayEighteenTwoThousandTwentyThreeMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_MrCalderaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mr.Caldera [Member].", "label": "Mr Caldera [Member]" } } }, "localname": "MrCalderaMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_NetIncomeLossAfterDividendNoncontrollingInterest": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net income (loss) after dividend non-controlling interest.", "label": "Net income after series C dividend attributable to noncontrolling interest" } } }, "localname": "NetIncomeLossAfterDividendNoncontrollingInterest", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "OMQS_NetIncomeLossBeforeDividend": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net income (loss) before dividend.", "label": "NetIncomeLossBeforeDividend", "totalLabel": "Net loss less series C dividend" } } }, "localname": "NetIncomeLossBeforeDividend", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "OMQS_NotePayableMarinMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note Payable Marin [Member]", "label": "Note Payable Marin [Member]" } } }, "localname": "NotePayableMarinMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "OMQS_NotePayableShareholderConvertibleNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note Payable - Shareholder Convertible Note [Member]", "label": "Note Payable - Shareholder Convertible Note [Member]" } } }, "localname": "NotePayableShareholderConvertibleNoteMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "OMQS_NotePayableSupplierMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note Payable- Supplier [Member]", "label": "Note Payable- Supplier [Member]" } } }, "localname": "NotePayableSupplierMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "domainItemType" }, "OMQS_NotePayableThometMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note Payable Thomet [Member]", "label": "Note Payable Thomet [Member]" } } }, "localname": "NotePayableThometMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "OMQS_NotesPayableRelatedPartiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes Payable Related Parties [TextBlock]", "label": "RELATED PARTY NOTES PAYABLE" } } }, "localname": "NotesPayableRelatedPartiesTextBlock", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayable" ], "xbrltype": "textBlockItemType" }, "OMQS_NovemberThirtyTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "November 30, 2023 [Member]", "label": "November 30, 2023 [Member]" } } }, "localname": "NovemberThirtyTwoThousandTwentyThreeMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_NovemberTwentyThousandTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "November 20, 2024 [Member]", "label": "November 20, 2024 [Member]" } } }, "localname": "NovemberTwentyThousandTwentyFourMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_NumberofTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of trading days.", "label": "Number of trading days" } } }, "localname": "NumberofTradingDays", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "integerItemType" }, "OMQS_OctoberFourteenTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "October 14, 2023 [Member]", "label": "October 14, 2023 [Member]" } } }, "localname": "OctoberFourteenTwoThousandTwentyThreeMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_OctoberSixTwoThousandTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "October 6, 2024 [Member]", "label": "October 6, 2024 [Member]" } } }, "localname": "OctoberSixTwoThousandTwentyFourMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_OctoberTenTwoThousandTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "October 10, 2020 [Member]", "label": "October 10, 2020 [Member]" } } }, "localname": "OctoberTenTwoThousandTwentyMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_OctoberTenTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "October 10, 2021 [Member]", "label": "October 10, 2021 [Member]" } } }, "localname": "OctoberTenTwoThousandTwentyOneMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_OctoberThirtyFirstTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "October 31, 2023 [Member]", "label": "October 31, 2023 [Member]" } } }, "localname": "OctoberThirtyFirstTwoThousandTwentyThreeMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_OmniqTechnologiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Omniq Technologies [Member]", "label": "Omniq Technologies [Member]" } } }, "localname": "OmniqTechnologiesMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_OneCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Customers [Member]", "label": "One Customers [Member]" } } }, "localname": "OneCustomersMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_OneVendorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Vendor [Member].", "label": "One Vendor [Member]" } } }, "localname": "OneVendorMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_OperatingLeaseRightOfUseAssetsAmortizationExpense": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of ROU lease assets.", "label": "Amortization of ROU lease asset" } } }, "localname": "OperatingLeaseRightOfUseAssetsAmortizationExpense", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "OMQS_OrionFourLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Orion 4, LLC [Member]", "label": "Orion 4, LLC [Member]" } } }, "localname": "OrionFourLLCMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_PercentageOfReserveAccount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of reserve account.", "label": "Percentage of reserve account" } } }, "localname": "PercentageOfReserveAccount", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "percentItemType" }, "OMQS_PlacementAgencyAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Placement Agency Agreement [Member]" } } }, "localname": "PlacementAgencyAgreementMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_PlacementAgentFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Placement agent fees.", "label": "Placement Agent fees" } } }, "localname": "PlacementAgentFees", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingDetails" ], "xbrltype": "monetaryItemType" }, "OMQS_ProceedsFromCapitalRaise": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from capital raise.", "label": "Raise capital" } } }, "localname": "ProceedsFromCapitalRaise", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "OMQS_ProceedsFromOtherCurrentAssets": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from other current assets.", "label": "ProceedsFromOtherCurrentAssets", "verboseLabel": "Other assets" } } }, "localname": "ProceedsFromOtherCurrentAssets", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "OMQS_RemainingAcquiredPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Remaining acquired percentage", "label": "Remaining acquired percentage" } } }, "localname": "RemainingAcquiredPercentage", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "percentItemType" }, "OMQS_RentalCarsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rental Cars [Member]", "label": "Rental Cars [Member]" } } }, "localname": "RentalCarsMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_RentalExpenseMonthlyPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Rental expense monthly payments.", "label": "Rental expense monthly expenses" } } }, "localname": "RentalExpenseMonthlyPayments", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "OMQS_RightOfUseLeaseAssetOnNonCashInformation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Right of use lease asset on non cash information.", "label": "RightOfUseLeaseAssetOnNonCashInformation", "verboseLabel": "Right of use lease asset" } } }, "localname": "RightOfUseLeaseAssetOnNonCashInformation", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "OMQS_RivalWareHouseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rival Ware House [Member]", "label": "Rival Ware House [Member]" } } }, "localname": "RivalWareHouseMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_SaltLackCityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Salt Lack City [Member]", "label": "Salt Lack City [Member]" } } }, "localname": "SaltLackCityMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_SaltLakeCityUTMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Salt Lake City UT [Member]", "label": "Salt Lake City UT [Member]" } } }, "localname": "SaltLakeCityUTMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of additional legal and other fees related to offering [Table Text Block]", "label": "SCHEDULE OF ADDITIONAL LEGAL AND OTHER FEES RELATED TO OFFERING" } } }, "localname": "ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingTableTextBlock", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "OMQS_ScheduleOfFutureMaturitiesOfNotesPayableRelatedPartiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Future Maturities Of Notes Payable Related Parties [Table Text Block]", "label": "SCHEDULE OF FUTURE MATURITIES OF NOTES PAYABLE, RELATED PARTIES" } } }, "localname": "ScheduleOfFutureMaturitiesOfNotesPayableRelatedPartiesTableTextBlock", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableTables" ], "xbrltype": "textBlockItemType" }, "OMQS_ScheduleOfOutstandingWarrantsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Outstanding Warrants [Table Text Block]", "label": "SCHEDULE OF OUTSTANDING WARRANTS" } } }, "localname": "ScheduleOfOutstandingWarrantsTableTextBlock", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "OMQS_ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of warrants outstanding expiry date and exercise prices [Table Text Block]", "label": "SCHEDULE OF WARRANTS OUTSTANDING, EXPIRY DATE AND EXERCISE PRICES" } } }, "localname": "ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesTableTextBlock", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "OMQS_SecuredPromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Secured Promissory Note [Member]", "label": "Secured Promissory Note [Member]" } } }, "localname": "SecuredPromissoryNoteMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities Purchase Agreement [Member].", "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_SeptemberOneTwoThoousandTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September 1, 2025 [Member]", "label": "September 1, 2025 [Member]" } } }, "localname": "SeptemberOneTwoThoousandTwentyFiveMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_SeptemberThirtyTwoThousandThirtyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September 30, 2030 [Member]", "label": "September 30, 2030 [Member]" } } }, "localname": "SeptemberThirtyTwoThousandThirtyMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_SeptemberThirtyTwoThousandThirtyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September 30, 2030 [Member]", "label": "September 30, 2030 [Member] [Default Label]", "verboseLabel": "September 30, 2030 [Member]" } } }, "localname": "SeptemberThirtyTwoThousandThirtyOneMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "OMQS_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vestednon-option equity outstanding as of the balance sheet date can be currently converted under the non-option equity plan.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber", "periodEndLabel": "Number of warrants, Exercisable warrants" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "OMQS_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of non-option equity outstanding and currently exercisable under the non-option equity plan.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice", "periodEndLabel": "Weighted Average Exercise Price, Exercisable warrants" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "OMQS_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares.", "label": "Weighted Average Exercise Price, Warrants exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "OMQS_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award non option equity instruments expired in period weighted average exercise price.", "label": "Weighted Average Exercise Price, Warrants expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "OMQS_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity.", "label": "Weighted Average Exercise Price, Warrants granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "OMQS_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "periodEndLabel": "Weighted Average Exercise Price, Outstanding, End of period", "periodStartLabel": "Weighted Average Exercise Price balance, Outstanding, Beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "OMQS_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock non options that were terminated.", "label": "Weighted Average Exercise Price, Warrants cancelled, forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "OMQS_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation shares authorized under stock option plans exercise price range.", "label": "Range of Exercise Prices" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "perShareItemType" }, "OMQS_ShareholderConvertibleNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share holder Convertible Note [Member]", "label": "Share holder Convertible Note [Member]" } } }, "localname": "ShareholderConvertibleNoteMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_SixthAmendmentAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sixth Amendment Agreement [Member]", "label": "Sixth Amendment Agreement [Member]" } } }, "localname": "SixthAmendmentAgreementMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_SixtyFiveEmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sixty Five Employees [Member]", "label": "Sixty Five Employees [Member]" } } }, "localname": "SixtyFiveEmployeesMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_StockIssuedDuringPeriodSharesConversionAgreementsPreferredShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares conversion agreements preferred shares.", "label": "Converion agreements - preferred shares, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionAgreementsPreferredShares", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "OMQS_StockIssuedDuringPeriodSharesExerciseOfStockOptionsAndWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares exercise of stock options and warrants.", "label": "exercise of stock options and warrants, shares" } } }, "localname": "StockIssuedDuringPeriodSharesExerciseOfStockOptionsAndWarrants", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "OMQS_StockIssuedDuringPeriodSharesWarrantIssuancesNetOfIssuanceCosts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares warrant issuances net of issuance costs,", "label": "Stock and warrant issuances, net of issuance costs, shares" } } }, "localname": "StockIssuedDuringPeriodSharesWarrantIssuancesNetOfIssuanceCosts", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "OMQS_StockIssuedDuringPeriodValueAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value acquisition.", "label": "Stock and warrant issuance for Acquisition" } } }, "localname": "StockIssuedDuringPeriodValueAcquisition", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "OMQS_StockIssuedDuringPeriodValueConversionAgreementsDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion agreements - debt.", "label": "Conversion agreements - debt" } } }, "localname": "StockIssuedDuringPeriodValueConversionAgreementsDebt", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "OMQS_StockIssuedDuringPeriodValueConversionAgreementsPreferredShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion agreement.", "label": "Conversion agreements - preferred shares" } } }, "localname": "StockIssuedDuringPeriodValueConversionAgreementsPreferredShares", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "OMQS_StockIssuedDuringPeriodValueExerciseOfStockOptionsAndWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Exercise of stock options and warrants.", "label": "Exercise of stock options and warrants" } } }, "localname": "StockIssuedDuringPeriodValueExerciseOfStockOptionsAndWarrants", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "OMQS_StockIssuedDuringPeriodValueForDangotAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value for dangot acquisition.", "label": "Dangot Acquisition" } } }, "localname": "StockIssuedDuringPeriodValueForDangotAcquisition", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "OMQS_StockIssuedDuringPeriodValueNoncontrollingInterestsDistributionsAndOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value noncontrolling interests distributions and other.", "label": "Noncontrolling interests - distributions and other" } } }, "localname": "StockIssuedDuringPeriodValueNoncontrollingInterestsDistributionsAndOther", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "OMQS_StockIssuedDuringPeriodWarrantIssuancesNetOfIssuanceCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period warrant issuances net of issuance costs.", "label": "Stock and warrant issuances, net of issuance costs" } } }, "localname": "StockIssuedDuringPeriodWarrantIssuancesNetOfIssuanceCosts", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "OMQS_StockOptionsAndWarrantsIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock options and warrants issued.", "label": "Stock options and warrants issued" } } }, "localname": "StockOptionsAndWarrantsIssued", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "OMQS_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Options [Member]", "label": "Stock Options [Member]" } } }, "localname": "StockOptionsMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "domainItemType" }, "OMQS_StockbasedCompensationOptionsWarrantsIssuances": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock-based compensation options and warrants.", "label": "Stock-based compensation \u2013 options and warrants" } } }, "localname": "StockbasedCompensationOptionsWarrantsIssuances", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "OMQS_SubscribedCommonStockShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subscribed common stock shares.", "label": "Subscribed common stock, shares" } } }, "localname": "SubscribedCommonStockShares", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "OMQS_ThometNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Thomet Note [Member]", "label": "Thomet Note [Member]" } } }, "localname": "ThometNoteMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_TwoCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Customers [Member].", "label": "Two Customers [Member]" } } }, "localname": "TwoCustomersMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_VehicleLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vehicle Lease [Member]", "label": "Vehicle Lease [Member]" } } }, "localname": "VehicleLeaseMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "OMQS_WorkingCapitalDeficit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital deficit.", "label": "Working capital deficit" } } }, "localname": "WorkingCapitalDeficit", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "OMQS_YadHaruzimMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Yad Haruzim [Member]", "label": "Yad Haruzim [Member]" } } }, "localname": "YadHaruzimMember", "nsuri": "http://omniqinc.com/20210930", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r516", "r518", "r519" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r508" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r511" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r523" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Series [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r510" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://omniqinc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_DirectorMember": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r176", "r303", "r305", "r481" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r232", "r269", "r309", "r312", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r479", "r482", "r504", "r505" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r232", "r269", "r309", "r312", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r479", "r482", "r504", "r505" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r176", "r303", "r305", "r481" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r232", "r269", "r307", "r309", "r312", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r479", "r482", "r504", "r505" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r232", "r269", "r307", "r309", "r312", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r479", "r482", "r504", "r505" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails", "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r119", "r124", "r310" ], "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r174", "r175", "r303", "r304", "r480", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503" ], "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r174", "r175", "r303", "r304", "r480", "r491", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r119", "r124", "r207", "r310", "r427" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r177", "r420" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r38" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent": { "auth_ref": [ "r46" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for compensation costs, fringe benefits other than pension and postretirement obligations, rent, contractual rights and obligations, and statutory obligations.", "label": "Accrued interest and accrued liabilities, related party", "verboseLabel": "Accrued interest payable" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableMember": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Obligations incurred and payable to vendors for goods and services received.", "label": "Accounts Payable [Member]" } } }, "localname": "AccountsPayableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableTradeCurrentAndNoncurrent": { "auth_ref": [ "r449", "r471" ], "calculation": { "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Other vendor payable" } } }, "localname": "AccountsPayableTradeCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r7", "r27", "r178", "r179" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes": { "auth_ref": [ "r472" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount for commissions, taxes and other expenses that were incurred but unpaid as of the balance sheet date.", "label": "Accrued Liabilities for Commissions, Expense and Taxes" } } }, "localname": "AccruedLiabilitiesForCommissionsExpenseAndTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/LitigationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedPayrollTaxesCurrent": { "auth_ref": [ "r15", "r40" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll and sales tax" } } }, "localname": "AccruedPayrollTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r34", "r201" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Property and equipment, accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingDetails", "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r63", "r64", "r397", "r398", "r399", "r400", "r401", "r403" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingDetails", "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r55", "r56", "r63", "r64", "r65", "r111", "r112", "r113", "r379", "r483", "r484", "r527" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r28", "r338", "r425" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r111", "r112", "r113", "r335", "r336", "r337", "r388" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": { "auth_ref": [ "r228" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.", "label": "Conversion of debt" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Cumulative translation adjustment" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "auth_ref": [ "r283", "r290" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "Subscribed common stock" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash (used in) provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r90", "r192", "r198" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Potential shares excluded from diluted net loss per share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative", "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r105", "r162", "r165", "r171", "r181", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r372", "r380", "r395", "r423", "r425", "r442", "r463" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r9", "r11", "r54", "r105", "r181", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r372", "r380", "r395", "r423", "r425" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r314", "r333" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r314", "r333" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r308", "r311" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r308", "r311", "r352", "r353" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r364" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business acquisition stock issued, shares", "verboseLabel": "Number of shares will be issued" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Acquisition percentage" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r350", "r351" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "SCHEDULE OF PROFORMA UNAUDITED REVENUE AND EARNINGS" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r350", "r351" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Net income (loss)" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfProformaUnauditedRevenueAndEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r350", "r351" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Revenue" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfProformaUnauditedRevenueAndEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": { "auth_ref": [ "r356" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.", "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value", "negatedLabel": "Non-controlling interest" } } }, "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r360", "r361", "r362" ], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "totalLabel": "Total consideration" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "BUSINESS ACQUISITION" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisition" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r355" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r355" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "verboseLabel": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r355" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Other Assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r355" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Accounts Receivable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r354", "r355" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Other intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r354", "r355" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "verboseLabel": "Inventory" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r355" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "negatedLabel": "Current liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r354", "r355" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Property and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "auth_ref": [ "r355" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.", "label": "Net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock": { "auth_ref": [ "r348", "r365" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for business combinations and other business acquisition transactions not accounted for using the purchase method, such as an exchange of shares between entities under common control.", "label": "Purchase Accounting and Business Combinations" } } }, "localname": "BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r33", "r425", "r489", "r490" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r5", "r33", "r92" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r86", "r92", "r97" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and restricted cash, end of period", "periodStartLabel": "Cash and restricted cash, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r86", "r396" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r102", "r105", "r128", "r129", "r130", "r133", "r135", "r141", "r142", "r143", "r181", "r217", "r221", "r222", "r223", "r226", "r227", "r267", "r268", "r272", "r276", "r395", "r522" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Warrant Exercise Prices", "verboseLabel": "Warrants exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Number of warrants issued for purchase of common stock" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Warrant Outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r203", "r204", "r205", "r214", "r494" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r111", "r112", "r388" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingDetails", "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r26", "r283" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r26", "r425" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock; $0.001 par value; 15,000,000 shares authorized; 7,448,597 and 4,684,736 shares issued and outstanding, respectively." } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Provision for Income Taxes" } } }, "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r59", "r61", "r62", "r70", "r453", "r476" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r151", "r152", "r176", "r392", "r393", "r493" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r151", "r152", "r176", "r392", "r393", "r488", "r493" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r151", "r152", "r176", "r392", "r393", "r488", "r493" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r157" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "CONCENTRATIONS" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/Concentrations" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r151", "r152", "r176", "r392", "r393" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r149", "r151", "r152", "r153", "r392", "r394", "r493" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r151", "r152", "r176", "r392", "r393", "r493" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r99", "r374" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation and Basis of Presentation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertiblePreferredStockMember": { "auth_ref": [ "r267", "r268", "r272" ], "lang": { "en-us": { "role": { "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.", "label": "Convertible Preferred Stock [Member]" } } }, "localname": "ConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r74", "r437" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "verboseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSoldAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSoldAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r106", "r341", "r345", "r346" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r150", "r176" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r359" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r101", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r246", "r253", "r254", "r256", "r262" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "OTHER NOTES PAYABLE" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/OtherNotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r20", "r21", "r22", "r104", "r109", "r229", "r230", "r231", "r232", "r233", "r234", "r236", "r242", "r243", "r244", "r245", "r247", "r248", "r249", "r250", "r251", "r252", "r258", "r259", "r260", "r261", "r409", "r443", "r446", "r461" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails", "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r229", "r258", "r259", "r407", "r409", "r410" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt instrument face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r104" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Debt instrument, increase, accrued interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r43", "r249", "r407" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r43", "r230" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt instruments interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative", "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r44", "r104", "r109", "r229", "r230", "r231", "r232", "r233", "r234", "r236", "r242", "r243", "r244", "r245", "r247", "r248", "r249", "r250", "r251", "r252", "r258", "r259", "r260", "r261", "r409" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails", "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPayment": { "auth_ref": [ "r44", "r459" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments including both interest and principal payments.", "label": "Debt instruments periodic payment" } } }, "localname": "DebtInstrumentPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "auth_ref": [ "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments applied to principal.", "label": "Monthly principal payments" } } }, "localname": "DebtInstrumentPeriodicPaymentPrincipal", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r44", "r104", "r109", "r229", "r230", "r231", "r232", "r233", "r234", "r236", "r242", "r243", "r244", "r245", "r247", "r248", "r249", "r250", "r251", "r252", "r255", "r258", "r259", "r260", "r261", "r284", "r287", "r288", "r289", "r406", "r407", "r409", "r410", "r460" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative", "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredOfferingCosts": { "auth_ref": [ "r53", "r185" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.", "label": "Offering cost" } } }, "localname": "DeferredOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r90", "r200" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r90", "r200" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_Dividends": { "auth_ref": [ "r290", "r458" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.", "label": "Dividends" } } }, "localname": "Dividends", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableAmountPerShare": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.", "label": "Dividends payable, amount per share" } } }, "localname": "DividendsPayableAmountPerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r21", "r23", "r444", "r464" ], "calculation": { "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividend payable" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r290", "r458" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Preferred Stock", "negatedLabel": "Dividend on Class C Shares" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r71", "r116", "r117", "r118", "r119", "r120", "r125", "r128", "r133", "r134", "r135", "r138", "r139", "r389", "r390", "r454", "r477" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net (loss) per share - basic attributable to common stockholders\u2019 of OmniQ Corp" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r136", "r137" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net Loss Per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r396" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Foreign currency Exchange" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails", "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r63", "r64", "r65", "r111", "r112", "r113", "r115", "r121", "r123", "r140", "r182", "r283", "r290", "r335", "r336", "r337", "r342", "r343", "r388", "r397", "r398", "r399", "r400", "r401", "r403", "r483", "r484", "r485", "r527" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingDetails", "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails", "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedCustomerRelationshipsGross": { "auth_ref": [ "r197" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date to an asset acquired in a business combination representing a favorable existing relationship with customers having a finite beneficial life.", "label": "Customer relationships, net of accumulated amortization of $9,279 and $4,885, respectively" } } }, "localname": "FiniteLivedCustomerRelationshipsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r197" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r193", "r194", "r197", "r199", "r438", "r439" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r193", "r196" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedTradeNamesGross": { "auth_ref": [ "r197" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a reasonably expected period of economic benefit.", "label": "Trade name, net of accumulated amortization of $3,714 and $1,156, respectively" } } }, "localname": "FiniteLivedTradeNamesGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r186", "r188", "r425", "r440" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r190", "r195" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangibles" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r90", "r187", "r189", "r191" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Impairment of goodwill" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r73", "r105", "r162", "r164", "r167", "r170", "r172", "r181", "r217", "r218", "r219", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r395" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).", "label": "Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net", "totalLabel": "Net Loss Before Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r107", "r122", "r123", "r161", "r340", "r344", "r347", "r478" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedTotalLabel": "Total Provision for Income Taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r93" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r89" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r89" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": { "auth_ref": [ "r89" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.", "label": "Accrued payroll and sales taxes payable" } } }, "localname": "IncreaseDecreaseInAccruedTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r89" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r89" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other Current assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r89" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r89" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r67", "r160", "r405", "r408", "r455" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r84", "r87", "r93" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r6", "r52", "r425" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r75" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal Fees", "negatedLabel": "Commission, Legal and other fees" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "auth_ref": [ "r214" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.", "label": "LITIGATION" } } }, "localname": "LegalMattersAndContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/Litigation" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r39", "r105", "r166", "r181", "r217", "r218", "r219", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r373", "r380", "r381", "r395", "r423", "r424" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r32", "r105", "r181", "r395", "r425", "r448", "r469" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity (deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r42", "r105", "r181", "r217", "r218", "r219", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r373", "r380", "r381", "r395", "r423", "r424", "r425" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long term liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r22", "r446", "r461" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "verboseLabel": "Line of credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r36" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of credit, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line of credit facility, unused capacity, commitment fee percentage" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_LinesOfCreditCurrent": { "auth_ref": [ "r20", "r443" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Line of credit" } } }, "localname": "LinesOfCreditCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r22", "r243", "r257", "r258", "r259", "r446", "r466" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "auth_ref": [ "r109", "r215", "r248" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r109", "r215", "r248" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r109", "r215", "r248" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r109", "r215", "r248" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r109" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.", "label": "2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfFutureMaturitiesOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r44" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes payable, less current portion" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r44", "r216" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r51", "r105", "r181", "r217", "r221", "r222", "r223", "r226", "r227", "r395", "r447", "r468" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Non-controlling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r144", "r157" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "NATURE OF OPERATIONS" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/NatureOfOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r86" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r86" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r86", "r88", "r91" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash (used in) provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from continuing operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r3", "r57", "r60", "r65", "r68", "r91", "r105", "r114", "r116", "r117", "r118", "r119", "r122", "r123", "r131", "r162", "r164", "r167", "r170", "r172", "r181", "r217", "r218", "r219", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r390", "r395", "r451", "r474" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net Loss attributable to OmniQ Corp" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r57", "r60", "r65", "r122", "r123", "r376", "r383" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net income attributable to noncontrolling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r116", "r117", "r118", "r119", "r125", "r126", "r132", "r135", "r162", "r164", "r167", "r170", "r172" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net loss after series C dividend attributable to common stockholders\u2019 of OmniQ Corp" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation of net loss to net loss attributable to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionDebtAssumed1": { "auth_ref": [ "r94", "r95", "r96" ], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of debt that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt assumed" } } }, "localname": "NoncashOrPartNoncashAcquisitionDebtAssumed1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r77" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other expenses" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expenses):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r38" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes payable \u2013 current portion" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r35", "r108", "r419" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes payable, related parties \u2013 current portion", "negatedLabel": "Less: current portion" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r108", "r418", "r473" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties.", "label": "Total notes payable", "verboseLabel": "Note payable, related parties" } } }, "localname": "NotesPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesNoncurrent": { "auth_ref": [ "r45", "r108", "r418" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).", "label": "Notes payable, related party, less current portion", "verboseLabel": "Long Term Notes Payable" } } }, "localname": "NotesPayableRelatedPartiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OfficersCompensation": { "auth_ref": [ "r72" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Annual salary" } } }, "localname": "OfficersCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r162", "r164", "r167", "r170", "r172" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r412" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Lease liability \u2013 current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r412" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Lease liability" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r411" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of use lease asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r414", "r415" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r413", "r415" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_OptionIndexedToIssuersEquityTypeAxis": { "auth_ref": [ "r263", "r385", "r386", "r387" ], "lang": { "en-us": { "role": { "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock.", "label": "Option Indexed to Issuer's Equity, Type [Axis]" } } }, "localname": "OptionIndexedToIssuersEquityTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OptionIndexedToIssuersEquityTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding." } } }, "localname": "OptionIndexedToIssuersEquityTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r19", "r441", "r462" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r53", "r425" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent": { "auth_ref": [ "r370", "r371", "r378" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent", "negatedLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r58", "r61", "r63", "r64", "r66", "r69", "r283", "r397", "r402", "r403", "r452", "r475" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Accumulated other comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherFiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r197" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of finite-lived intangible assets classified as other.", "label": "Other intangibles, net of accumulated amortization of $1,402 and $1,104, respectively" } } }, "localname": "OtherFiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilities": { "auth_ref": [ "r450" ], "calculation": { "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other.", "label": "Other Liabilities", "totalLabel": "Total other liabilities" } } }, "localname": "OtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r13", "r14", "r40", "r425" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other current liabilities", "negatedLabel": "Less Current Portion" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities Disclosure [Abstract]" } } }, "localname": "OtherLiabilitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "OTHER LIABILITIES" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/OtherLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r46" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other long-term liabilities", "verboseLabel": "Total long term other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other liabilities.", "label": "SCHEDULE OF OTHER LIABILITIES" } } }, "localname": "OtherLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/OtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLongTermNotesPayable": { "auth_ref": [ "r44" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term notes classified as other, payable after one year or the normal operating cycle, if longer.", "label": "Other Notes Payable, Noncurrent", "verboseLabel": "Total notes payable" } } }, "localname": "OtherLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r78" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other (expenses) income" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNotesPayable": { "auth_ref": [ "r22", "r446", "r466" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term notes payable classified as other.", "label": "Other Notes Payable", "verboseLabel": "Total notes payable" } } }, "localname": "OtherNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNotesPayableCurrent": { "auth_ref": [ "r40" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Other Notes Payable, Current", "negatedLabel": "Less current portion" } } }, "localname": "OtherNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSundryLiabilities": { "auth_ref": [ "r21", "r23", "r445", "r465" ], "calculation": { "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate carrying amount, as of the balance sheets date, of obligations not otherwise itemized or categorized in the footnotes to the financial statements.", "label": "Others" } } }, "localname": "OtherSundryLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r79", "r363" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Cash purchase price" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r79" ], "calculation": { "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 }, "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Cash payments", "negatedLabel": "Payments for acquisition, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r80" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r314", "r333" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockConversionBasis": { "auth_ref": [ "r25", "r284" ], "lang": { "en-us": { "role": { "documentation": "Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.", "label": "Preferred stock conversion, description" } } }, "localname": "PreferredStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockDividendsIncomeStatementImpact": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "OMQS_NetIncomeLossBeforeDividend", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.", "label": "Preferred Stock Dividends, Income Statement Impact", "negatedLabel": "Less: Preferred stock \u2013 Series C dividend" } } }, "localname": "PreferredStockDividendsIncomeStatementImpact", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockLiquidationPreference": { "auth_ref": [ "r25", "r102", "r272", "r284", "r285" ], "lang": { "en-us": { "role": { "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.", "label": "Preferred stock, liquidation preference per share" } } }, "localname": "PreferredStockLiquidationPreference", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r25", "r267" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares designated", "verboseLabel": "Preferred stock shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r25", "r267" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r25", "r425" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock Value" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockVotingRights": { "auth_ref": [ "r25", "r284" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Preferred stock voting rights" } } }, "localname": "PreferredStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r8", "r10", "r183", "r184" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassifications and Comparability" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r81" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r81" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from private placement", "verboseLabel": "Proceeds from placement" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r81" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "verboseLabel": "Total" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "auth_ref": [], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).", "label": "Proceeds from / (payments on) line of credit" } } }, "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromShortTermDebt": { "auth_ref": [ "r82" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Proceeds from notes/loans payable" } } }, "localname": "ProceedsFromShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r81", "r334" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Net Proceeds from Options Exercise" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockPlans": { "auth_ref": [ "r81" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the stock plan during the period.", "label": "Proceeds from ESPP stock issuance" } } }, "localname": "ProceedsFromStockPlans", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r81" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Net proceeds from Warrant exercise" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductLiabilityContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Liability Contingency [Line Items]" } } }, "localname": "ProductLiabilityContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProductLiabilityContingencyTable": { "auth_ref": [ "r206", "r208", "r209", "r210", "r211", "r212", "r213" ], "lang": { "en-us": { "role": { "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from product liability related to an individual product.", "label": "Product Liability Contingency [Table]" } } }, "localname": "ProductLiabilityContingencyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r3", "r57", "r60", "r65", "r85", "r105", "r114", "r122", "r123", "r162", "r164", "r167", "r170", "r172", "r181", "r217", "r218", "r219", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r370", "r375", "r377", "r383", "r384", "r390", "r395", "r456" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "OMQS_NetIncomeLossBeforeDividend", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net loss", "totalLabel": "Net Loss", "verboseLabel": "Net (loss) income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow", "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r17", "r18", "r202", "r425", "r457", "r470" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net of accumulated depreciation of $767 and $555 respectively" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r416", "r417", "r418", "r421", "r422" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r83" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "negatedLabel": "Payment on notes/loans payable" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r339", "r436", "r506" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research & Development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r12", "r19", "r97", "r492" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r29", "r290", "r338", "r425", "r467", "r486", "r487" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated (deficit)", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r111", "r112", "r113", "r115", "r121", "r123", "r182", "r335", "r336", "r337", "r342", "r343", "r388", "r483", "r485" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r158", "r159", "r163", "r168", "r169", "r173", "r174", "r176", "r302", "r303", "r437" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Total Revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r100", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r306" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition." } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r151", "r176" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "SCHEDULE OF ANTI DILUTIVE SECURITIES EXCLUDES FROM COMPUTATION OF EARNINGS PER SHARE" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r352", "r353" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetails", "http://omniqinc.com/role/ScheduleOfRecognizedFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "SCHEDULE OF OTHER NOTES PAYABLE" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/OtherNotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r34", "r202" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "SCHEDULE OF RECOGNIZED FAIR VALUES OF ASSETS ACQUIRED AND LIABILITIES ASSUMED" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.", "label": "SCHEDULE OF NOTES PAYABLE, RELATED PARTIES" } } }, "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r314", "r333" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "SCHEDULE OF STOCK OPTIONS, EXPIRY DATE AND EXERCISE PRICES" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r318", "r328", "r329" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "SCHEDULE OF STOCK OPTIONS GRANTED" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.", "label": "SCHEDULE OF OUTSTANDING STOCK OPTIONS" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails", "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r47", "r102", "r141", "r142", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r272", "r276", "r281", "r284", "r285", "r286", "r287", "r288", "r289", "r290" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r292", "r313" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "SCHEDULE OF WARRANTS ACTIVITY" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r76" ], "calculation": { "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesCPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series C preferred stock or outstanding series C preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series C Preferred Stock [Member]" } } }, "localname": "SeriesCPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r89" ], "calculation": { "http://omniqinc.com/role/StatementsOfCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "Date the equity-based award expires, in YYYY-MM-DD format.", "label": "Stock options, expiration date", "verboseLabel": "Stock option expiration date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised", "negatedLabel": "Number of warrants, Warrants exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": { "auth_ref": [ "r326" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations", "negatedLabel": "Number of warrants, Warrants expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "auth_ref": [ "r325" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.", "label": "Number of warrants, Warrants cancelled, forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Number of warrants, Warrants granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r319", "r321" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Number of warrants, Outstanding, End of period", "periodStartLabel": "Number of warrants, Outstanding, Beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "periodEndLabel": "Number of stock options, Exercisable stock options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price, Exercisable stock options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r326" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period", "negatedLabel": "Number of stock options, Stock options expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r325" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Number of stock options, Stock options cancelled, forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Stock options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of options granted to purchase common stock", "verboseLabel": "Number of stock options, Stock options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r320", "r333" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Stock option outstanding", "periodEndLabel": "Number of stock options, Outstanding, End of period", "periodStartLabel": "Number of stock options, Outstanding, Beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Stock option exercise prices", "periodEndLabel": "Weighted Average Exercise Price, Outstanding, End of period", "periodStartLabel": "Weighted Average Exercise Price, Outstanding, Beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails", "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r313", "r316" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsExpiryDateAndExercisePricesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted Average Exercise Price, Stock options exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Weighted Average Exercise Price, Stock options expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted average exercise price, stock options granted", "verboseLabel": "Weighted Average Exercise Price, Stock options granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r314", "r317" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Exercisable Warrants", "verboseLabel": "Exercisable Stock Options" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Outstanding Warrants", "verboseLabel": "Outstanding Stock Options" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit", "verboseLabel": "Range of Exercise Prices, Upper Range Limit" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price", "verboseLabel": "Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average residual life span (in years)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Shares, Outstanding, Ending Balance", "periodStartLabel": "Shares, Outstanding, Beginning Balance" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/RelatedPartyNotesPayableDetailsNarrative", "http://omniqinc.com/role/ScheduleOfNotesPayableRelatedPartiesDetails", "http://omniqinc.com/role/ScheduleOfOtherNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTextBlock": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for short-term debt.", "label": "CREDIT FACILITIES AND LINE OF CREDIT" } } }, "localname": "ShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCredit" ], "xbrltype": "textBlockItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r98", "r110" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r24", "r25", "r26", "r102", "r105", "r128", "r129", "r130", "r133", "r135", "r141", "r142", "r143", "r181", "r217", "r221", "r222", "r223", "r226", "r227", "r267", "r268", "r272", "r276", "r283", "r395", "r522" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r50", "r63", "r64", "r65", "r111", "r112", "r113", "r115", "r121", "r123", "r140", "r182", "r283", "r290", "r335", "r336", "r337", "r342", "r343", "r388", "r397", "r398", "r399", "r400", "r401", "r403", "r483", "r484", "r485", "r527" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfAdditionalLegalAndOtherFeesRelatedToOfferingDetails", "http://omniqinc.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails", "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r111", "r112", "r113", "r140", "r437" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/BalanceSheetsParenthetical", "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r94", "r95", "r96" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock issued for services" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r25", "r26", "r290" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock and warrant issuance for Acquisition, shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r49", "r247", "r283", "r284", "r290" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Conversion of Equity, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r25", "r26", "r283", "r290" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "ESPP Stock Issuance, shares", "verboseLabel": "Stock Issued During Period, Shares, Employee Stock Purchase Plans" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock and Warrant issued for service, shares", "verboseLabel": "Number of shares for services" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r25", "r26", "r283", "r290" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock issued", "verboseLabel": "Number of stock issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r283", "r290" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "verboseLabel": "Stock issued during period, restricted shares" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r25", "r26", "r283", "r290", "r324" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Stock options and warrants exercised", "negatedLabel": "Number of stock options, Stock options exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfStockOptionsGrantedDetails", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r50", "r283", "r290" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Conversion of Equity" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r25", "r26", "r283", "r290" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "ESPP Stock Issuance", "verboseLabel": "Stock Issued During Period, Value, Employee Stock Purchase Plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock and Warrant issued for services", "verboseLabel": "Number of shares for services, value" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r25", "r26", "r283", "r290" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock issued during period, new issues" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Other misc. items" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r25", "r26", "r283", "r290" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Professional fees \u2013 restricted shares" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Stock-based compensation \u2013 options, warrants, issuances" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r26", "r30", "r31", "r105", "r180", "r181", "r395", "r425" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total OmniQ stockholders\u2019 equity (deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 equity (deficit)" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r64", "r105", "r111", "r112", "r113", "r115", "r121", "r181", "r182", "r290", "r335", "r336", "r337", "r342", "r343", "r368", "r369", "r382", "r388", "r395", "r397", "r398", "r403", "r484", "r485", "r527" ], "calculation": { "http://omniqinc.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "TOTAL EQUITY (DEFICIT)" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheets", "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r103", "r268", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r282", "r290", "r293" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r426", "r428" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "GOING CONCERN" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplementary for non-cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r48", "r291" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/BusinessAcquisitionDetailsNarrative", "http://omniqinc.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative", "http://omniqinc.com/role/OtherNotesPayableDetailsNarrative", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r145", "r146", "r147", "r148", "r154", "r155", "r156" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/CreditFacilitiesAndLineOfCreditDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfAntiDilutiveSecuritiesExcludesFromComputationOfEarningsPerShareDetails", "http://omniqinc.com/role/ScheduleOfOutstandingWarrantsDetails", "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.", "label": "Warrant expiry date" } } }, "localname": "WarrantsAndRightsOutstandingMaturityDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/ScheduleOfWarrantsOutstandingExpiryDateAndExercisePricesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants exercisable period" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r127", "r135" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted average number of diluted shares outstanding" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r125", "r135" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average number of common shares outstanding - basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://omniqinc.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r110": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r157": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.A)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r205": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r214": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466103&loc=SL6014347-161799" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r262": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "63", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=117411753&loc=d3e23176-110880" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r293": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r306": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116873391&loc=d3e408-128459" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "15", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=13988685&loc=d3e8784-128493" }, "r366": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90193-114008" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90198-114008" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r4": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=51888271" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r404": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r422": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r428": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.23)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r507": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r508": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r509": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r511": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r512": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r513": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r514": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r515": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r516": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r517": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r518": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r519": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r521": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r522": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r523": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r524": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r525": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r526": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" } }, "version": "2.1" } ZIP 70 0001493152-21-028718-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-21-028718-xbrl.zip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

J^O45=9(F\ M'E7<1&0E]IJ0\HN01L9F)K=#.N2ESRK\L3_'2YM5L7+0Z.Q)C4Y3*E3RNS+Q MV;W2:1^.[$YLI;Q*:A9O)-)"4VFC1ZE\1?D3_>KKUEG'K[[>WM*Q/]B?#3+3 M=$(13_;Q:*I?KL ;$OG=@@=5=)\GM.RNKV7)SJD[.C=@1 .=8NC0P@;V#-]A M\/3M]M:^;C!"4/ E1^R:22=]78_6*5)&"O_UDW.\!H4%E^BP!OI8-I'-'VY MS5*0:JZ2V62?'-'N;*R:9O%Q<)0T&MK=]6_#[?W*'.&OZ1>4J-M;9+TFMG:[ M"W9VS#JQ/3LC>WH_W@@HMRN/R :G\921V.YYZ\#@A=MC^JZ'NC9[C][N'/[: M/[B_J98KHP#SU?1"C#F@>0O]F@6+=OA+4ASQ^;5'IP>!#3]_VLZ7E7.E M4GYN:)JNR/0Z[$>P#H% /U^'0K__]4DS?M]JNOCKL.IYM+-7H90K%NNY2G'6 M>;1L%7*!)B@ZZNC6> MN(7Y.3V>HC&>Q]H'CSIH^#PMJE1&.D5L Y=4JW1'[2/--5"[UP@P9]QZU.+Y M:HW>O\GT*'.LV[UI+VZ.YU[IY^/Y5%LM99%.1Q@<% M\1(-MFLC(NGU52Q K>15"VCCG*PZ9DM0W.]NA U-QT-#>?Z' M[J?1SI=.\VMK__*XM;W5/I :IQ='TO[1\>7%T<\6;7JY/#^Z.&IUI-:OYO'E M/OGAX+Q](C7;)V>7%^P,1#HFI-4X/STZ/>Q(9ZUSJ?.U<=[R^+3H%*00M3KA M&;NXJJ>>_[]7AR!-U_'PLJ(9X_@7%R;Q)Q\$=;W!=AW*5<]W/&]=^ MGWXM.R5\<2"//.FST? [SV&>M'CSS=O.]!)4IM; ID!]>6%'RV?Z=P=?'PK- MV[B%;SY#Q+!>*Z3?%TA:,9CFN]JZ^MWU?#8G5C M\?IV'^,ZH<]"3&A]?53QC"++0-J[<7#]TCMZ/"@5\H^_?W3%RDRG53+J#^=M M!F;S-DRM30O5S[P]8;OG7Q4L;7^[N#18?Q79,ZY?^H>%Q^=RKU;HB#_PO7#] MHE?[WW&OH)Z6"7_\5]W>&I_;P0>]^P.2@PR"UI$$)M1X$]-&Q^5V9XZJ'I?9 MCZ(D?C=N+SAT;6IHFG>*\53K()\F.NIF4^B!4=M;S*:,AQVPYHEGO]K?H6J3 M#36@YH >6\>/,"1?51QV,%]@S R= 188MD-O,>JB\ KW)Z<03(S-H6>&\<8! M=@YKSB-E:K;.C4[/#-8Q&U9)3_K+^<]@U?[!^6 SIQ[,O)TUGJ*SO35Q]=3, M'&\Z'3W!D3Z*#<2Q$6VY(*S@='!&7$R,"*)G O*A/Z,[291MSO.L$3ZLE2;( MU_&7YO5YT&);6N:,:;FMUQ[C6./Q16*+PYI3=.0\C-&)>(Q.%<;HO%/3P\H0 M^= O?PZ\IS("9[BS4C\Z\\N2S5;K/@?&<[*37;VS6W1D9M:+,C/6F=(E/?[I"/6N=G0=C/\^=[4J-#.SN(.-*19-,/ MH[?$;O>6]=-[LQU9+R ]!?:1V4/$!L:X0\WK*AQ-E0P>5TR;(!4=DWU'X-A6 M\N[&,T;^/''/:-*C:AUO7+8W_)K-L?%-2N!0".GQ\JTN M=XVN"$N;WCF=;^]*BH%=R7(W(KY\J>RX-T\'][^RL//X>7_P^T?YZ-?S">&! M]ZK;6^?CR8H^O"1H?HMD-T&DG\Y;=_@81N+V6R/7W1LS0;A/%UNA^46.ZB.F,"VM(1*R2K^3H M.K,%Y\JE.4F&#W L?1A]Y2,1W"\QEY+'@X*Q>QAT!Z?=Q:7?8\*EF^M5OBK= M#O^ &5[FC$1%^/O-W-%[;Y'_5(AP,S\K]BL$G?JG^&A E+)XV@3! 1^*$Z1G1+]Z 5=9D;W7)4Y2)L=N^^@%E X2! MLA%U$70QM01=!"$53\L[>F>L>##1)[CG:1XO6S1'Y^1F(VI4CI:) *I8 M-$X7Y8Q"Z+G9,70O@ER]#QN=M P#X)W+?)M6FNC(R\;RNHM M1R'_BQ])[91](RVUO#95G[Q01VYN_B3!=8!WW:3IO(J+75UCE$*&-#YMU MN_QX.X\B@QZ9[)VI]*KRQAN5UV6E*V(O4E: Y)^K-?- ^7&ZA**(99(?::D4 MXN-T55MGYR52MZ-+#VKT3M0DRVK9K(;HAI_,I7D98._D,IYWH4E]Z<9FX[;( MY;1(F)V;R(Z$\:JZV-*S8W#&M]9[E BKR]+WWJED_D%E-&/L@74TP0A2-I"R M@91-U)L13@>MV^.R[M69T+(_;DS\CZC1>/;.C[\;'#E*],9';D<#]!,)@ MI==]GE1*?M7:#3LBBDUKY__QW4]R M TVW^0$W1'UYFLSRIS7SK=#H88'LM:?/_(.JNZBO&#UVS#- & @#!2?H(@B: M4)KRM7R-L\C+XNTYWDZ.7T5O@0/W8 EOKLW\[ATZ%IEMZU\]S]=P83PV".]$ M<"JX7Z)N(^],J+X^].H3R==<&G]S;5JC2#?8V*7'SM+?B('"9)](C1E96GI@ M#5MRWVCY2_]):KN!V!&KW9YRS+>W1I9,"1K8GLOZJWQ@\)O3!_DFUS_-@%A< MBI8@M0Q1'JUDIT^!JKP!.MHHM+T5>/:,"X*/4^8^C!63CDX1#X0S_!#"*-[E M9U%>2!X^ IZOY71WRSE?%I1G.>Z9ID%VZP$W9?/1&"7!$< M4>J?+Z,Z MT[9 _Y!4Q\I!S.K=Q*S\@:.EX9,8/E(4! GI&5UY.2G>8X2'-&!,,4BS(CW7 MZ.F&,>I*)MZ2CM&K[=L\Z:>=L53LGX<4&K1_F$LP'C^(;Q)'IX8Q0E1Z#EP@ M?;'@&4<]7V\074$$5B75\)XU<_+=4'DUB=U$@E>&Y MA4I@9TRW5[[:X4?]!'9CD]IIEDZ:WM81+8NH^C35\<:*GD/&>GZEKLY[:D=] MRLQ/FNJC8<>&H1O+T?G])C5V _J!5Y3 ;43<88K41DK(,%(BXI$2-1@I 5O" M>+:$(E4L1%2 M^6SD7YY-[7GU5_1D<7:J*#)13W=XQ94?$^-&VAF]V\3QK%Z8-YA!F KY3I5T MS-M*08)@C8BF?X ]\]]HY=M$)X!FL=AB$%;L#$F^12>.ZT0QG3G=29 +1#+- MB1J\\0V\RCY^=+PW??RZEC6Z,P M_-]5O@<=?T^_M;H*>Y/#ZKU7%='& 3#!Z8]+( &R0<(2V(:K_^:800$D$""! M<'/.LU=C4)ASS)&C-1>7)$] 4.4;1JDBG,2< +>+&Q /$NN3MYJQF@TI/0%4 MSR"5NH1)V^X!>^>1Z07MNGMX=*7.K&@+I55^N(7,D LN:V YAA$E*G>! \8, M3T_F'\R9 T@V?K0Y<](::K6N:=V3/CU9=M3&(4,:;5?$43V<'ZYI-H?-K3AK MES5+"VM-&DQZQ]1-FF)JM(,0)R =218U0T'"9$BZ8E+/ MA+947PLMU.(..H=.!NVH$SUB( M79*]&M-^)5.T%-=QT( Y)G&!5C:3/JZB[.+YQT#F 5NMRY+:@Q/=]&V5P;=L M35DYK 3+V51SJ,0+**(%%K=^6"BDR4+7NC@$9CX0>\@XQ,K=7'#UB$7[QJ) MHI&%+9G5K5%_JL$A?=^C?^5;-LO8V7VBN9] M =SURXAIS&G\@*16Z,EA1JZ!NNAX)A8R\5R@TUWF&#\](8XQS>(;UT)&(@7D MV..,"W/C'2/OFW4\1X\EJ]1=Y:86YFS$?TW <(\E1@01):8\C*W@R6O,'R),J2I$EJ%$(,)]OS80K5X MU=V)3$)PO$;]Y#28P:!$R/3TQ+0^XJ"T@YVE,:D^ <%4+:(+I))BQA@<&U"- MN)_NBA_W%4VT%+/,E$D+N+[F^[6P M6"#-(="CDS;B2[,1S69,P:*6+1C]2-,0:;HE<"*FH]&<2,.S?)_^")T-L )RB:@.U)H%UL"#/UTSLB!@L9-13^4% M$2T&72 K.F=!MC'(^1 3S ,8'@.]E#I]61DHO2F$/V5T_AU^9)JD!> V8Y> MBA8G3%0](04AAB(8+&IQW;!@"28Q=+NBN53M"^;=>8K_"I=!JL:Q!4(\49B_-AR7!/7MKP"VHYA MER(2<3 #C$P@9F8-I%-[' HJ;,J&9%G@H M'GK;T;E[#'(NQ3T#?7!^*J\A<8*;5_:E'H@V4IU*<8WJ[!H@@T:[0TU&Y\@: M1Z8)%53 =X]XMW>\.S3$HXF4717KSW@(-GB4>UB7INR,H:'.+W]I$YC>J1D7 M@)4'B6,XN0Q7?X=H@?HQ_+5O3 UD_,L643M]1=$(%H*O%_$[?HJ[ M?0Z^H,)%DK4Q)# R)GF,C/E3ZP'IYVRF# TA;>"L\L!R.CVAWK.0E2O1;TTA MKDW6-Q>QP_&XY=['8!_=0:"7#$;V?B(R..B_79(=!S,1Z%5Z?(&T'H*+\'CX(1YE3YO6 M "9/!E!2H.$#'P[)>'7HV( 'L4-% 5PHP;AWR!$&["DW@08G-"YK&85LNQ20 M'B;F3$L.,$*-T>[Q2F#JO2K!X'F"7Z0OX$A1B4#!<1B:U,#B%YT)3A+$;8ZD M;_@D&MO\4M1W8VW6!2P$C40>YL^C0\+J,=R*6P/JS7]IBS:6F@@5E&;:.^+] MUFMDJ3FG)SIK!(Y".Y\8*,72(Q!>F##='(F>@ B:R]_YI%YG/;HEFBM^V-VX M2,XL/TY/T$-$O<$SK:S1%1OZ! -YYH*4I# '$B?&T)UD<73%>ME$9@Z-EJH' M >$NQ.Z-I7%B?S0<)$QLF"P@^'I1GP11QW1^]M([#'Z,$B*E-N>GCS.+](2 MH5TF1ZPY1PL 0/^2M^+[%607T>7ZRD35=&HW56B2L]3/EMS'Y#2] MS530 -M'FH7=57B2/#"XL6B^&G"#F,J$R>"#)J\E3+$-H595'*%#%H&#ZMOO MDJ6;YHN8$>:80^7U&O,*Z51T>I(EM6Y0EY8G9H2!@(8N0Q0Z&JFR&5V3;>2A MKM'Z',B"PZ%/? _&&=;^%M^DTQ-M%8ISKW L'[>&5W"T2.K,J:@*R\8B^&M" M/8:20@B97B)/B,YHRD2F9>@Y!!0)&?4R#12L+AFB5N*0$5B;'^"=:GT8Q8-Y M#:8MF3[SB(]>:'$E583JJM.3/&@LNLI&1QGA85EP&%UR&>.\@"5C<^H'LXIQ M&V?<@)!<3_4@3<\")7FB>GWJHET!PLQ&&2+F!GLL>&H06R(ECCR1U#L0J'($H:QA8U1'\FY6%L@Q)'$@IJ2%6H-64@=29XHP) M2?C?V;?P_9J.9U]%^K#S\PV>]CJ+W,^DM]SL.]7;('#L)VVVZ9WZ7I/9UUF& M+[[U7L;=^EW\[$]CK'3>S_&&@7Z-+>L'B9YQ@'@7K#5"U1?1IEB37$V;0.D\ M CZGC(BC!%M>Q!>"9:B(9*(R%6E*/**:<^,;),CA"T05$HA2E9=PEH@EK[UK M[AP!CT!?()U2DA%?@8L[A%L_$C\D&Y)H7I-Y24B+Q0O#*R=F(C(6L*2VK-6B MX/(39#VJ:(G8*NA-)*)X6)PW);(@M(LL608\LD&;"FA<3H'> K_@:=!$(!K^ MIY1MY/#'R#]_4X<1_$KBD53_Y*'"";=.%'EMHAHK A47+L*[L2KM K6Z#1K MRC,X;.G-&H(O"()SK&A0XYTIY0P:Y)P/DED':XU -%0(8Z0\)ZAE>T!$JZ7( M:&EJ@S-Y0"B #8]3"EPCU@C<+H1BXT]!: M; E\HK%L7YRN>M[H]!6"616Z,/],LD73"R-^2@I:I++$>D0M[HDV MDYMK'T;]2&=^/B79"B^ZL,5SWK\=]P>!W7H6* M,G8Y80@,ZM2=9M1=F;P/;,?6.\A8$S9-F3@0S08:CI\IG<[D(+U;:Q0(Q(X% M AX7"$3"QPJ! _(TH 494J2F*C+ZV"$:&?$$D'^;Z#VY =)6YMP,!9.;8=U' MO MT9..N%7A$$"0F0#/D=@.DI>?K*2:%ZB2C04;>"9I"RT6MN9(.1P;8F-GH!RB M)-P! ZFIDJ+6L'\ D<2 US1=^\P*L"D 7D&$3&M\!',,)&%B(.L^ZG4V2WQ6 M.[>)NU9)"#P#";_.")*X@-"1FR+56R/L @]]4?5C(YJ]M=."'HJ#VUA0C]=3@#KD<,%S M>'HRFJ@C2+&EQ6A]'ARB)D9$(HHXIJ=W7I5D](C%1*UY,C=16"*%Y&R\/*EJ M [%6'@2+3/867S$:L1:427N<;2N3\:6"A'@> KJJ[*#OA,/FL(KKA[S.WO.3 M3"T]Z5UV^6"= &)4E6JS>'H2TYV&,5-V?\<$*@YG[P]D?F) M@$>4(I(3P"4MX,8RV.XET6P[SFFP2L3^$+?#Z=S:9$B 1#]\$XT80;/F#DGP^C\K M$F?"J5>1A,+/SQ_);7ER5X'<]"J57T=R0DZ^=N UX4P,R>M:.#LNS_I:O83L M$]P0\W]GC_8O/6-LJJ32Y"G"<:IW]XW?MF\\LW"RK%;MFKD7=L6,_W<3 Z0?M?V?G"<1,D-&/WI,\0^U&H6S/Y'D19)Q4K8F M1J+<$&9*TE@8C_-G)L,)R5!8!L22B?O5Q3'.ORGR*J29:EGC&3I(*PRF@F0& MJSRZSR0KJ:=I5M+!FEU<@A-(&1-?O0+/00PYM>B[>5@G4Q>95;!F6?%=GK5L MPCYBC(F1&M "]!=GE:XTMF'7>7PI-35M[J4W\"Q%?NXFTF]E M!!G\8.9.1C!L86QY)>D:,Q8Y;=(%>(/>T^&U/M>%I"ETP1 RE'!UKREW7L\; M'DQ)N#%D#!@@(WLFG8ZH:=T);I*..1+,W*&=98#S7.R*)QJ^I$W?9MN@VG8) MN)48WR/.8YRLIINZF$QQVP0,A"T0X5$T6<:T!H#O].$+7>\=6YK"(Q55PI%N M0%Q%Q7%"\5,B\2D<0#;4($X /8CB*]C1[I;%_<*Y0H,!"2["+,"_?Q.@'Z02 M$2CU80Z%-^D4$5V]W@T[1;@K(IV?5A;Q M5R_5FIS>>.;:!'0GX9-+E*C$2K&^JXIJG9"#@U,'@.T+2@^H)RR#&LF_10/# ME@YB)L4WCQY!K(6XU5IHO#]\5M-OUXJ(M<6N]8C/\^'OQ!'?QD=([,X[$I3[22;12R]S2[4!_-)\I]FB1-"K_'1@<( MDKEMZDF*;SWBP4'A01\A@:+B#A]V9K*;E ,WPHYB)#PT'" M+?./S#G3EKEM? ^H;N^IV&M\QO^ (8[H0>4F4%!=TMX+DM89*)#LZ10J+)IM M!A>W(W-9ON8SZ2A?2XL!#1+&'8.$D=?9E+^L\H582;@3SO[@\&"E6<\VR]5* M8]=Y#/1+"3NOP=6SS9C[0\AM*"DJ\<;*DBR>XVX&4.T,/15L3%Q6P8"3%,A5 M!;%#+XK@B]"EXR]SDP%K^O6\@9QTC,+YGOR7-="EN;T][4%3$\1W>RO)'01;KW%/R=+,+5[/G:>KX M_/P.E&EVJ48>P9QDS2]%_X7>-$M_#M.3R%@*60&Z9U\O@8FPSK_80 M8;^NVBG9S^OB=ESZ(LJ5DNZ,.(^:O!%P[&=_HLF+B),[@OUG,SKX"Z3!-@\ MTIA'[NS&R!W6D1L=4BSR\Y"[EHX5Y=YHFA^^>X[<81VYP^>1Z#D"WT$@=RQU M$?4)N4-0/,@:TD#?&!JMLPGM&DD:;-;&;O)7_W62E^9_:ZS9$';!V'N6@;C[BL\3VFERQK,T3F#-N0QAK+=[%2295Z%!PT2%V4+H_C:4!XJ: M!HTA3!-1-/T=2WW;NQ?=#'YU?<=[8W L 4.5U1ZA5BG<)\7'*-5/HAO1ZBL MR>1LMN21" _[QN6V%>&L7)Z"T$1+*R(_N!&E(ELF^1E]>>;I)KQ?K2! =%.5 MQ06RZ42GS<%4*O=*J^-?WBD&7I'-XHZ\H9JX8TK>UC1#L9YA./K3C@ 0XB]( MH$,L;%FCQ#-^+/'TNL0S_%&[&;.B1O4SH8>F7@D#J=NWFJYKXC8KJS!XTR>$B=B5[$_=0FK(HIE#N'O Z^RZ5@A7 MGJ_3)3&HL<6$8VPQ^CK3.F^Y6N'F;I!.G/W)M1KE2K'1X++Y^U:Y4880X[%2 MVN/)("6QK4Y D2.T7+VKE.]-_9-QV1AN8:Q/M>=[JFA*.RM.Q1'_#<,&\F1* M 60TW-[F8<)('BT4\4!9XKF!-,0UAM!2B21#T!+$D-Z\BCR)-:JB PV *>F] MRY4O&7307V!5,8[#F=HK-I!5ABY@CPC!HO5>5WKU$=N)@.PC7"K.BJ_UGO;T M.4B31:L@Z3/Z]J'OFGT6O;E)2HUVD6LJ6=P)3&0$+&J7T%+]=23'Y!@5YU$F MSL/1:-HD74'@5KM9/$H$0]PJ.G$3[1I=5Y:=RH(D9V_.&IFDUN<0N)>;QOFA MXV/B6%.^!V_EF]+=U9LEVWD.(*M$]2IX.(GK*!/7Z!."#16T2W=.KUFR*[>9 MUC%=+L?F,ZVC<<>2@5 X',:%K9;AWZ8V9=;^A493.3/FS>-6PD86F ZTB/N* ME3'9:F.MC)]95>&_(,\KN$U_M8L[!--?L5X9?/S+9C(E,:.T;GBCB+2B3QW MC1LU4F?<%BDL5^&B-_ +(L9B55)'5++:LS_I,*"D8UT A:%]C!'*4X=#1:99 MIK20F';9@4:(C LLJR&V;TQMPJORK$-H'^!X.=D>WP&[.BMQC,N<, M&9'24D$?7P>WM;6 _XB[]8M"%H;.]L0B74P-UG(@.-^_SB3O!H7RZ+IC=%.@ MV^)XLJ\Y*(>L'84906R-]][!/OCT@-22&J.)Q,42BA@AYH.I(@0YRS#&!!?< M\WKK+5:HCRY"8A5Z@W,?R$08PZ0*, FZX#+X%?\;NIGB@4)X1*C1DTW\'B$% M#WP(\X03\4(H%.'QQ +FQ^*K< @TT9EFNI_C[&5--K3HAK6)MJAO"_<^.'/A MAM@-_L%J<*:IP$\ADU24W8VQ6/LHS_X8QF@:.Y=B"ZX9@L/6L266:3\\LFE) M*V8RJL1JK-ZI%]PMS#WM@VT*"GG(/,.+&)C \PET0N1^6G,SXJ?X ?1.;!K+ M,I" Q@]@U:MZJ52A?0;2[LU0\L(0+.K[7ON= M2G?$L/6Z\2WF\Y.2K$:,QBWFG:YBS'8;78^#.F^)7C"W: ],NH@SS\0F7;!] M.8?@;ZHBVKQ#1!1C/9[,=C!(CNI0ECZXIMCIR\I Z4&'=2AO!1K]ZBO0)P8( M5,"U-I(@49HS/X7YDA:?I(_=H.P"YO4!OR"RT,Z]91[<0>MN,1OC&&?E=-PT M9GHP+G/%2T-:K6MMN0X/-3_M]&3Q<2$[2."%"4N-KM1R+X$1'JEV'Q1@^;K% M2[TR JYX7XRB)L(Q]^P(NC+)N)F,65AN+ED)M/229X01C%&]9^O9>^7VZO+# MU&#*J)<>Z?O=P"7@ EA.U?R)B;B-[Q3X91#@@3I6%WC#J"*)V?WXH]?E"4T4%-YV* M@.QF7-?3SJ61,!QFTKG(^YS:Y,[3XV[93O%O=(S1Q0-U6.Q6-FPBM$3X4!-6 MSP)G[5RHR;38$X#Q3)DK:RHO#K /Q\(=R1V&FQP[OHTOL6FL*5!C#J]&G!<) MVI"9I85HFU/S\ 4H+?U$R$?8W+(T2H=CP>E;!C)-R.H177YI??%#'%#42B$V M]TH_K:$DN>-*&R)JJY&J3.I"]Z'!SR$JV29']LF1C89(IEH(2TJ*@YMALA5D M3HB<0O^G?TIOPIFV0_JP">7G#_7L3S062L7#H<02"JB4&]POM,W3$WH[$IWB MNSCX.V1,UB3&*,*\5F-!"7?!RN:0S]PC,H@(5U.2PWXN5\BFXD>$6ZMA9LI% MOTRSYIYOBZ X=#U$-)% MU+^";9GQWWQD.@BX5.[GB"C(DWS6UBC<+TI(GJN+*J_N5_\WW8Q MNV7J]]H:TX9RYQ K-[-= MI" :1GI6S$6H $_4-8<&^OPGGH;+K$5]J-."J,FZQ8$ZLB14"<:;X\NP/XR$ MMA@^)'V3.K-PK%)\_IQ%'H9=6\6:$PA*C"A*J/IB*92VP@['K2_!EN1F\F0[ MA &_S]+HDG5B*(UM4#U] $U^Y]$C8W1:)'% I=M4>2@K*/!3#:SO"?U;@+\[ M?B% LWX]B<;;O6C++C Y)DO@8 U+>S?:[,')*-[)R9E@=_8GYGQNY@W2 1"0 MY8XD#WS["SNIN! L_.]_L&?J5_MOD@?$.L7@_'B<0+G B(V701].\A6]_/^ MJB-=E3Z2GG4C].FHPO.J6"*47$Y?1SUHZS6"T7YZ0ET$Z!@4/=O SL6(T!@I MKY]*AV0!+Z9YD&E,0U["A+*LQMA?EQ%LJ\"C/>D2[>;K^NGCLYF.SUO@^W,5 MS2UR*UD4#V7D/%VC7R?SB/7'2Q9.)U1XZ&\];9&UT".#A-WK#WKU4S'W+'5?6 M$H(;^27H7C8/4(6$SN.Q4"3NV"@"IQSA2>A+K>4=9](A41>(Q*%%?!.:]^5\ MHY7Y^([\Z!2X#='/4=*:4^"<@YTVTM;0:)D/"(;7D,DT@C28@+J,9]C\;<0; MQN!@U-!A<&1^"PTX4SG)DWG><^*2C4&?)X/HCXS;+R)V0@J_1=\:X8=Z_# B M\EYCZ,I(_ 57)HH<=/,:D\:S-H9:IZ_ 2$DPS?1,6E-B":'MT.F)-.:&:">< MH'#(\I-DG$:#A\6WI]9DYX5"*9NWDH10(U-FS U$<')%DW\QIY>IYH6NA5 4 M--RQ)RF+'MH8(1AVI0Y7XU7<29=Q(*:,7G"-OC(9V%JO%D@X/HE A6P%SZ'" M)BVP/=*>=S@:B&/12KUTA(K7Z)P])MX$S\R64^DY?YDB%XIS43" MW:WY#SW$462]Y^H#(?-_?\_OVX>QIYV^*$P@Y;,N=I2>C!8LE*%1'YYF MBR6SSC&SLG!+2S(1#65A@J,H-&&W#F7)&4MEC[=O>IU]I(I7[W)#+*5B :M? MMA8KYR*O,RESE7_[^GYY>Y3TM0J2-AKPT]\<.E+$Z1OYJV*A=5ODJB6N7LQ7 M+ROEEV*!*V7+=>XA>]LJ-N"7;*-1;-(RYSKZ.5LI<+?E;*Y\6VZ6T27H]]9= ML3!7]+\XZLM%@R+WL%S=RB@=_FOEI"_22\EFV!==J]YL"3=BHHV1OD0R#ZVM M#(2S/WIZ)-9"YV*YO[#?0YEHB.ZTOTE;HDU>8CN: .T80/V_,R3"VG]MJ_HN%X*!I+AZ*)Q-_.P^92R;_LFFN1"F>Z^'E@T5NC?SF@ MS5Q7+ML7_)_30^=;>&'-9(OJZ@4PK^?"7D16#S+M$Z%P(FVC MM"Q!Y^J]$P M;OB]LYT.DI("[>W25*I0Y6%!MW3B*=U\Z$8GWYN@VV-?&HLV.+:X;+H2O<\* MTCAQR0G;^U*$LIL9;069:\3!OG-;L 0 /9*V?D;GG;K%B(B!$3;M5"S\L<1+ M*G;"6;#DIC/NU[47M2I%O65*?^!]1E*)9O8M_IIW%A3]:P7@L50;9O,/0G\P MKC>,)(._/3NQA^M+(CLNE M2J%1?"@^M+Y+Y6+FLERZ+MV',U?-]P%?;]WWZN^EZY:4>[QO?3_4'^YZS?!S M[_ZATJP_U)%:52JT'AZN6^\/1?2Y6L_G[AJM4K[1^KY^* Y*K6DNUXI4'IHM M]'N^7WQYJO?YQ^_932.KM"Y+TY?'1)B_? CSCY5^._^>W6// >^)$/J'"04+8GM,#;&( MA=/5\J*6?DL,LV+:0WGHH&4N;A+6!4UY8&&N5-7EFMAZFO0R?%SO2:YTMS6. M* !HFPC%(JNEL^N#7HW-*YJ@6>B[J?*RUA55%=!9:M+2VN'8P.O9=-DYLLLXZ-EET0T3']^&19 /1E2FRYE-<8?DZ1Q< -(_$D(EB M%\]T<43KX/G6K'6.3_DE=%=?Z/$^ERG+8,UNN&$#UW5].FW76LN$IHN.3=#. M7+@VL=$M"T6]+$XCXZ19N;\G*K;4E!X*'[.KE/IN3?]<6X-:0JD>@L!5@,X7 MHS)I5_:S,WQ>RT5 >K$:PPV\H6X#X^W*Q#TY;E+Y1*XTEN\'WHMJ].7K+C=Y MD 13Z?<"Y )"!@YPV1LQ(/$63WGI9/&4OY=EB'TKZM1KO _[A/?Z@GU ]&KE M.EQ0(^7XM>%#T=\7#/0V+6=/^!P/)2,'PMZK.()/H.HU?A=VP=?Q!GQ =.TQ M^I;Z:.>S38.CFX$5#%Q?!,7>D!Z9XIG5)LI^>+CSVVLJ3"@?DWX_T#)B!)$K MKRDAXA,EL-77!CQ" J+9X@WX0!"9F\^VTAFT[RZ-BA9[Z 6#-!QALS^=/[8Z MRKA+6_U2401H5>PUMB>7!K8V/E"V7!]P6V@^EOKE]W*U:F34L]>MC\U.SO^M M=[X_!3V48X8JT UL <-\.)'LC@U@H$K.K#@T2LW<=T2,FFR2/$:0D/%C08NKN M-XKKOPNTK&_<#Z_G.%.>7LFYC%Q\F[.1%P"^81KI'IQ'.L#V1H#IS&KRVSJD M[6?(@(PO8K7S'L;&['+-O#AUJZ9M7J<((0)"\HX&OR]C[V\OUTP!4 M>UT1\WS0^OB".HQJ5[%*QT2=B_!?3IC>9SCZ",1]IH[XGQGY'US3 M:C^?Z2V*QC>18F[?X.ES6TR5*4$IUR6R6%#=JU# M*?>JOB-+GO0Z2Q5ODD_*^.FE\!XDR,\5[H]4!2\>H3$_$? (8A5Z:TQ$$D/E M56CH ,HP)]$6%J;"I#XO<&U1E)%L[PPF AF)S$K_083SY($P04L?,DBG+< J M2+L7Z ?!P>@L3I1QV]&%(>H>-VSPM_2]^#J[D0?]E]MOJ7MEU(+57K=UFN5-\68U+D*B)E^[[ ,.P?#(GZX&$S MBF @?M+[=@<6WSG&9@CJ'A,=%X9__\U! MHU^IXYX-N'V>I3?.?W3]=Z%+S@;KQX(?C9UB40W:>KB H!.E9*+-N36=G\J&LK$5Y>,N&[: M\A,A'R:0)Y\\@GLR&8JXJ+C>LEF.7;#+;O<5<5R6D7TKWL*@&DJ^/45MYOJE M7K:0\+5Y#GCT)/QV[M< O7_35A,+R+*Y%WXEC'RE4)A7@KZ;1YD,8H6;I-4= M+#R]H3L':*9"Z8W*+.;C$6OX-/.WA,,>'\]&2D*@0+ M=/<%>]#"?;B% M+(^VA-0FZ,DJ#4<(1>A(J-,3.C%.[S3=E61>[DAX?"NZ!7=M"[3SS]&1+7YC MC^B?__Z_\W.N)(D#X3=7XWOB/^C.CXDH=Y#F&$G\0R9/HH_<^3EC)@BV[@T% MLC/]BB1$R-;SM[GSHC&=5YJ)!#+P&D>S8*R,["2MC40.SW?T8\9"Z=P,.@:T M?SCHTOV;RZI\6^K\PT&"-@%L10$01J+FN_[#;H.?#(;#F,U__X- ;0=U5>3? MS]LBH@CT\!$^-0IGM#$&9!T-3\SMY:Q:SRDGWL#B(!ZZ7;_E.I-HNG)TG< M]SL2^6>N(WXZBJ1@=) 5R^&D_)8_^Y.O%POE)E?*YO6>N+A';@5WUB6_ZCRJ MO>">]Z6U-/T2B0H1'AJ^2$ARH&2KU\?VB.09-$ ?H_]Q4.O'0P]^#N;$X-A7 M1Q4%"4:#(P&HX($H$&&#<6(#F)Y)?X>?60;:ES3N(Y- ?M?PI40XL@":1/K; M(SF.)+'(34#JJN]X#">=CK2;-N>'>LYVQM87,;8V5J].3_# W&@XD@QQ7R*' M11F.BJ*3XKF2Y>3I--PVTY/8 ""!L).TOK08)\?T.G*M!6(JG?;F$._*8P.1VMO3V$?0W[**6V, MV!IPTW.TK2%3UM!VT%6:2+*\8&>\QD9%HA>)(RQL3T_L7HK61Y9\P=5,(Q8 M#+#_$/ZD3,9H#R0T/$+@ZT@CM'TR8A+O1O@$NM#0,A$AH+500/%C#J81C]$A MT1$ 2",]/4$25T1GLC"+R9S,?8N(MMK-8Y"4*$3N^&]I.!GF%%7%L7-T#NB7 M,>UJ0>>A(_1-Q2+NAXKH*)&5!880:PYD(KNE6&%""I;]TU'?\E>9?#1;;NO9 M/[ _,T\:DKU!1)5L#B:LX=VM<@:M RF[K)Q($N8S(9#1K!PW &$S=)9NW(-9 MZ,F+1<\2Z#B6/O.;\0HZ2OV"X2HRPD3U4R2,'JB]KPP$C9N,, W;3)%CIV^> M^E(G#Z&-?A8&W@!NDFAF +%TU*FKE?O;^[MQ;VF9F_-^[7P?!+O ][%O/%LU M\\:I;^QV:/87'L&+DVSXCFCBF=30QX#3AW$(9 P+Q47V,\)1K+]8HJ)D(CP@ MZT*R#F':;7Z E143\SX]@='R"WPW[,!W+7R5Y3#2CG;YPW:RE')C9.@S+ M*4UP'2?9$OZ1N+!+X"7M@"D#P"!<.A;0&20(K1$^SY[$8GZ0BU2>HCV_0!(^ MCT01[7@ DOB%XZ!/!IGM.&KH] 3A[TCLP 2KP717.K#7NN1!*\(XQY"7Y0DX M_&A&+J?"4%6LQ]+S88J>P$M(9V;3X76^T468,^(EP5#OS'H@6JNHZGHB]PML M(CQ."D^8PC->T4/)4+K3$TF#;C!H-?255%NNJ: :UM'"J,8,;WT$+QE2U=6> MPN60[<55+K(7W&B #*QY,HVOT!A;\@0F#U+M)Z\,A](8Q$M)%$VCA0])3!M+ M>>!5G*X-T"./,*:: %CA>R;;DX5TOE%-M;O1J .',ID=$PPT7?\,@;E+X<9U M1='%Y.-EJJFK(]F3)L$@^#H'0&\TC*B-,FN,6,;X;1 . %JGF'FT+_WKT'YV M%8\H%379NH]'CACLMRX%XB)<^A-"@R2@=ER=#!@ M1]'&$+SJ0+6G8/(46*5)B*:S8P<&# X$*8 .3KO@FDS@ '@E>2+BR84X@1WM MO(.3YD]/Q&X7Y-M$'L D#_"50,4+>:,HZ3,*I\B\0R^/A9$(G&HT!@8>#D7E MOM 9C$49/!82;,AXL17;8-0JCM>@MR"Q/A.)]G2&R/P#) ^$6"?-A2Y8$H2;DL^E,0N_QD,"9. M20VNHEG^T+Z<'"1])TR(153]L]0S_X(?V/2M*&-1H^.(<&<6&$ZD O"=PB 9 MPT_@XN;7F9Q1Q.9'+5/HI@,:$DDYAD2BK[.VP-=?>HG:1$B<_:D7;[-02%'+ MUIO/'-S=0)^?L[G;X@\,A?@[)5-'EVG31,E+QV#&',9@NGG4Z^RY]G3_W7X; M7N:"A8=T_:_X+_T9N_;Y,XO9I?;)=.43>GKRU,3;VZ 4"2YLAU+OM41- M^"PFDO?)@T I&N;P':6229\J%ORL+K#AEW;P] MW,?XSGW;%0H'BQ.:]^)%5[RM)P_[,\)@#WS.BB7C1C?^7!/D;B,>6"QQ9FX> M8TD\LM>FU)H II%#94TN$L3I$0A.RVOR'@Q((C@TJ#U M[TOL5WZ90&6"%%R@JV5:IB-+PVZD+[CB5INU2#8[A\XUL7,N?9_W)4$0T34( M4%'INZT.(K%XYNS/N>X,\J"I<' 0(;M?$;4:$?K-6_E%G8XZ^3Y;8V\VG63QX+W6V6*>;?32NF]>/X[(F1@)[D&NF0"X=ZQ()YC1&QJC@=22ZLLBE')4VZ,7) M40!R(T6%31VH0!Y _4I7TJ<9VO5,Q@RH\5XI?R:N9]^JT4D M8R<^LZA89C6+6K=A<7"P)^45]E"N-QV&GRYSPT+ONWW V.,=7XR[Z,H1M';7 MJ]DC;5I]JZ#O<-6<2]ZXRV;7.5>8O4(;BTEWRE59GMPH70.=T:XY*+W&AKK& MU=P8%%LVFG:S@0#R05<=H'\"NE#N)U2[Z4RUGDG>I0X37;QC?,GT^HQOXX;A M*]KKQ%YG3^JH+TR?Y*O'9+"2KPZA"0 D*B*,.CVA*,6=TX2"':4:_FC@0H&] MGJZ#&$G*KLA^H9C.(S=<)+6&&PX?NMG55O\4WF;7D&KNJRI#[ZL,_Z$&J^"DAE($:0CHT!')O)=48- "=7A$TXW^3 @?C-5 ]P1:" MODJ&]0(HH\\$^AVW(8.4G)$272RDB)(G1JYO<:>9V(HZ4B8%CRA3YNC M8U9\N>]J7R^E1G0]='1:HFWQ4/H\$B;%0_B3G\PEZCMOX=HBDE$RF4K%53MC MA4J4-#1DZ*@3(DXPSD*N-\$0WJ$,'DDAN[IVLY.4MBA@;!UQE">?WH F34S?+J];P.9<+Q_*CF[AI5J"A$H3( M-'2TCQ%9T.X5YOE%>Q&^2SB67W.&RCL35875!W/K*4]DS3;:$X]PQ=">5BM/ M?5Q2BE4G;DYS,KUC:]4ILWO5:1$7U717>+\JR]\?AM/RSG$?^U"O?$!%V_P\ MC(FG)RXTI&!SQD/@WHXBB,XS=CL2FXF/9*;Z_"JU=E;LZ=&^^IE M4"Y>9@(C1^>8UPX2L%*V.>GS$\*M-A19%LF)$"\6NORJV>#*0^A; M4E.5CJAI2,"&N++#NU O@_Q)WBR#=0W0G0B\S98(6VY?$+B=^BYT)O)FK M=KM21R2K*R"5#9JW@#H&+S"4%LVT7;0:NB7RGCRO#A2-N[[@*I*FB;*F]!&G MY'$!^V0PYK'R*>"1#Q)Z%_K[]&3N>=6[2OD^M/*U)N@1%7+9*6 _BBJ.)<*, ML7/E(-4-CQM_&/T32I,Q(I [XJU C+G:7=+78UE[AH31&<2+I[_.A&^$5-'K MWN--+UA10[(IW<4CD6;<9M$XU\=AB9\/IF'P&FWKH.VKG4/N==9];]Y_597\ M_;15PWU?G;Y%$[WTY_UTI>1K^)'*X-4^B\',K#K MV^%%E?G2^O7(_')<)=UL"W>?(Q*9E-\#Y6*;(6%9KJ"7-;_$P:>(W52:"0/+ ML]DLU[D4\Y^9#3#03=6>&=6B?MH9!BT +0/K?)D@3WQ1I@&2:7XH)5Z11 M-/J2*R T(:"S6=LB6:\+)>VGUFY_K;[JBB:\*7RW;O1[EK2 M4R.Y ]X2]QU)7!:GII/.Q:F;G$EQLS/)=L>B"L=20N:_Z52*@Y<7\?FQ5*V] M[Y"*FS 7AH*K36_QIC+Y'',I==C+F/_ MWC&77'B;P"M;^&(PU?_1E<"Y"F20[D1U[,>,IINMW7EZ\[766 ME<*QF_MQ3)OPP4*B*O3(/SV9<\N/UQA!15LQ:PN=F/?EM(^_SM2O=#633Y6? MAZZ<]DO(XMAXV6W_7WRU?1==_:A^F3OI+I2=+^_S&Y0&S9MW8@YBRV6O>BMO MYVI/S/.M_MZF_-IB7FE.8HK3<]Q.B.6%:* M\/+\]JS&WRN=Q%J-7#<*#BQL:^&A"Z5=M'D*4 _@DGL$V;2WV!R" M2/?)]F.[-%.>W37 W &"+&D+YC6")$-Q+Q'$]^Z+OH1W-^O;M(]>F;M;Z2[; MC^B'FAT,.$PBNW+/&HPGZ8]D0CO"3].3)(5*1[G*3VZ>]]:W<",A9=V'!XPG M$8I$[4:E>4A-GN)'SA_!-(\?L>3G<[I5>QBV^&#CQYR,\AP_5NO?%FW[:TH5O MITWXG%;M,R-(A)+QR 9X]_?NSSBVT1E3AA'M5Z]CD_R'^)8XD#/VE+?$[?J[ MN#SCW=FB#LW?=I&T8*!9?![-6-+!2BWA^3;7%<+7TR_%W?@L/S(D'%?L=PI; M*!;=5M7)7]/.N'!72!W+"'O:LWG4Z3/1UUKU1P[58OI"] M"5B(^R"*6Q;Z$.IA"NY0H^K!G\U#*0>%Y8AO)$/F\>HX5@U_ZRU0G*8J0TG3%)54J(58/P^.#)B'6E !RE^5+D?>REXJX;HFRF MIF_&7.]\-RM<-NNYCB2^.]4[PZQ[D6Y@O6)G8_VVIX,I6&\^.% MHO>$=T7O'F) ;_P]?;Z;/3\]1X-1\>XY6JQJP&CGBZ'5[B-#+SC],3: M3OG&>"ZL+9PUX '#\8*"WWC%Q <2 ^(56:#)B/4-)EH;H-:XXAC,BS?6\ M,?6^ (Q)X8X]'N).\7(D9:97N=OJDFX)([HFUL9GJRX^MLU[",:D?&$IR]1N M%RVE.)'O]$.TK0'((!77TT%?GQ5H(4Q$_ -#. 2GN;R-2/(@B_.-A"=S@M-\ M M3:^[!D^CIF/RTD/+E_@4WRLLMQH-46 5 M:&/H>V :< =KEDF43_2.:UZ>\.BAE"UD:*>/N<4@?@9M?#NJR&OB?-L0*FW0 MPY9V+72GGZ;#F7#*$PEC/ /NJW:SJLK+/=&FLP]L5M]KMJ>*^"(FJ.+A9.]9 M"']Z&K(MJ!SZ% (R M)0.)5LD+1TW:0*LV4H&0+&:\C#)27*J0^@=S)61>HZ,:PQ6@_RB3,5*G"??C M:=]DDQ9.62SN.M6>4JZF-]6$_:'7B@)!84.G9F='6"5CYU]HE1CJDCS!G'7( MOQMZO=Y.4Y+Q>Y9HZ,X\TUE##S ]N$L#*4FJ-L:5R[2%)]VCQJA*$8P'+0)[0>ALN$'!A"AX@%0O2#(VK; MH/8MCP[T2W' Z_AU3TJFI$YEM,2%\@/P>AD4O B'KX/4 QYP^DM9Y,Y(J85K M#+F@"Y?%+O,.(=;]&86!M0+_I0L[8L<>%A9TIT 6L9@!+06+9)9[!,1/],VF M/H'YF]?S"D!(:LXEL+ :+/1'JO(I"=@GP(\MNUFJ$)-5^.[M=K8QG16.3#A. M^].C3Y#GKJECI E ^ &N;'1$F4?WVNBO=V1I])%,PE\6P[7OJZ@D9WK[E/!( MJ,=)EWK\RWU9;J\R!P!9%TO^8'5I43X=(7KPK$#:6*=/2! M;01E MWG\'6@*.H5Q0NX?)3JQX4=I7IP#R'H4AW+RZC>:]A1J,,/14@6VU"J MS]^[EE#/3GIHNUPD@9<9Q3(6O7#287=8&[/C83/+QBDXQ^H+Z,5RCTBEA02$ M:"221_95-2E@"4[US?.+'!\:QV,=W(Y_ON._P9AQ@1PI=6M=_E9.)XS M4HC+WB0EF#=J)W4A43-U'LFP3U%=ZMKO!RW_U;)Z_],4$&+,'W+D( Z9:"SZ MD-9\^UF[5;N->OL@#MF\>H\.V5'5^HMH5PN,QZ+ $Q:RGA:_K@*/GFTH\%O- MY+0D<7N&:;-W\3;U4DCDTDG'6-\.=/4U$6I7/F'0TPF6X.._X+(:UM3;HD@\ MOQU>$TF>(URJQU*0@4;7:Y6,DD9';0!N02JVV%.0M@\OUXRQ&W3>A*ZY8R%) MEC$O*1%V$A%H(__P!C3('Y&T/L)"&8ETC798PIA+C0L'2T#/?3Z$-)DUVONE MCNW]O&[O%S^V]SN\]GZD.,.8H+NZU=]B,]N^VG,V5;\OFD2.[*D_P-/5_5XT Y]%D:2O MA4Y1CC>^SAX^2^K#:/B6%J5@H59V?'KBOO&? MOD!L8^62M I$,&I1=@XG6F MU(ORS6-#OAJY;P5H0RK'1H![; 3X#\=:6;"7X]>Z:*AGC,*)F$;A5"O7L>?X MXT>TL)<6@K:;L7F^Z\Z"7L G_&H48,9ORK?C0N9KQ+>]A\_*GH2;@6?U^)Y;CH=7EU7N_>V@GN'MW=5S)["VYZR+?=Q063?@SS"ACC"O-*?)D;H?\*HJZ:O?NQWFEK/!O.QR4@U>Z)66Y M'%\3CZ=MX\Q+L>D\V&B-1]^N.FV_\=G+#GKVL[FP!M5 Z*9.3=:Y+19KXG.K MQ.<237_%@J/>CI>JN5*,EZL>^YX)M;K'RL*!^-Y")YU>W9//P09Q"ZQ_\4EY MV HG%$^MY@H;G90]LUAHJFMA$TV=3XP9GQC)M[>?P[OB1SBUR[%PN!72@OMM MORK1/+Q\IN)X*+VU A1H4'DH64.)Q+9-2.WI);J$7FP[!Y*LN!LA71Q7LS;2/%SN[:8CXN+A^"YI4YFD=_Q[P4W\KSXF3\5L).KY,:V> MU3F_6SO#28Z>5OR82&-<(+PZ?29CGG3H]AFO,^7ELY!6&X5H,Q8L M^.M)-)&P8Q9-YG66C\Z^JN6;^[8\./O3:%;S-U?5VT*QWJ"%QESQOE5N/A_X M#,U@K1$=3:U>+!7K]6+A] 0#_0A8CP +GR!W/'N$J"?Y4@B42M=F5BK.G%9% M[@O^65;E6E/%KH@$LX"9:J//JZ*6G8S[BBK-1($U!+6;XJ1GS.<'O(;$.'X MR9HWKL''G;6^A"7/1P:5U/654KH<1_3D>?U*! MT*:?A!7&\OJ)5BL?R_2R= MW$0?\;IDT>M47NAZ"5D$J";AH]7Q9]3O9&D_.U=>-A[%U>=JJG=TB;':MJ4I^<*H3J.NC@&CW ""D_9T>)RUF: /AJMXR> M_RD)$WY@JH0J2*K8&2OZ"*UA/G933_7&TQ?!\<0^\6N)[J^=N5<,3<< 94S6 M5\_KALX[199O7T1F-J\*F.$)]#EZA3:K$3$7/^;@A_'S6.&BB3""Q'"(D)><\<6"/LV$29!ERB'(/9,F MD3MJ$KO1)'AM@4T5=ZQ(Y.Q%3NVIT/SN5,+%03* BH3MHK=3)!S%S9R46:4V MK#H_/]0&AS.LWQ;N;SYBL6:Q%TBU8?4I>JDV+-46@LU(#H'9F<1'_B@^]F>( MKC);UI0?Q!<(JJ B0VWN'/^Q93R;L+"\/0OKSZ(1I3"[']QW RB&[!?-KO%< M1L56&;M0Z(65[#QG (G%Z'*FC;Q2AEQP()+K3%+ M)DN%>M91D(48&DAX.?-%8]:^IR[ELB][4?G1I)R\O6[=.=KR(8^D,CF9;?%Y M*Y3=E2KA_L?Q^E3GJ^??X3V;Q$,8%.U_R M&A.$V//2>0N>1XTC"_)JKXU;Y23+E2>$GGIN/:C3&N7E\.RP\/L1:$ M,/(' VS=='_KCO:">ZU&H<;P+WP1MHNY4CZO[](ZX@AC%#K3@83$MH#;>' , MO3JB;;N7L"-?O#4>4M.? 2?MRRE_]:-7WW6UT!LNX?$.^W)]YBXVN/>#=[1$ M3:=^L0^T]/ M\ -PWQEGW53O.B3H9*K(9MYET4_PBL 5LH";*3L&9&D[-.>G]0X=M>_^9TPM M3GJU]T6FXYJU.'46FG/C>H=62],XEC$45K=]M(2WMX1=!Q[RF$@U=! Y7I,< M8@_>X72[?=/5DOE*J_CN:$QU]"6%P-/54:41'NV]47C"%5XOX]!S ,(A"WLC M!R\>.F%9A=\G-%;"DM'8&'1(H\(P3:OTD;MLD8H0I.<$0*&+U/(YPY3ZYN,,Z\_JHH5R;+XMRMBDZ* MP%UX%UK.Z2WW+5*#@!<2@NC\.PK%F&FUIR<0[XF&+9,5QRJ/!9/ 3X\!'#\] MI8C@>"D10T*.GO*",2'" (\XS MKBQ#EPP@A-J MTZIA2^8)P:9,!H=VT4OQ_8;'FG,1BJ=GHC#T4"9BM3:X\=C M$.6XE9[^2\B(Y8;0VKJ(3N$34.1D@)1$?6*,\"EIL&3:_982_P57FZC:A#?: MXL(J0YB9T#E0IR>_EOE7,"LCW@=SXTZBX2)(XY\TW6(,A]-4Y*%/L8C9O8A> M#,W=YAI'8K#J4(6+G#V/*QR8A/E:Q&1AT)B)Q=J]$M.E).)5;=( D7!"WV?"=F%'_B;8_&T22*LD2 B:R5.9O*#L MF[-137NH\6I5)8.'<9=$.Y=#(- FK5Q>OF1R?:4LZ7B3MVX>2TS7QJH+(#@D M?N\%8^:<%[:]0HB+S#(C ]]AL$ (9P?!#&=@31UQ MF0GZ)>+4%.J*6^;Q6$JBY/N2HB)1\(F.3C/YN)R4]+51;UEJ$;L];W#NK"QD M*=OV$GGO7]ZR3_=7T^KMFQW3(Q0.FIU&0;$5[UL K$L[>25&TPN6PLL?/AE+ M.E5)$)QG3%)=9'R%U?B(B=X&'=DPSI^'D+UOGK]+9//YEY0[A P1N;(A7MH# M^)#0IYP I[9T^=/]>,#**C5J-2=@+KD3S,65)1M8Z;B,. M(2-LH-OT"37LC1%]P182E2V9*#7T>;#>+42KTR,]-0E:R9OATTVJ_I392O Y M[W]-5K-BTW[9 K'4HH2#$C>+!VG;+91 M9&[.A*TI%O/"%(M&XI2NHY&$)W3Y*HC2^?FMV.,'1M MI%(TL;3^RPAGXX5Q\1"'%@:N5AAL")#EF>*+8^=L921CA]Z-O1+8OL!),PN" MR@4>.YIPAH#Z*8C\,ISUVY7WNY&:#)[M%AQT7BH.;;O9'6/U7J^Q!"Y%9@UQ MJXRAT-*BPJ7L%O]8Q;%TK?@MJAT)&5(NC)XME,O)]$JZ^7S[ODX9X7YB*BID M'=C(_^*!PI'%+[)5;256;/>Y9AJ,QYZY>#243"ZVFO%(O918=-P,5!J.9Z % M\7%ZH@.8PP$]I%TCQHKYX#Q6Y3:/I?F"2;/OWF7I6X[%"S$?8UZ[0HAH*)6. MA\*V7@*)BJ(@C?'[/D4-G&V+\>^E3X3 .&?>#EE,GJ;)%!#5&>$M M\T8U98"S!/@>>E0/9V'W5$738!QD1Q0%S46^+KD0"*A,XV)EA.X2/ZA-V@.I M4^UV12!"-J01R2LZI#&<=J_J&=MGNU]0^:*W[:BJMK1TI&U*+:/;P%-L%;J4 MU2FZ+O?D/+411E#23VFFK*W<@TN6$E[0U!(K7>OH&.$>S8*E+?A&QT8R9@Z] M1YATL!TR&O =@MI\#_[MXKP.PT./Q

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end